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Abstract 
Background   
Sedation withdrawal is one of the terms used to describe the behavioural response to 
stopping or reducing sedative drugs in physically dependent patients. Withdrawal 
behaviours differ according to the drug involved and may be unpleasant and interfere 
with recovery.  Recognition of sedation withdrawal is challenging due to differences in 
patient presentation and may be further complicated by the patient’s condition and 
concomitant drug therapy.   
Overall Aim of the full thesis   
To improve the accuracy of sedation withdrawal assessment in critically ill children. 
Objectives and Methods 
A mixed methods interactive approach comprising six studies. 
Study 1 evaluates the psychometric properties of the Sedation Withdrawal Score, 
Studies 2 and 3 examine the complexities/challenges of withdrawal assessment by 
critiquing existing tool validation studies, 
A further three studies examine the nurse and parent perspectives of sedation 
withdrawal assessment in critically ill children. 
Study 4 investigates how nurses use a sedation withdrawal tool, 
Studies 5 and 6 investigate what behavioural signs parents recognise and ascertain 
parents’ willingness to participate in withdrawal assessments. 
Key findings  
Nurses found withdrawal behaviours difficult to interpret in critically ill children and there 
were differences in how these behaviours were construed. 
Parents identified a broader range of behaviours than included in existing tools. Most 
parents were eager to participate in the assessment. 
The elusive theoretical basis for the existing approach to withdrawal assessment may 
account for the lack of a standardisation and poor accuracy of the current tools. 
A model of the causal relationship between dependence and withdrawal is proposed.  
Recommendations  
The model identifies the diagnostic criteria upon which a definition for Pediatric 
Withdrawal Syndrome may be based. These criteria also provide a novel framework for 
withdrawal assessment.  Focussing on the shared diagnostic criteria and including the 
parent perspective of the child’s behaviours may aid the assessment and support 
decision-making.  
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Part 1: Introduction 
 
Part 1 of this thesis presents Chapters 1 to 3. 
Chapter 1 introduces the subject of sedation withdrawal and describes the clinical 
impetus for undertaking the studies in the thesis.  
Chapter 2 is the literature review and includes a critical analysis of withdrawal 
assessment tools.  This chapter will provide important background information regarding 
the key clinical syndromes of withdrawal and pediatric delirium and related 
pharmacological concepts of physical dependence, adverse drug reactions and opioid 
conversions. The two validated withdrawal assessment tools, the Withdrawal Assessment 
Tool -1 (Franck et al 2008) and the Sophia Observation Scale (Ista et al 2009) are 
presented and critiqued.  
Chapter 3 presents the methodology and the conceptual framework. This chapter will 
provide the rationale for the choice of an interactive multistage mixed methods design, 
comprising explanatory sequential and convergent components to answer the research 
questions.   
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Chapter 1: Introduction   
 
1.1 Introduction  
Babies and children admitted to the Paediatric Intensive Care Unit (PICU) will receive 
sedative and analgesic drugs, to facilitate mechanical ventilation and to relieve pain and 
suffering.  These drugs can cause physical dependence when administered continuously; 
the rate of dependence depending on duration, dose and patient factors. Patients who 
are physically dependent may experience withdrawal syndrome if these drugs are 
stopped abruptly or reduced too quickly. Withdrawal can be ameliorated by weaning or 
tapering drugs at a rate which can be tailored to the individual depending on their 
condition, comorbidities and response to recent changes in drug doses.  Withdrawal is 
unpleasant and may slow recovery and delay discharge from the Paediatric Intensive Care 
Unit (PICU).  Prompt detection and treatment of withdrawal can reduce suffering and aid 
recovery.  
1.2 Background to the study 
The hospital in which this study took place is a large tertiary children’s hospital in the UK 
with 24 ICU and 30 HDU beds. In this hospital a systematic approach to the assessment 
and management of withdrawal syndrome has been embedded in practice for 15 years. 
This approach comprises a withdrawal assessment tool, the Sedation Withdrawal Scale 
(SWS) with an assessment schedule and treatment cut points, which was created by the 
pain team in the absence of an existing alternative (Cunliffe et al, 2004) (Appendix 1).  
The pain team oversee sedation weaning in patients discharged from PICU; a cohort of 
about 100 patients annually.  
Despite clinical utility, there have been recurring issues with the existing approach to 
withdrawal assessment arising from the diagnostic reliance on non-specific behaviours. 
The potential for error arises on occasions when the child’s typical behaviour or 
underlying condition imitates withdrawal behaviour.  In these instances the child may be 
diagnosed with withdrawal, but is not withdrawing. In other situations, withdrawing 
patients may present with only one withdrawal behaviour, which in a score relying on a 
summing of behaviours, translates to a lower score than is typical in a withdrawing 
patient.  
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This thesis owes its inception to a parent story told to me by a mother, whose baby son 
spent most of his life between PICU and the High Dependency Unit (HDU).  This mother 
described the distress that withdrawal behaviour elicited in both her and her son. She 
also revealed that despite the existing approach to withdrawal assessments, her son had 
suffered with withdrawal after every episode of his critical illness. Her son passed away 
shortly before his first birthday.   
This mother’s story embodied the shortcomings of the existing approach to withdrawal 
assessment and prompted the design of a study to investigate whether the parental 
contribution might be more formally included in and enhance the existing approach to 
withdrawal assessment.  With the overall aim of improving the accuracy of sedation 
withdrawal assessment in critically ill children, the a priori study comprised three phases; 
to evaluate the current SWS tool, interview parents to explore whether parents 
recognised withdrawal behaviours and were willing to participate in withdrawal 
assessments; incorporate a parental component in the assessment and evaluate the new 
approach.  A mixed methods design was considered to best answer the research 
question; the parent interviews comprised the qualitative inquiry to inform the 
refinement of the quantitative instrument, the SWS tool.  The project evolved to an 
interactive, emergent design in response to unexpected findings in the planned studies 
and to changes within the broader theoretical landscape. These changes will be described 
briefly.  
The study evolved initially in response to data analysis in the first study; the SWS tool 
evaluation study.  Unexpected findings prompted an additional study to explore nurse 
decision-making when using the SWS.  Further change was prompted by the 
interpretation of findings from the parent interviews study. The rich descriptions and 
diversity of behaviours reported by parents and the insight they demonstrated motivated 
further exploration of the clinical context at the time of withdrawal and sought to explain 
the cause of the behaviours described by parents.  Five cases demonstrated the unique 
and complex context and a level of uncertainty, which were poorly reflected and 
operationalised in the existing approach.  
Although the overall aim of the thesis; to improve the accuracy of sedation withdrawal 
assessment in critically ill children remained the same, the aims and objectives of the 
component studies altered in response to the change in focus; to examine and illuminate 
three different perspectives of withdrawal assessment.  The first perspective comprised 
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three studies examining the existing approaches to withdrawal assessment.  Study 1 
examined the psychometric properties of the Sedation Withdrawal Score (SWS); Study 2 
compared two studies which characterised withdrawal signs in critically ill children and 
Study 3 was a pragmatic critique of the WAT-1 dataset.  The following three studies 
explored the impact of two new perspectives; the nurse’s perspective and the parent’s 
perspective, on existing knowledge and understanding of sedation withdrawal 
assessment. 
During the course of this thesis, the entire theoretical landscape surrounding withdrawal 
has changed fundamentally.  Two validated withdrawal assessment tools have been 
published (Franck et al 2008, Ista et al 2009), the concept of pediatric delirium has been 
established (Schieveld et al 2007), the focus of withdrawal research has evolved from 
improving recognition of withdrawal to the identification of risk factors for withdrawal 
(Best et al, 2016) and most recently, the constructs of withdrawal and delirium appear to 
be merging (Schieveld et al 2013) and the challenge of differentiating between them has 
been recognised (Madden et al 2017).   
The changes in the component studies of this thesis and the developments in the 
theoretical landscape have highlighted the complexity of the clinical context within which 
withdrawal assessments in critically ill children are performed.  In turn this has impacted 
on and broadened the working hypothesis and research questions and provided the 
theoretical framework of judgement and decision-making.  
1.3 Structure of the thesis 
This thesis comprises six studies and is presented in twelve chapters, within five parts 
(See Table 1.1).  Part 1 is composed of the first three chapters (Introduction, Literature 
review and Methodology).  Part 2 addresses Chapters 4, 5 and 6 (Studies 1, 2 and 3).  Part 
3 presents Chapter 7 (Study 4). Part 4 presents Chapters 8 and 9 (Studies 5 and 6). Part 5 
presents Chapters 10, 11 and 12 (Integration, synthesis and conclusions).  A summary 
preview of each chapter completes the introduction to this thesis. 
Part 1: Introduction.  Three chapters are presented in this section. 
Chapter 1: Introduction. This chapter introduces the subject of sedation withdrawal and 
describes the clinical impetus for undertaking the studies in the thesis.  
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Chapter 2: Literature Review and critical analysis of withdrawal assessment tools.  This 
chapter will provide important background information regarding the key clinical 
syndromes of withdrawal and pediatric delirium and related pharmacological concepts of 
physical dependence, adverse drug reactions and opioid conversions. The two validated 
withdrawal assessment tools, the Withdrawal Assessment Tool -1 (Franck et al 2008) and 
the Sophia Observation Scale (Ista et al 2009) are presented.  
Table 1.1 The presentation of studies in the thesis. 
Part Chapter Title 
Part 1  
Introduction 
1 Introduction 
2 Literature review and critical analysis of 
withdrawal assessment tools 
3 Methodology 
Part 2  
Nurse assessment 
4 Study 1 Retrospective evaluation of SWS 
5 Study 2 Comparison of OBWS and SBOWC 
6 Study 3 Pragmatic review of the WAT-1 data 
set 
 
 
Part 3  
Nurse judgement 
7 Study 4 The Nurse Perspective 
Part 4  
Parent perspective 
8 Study 5 Parent recall of SWS signs 
9 Study 6 Parents’ experiences  
Part 5  
Towards a theory of 
withdrawal in critically ill 
children. 
10 Case studies as test cases 
11 Withdrawal sign synthesis 
12 Conclusions, contributions, implications 
 
This review highlighted the lack of theoretical and operational clarity regarding 
withdrawal, including an operational definition, risk factors, empirical indicators, 
assessment approach and treatment.  As part of the critical consideration of the 
literature a propositional model was constructed to make explicit the causal relationships 
between the factors linking sedation, physical dependence and withdrawal syndrome in 
the critically ill child.  
Chapter 3: Methodology.    This chapter will provide the rationale for the choice of an 
interactive multistage mixed methods design, comprising explanatory sequential and 
 
 
 
 26 | P a g e  
 
convergent components to answer the research questions.  The additional study 
investigating the nurses’ perspective introduced/ embraced the notion of subjective 
reality; people perceive things differently.  The move away from the deductive truth of 
rationalism towards the induction and abduction of empiricism, prompted a realigning of 
the thesis research methodology towards a pragmatic mixed methods approach.   
The theories of judgement and decision-making provide the analytical framework for this 
thesis. Decision-making theory is pertinent to each of the component studies.  The 
studies cover the clinical utility and generalisability of withdrawal assessment tools, nurse 
judgement and decision-making and parental perception and interpretation of their 
critically ill child’s behaviours.  A conceptual model of withdrawal assessment is 
presented showing how each component study provides a different perspective of 
withdrawal signs.  The conceptual model and provides the structure for the presentation 
of the thesis which will be presented in sections, according to the model. 
A thesis map of the mixed methods studies comprising the qualitative, quantitative and 
mixed methods components is presented. Integration is a key component of mixed 
methods research and delineates mixed methods aims from qualitative and quantitative 
aims. 
Part 2: Nurse assessment.  This section comprises three chapters, presenting three 
studies which focus on the existing approach to withdrawal assessment using different 
withdrawal assessment tools.  
Chapter 4:  Study 1.  The retrospective evaluation of SWS.  The aim of this study was to 
evaluate the psychometric properties of the SWS tool with the purpose of establishing 
whether improvements were indicated.  The highest SWS score was selected and the 
likelihood of withdrawal at that time point was assigned.  In the absence of an existing 
measure that could be retrospectively applied, criteria were developed drawing on 
current criteria for diagnosis of withdrawal from opioid and sedative drugs in adult 
practice and for assessing the probability of adverse drug reactions in adults.  
The findings from this study demonstrated a variation in presentation of patients with 
different levels of likelihood of withdrawal. The accuracy of the operational cut-point for 
withdrawal was calculated and discussed in light of this heterogeneous presentation. The 
disparity between a dichotomous cut point and treatment options was highlighted. 
Analysis of the data highlighted occasions when the motivation for undertaking a 
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withdrawal assessment was unclear. These findings were unexpected, due to the widely 
held assumption that nurses consider the clinical context during the assessment and 
exclude other causes for the behaviours (Ista et al 2013, Harris et al 2016).   
Chapter 5:  Study 2.  Comparison of OBWS and SBOWC.  The aim of this study was to 
compare the characterisation and operationalisation of withdrawal across different sites. 
The purpose of this study was to identify to what extent there is a shared or generalisable 
component of the construct of withdrawal and to consider how this comparison might 
aid understanding about the construct of withdrawal and add to the existing knowledge 
base of withdrawal.  Similarities and differences in the assessment and presentation of 
babies and children undergoing withdrawal assessments were examined.  The data were 
drawn from the results of two published studies (OBWS (Franck et al 2004) and SBOWC 
(Ista et al 2008)) and transformed to enable comparison.   
Chapter 5: Study 3. A pragmatic review of the WAT-1 study data.  The aim of the study 
was to critically evaluate the operationalisation of withdrawal underpinning the 
construction and validation studies of WAT-1.  This study demonstrates the influence that 
different perspectives can have on the presentation and meaning of a single dataset. 
WAT-1 (Franck et al 2012) was developed as part of a large multicentre sedation study 
(Curley et al 2015).  Other studies reporting secondary analysis of this study data, in 
relation to withdrawal assessment have been included for the additional perspectives 
they contribute.   
WAT-1 was critically reviewed in Chapter 2 using a realist framework reflecting the 
quantitative nature of the study.  A contrasting approach was taken to the evaluation of 
these studies offering multiple perspectives, reflecting the pragmatic ontology, decision-
making perspective and inductive/abductive methods underpinning this thesis. 
Krathwohl’s (2009) standards for credible results provided the pragmatic framework. 
Part 3: Nurse Judgement. This section comprises one chapter, presenting a study which 
focuses on the decision-making stages involved in undertaking a withdrawal assessment.  
Chapter 7: Study 4. The Nurse Perspective.  The aim of this study was to explore nurses’ 
decision making when using the SWS with the purpose of identifying and understanding 
variations in use of the tool.  Using two developmental vignettes during cognitive 
interviews, nurses described how they diagnosed withdrawal and how they defined and 
recognised four of the component items (insomnia, irritability, respiratory distress and 
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hypertonicity) in the SWS tool.  The existing withdrawal assessment presents a significant 
cognitive burden and does not diminish the potential for cognitive error. 
Part 4: The Parent Perspective. This section comprises two chapters, presenting two 
studies which focus on the parent perspective of withdrawal. 
Chapter 8: Study 5.  Mixed methods study of parent’s recollections off, and distress 
evoked by, signs of withdrawal, in children less than 5 years of age and  
Chapter 9: Study 6.  A multiple case study of parents’ experiences of their child’s 
withdrawal 
Studies 5 and 6 are a nested multiple case study exploring parents recall and impressions 
of their child’s withdrawal using questionnaires and interviews.  The aim of study 5 was to 
examine parents’ recall of SWS signs when their child was withdrawing and the distress 
these signs evoked.  The aim of study 6 was to further explore parents’ perceptions of 
their child’s withdrawal and ascertain the acceptability of a potential role for parents in 
withdrawal assessment.  Findings revealed that parents recalled both SWS and other 
behaviours and also described behaviours suggestive of other differential diagnoses in 
addition to withdrawal.  Most parents were receptive to the idea of participating in 
withdrawal assessments in collaboration with nurses, to share their unique perspective of 
their child. This was perceived as reducing rather increasing their stress burden.  
Part 5: Towards a theory of withdrawal in critically ill children. This section presents the 
concluding three chapters in the thesis, integrating and synthesising the findings from the 
studies.  
Chapter 10:  Case studies as test cases.  Theoretical substruction provided the framework 
linked to the propositional model identified in Chapter 2 to identify the gaps in the 
existing theoretical basis for withdrawal assessment. Findings from Studies 1-5 sought to 
illuminate those gaps. The lack of such a framework for withdrawal and the presence of 
poorly defined construct and concepts have hampered evaluation of findings in the 
studies in this thesis. 
An adverse drug reaction (ADR) causality assessment tool was adapted by the researcher 
and renamed the Withdrawal Causality Assessment Tool (W-CAT).  The W-CAT was 
applied to five case studies derived from Study 5 to test clinical utility. 
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Chapter 11:  Withdrawal sign synthesis.  The integration chapter merges the findings 
from each of the component quantitative and qualitative studies in relation to the signs 
of withdrawal in critically ill children.  Integrating the findings from the SWS evaluation, 
nurse perspective and parent perspective in relation to behavioural signs facilitates a 
more complete understanding of the construct to emerge, compared with either 
qualitative or quantitative results alone.   
Chapter 12:  Conclusions, original contribution to knowledge and implications for 
practice and policy.  The final chapter summarises the findings of the thesis introduces a 
new construct of and diagnostic criteria for Paediatric Withdrawal Syndrome, and 
proposes a propositional model.  
The main contributions of this thesis arise from recognition of the complexity that 
surrounds the withdrawing child.  The theoretical proposition is that withdrawing 
patients share diagnostic features, rather than a specific presentation in common. This 
proposition challenges the existing approach to withdrawal assessment, which relies on a 
shared presentation. 
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Chapter 2:  Literature review and critical analysis of withdrawal 
assessment tools 
 
2.1 Introduction 
In this chapter an integrative review of the literature regarding withdrawal syndrome will 
be discussed with the aim of determining the evidence base for the existing approach to 
the assessment and management of withdrawal syndrome.  This review has evolved over 
time, in response to findings from the studies in this thesis.  As a consequence a range of 
competing differential diagnoses for children being assessed for withdrawal syndrome, 
including Pediatric Delirium (PD), is also presented. The term PD is presented with the US 
spelling, which reflects the origins of the literature about this syndrome. 
The review will consider what is known about withdrawal syndrome in critically ill 
children and the challenges in identifying withdrawal in light of other differential 
diagnoses that coexist in the critically ill child.  Following this, a critical review the two 
validated withdrawal assessment tools is presented; the Withdrawal Assessment Tool -1 
(WAT-1) (Franck et al 2008) and the Sophia Observation Scale (SOS) (Ista et al 2009).  
 
2.2 Search strategy 
All peer-reviewed publications that referred to withdrawal syndrome or delirium in 
children aged less than 18 years were identified for consideration.  Studies were primarily 
identified through online searches using Medline, EMBASE and CINAHL. The date of the 
last search attempt was July 2017. No start date was specified for the literature searches 
and the final articles included in the review dated from 1986 to 2017. 
The search terms included the following terms “withdrawal syndrome”, “delirium” 
“pediatric” and “critical care.”  Limits were set to include only human populations from 
birth to 12 years of age (including preschool and child but not adolescent populations) in 
English language, peer reviewed articles.  The detailed search strategy is shown in Tables  
2.1 and 2.2.  Reference lists of articles were also examined.  Articles describing Neonatal 
Abstinence Syndrome or Emergence Delirium were excluded manually.  
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Table 2.1 Search strategy for Withdrawal syndrome 
 Search term used for withdrawal syndrome in 
critically ill children 
Medline 
results 
EMBASE 
results 
CINAHL 
results 
1 Exp “Substance withdrawal syndrome” OR 
(“Substance withdrawal syndrome”).ti,ab OR 
(“withdrawal syndrome”).ti,ab 
22872 31776 2838 
2 Exp “critical illness” OR exp “Intensive care units, 
pediatric” OR (“critical illness”). ti,ab OR 
(“paediatric intensive care unit*”).ti,ab OR 
(“pediatric intensive care unit*”).ti,ab 
43816 36125 17040 
3 1 AND 2 (filtered) 73 27 64 
Filters: English, human, child (infant and child)  
Table 2.2 Search strategy for Pediatric Delirium 
 Search terms used for Pediatric delirium Medline 
results 
EMBASE 
results 
CINAHL 
results 
1 Exp delirium OR (delirium).ti,ab 
 
13060 27007 4704 
2 Exp “critical illness” OR exp “Intensive care units, 
pediatric” OR (“critical illness”). ti,ab OR 
(“paediatric intensive care unit*”).ti,ab OR 
(“pediatric intensive care unit*”).ti,ab 
43816 36125 17040 
3 1 AND 2 (filtered) 57 79 28 
Filters: English, human, child (infant and child)  
2.3 Physical dependence and withdrawal  
Physical dependence is the physiological adaptation in response to repeated 
administration, which necessitates the continued presence of the drug(s) to maintain the 
modified physiological equilibrium (Jenkins 2002).  When these drugs are reduced or 
withdrawn, the adaptive mechanisms take time to readjust and are manifested as the 
unpleasant behavioural signs of withdrawal syndrome (Jenkins 2002).  Withdrawal 
syndromes are a class of adverse drug reactions (ADR), occurring when drugs capable of 
causing physical dependence are stopped or reduced after prolonged use.  Withdrawal 
syndrome is classed as a Type E or end-of-use ADR (Edwards and Aronson, 2000).  An ADR 
is a response to a drug which is noxious and unintended (ICH, 1994); a reaction that 
“warrants prevention, treatment, alteration of the dose regime, or withdrawal of the 
product” (Edwards and Aronson 2000, p1255).  Classes of drugs causing physical 
dependence in babies and children in critical care include opioids, such as morphine and 
fentanyl, sedative, hypnotic or anxiolytic drugs, such as benzodiazepines and chloral 
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hydrate and the inhaled anaesthetic, isoflurane.  This review will consider the diagnosis, 
incidence, risk factors and treatment of withdrawal in critically ill children. 
 
2.3.1 Diagnosing withdrawal 
Drugs causing physical dependence are more commonly prescribed to adults rather than 
children, so the adult literature was also reviewed.  The Diagnostic and Statistical Manual 
of Mental Disorders (DSM) provides diagnostic criteria for withdrawal for opioid and 
sedative, hypnotic or anxiolytic drug classes (DSM-5, 2013). In addition to a drug-specific 
criterion, there are three standard criteria for diagnosing substance withdrawal;  
 a change in behaviour causing significant distress or impairment,  
 a temporal link to the reduction or stopping of a drug,  
 the change in behaviour is not due to another medical condition or disorder (Table 
2.3).   
Table 2.3 Criteria for substance withdrawal (DSM-5 2013) 
Criterion A 
 
 
The development of a substance-specific problematic behavioural 
change, with physiological and cognitive concomitants, that is due to 
the cessation of, or reduction in, heavy and prolonged substance use. 
Criterion B Substance specific withdrawal symptoms developing within minutes to 
several days after Criterion A: 
Criterion C The substance-specific syndrome causes clinically significant distress or 
impairment [in social, occupational, or other important areas of 
functioning]. 
Criterion D The symptoms are not due to another medical condition and are not 
better explained by another mental disorder. 
 
The substance specific criteria set for opioid and sedative, hypnotic or anxiolytic 
withdrawal is shown in Table 2.4.  Some symptoms are common to the withdrawal 
syndromes of both classes of drugs; these symptoms are shown in bold type. 
 
2.3.2 Withdrawal in critically ill children. 
Withdrawal in critically ill children differs to adults in three of the DSM-5 diagnostic 
criteria.  In Criterion A, substance use may not be prolonged, as withdrawal has been 
described after as little as four days continuous treatment of opioids and 
benzodiazepines (Franck et al 2004).  “Heavy” use may not be a relevant concept in this 
population, but the causal relationship between peak doses, cumulative doses and 
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withdrawal has been investigated (Da Silva et al 2016, Amigoni et al 2014, Franck et al 
2012, Ista et al 2013).  Studies draw different conclusions about whether these variables 
are risk factors for withdrawal or not, as the table drawn up from the literature by the 
researcher, demonstrate (Table 2.5).   
Table 2.4 Examples of drug-specific withdrawal symptoms (DSM-5 2013) 
Opioid withdrawal (e.g morphine, 
fentanyl) 
Sedative, hypnotic or anxiolytic withdrawal 
(e.g benzodiazepines) 
Dysphoric mood 
Nausea or vomiting* 
Muscle aches 
Lacrimation or rhinorrhea  
Pupillary dilation, piloerection or 
sweating* 
Diarrhoea 
Yawning 
Fever* 
Insomnia* 
Autonomic hyperactivity (e.g. sweating*, 
increases in heart rate, respiratory rate, blood 
pressure or body temperature*) 
Hand tremor 
Insomnia* 
Nausea or vomiting* 
Transient visual, tactile, or auditory 
hallucinations or illusions 
Psychomotor agitation 
Anxiety 
Grand mal seizures 
*Symptoms common to both withdrawal syndromes are shown in bold 
Table 2.5 Risk factors, incidence and treatment of withdrawal syndrome in critically ill 
children 
Characteristic Finding Author 
Risk factors Midazolam peak dose > 0.35 mg/kg/hr  Da Silva 2016 
Midazolam peak dose > 0.42 mg/kg/hr Amigoni 2014 
Midazolam, cumulative dose (Yes) Franck et al 2012, Ista et al 2013. 
Midazolam, cumulative dose (No) Amigoni 2014 
Fentanyl, cumulative dose (Yes) Franck et al 2012 
Opioid peak dose (No) Amigoni 2014 
 
In Criterion B more than one drug may be implicated.  Opioids and sedative drugs are 
administered to children in PICU to minimise the child’s distress from, and to promote 
compliance with, mechanical ventilation. The most common opioid/sedative drug 
combination administered to critically ill children in the UK is morphine and midazolam 
(Blackwood and Tume 2015) and this was the drug combination that patients were  being 
weaned from in the validation studies of WAT-1 and SOS (Franck et al 2008, Ista et al 
2009).  However, more than 20 opioid and sedative drugs are administered to patients in 
PICU (Playfor 2003, Jenkins 2007) and each class of drug will have substance specific 
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withdrawal symptoms. Withdrawal from Isoflurane, an inhalational anaesthetic agent, 
has been reported in children (Arnold et al 1993, Hughes et al 1993, Kelsall et al 1994, 
Sackey et al 2005, Cooper and Bateman 2007).  Data from these case reports and short 
case series was collated by the researcher to characterise isoflurane withdrawal (Table 
2.6).  In these cases, the substance specific withdrawal symptoms were profound 
agitation, seizures, motor disturbances, hallucinations and confusion for up to 5 days. 
In Criterion D numerous other differential diagnoses exist, which share behaviours in 
common with, and risk factors for withdrawal. These differentials include the patient’s 
primary medical condition (Franck et al 2008), pre-existing behaviours, pediatric delirium 
and other adverse drug effects including drug-drug interactions and adverse drug 
reactions such as neuroleptic malignant syndrome, akathisia and non-convulsing status 
epilepticus (Schieveld et al 2007, Pershad et al 1999, Godinho et al 2002, Mejia and 
Jankovic 2016, Abend and Duglos 2007).  The researcher compared the clinical features 
and risk factors of these differential diagnoses to demonstrate the similarities in 
presentation of these conditions (Table 2.7).  Whilst there is an assumption that the 
nurse will exclude other causes for behaviours during a withdrawal assessment (Harris et 
al 2016), this step is neither an integral component of the tools nor practical given the 
similarity in presentation of these differentials.   
2.3.4 Diagnosing withdrawal in critically ill children 
Three published tools have been developed to monitor withdrawal in children; the 
Sedation Withdrawal Score (SWS) (Cunliffe et al 2004), the Withdrawal Assessment Tool 
(WAT-1) (Franck et al 2008) and the Sophia Observation Score (SOS) (Ista et al 2009).  
Each is a checklist of non-specific signs that, in combination, appear to support a 
diagnosis of withdrawal. The researcher compared the item content of the three tools to 
identify similarities and differences of item content (Table 2.8).  The tools share items in 
common and have a combined item pool of 22 withdrawal behaviours. Six behaviours 
(27%) are common to all three tools, a further six (27%) are shared by two tools and the 
remaining ten (46%) occur in one tool only.  The diagnostic principle, upon which these 
tools are based, is the correlation between an increasing number of non-specific 
withdrawal behaviours and intensity of withdrawal, as proposed by Finnegan et al (1975) 
during the development of the Neonatal Abstinence Score (NAS).  
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Table 2.6 Case reports of withdrawal syndrome after Isoflurane   
Author Pt Age Gender Diagnosis Duration of 
Isoflurane 
Behaviours after isoflurane stopped Concurrent 
sedatives  
Arnold et al 
(1993)  
 
1 9 
mo 
NR Bronchiolitis 95 hours No behavioural complications Opioid and 
benzodiazepines 
2 6y NR Pulmonary 
haemorrhage 
6 days No behavioural complications Opioid and 
benzodiazepines 
3 4y Male Radiation 
pneumonitis 
32 days Marked hypertension, tachycardia, agitation, 
diaphoresis, and diarrhoea  
Opioid and 
benzodiazepines 
4 6mo Female Bronchiolitis 73 hours No behavioural complications Opioid and 
benzodiazepines 
5 3wk NR Congenital 
diaphragmatic 
hernia 
30 hours No behavioural complications Opioid and 
benzodiazepines 
6 2.5y NR Near drowning 10 days Marked agitation, choreoathetoid movements  Opioid and 
benzodiazepines 
7 4y NR Bacterial 
pneumonia 
7 days Marked agitation, non purposeful movements  Opioid and 
benzodiazepines 
8 6mo NR Bacterial 
pneumonia 
17 days Marked agitation, tremulous non purposeful  Opioid and 
benzodiazepines 
9 19y NR Status 
asthmaticus 
29 hours No behavioural complications Opioid and 
benzodiazepines 
10 6mo NR Aspiration 
pneumonia 
18 days Marked agitation, non purposeful movements  Opioid and 
benzodiazepines 
Hughes et al 
(1993) 
11 7y Male 15% burns NR Hallucinations, generalised seizure, 
disorientation for 5 days 
NR 
Sackey et al 
(2005) 
12 11/1
2y 
Male Acute 
pancreatitis, 
abdominal 
sepsis 
6 days Clonus L foot, resolved in 48h. 
? but sedatives increased/ commenced <24h 
after stopping Isoflurane. 
Morphine, 
clonidine 
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13 9y Male Status 
epilepticus 
2 x 96 
hours, with 
48 hours 
between 
Two seizures, no other typical withdrawal signs 
or surgical abnormalities 
Midazolam 
restarted 24h 
before Isoflurane 
weaned and 
stopped. 
14 4y Male Hirshsprungs, 
abdominal 
sepsis 
Almost 8 
days 
Involuntary movements and ataxia, resolved 
over 4-5 days 
Morphine, 
midazolam, 
clonidine. 
Cooper and 
Bateman 
(2007) 
15 4y Female Bronchospasm 
Ex prem, 
Chronic lung 
disease 
64 days Profound choreoathetoid movements causing  
significant bronchospasm, difficulty with 
secretions, and poor respiratory coordination. 
Jittery, muscle twitching. 
Fentanyl and 
lorazepam 
weaned to off. 
Kelsall et al 
(1994) 
N=
12 
NR NR Croup/ 
epiglottitis 
>24 hours Reversible ataxia, agitation, hallucinations and 
confusion ≤72 hours 
NR 
N=
5 
NR NR Croup/ 
epiglottitis 
1-15 hours No neurologic dysfunction NR 
NR = not recorded 
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Table 2.7 Differential diagnoses for critically ill children treated with opioid and sedative drugs 
 
Author 
Differential 
diagnosis 
Clinical features 
Risk factors Consciousness Motor 
disturbance 
Autonomic effects Other 
Schieveld et al 
(2007) 
Pediatric delirium  Reduced 
awareness 
Purposeless 
actions 
Autonomic 
dysfunction 
Inconsolability High dose and/or 
prolonged use of opioids 
and/or benzodiazepines 
Pershad et al 
(1999) 
Drug- drug 
interaction 
(Chloral and 
furosemide)  
 
 Agitation Sweating, flushing, 
tachycardia, 
alterations in blood 
pressure 
 Occurs within 5 mins of 
dose of furosemide, lasts 
15-20 mins, if chloral 
given within previous 24 
hours. 
Godinho et al 
(2002) 
Neuroleptic 
malignant 
syndrome 
 
Confused, 
altered 
consciousness 
Rigid muscles Temperature > 
38C, autonomic 
imbalance 
 Promethazine, 
chlorpromazine, rapid 
withdrawal of 
benzodiazepines. 
Mejia and 
Jankovic 
(2016) 
Akathisia 
 
 Need for 
constant 
motion, 
restless legs 
 Inner sense of 
restlessness 
Promethazine, 
chlorpromazine, rapid 
withdrawal of opioids 
and/or benzodiazepines. 
Abend and 
Duglos (2007) 
 
Non-convulsing 
status epilepticus 
 
Fluctuating 
consciousness 
Motor 
disturbance 
Autonomic 
dysregulation  
Complex cortical 
functions 
disrupted 
Acute withdrawal from 
sedative-hypnotics 
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In the UK, just under half of PICUs (10 of 23) use withdrawal assessment tools, with WAT-
1 most commonly used (n=5), followed by SWS (n=4) and SOS (n=1) (Blackwood and 
Tume 2015). The SWS is the withdrawal assessment tool and treatment protocol 
developed and used in the study hospital since 2002. The SWS has proven clinically useful 
in identifying withdrawal signs in PICU and ward-based patients, but has not been 
validated (Macqueen & Bruce 2012). Both WAT-1 (Franck et al 2008) and SOS (Ista et al 
2009) have been validated but rigorous psychometric testing was hampered by the lack 
of a gold standard, and clinical utility is further limited by the lack of treatment protocols 
linked to identified cut points. A critical review of WAT-1 and SOS will be presented later 
in the chapter.   
 
Table 2.8 Comparison of withdrawal behaviour content in SWS, SOS and WAT-1. 
Withdrawal sign Agreement SWS SOS WAT-1 
Sweating   
Item 
occurs in 
all 3 tools. 
   
Tremor        
Fever    
Diarrhoea   Loose, watery stool 
Vomiting   and retching, gagging 
Hypertonicity    
Insomnia  
Item 
occurs in 2 
of 3 tools. 
*   
Irritability    
Respiratory distress  Tachypnoea  
High pitch cry  Inconsolable crying  
Sneezing    
Motor disturbance   Uncoordinated, 
repetitive movement 
Agitation  
Item 
occurs in 1 
tool only. 
   
Hallucinations    
Convulsion    
Yawning    
Tachycardia    
Grimacing    
Startle to touch    
SBS**≥ +1    
Time to regain calm 
state (SBS≤ 0) 
   
Anxiety    
Item total  12 15 12 
*originally ‘hyperactivity’ in Cunliffe (2004) 
**SBS State Behavioural Score (Curley et al 2006) 
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2.3.5 Scale development and item content  
Withdrawal cannot be measured directly, so withdrawal assessment scales have been 
developed to infer the existence of withdrawal from observable behavioural 
consequences.  Measurement theory requires that “items must share one and only one 
underlying variable if they are to be combined into a scale” (DeVellis, 2012 p.159).  This 
means items in a withdrawal assessment share a single common cause (of withdrawal).  
In the absence of characteristic signs of withdrawal, signs, either singly or in combination, 
are indicative of withdrawal only if a temporal relationship exists with a recent reduction 
or stopping of a drug capable of causing physical dependence; conditions which 
correspond to Criteria A, B and C (DSM-5 2013).  However, even in this context, the same 
combination of equivocal signs might indicate another differential diagnoses, including 
those listed in Table 2.7.  Madden et al (2017) have demonstrated this challenge recently 
in their paper describing the overlap in features of withdrawal, delirium and 
anticholinergic drug toxicity in critically ill children.  If there are other coexisting causes 
for these signs, Criterion D (DSM-5 2013) may not be met. The complexity of the context 
within which withdrawal assessments occur cannot be underestimated; a level of 
uncertainty that is not reflected in a dichotomous yes/no diagnosis of withdrawal. 
The item pool for SWS, WAT-1 and SOS was derived predominantly from case reports and 
short case series published over 20 years, from the mid-1980s.  The demographic details 
of the cases reported are shown in Table 2.9 and the withdrawal signs reported are 
shown in Table 2.10.  This literature provides a rich description of the withdrawal 
behaviours first documented in children and young people after treatment with opioids 
and benzodiazepines.  These behaviours can be broadly delineated as abnormal 
movements, communication disturbances, neurological instability, autonomic signs, 
symptoms (relying on patient self-report, rather than observable signs) and other signs.  
All categories contributed items to one or more of the tools (SWS, WAT-1 and SOS) 
except for “communication disturbances.”  Whilst absent from withdrawal assessments, 
communication disturbances, defined as “inattention” is the most fundamental sign of 
pediatric delirium (Smith et al 2016).  This suggests that the early literature, whilst 
reporting what the authors considered to be withdrawal syndromes, and in the absence 
of either withdrawal, or delirium assessment tools, may also have been describing 
children and young people with delirium.  
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Table 2.9 Demographics of early sedation and/or opioid withdrawal case reports in children 
Author No of 
patients 
Age Gender Diagnosis Opioid Midazolam Duration of 
treatment 
Miser et al 
(1986) 
 
N=2 
15y Female Osteosarcoma Hydromorphone  No 7 days 
14y Male Leukaemia Hydromorphone No 7 days 
Sury et al (1989) N=3 
 
4y Male Pneumonia  Morphine  Yes 7 days 
11y Female Asthma Morphine  Yes 14 days 
12y Female Asthma Morphine  Yes 17 days 
Lane et al (1991) N=5 1.9y Male Closure of abdominal defect Fentanyl  Yes 7.8 ±4.9 days 
1.9y Female Croup Fentanyl No 
0.5y Male Subglottic stenosis Fentanyl  Yes 
2y Male Subglottic stenosis Fentanyl  Yes 
3.5y Female Subglottic stenosis Fentanyl  Yes 
Bergman et al 
(1991) 
N=3 5 mo Female Bronchiolitis Fentanyl  Yes 6 days 
15mo Female Wheezing  Fentanyl  Yes 10 days 
3mo Female Repair left anomalous coronary 
artery 
Fentanyl  Yes 5 days 
Van Engelen et al 
(1993) 
N=2 15mo Male Septicaemia  Yes 12 days 
14day Male Repair of patent ductus arteriosus Nicomorphine Yes 29 days 
Hughes et al 
(1994) 
N=4 1.3y unknown Croup Morphine Yes 77h 
1.7y unknown Croup Morphine Yes 37h 
3y unknown Croup Morphine Yes 189h 
3y unknown Epiglottitis Morphine Yes 22h 
Hughes (1994) N=1 18mo Female Repair of Fallot’s Tetralogy Diamorphine  
Fentanyl 
No 7 days 
14 days 
Ducharme et al. 
(2005) 
N=1 40mo Male Tracheolaryngoplasty Fentanyl  Yes 7 days 
(Carnevale and 
Ducharme 1997) 
N=5 11mo Female Repair of Fallot’s Tetralogy Fentanyl  
 
Yes 3 days 
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7mo Male Skull fracture Fentanyl  
 
Yes 8 days (Fent) 
9 days (Midaz) 
16mo Female 30% burn Morphine Yes 24 days 
(Morph) 
16 days (Midaz) 
2mo Male Bronchiolitis Fentanyl Yes 5 days (Fent) 
6 days (Midaz) 
5mo Female Bronchiolitis Fentanyl  then 
morphine 
Yes 16 days 
Y = years; mo = months 
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Table 2.10 Signs and symptoms of withdrawal identified from early case reports (1986-2005) in children and young people after treatment with opioids 
and benzodiazepines. 
Abnormal movements Communication 
disturbance 
Neurological 
instability 
Autonomic 
signs 
Symptoms  Other signs 
Chorea 
Myoclonus 
Ataxia 
Constant choreathetotic 
movements of head, face, tongue, 
extremities when awake. 
Frequent dyskinetic movements 
Puppet- like movements 
Non-purposeful movements  
Moving all 4 limbs vigorously 
Small amplitude choreic 
movements of hands, feet, tongue 
Grimacing 
Odd repetitive facial grimacing 
Rapid repetitive tongue thrusting 
Twitch 
Stiff posture 
Hands fisted 
 
Uncommunicative 
Not recognising parents 
Poor visual following 
Globally aphasic  
No social interaction 
Unaware of parent’s 
presence 
Unresponsive to 
mother/ nursing staff 
Inconsistent/ not 
fixing/following 
Insomnia 
Convulsions  
Jittery  
Hyperactive 
Irritability 
Tremor 
Restlessness 
Fussy 
Tachypnoea 
Tachycardia 
Pyrexial  
Chilling without 
fever 
 
Abdominal pain 
Anxiety 
Disorientation  
Visual 
hallucinations 
Auditory 
hallucinations 
Inconsolable 
crying 
Gagging 
Poor feeding 
Vomiting  
Itching  
Aggressive 
Inappropriate 
laughter 
Aerophagia 
Looking at objects 
in the air 
Reaching out for 
objects in the air, 
picking at clothes 
as if visual 
hallucinations 
Items in bold occur in one or more of SWS, WAT-1 and SOS.
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One of these original withdrawal papers (Sury et al 1989) has recently been interpreted 
by Hatherill et al (2009) as reporting delirium in children undergoing benzodiazepine 
withdrawal.  These observations, along with similarities in both risk factors and 
presentation point to a possible association, or coexistence between withdrawal and 
delirium in critically ill children.  In light of this, the literature on assessment of pediatric 
delirium will be reviewed briefly. 
 
2.4 Pediatric delirium 
Delirium is an acute brain dysfunction caused by systemic illness or the effects of 
treatment, which is characterised by acute onset, fluctuating course and disturbance of 
awareness and cognition (Schieveld et al 2007, Turkel et al 2013, Traube et al 2014).  The 
DSM diagnostic criteria for delirium (Table 2.11) are applicable in children (Turkel et al 
2013).  The delirium assessment relies on verbal communication and diagnosis is usually 
undertaken by a psychiatrist.   
Table 2.11 DSM-5 criteria for delirium (DSM-5, 2013) 
Criterion A A disturbance of attention (i.e reduced ability to direct, focus, sustain and 
shift attention) and awareness (reduced orientation to the environment). 
Criterion B The disturbance develops over a short period of time (usually hours to 
days) and tends to fluctuate during the course of the day. 
Criterion C An additional disturbance in cognition (e.g., memory deficit, 
disorientation, language, visuospatial ability, or perception). 
Criterion D The disturbances in Criteria A and C are not better explained by another 
pre-existing, established or evolving neurocognitive disorder and do not 
occur in the context of a severely reduced level of arousal, such as coma. 
Criterion E There is evidence from the history, physical examination, or laboratory 
findings that the disturbance is caused by the direct physiological 
consequences of another medical condition, substance intoxication or 
withdrawal, or exposure to a toxin, or is due to multiple aetiologies. 
In pre-verbal infants and toddlers, recognition of behaviours synonymous with the 
disrupted regulation of state and attention are critical to the diagnosis, due to the 
challenge of assessing perceptual disturbances, such as hallucinations, in children under 3 
years of age. (Turkel et al 2013).  As the majority of patients in PICU are less than one year 
of age (Schieveld et al 2013), behaviour-based tools have been developed to allow for 
assessment of the youngest critically ill patients using DSM diagnostic criteria (Traube et 
al 2014, Smith et al 2016).   
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2.4.1 The Cornell Assessment of Pediatric Delirium (CAPD) tool (Traube et al 
2014) 
The CAPD tool (Traube et al 2014) contains eight behavioural items, which operationalise 
the diagnostic domains of consciousness (awareness) and cognition (including 
orientation), and also measures psychomotor activity and affect/distress (See Table 2.12).  
Each item taps into one or more of these domains and is scored 0-4 depending on the 
frequency that it is observed.  A CAPD score greater than 9 indicates pediatric delirium. 
The CAPD is validated from birth and anchor points for seven developmental stages 
between newborns and 2 year olds have been published to aid and standardise 
assessment (Silver et al 2015). 
Table 2.12 The Cornell Assessment of Pediatric Delirium Items and DSM domains 
(Traube et al 2014) 
 Item DSM Domain 
1 Does the child make eye contact with the 
care giver? 
Consciousness 
2 Are the child’s actions purposeful? Cognition 
3 Is the child aware of his/her 
surroundings? 
Consciousness 
Orientation 
4 Does the child communicate needs and 
wants? 
Consciousness 
Psychomotor activity 
5 Is the child restless? Cognition 
Psychomotor activity 
Affect/distress 
6 Is the child consolable? Orientation 
Cognition 
Affect/distress 
7 Is the child underactive – very little 
movement when awake? 
Orientation 
Affect/distress 
8 Does it take the child a long time to 
respond to interactions? 
Consciousness 
Psychomotor activity 
 
2.4.2 The Preschool Confusion Assessment Method for ICU (psCAM-ICU) (Smith 
et al 2016) 
The psCAM-ICU (Smith et al 2016) is valid from 6 months, and categorises the features of 
pediatric delirium as mental status, inattention, altered level of consciousness and 
disorganised brain (Table 2.13).  The first criterion; an acute change or fluctuating course 
of mental status performs the function of a starting rule; if this behaviour is absent, the 
diagnosis of pediatric delirium does not need to be considered and no further assessment 
is required.  This is an elegant feature of this tool.   
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Table 2.13 Delirium components of the psCAM-ICU (Smith et al 2016) 
Delirium feature Behavioural components 
Feature 1: mental status Acute change in mental status 
Fluctuation in mental status 
Feature 2: inattention No eye contact 
No tracking of the cards* 
No purposeful action 
Attends to ≤7 cards* 
Lack of attention between prompts 
Feature 3: altered level of consciousness Alert and calm vs other 
Feature 4: disorganised brain Inconsolability 
Unawareness of surroundings 
Sleep-wake cycle disturbance 
*Mirror and picture cards are used as a standardised visual stimulus. 
However, debate about behavioural components of two of the features has arisen, 
pointing to the challenges of agreeing behavioural manifestations of the underlying 
pathophysiology of brain dysfunction.  In psCAM-ICU, “no purposeful action” is a feature 
of inattention and “unawareness of surroundings” is a feature of disorganised brain.  
Schieveld et al (2016) consider the reverse is more accurate (“unawareness of 
surroundings” suggests inattention and “no purposeful action” suggests disorganised 
brain). 
Some features of pediatric delirium are similar to features of withdrawal, such as 
inconsolability, insomnia and restlessness.  Strikingly, each of the communication 
disturbances described in the original withdrawal case reports, which were absent from 
withdrawal tools (Table 2.10), subsequently feature in one or both of these delirium tools.  
The overlap of signs between pediatric delirium and withdrawal presents a risk that these 
conditions may be confused or hard to differentiate.  With similar risk factors it is also 
possible that withdrawal and pediatric delirium may co-exist in critically ill children 
undergoing weaning of analgesic and sedative drugs.  It is also unclear whether 
inattention is a sign of withdrawal, as the earlier case reports suggest, or is a sign of both 
withdrawal and pediatric delirium. 
2.4.3 Recognising subtle behavioural changes 
Assessing inattention and unawareness of surroundings in the youngest patients might be 
challenging for a clinician who is unfamiliar with the baby and their developmental 
baseline.  This issue has been dealt with in different ways by research teams. Smith et al 
(2016) report these features and other subtle neuropsychiatric behaviours might be more 
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difficult for a clinician to recognise, limiting their sensitivity or specificity for delirium. 
Hatherill et al (2009, p.160) describe the primary caregiver as “a crude yardstick against 
which apparent deficit can be measured in relation to usual functioning”.  Despite this 
ungenerous description, Hatherill  (2009, p.163)  subsequently appreciated parental input 
in recognising subtle behavioural changes, preferred their presence at the bedside for all 
assessments and valued parents as “a cornerstone of the environmental management” of 
young children with delirium.  The participation of the primary caregiver features 
substantially in the CAPD assessment, incorporated in behavioural anchor points for three 
of the items, such as “holds gaze, prefers primary parent”, “upset when separated from 
preferred caregivers” and “not soothed by usual comforting actions.”   
 
2.5 Distinguishing between differential diagnoses 
The possibility of delirium superimposed on withdrawal in critically ill children raises 
similar diagnostic challenges to the issues that delirium superimposed on dementia (DSD) 
raises in older adults.  When delirium occurs concurrently with a pre-existing dementia, 
delirium is frequently unrecognised or misattributed to dementia (Inouye et al, 2001).  
Whilst a relationship exists between delirium and dementia, delirium features including 
an acute change in mental status, impaired attention, symptom fluctuation and altered 
level of consciousness are not features of dementia (Steis et al 2012). In a study 
measuring nursing identification of DSD using standardised case vignettes, 83% (n=25) of 
nurses correctly identified dementia alone, but the diagnoses of delirium only 
(hyperactive 52% (15), hypoactive 41% (n=12), and DSD (hyperactive 59% (n=17), 
hypoactive 21% (n=6)) were more challenging (Fick et al 2007).  In the hard-to-assess 
patients with dual diagnoses, these results highlight that the diagnosis was perceived 
incorrectly by nursing staff about half of the time.  In hard-to-assess patients, validated 
tools are also prone to the same error rate.  The CAPD tool showed a specificity of 51.2 % 
in children with developmental delay (correctly identifying those children without PD only 
half of the time, compared with 86.5% in children without developmental delay (Traube 
et al 2014).  
These studies demonstrate the difficulties, with cognitive or behavioural assessments, of 
ascertaining a difference from baseline in patients whose baseline function is not known 
to the assessor.  Acknowledgement of the unique position that family caregivers are in 
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has led to the development of a screening tool for delirium which is completed by family 
caregivers (Steis et al 2012).  The Family Confusion Assessment Method (FAM-CAM) (Steis 
et al 2012) demonstrated a high level of agreement with an interviewer rating using a 
standard diagnostic assessment and a sensitivity and specificity of 88% and 98% 
respectively.  As care providers with most contact with the older person, family caregivers 
notice characteristic changes promptly; the study concluded that caregivers provided 
accurate and timely information to determine whether delirium was present, which could 
then be brought to the attention of clinicians, prior to a formal diagnostic assessment.  
2.5.1 Differential diagnosis of withdrawal in conditions of uncertainty 
As previously highlighted, a diagnosis of withdrawal is complicated in the paediatric 
critical care population due to the non-specific behavioural signs of withdrawal and the 
number of other possible differential diagnoses with a similar behaviour profile.  Given 
the unstable nature of these patients, and in the absence of a definitive diagnosis, a 
working diagnosis of withdrawal should be continually reviewed in light of the child’s 
overall condition, to detect and treat any clinical deterioration promptly.  Causality may 
also be complicated in this population by the tapering or stopping of more than one 
opioid or sedative drug concurrently as effective treatment requires the reintroduction of 
the causal drug rather than any sedative drug (Edwards and Aronson 2000).   
A key concept in adverse drug reactions (ADR) is causality, which describes the strength of 
the causal and temporal relationship between the drug and the undesired effect (Smyth 
et al 2014).  In the absence of a definitive test, an ADR diagnosis is described in terms of 
probability (certain, probable, possible, unlikely), depending on four criteria (Table 2.10); 
1. Temporal relationship between the drug use and the adverse event. 
2. Absence of other competing causes (medications, disease process itself). 
3. Response to drug withdrawal or dose reduction (dechallenge). 
4. Response to drug re-administration (rechallenge). 
As withdrawal is a Type E (end-of-use) ADR (Edwards and Aronson 2000), criteria 3 and 4 
would be reversed; the harm arising from stopping the drug (dechallenge), with 
improvement expected if restarted (rechallenge).  Classifying the likelihood of withdrawal 
in infants and children in critical care as probable, possible or unlikely (WHO-UMC, Gill 
1995, Gallagher et al 2011) may be better reflect these uncertain withdrawal 
circumstances, rather than the dichotomous diagnosis of yes/no or absent/present.  
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Table 2.14 The WHO–UMC causality assessment criteria (https://www.who-
umc.org/media/2768/standardised-case-causality-assessment.pdf)  
Categories Temporal 
relationship 
Absence of differential 
diagnoses 
Dechallenge* Rechallenge* 
 
Certain Yes  Yes  Yes  Yes  
Probable Yes Yes Yes No 
Possible Yes No No No 
Unlikely No No No No 
*Reversed in withdrawal 
 
2.6 Incidence and treatment of withdrawal syndrome in critically ill 
children 
There is considerable difference in the incidence of withdrawal reported between studies, 
ranging between 5% - 87% (Best et al 2015).  It is not clear what the causes for this 
variation are, but as withdrawal may take up to 36 hours to manifest (Fernandez-Carrion, 
2013), the time frame over which monitoring for behavioural signs of withdrawal occurs, 
may play a part.  Other contributing factors may be the different sedative combinations 
administered in PICU, or the absence of a consistent approach to the detection of 
withdrawal syndrome and/or a heterogeneous individual presentation of withdrawal.  
Withdrawal occurs in response to reducing or stopping sedative drugs in the physically 
dependent patient (DSM-5 2013).  In critically ill children, rapid tapering of sedative drugs 
may occur in patients being prepared for extubation (to avoid opioid induced respiratory 
depression and maximise the chance for successful extubation) and subsequent discharge 
from the critical care environment (Best et al 2015).  Abrupt discontinuation of sedative 
drugs may also occur inadvertently due to unexpected loss of intravenous access or as a 
consequence of vomiting after an oral drug has been administered.  In these 
circumstances the potential for withdrawal may be overlooked, or the more immediate 
focus on readiness for extubation may take precedence over the possible consequent 
development of a drug withdrawal syndrome.   
Despite the potentially high incidence of withdrawal, there is a paucity of literature 
regarding the treatment of withdrawal syndrome in critically ill children (Table 2.15).  
Treatment strategies, where described, include tapering at 10-50% per day and 
converting to oral equivalents of the causative drugs, slowing or stopping reductions in 
response to signs of withdrawal and adding in clonidine.  
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Table 2.15 Treatment of withdrawal syndrome in critically ill children 
Author Weaning protocol 
Cunliffe et al (2004) Continue reducing; stop reducing; increase to previously 
tolerated dose; seek advice/ add clonidine. 
Amigoni et al (2014) DaSilva 
et al (2016) 
10 -20 % reductions per day, convert benzodiazepines to 
lorazepam and opioids to methadone. 
Neunhoeffer et al (2015) Decrease sedatives by 50% every 24 hours if duration <5 
days, or by 10-20% every 24 hours if duration ≥ 5 days. 
Suspend reductions for 24 hours if SOS ≥4. 
 
2.7 Validated withdrawal assessment tools  
The main focus of the research into withdrawal in critically ill children has been on 
improving the detection of withdrawal. Two validated tools have been published; the 
Withdrawal Assessment Tool -1 (Franck et al 2008) and the Sophia Observation Scale (Ista 
et al 2009).  These tools will be critically reviewed in this second half of the chapter. 
 
2.8  The Withdrawal Assessment Tool-1 (WAT-1) (Franck et al 2008) 
The Withdrawal Assessment Tool – 1 (WAT-1) was constructed and validated within the 
context of a multicentre clinical trial testing a sedation management protocol on children 
intubated and mechanically ventilated for acute lung disease in the United States of 
America (USA) (Franck et al 2008, 2012).  The Randomised Evaluation of Sedation 
Titration for Respiratory Failure (RESTORE) trial required standardised assessments of 
adverse events including inadequate sedation management and clinically significant 
iatrogenic withdrawal across 31 study sites (Curley et al 2015).  The State Behavioural 
Scale (SBS) (Curley et al 2006), the tool adopted in the RESTORE trial to assess inadequate 
sedation, is a component of the WAT-1 tool. A brief overview of the construction and 
psychometric testing of SBS will be presented prior to a synopsis of the published WAT-1 
studies, an overview of the WAT-1 assessment, a comprehensive review of the reliability 
and validity components of these studies and identification of any omissions in reporting 
in light of the Standards for the Reporting of Diagnostic Accuracy Studies (STARD) 
checklist (STARD 2015).  
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2.8.1 The State Behavioural Scale (SBS) (Curley et al 2006) 
The SBS was designed to describe the sedation/agitation level in intubated patients on 
PICU (Curley et al 2006) (Appendix 2). The SBS score ranges from -3 to +2 and is based on 
the child’s behaviours before, during and after a standard progressive stimulus is applied 
to elicit a response (Table 2.16). The nature of the response is not specified.  The initial 
validation study for SBS was undertaken on 91 patients, aged 6 weeks to 6 years, sedated 
with a combination of opioids and benzodiazepines.  Exclusions included patients who 
were in pain, were physiologically unstable, at risk of opioid withdrawal or were receiving 
neuromuscular blockade.  Five distinct levels along the sedation-agitation continuum 
were identified from the data. The majority of patients were either calm or sedated, with 
fewer than 10% (n= 8) of patients presenting in an agitated state (SBS +1).  Curley et al 
(2006) added a further level (SBS +2) to represent extreme agitation, based on their 
clinical experience, although no patients in their study fitted this profile.  Validation of 
this level and further validation studies of SBS are awaited.  Given the low levels of 
agitated behaviour displayed and the exclusion of children at risk of opioid withdrawal, 
this study casts serious doubt on the reliability or rationale for including SBS in a 
withdrawal assessment tool.  There also appears to be a blurring of boundaries across the 
constructs of sedation and pediatric delirium, in light of the recently published delirium 
tools. Behaviours which are common to both SBS and the delirium tools are inattention, 
restlessness and inconsolability (Traube et al 2014; Smith et al 2016; Curley et al 2006). 
Table 2.16 SBS progressive stimulus (Curley et al 2006) 
Sequence  Stimulus 
1 Voice Nurse says the patient’s name in a calm voice. 
2 Touch If no response, nurse says the patient’s name and 
gently touches the patient’s body 
3 Noxious 
stimulus 
If no response, patient’s response to a planned 
noxious stimulus, such as endotracheal suctioning, or 
<5 secs nailbed pressure is elicited. 
   
The WAT-1 is a scale consisting of eleven physiological or observational items, which are 
summed to provide a withdrawal score ranging from 0 to 12 (Franck et al 2008) (Appendix 
3). WAT-1 scores ≥ 3 indicate withdrawal.  The authors have published two papers 
containing construction and validity data for WAT-1 (Franck et al 2008, 2012).  Both 
studies took place within the context of a clinical trial testing a sedation management 
protocol.  The inclusion and exclusion criteria WAT-1 are those of the parent RESTORE 
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trial (Table 2.17).  Patients, who were at least two weeks of age and less than 18 years old 
and who were intubated and mechanically ventilated for acute lung disease, were 
included in the RESTORE study.  
Table 2.17 RESTORE trial inclusion and exclusion criteria 
Inclusion 
criteria 
 At least 2 weeks of age (and at least 42 weeks post-menstrual age) and 
less  than 18 years of age 
 Intubated and mechanically ventilated for acute lung disease 
Exclusion 
criteria 
 Cyanotic heart disease with unrepaired or palliated right to left 
intracardiac shunt 
 History of single ventricle at any stage of repair 
 Congenital diaphragmatic hernia or paralysis 
 Primary pulmonary hypertension 
 Critical airway or anatomical obstruction of the lower airway 
 Ventilator dependent upon pediatric ICU admission 
 Neuromuscular respiratory failure 
 Spinal cord injury above the lumbar region 
 Pain managed by patient-controlled analgesia or epidural catheter 
 Patient transferred from an outside ICU where sedatives had already 
been administered for more than 24 hours 
 Family or medical team has decided not to provide full support 
 Enrolled in any other critical care interventional clinical trial 
concurrently or in the 30 days before study entry 
 Known allergy to any of the study medications 
 Pregnancy 
 
The initial construction study by Franck et al, included 83 children, median age 35 months 
(IQR 7-121 months) and was conducted in two PICUs between 2004 and 2006 (Franck et 
al 2008).  Exclusion criteria were not reported in this study and no reference was made to 
the exclusion criteria of the parent RESTORE study.  A prior study, the Opioid and 
Benzodiazepine Withdrawal Score (OBWS) (Franck et al 2004) contributed a pool of 
withdrawal items for the WAT-1 construction study. The OBWS study will be examined in 
Chapter 4.  Items defined as redundant (assessing sweating, unco-ordinated /repetitive 
movement, tremor, yawning and behavioural state during both prestimulus and stimulus 
stages), nonspecific (elevated respiratory rate, suctioning, dilated pupils) or difficult to 
assess (although no items were defined in this category) were rejected to create WAT-1.  
The subsequent validation study by Franck et al (2012) included 126 children, median age 
1.6 years (IQR 0.6-7.7 years) and was conducted in children with acute respiratory failure 
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supported on mechanical ventilation, in a multi-centre trial in 21 PICUs. The authors 
reported good psychometric performance and generalisability. Exclusions were reported 
as cyanotic heart disease, immediate post-surgery or neuromuscular respiratory failure, 
rather than the full list of RESTORE study exclusions. 
2.8.2 Performing a WAT-1 assessment 
WAT-1 is designed to be used twice a day, alongside the SBS sedation assessment, at 8 
am and 8 pm, and at other times if clinically indicated, during weaning of analgesics and 
sedatives.  The format and 12-hourly assessment schedule was copied from a neonatal 
withdrawal tool (The Neonatal Withdrawal Index, Zahorodny et al 1998); the rationale 
being to standardise the assessment period to before, during and after routine cares and 
reducing bias that occurs with frequent, serial measurement (Franck et al 2008).  No 
justification is provided for why the observation of withdrawal behaviours must be time-
limited, or the basis for a concern about serial assessments and the nature of the bias.  
The WAT-1 assessment schedule involves observing the child before, during and after the 
progressive stimulus, undertaken as part of the SBS sedation assessment (Curley et al 
2006) (Appendix 2).  During the 2-minute pre-assessment period the SBS score and five 
behaviours (tremor, sweating, uncoordinated repetitive movement, yawning or sneezing) 
are scored; a further two behaviours (startle to touch and muscle tone) are observed in 
response to the progressive stimulus and after the stimulus, the time taken for the child 
to calm (SBS score≤ 0) is also scored. Three further items (loose, watery stool, any 
vomiting, retching or gagging and temperature greater than 37.8C) are identified from the 
patient’s record over the previous 12 hours.  The SBS component of the withdrawal 
assessment can contribute a maximum of 3 points to the WAT-1 score.  
2.8.3 Interrater Reliability 
In the initial study, Frank et al (2008) reported interrater reliability as good; assessed by 
correlating WAT-1 scores of two nurses (a clinical nurse specialist and the bedside nurse), 
who simultaneously applied WAT-1 to 30 children (Cohen’s kappa 0.80; intraclass 
correlation 0.98).  
In the subsequent study, Frank et al (2012) assessed interrater reliability across 21 sites in 
the USA by correlating WAT-1 scores of two bedside nurses. Absolute agreement 
occurred in 349 of 420 (83%) paired assessments. The reason for variance in the 
remaining 17% of paired scores was not explored, but it is interesting, from a clinical 
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perspective, to speculate why these different perceptions of a patient’s behaviour may 
occur.  Nurses may have differed in their recognition of four component behaviours 
requiring a yes/no response (e.g., absent versus present), and/or their rating of behaviour 
intensity of the six behaviours requiring a severity rating (e.g., normal/mild versus 
moderate/severe).  Whatever the reason, the concordance rate for WAT-1 <3 versus 
WAT-1 ≥3 was much greater, at 97.4% and the Spearman rank correlation coefficient 
between paired scores was 0.93.  The difference between exact and ranked paired scores, 
in favour of ranked scores, demonstrates that there was a subjective, but consistent 
difference in the way individual nurses perceive the WAT-1 behaviours.  The concordance 
figures also show that differences in paired assessments did not result in to a difference 
in withdrawal diagnosis and so were not clinically meaningful.   
2.8.4 The impact of the inclusion of SBS on the internal consistency, content and 
construct validity of WAT-1: clinical perspective 
That WAT-1 measures a single phenomenon is cast into doubt by the inclusion of the 
State Behavioural Scale (SBS) (Curley et al 2006) impacting on construct validity.  No 
evidence is provided that demonstrates the necessary causal link between state 
behaviour and withdrawal syndrome which is an essential prerequisite for content 
validity (DeVellis 2012).  The justification for including SBS in the WAT-1 tool was not 
elucidated, other than the motivation for mirroring the style of the SBS assessment in 
terms of standardising the time over which the nurse observes for signs of withdrawal.  
The rationale for this may have been a pragmatic attempt to minimise the assessment 
burden on the nurses participating in the trial, in order to optimise compliance with the 
assessment schedule, by combining the sedation and withdrawal assessments. However, 
it is not known whether the WAT-1 structure of 8am and 8pm is a representative time 
frame or assessment period. Limiting the withdrawal assessment to a fixed duration at 
the start of a nursing shift, akin to a behavioural snapshot, risks the assessment being 
confounded by other aspects of the child’s clinical condition or transient causes of 
distress, rather than a reflection of the child’s general state.  This structure is entirely 
different to the SWS approach, where the assessment is based on behaviours noted over 
the previous 6 hours, which reduces the impact of transient distress (Cunliffe et al 2004). 
The cut point of WAT-1 as “a reasonable designation of clinically significant [withdrawal] 
symptoms” is a WAT-1 score ≥3 (Franck et al 2012, p147). This score can be accrued 
entirely from the SBS content of the WAT-1 tool, in a child who is distressed at the time of 
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the withdrawal assessment, regardless of the reason for distress.  The opportunity to 
undertake additional assessments at other times when clinically indicated was not 
documented and not explained.  Given that a child’s distress may stimulate the nurse to 
undertake an additional WAT-1 assessment; this has the potential to be a self-fulfilling 
prophecy resulting in a specious diagnosis of withdrawal, which further limits construct 
validity.  This possibility appears to be borne out by the number of patients (n= 242, 29%) 
who were reported as distressed at the start of the withdrawal assessment (SBS≥ 1) 
(Franck et al 2012). A similar number of patients (n= 268) took more than two minutes to 
settle after the withdrawal assessment; of these 109 (41%) took more than five minutes 
to settle (Franck et al 2012). 
Sedation is administered to the intubated child in an effort to achieve a calm but 
responsive state, signifying that the child is tolerating mechanical ventilation.   Sedation 
assessments are performed in the intubated child to monitor and maintain the treatment 
goal and to identify a child who is under- or over sedated.  Sedation and withdrawal 
assessments assess different aspects of care. Whereas agitation in the intubated child 
may indicate poorly tolerated mechanical ventilation, this is not the case for the 
extubated child where agitation may indicate, depending on the context, imminent 
hypoxia, pain, withdrawal, delirium, distress, fear or an ADR (Van der Zwaan, 2012).  
Withdrawal assessments are performed on intubated and extubated patients.  This aspect 
of the WAT-1 binds the assessment in the self-ventilating child to their response to being 
disturbed for cares, which might provoke an unfavourable response from the child, 
compared with observing behaviours at rest.  
It should be noted that peri-extubation agitation may prompt a withdrawal assessment. 
Whilst the study protocol advised against sedation assessments related to extubation, 
there was no mention about withdrawal assessments and the potential for Type II error 
inherent in agitation-based assessments during this time. 
2.8.5 The impact of the inclusion of SBS on the internal consistency, content and 
construct validity of WAT-1: statistical perspective 
Internal consistency is about the factor structure of a set of items.  Franck et al undertook 
exploratory factor analysis in 2008, when the relationship between the items was 
unknown. Subsequently in 2012, confirmatory factor analysis with varimax rotation, was 
undertaken which is a popular technique where all factors remain uncorrelated with each 
other and which aims to distribute items uniformly and load factors on one item only 
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(Streiner and Norman 2003).  Four factor solutions were identified in both studies, which 
accounted for 58% (2008) and 56% (2012) of the variance in analysis of all assessments. 
Factor structure varied between the 2008 and 2012 studies (Table 2.18 and 2.19). The 
factor loading in the 2008 study varied for children over 6 years (n=35, 42%) compared 
with the younger age groups (n=48, 58%).  In the older age group, motor-related 
symptoms and behavioural state loaded on the same factor and yawning and startle did 
not meet the threshold for inclusion in any factor (Franck et al 2008).  The main 
differences between factor solutions in the two studies include the absence of sneezing 
from any of the factors in 2008; the combination of yawning and sneezing in 2012 and 
their subsequent inclusion in two factors, albeit with factor loadings (0.43 and 0.46 
respectively) just above the threshold for inclusion in any factor (0.4).  The rationale for 
inclusion of yawning/sneezing was due to the occurrence of significantly higher WAT-1 
scores on the few assessments (n=67, 8%) when these behaviours occurred.  WAT-1 
scores median (IQR) were 4(3-6) when yawning/sneezing occurred and 1(0-3) when 
absent (Franck et al, 2012).  These differences in factors by age and study cast doubt on 
the identified factors being the high level interrelated solutions, typical of factor analysis. 
Table 2.18 Four-factor solution for WAT-1 (2008) 
Factor 1 Factor 2 Factor 3 Factor 4 
Motor-related 
symptoms 
Behavioural state Autonomic Gastrointestinal  
and yawning 
Tremor 
Startle to touch 
Uncoordinated/repetitive 
movements 
Muscle tone 
 
Prestimulus state 
and return to 
calm state 
Temperature 
Sweating 
Any vomiting, 
retching, gagging. 
Any loose/watery 
stools. 
Yawning 
 
 
 
Table 2.19 Four -factor solution for WAT-1 (2012) 
Factor 1 Factor 2 Factor 3 Factor 4 
Motor-related and 
yawning/sneezing 
Behavioural state Gastrointestinal Temperature and 
yawning/sneezing 
Tremor 
Startle to touch 
Uncoordinated/repetitive 
movements 
Muscle tone 
Yawning or sneezing 
Time to gain calm 
state ≥ 2 mins 
SBS ≥ +1 or 
awake, distressed 
Sweating 
Any vomiting, 
retching, gagging. 
Any loose/watery 
stools. 
Yawning or 
sneezing. 
Temperature > 
37.8C 
 
 
 
 
 56 | P a g e  
 
2.8.6 Concurrent validity 
The bedside nurse’s clinical judgement was the existing standard of care, which Franck et 
al (2008) described as a ‘tin standard,’ reflecting the lack of a gold (criterion) standard.    
Concurrent validity was assessed by Frank et al (2008) by comparing WAT-1 scores with 
the same nurses’ subjective rating of withdrawal intensity on a 0-10 Numeric Rating Scale 
(NRS). This showed a predictably high degree of convergence, given that the same nurse 
applied both the index (WAT-1) and criterion (NRS) tests.  Concurrent validity requires the 
independent corroboration that the instrument is measuring what it means to measure 
against a criterion standard (Bowling 2004).  This interdependence demonstrates a 
further serious limitation in the design of this study.  
2.8.7 Construct validity  
In both studies (Franck et al 2008, Franck et al 2012) construct validity was demonstrated 
by children with WAT-1 ≥3 having longer PICU and hospital stays, longer time undergoing 
mechanical ventilation, receiving greater cumulative opioid doses over a longer duration, 
prior to weaning, and taking longer to complete weaning compared with those with WAT-
1 <3. Construct validity in these terms is called predictive validity, which is demonstrated 
if WAT-1 scores are higher in patients who have a greater number of risk factors for 
withdrawal, than WAT-1 scores in patients with fewer risk factors.  However, Franck et al 
(2008) admit that the speed of weaning may also have been influenced by the initial 
WAT-1 scores, rather than being an indication of the underlying construct of withdrawal.  
The relationship between these variables and their role as risk factors for withdrawal was 
not explicated by Franck et al (2008, 2012). To better understand the cause and effect 
relationship between these variables, or risk factors, the researcher created a pictorial 
representation, as shown in Figure 2.1.  The concepts of physical dependence and WAT -1 
score ≥3 as an indication of withdrawal are represented as ovals. The variables, or risk 
factors, are represented as rectangles. Arrows show the direction of influence or effect.  
This model helps to clarify the causal relationships between the variables described by 
Franck et al (2008, 2012).  It shows that duration of mechanical ventilation is a risk factor 
for three variables; drug duration, cumulative dose and length of PICU stay. Duration of 
mechanical ventilation is also indirectly linked to length of hospital stay (through length of 
PICU stay) and indirectly to physical dependence (through drug duration and cumulative 
dose).  
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The five risk factors for WAT-1 ≥3 described by Franck et al (2008, 2012) are what might 
be best described as a ‘clinical tautology’ linked to the duration of mechanical ventilation.  
Patients who spend longer undergoing mechanical ventilation will receive sedatives over 
a longer duration, which will result in greater cumulative doses and are likely to be in 
PICU longer compared with patients who spend less time undergoing mechanical 
ventilation.   
 
Figure 2.1 A proposition of the causal relationships between the factors supporting 
construct validity for WAT-1 score ≥3 
In terms of risk factors for withdrawal, this model demonstrates that the only causal 
relationship or risk factor for, withdrawal appears to be the speed of weaning in the 
context of physical dependence. Franck et al (2008) reported that they were unable to 
examine the relationship between the weaning rate and the emergence of withdrawal 
symptoms due to variability of the weaning pattern during the study.  
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The remaining factors listed in support of construct validity for WAT-1≥3 indicating 
withdrawal are effects or consequences of the duration of ventilation. In other words, the 
duration of ventilation and the speed of weaning both have a causal relationship with, or 
are risk factors for sedative drug duration and the cumulative doses administered. Both of 
these drug factors, duration and cumulative dose, contribute to the development of 
physical dependence.  Duration of ventilation also has a causal relationship with, or is a 
risk factor for length of PICU stay and length of hospital stay.  As these factors are not risk 
factors for withdrawal, they do not support predictive validity of WAT-1≥3 indicating 
withdrawal. 
Franck (2008) concluded that WAT-1 showed greater validity than NRS due to better 
performance in relation to known risk factors such as opioid exposure and length of 
therapy.  This is an illogical proposition, as the validity of the reference test is the basis 
upon which to demonstrate the criterion validity of the index test; hence questioning the 
validity of the reference test casts doubt in the validity of the index test.  However, 
evidence of construct validity is considered more important than criterion validity if the 
index test has been developed to predict the severity of a construct by means of an 
observable behaviour (Streiner and Norman 2003), as is the case for WAT-1.   
2.8.8 Discriminant validity  
Discriminant validity, the lack of correlation with unrelated differential diagnoses, was not 
reported in either study. However, it was highlighted as a limitation on the first study 
(Franck et al 2008) in relation to the impact on withdrawal symptom intensity of the 
patient’s primary medical condition.  It is also not clear that SBS discriminates other 
causes of agitation including pain, hypoxia and withdrawal, as patients with these 
conditions were not included in the validation study of SBS (Curley et al 2006). 
2.8.9 Measures of diagnostic accuracy 
Sensitivity and specificity were presented in the construction study as measures of the 
diagnostic accuracy of WAT-1 (Franck et al 2008).  The Positive Predictive Value (PPV) is a 
measure of how well WAT-1 discriminates withdrawal from other unrelated differential 
diagnoses.  However, results of the reference standard, prevalence of withdrawal and 
positive and negative predictive values were not presented.  The extent of these 
omissions can be seen in Figure 2.2; where each of the four boxes in the cross tabulation 
table should contain accuracy data demonstrating the agreement and disagreement 
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between the reference standard and the index test.  The relationship between sensitivity, 
specificity, prevalence and positive and negative predictive values is also shown in Figure 
2.2 and allows the calculation of the missing figures to be performed.  The missing 
statistics were derived from a key piece of data reported in text in the data analysis 
section of the paper stating that NRS ≥ 4 represented “top 20th percentile of scores, likely 
in withdrawal” (Franck et al 2008, p.575). 
This statement provided the number of NRS ≥4 scores, from which the number of NRS ≤3 
could be determined. The number of NRS ≥4 equates to (TP + FN) and the number of NRS 
≤3 equates to (TN + FP).  TP was then calculated from sensitivity and FN was calculated 
from specificity. Calculations performed to identify missing accuracy statistics are shown 
in Table 2.20.  A cross tabulation with these results is shown in Figure 2.3. 
As the cross tabulation of index and reference tests was not presented or a rationale for 
the distribution of alternative diagnoses in the false positive cohort. These omissions limit 
the validity of this study findings and do not meet the STARD reporting criteria (STARD, 
2015), the first version of which was published in 2003, prior to the publication of this 
study. 
 
 True condition 
NRS “Tin standard” 
 
NRS ≥4 
Present 
NRS ≤3 
Absent 
 P
red
icted
 
co
n
d
itio
n
 
WAT-1  
≥ 3 
True positive  
(TP) 
False positive  
(FP) 
Type I error 
Positive predictive 
value 
=TP/ (TP+FP) 
WAT-1  
≤ 2 
False negative  
(FN) 
Type II error 
True negative  
(TN) 
Negative predictive 
value 
=TN/ (TN+FN) 
 
Sensitivity 
=TP/(TP+FN) 
=0.872 
Specificity 
=TN/(TN+FP) 
=0.880 
Prevalence  
= (TP+FN)/ 
(TP+FP+FN+TN)  
 
    Bold findings were published.  
Figure 2.2 Cross tabulation emphasising missing data (2008 study) 
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Table 2.20 Calculation of diagnostic accuracy for WAT-1 
 
 
 
 
 
 
 
Bold figures were published by Franck et al (2008). 
 
 True condition 
NRS “Tin standard” 
 
NRS ≥4 
Present 
NRS ≤3 
Absent 
 P
red
icted
 
co
n
d
itio
n
 
WAT-1  
≥ 3 
True positive (TP) 
142 
False positive (FP) 
78 
Positive predictive 
value 
=TP/ (TP+FP)= 0.65 
WAT-1  
≤ 2 
False negative (FN) 
21 
True negative (TN) 
575 
Negative predictive 
value 
=TN/ (TN+FN)= 0.96 
 
Sensitivity 
=TP/(TP+FN) 
=0.872 
Specificity 
=TN/(TN+FP) 
=0.880 
Prevalence  
= (TP+FP)/ 
(TP+FP+FN+TN)  
= 20% 
Figure 2.3 Cross tabulation of NRS ≥4 with WAT-1 score ≥3     Bold findings were 
published. 
  
NRS≥4 = top 20th centile = 20% of total (n=816) = 163 
Hence NRS≤3 = total (n=816) - NRS≥4 = 816 – 163 = 653 
NRS≥4 = TP + FN = 163  NRS≤3 = FP + TN = 653 
Sensitivity = TP/(TP+FN) =0.872        Specificity = =TN/(TN+FP) =0.880 
TP = 0.872 x 163 = 142  TN = 0.88 x 653 = 575 
FN = 163-142 = 21   FP = 653-575 = 78 
PPV = 142/(142+78) = 0.65  NPV = 575/(575+21) = 0.96 
Prevalence = (142+21) /816 = 20% 
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2.9 Sophia Observation Scale (SOS) (Ista et al 2009) 
The Sophia Observation Scale (SOS) is a physiological and observational scale consisting of 
fifteen items that provide a global withdrawal score ranging from 0 to 15 (Appendix 4). 
The assessment involves observing the patient for three physiological signs (heart rate, 
respiratory rate and temperature), ten behaviours (sweating, agitation (or irritable or 
restless or fidgety), anxiety, tremor, motor disturbance (involuntary movements of the 
limbs, muscle twitching, choreoathetosis of arms, legs and/or head), increased muscle 
tension, inconsolable crying, grimacing, sleeplessness and hallucinations) and gathering 
two further items (episodes of vomiting and/or diarrhoea) from the patient’s record.  SOS 
is designed to be used every 4 hours, during opioid and benzodiazepine weaning.  
The scale components of SOS are derived from a pool of 24 items formulated for the 
Sophia Benzodiazepine and Opioid Withdrawal Checklist (SBOWC) and published by the 
same research team (Ista et al 2008).  These items were tested on children and refined 
through a combination of factor analysis and expert opinion. The SBOWC study will be 
examined in Chapter 4. 
The SOS construction study (Ista et al 2009) included 79 children, median age 3.4 months 
(range 0-15.5 years) and was conducted on a single site.  Children in PICU, aged ≤ 16 
years, were eligible for inclusion if they received midazolam and/ or opioids by 
continuous infusion for at least 5 days.  Exclusion criteria were status epilepticus treated 
with midazolam, use of neuromuscular blocking agents and severely disturbed behaviour 
pattern as a result of underlying neurology. The subsequent validation study (Ista et al 
2013) included 154 children, median age 5 months (IQR 0-42 months) and was conducted 
in the same setting, with the same inclusion and exclusion criteria.  
2.9.1 Reliability  
2.9.1.1 Interrater reliability  
In the SOS construction study (Ista et al 2009), interrater reliability was assessed by 
correlating scores of two nurses; the bedside nurse, who had received verbal and written 
instruction on the application of SBOWC, and the principal investigator who 
simultaneously applied 23 items from SBOWC (ICC 0.97 (95%CI 0.92-0.98).  The Cohen’s 
kappa, which tests exact agreement rather than extent of correspondence, for individual 
items of the SOS ranged from 0.73 to 1.0. Although these kappa scores are satisfactory 
from a statistical perspective, any kappa less than 1 indicates occasions when two nurses 
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observing the same child for the same behaviour disagree on the presence or absence of 
the behaviour. This may be due to the complexity of interpreting behaviour in critically ill 
children or arise from differences in nurses understanding of the behavioural items.  The 
subsequent study (Ista et al 2013) did not report further reliability testing. 
2.9.1.2 Internal consistency 
Multidimensional scaling (MDS) was performed and a three dimensional solution was 
identified, which was described as statistically robust. The purpose of MDS is to simplify a 
complex matrix to show the relationship between items being analysed.  Ista et al (2009) 
reported that the dimensions did not constitute the homogenous clusters of behaviours, 
which would be expected when detecting meaningful underlying dimensions.  This means 
that although statistically robust, these dimensions did not translate to a clinically 
meaningful explanation for the manifestation of withdrawal.  This led the team to suggest 
that withdrawal signs may vary between individuals (Ista et al 2009), an admission which 
conflicts with the necessary underpinning assumption of homogeneous presentation 
when constructing an assessment tool with summed behavioural items (Streiner and 
Norman 2003).   
 
2.9.2 Validity 
2.9.2.1 Content validity  
Signs of withdrawal were gathered from the literature and refined through a combination 
of factor analysis and the expert opinion. The expert panel constituted 85 clinicians (22 
doctors and 63 nurses) who had worked for a median of 8 years; it was not reported 
whether this work experience was on PICU.  
2.9.2.2 Concurrent validity 
Nurses’ expert opinion was considered the ‘silver standard’ by Ista et al (2013), in the 
absence of a gold standard.   The Numeric Rating Scale (NRS) is a 0-10 scale of withdrawal 
intensity with 0 indicating no withdrawal and 10 indicating the worst possible withdrawal. 
An NRS score ≥4 was considered to reflect withdrawal syndrome, a claim substantiated by 
reference to the initial WAT-1 study (Franck et al 2008); where the authors had described 
the nurses’ opinion as a ‘tin standard’ which infers a second-rate reference test.  In 
common with the WAT-1 studies, the interdependence between index and reference 
tests demonstrates the same serious limitation in study design.  In common with the 
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WAT-1 study, no details about the validity or inter-rater reliability of the NRS scale, was 
presented. Concurrent validity was assessed by comparing SOS scores with NRS scores in 
3754 paired assessments.  Sensitivity and specificity were 0.83 and 0.93 respectively for 
an SOS ≥4 calculated against an NRS score ≥4.   
2.9.2.3 Discriminant validity 
The positive predictive value (PPV) was 0.49, which means that among those who had an 
SOS ≥4, the probability of withdrawal was 49%.  Ista et al (2013) reasoned that the low 
PPV may be due to the overlap of symptoms between pain, distress, delirium and 
withdrawal. Excluding children whose presentation may make SOS unreliable, limits the 
clinical utility of the tool.  In the conditions within which SOS functions, the item content 
of the tool covers other differential diagnoses, not just withdrawal.  The challenge of 
interpreting other differential diagnoses and the low PPV suggests that SOS does not 
make this easier.  Similarly to WAT-1, further studies examining whether SOS is more 
specific for withdrawal than other differential diagnoses, and performance in patients 
excluded from initial validation studies are awaited. 
 
2.9.3 SOS (Ista et al 2013) 
The objectives in the second SOS study were to establish cut-off scores, test sensitivity to 
change and identify risk factors for withdrawal syndrome (Ista et al 2013). These 
objectives will be summarised in turn. 
The cut-off score of SOS ≥ 4 indicating withdrawal proved controversial, with nursing 
opinion of withdrawal (NRS ≥ 4) conflicting with this diagnosis in more than half of the 
assessments where SOS ≥ 4, shown by PPV 0.49.  However, no accuracy data for the NRS 
scale were presented. The measure of diagnostic accuracy will be considered in detail. 
2.9.3.1 Measures of diagnostic accuracy 
Ista et al (2013) provided most of the diagnostic accuracy data recommended by STARD 
(2015) for transparency and completeness. Sensitivity, specificity, positive predictive 
value (PPV) and negative predictive value (NPV) were reported in this study.  Sensitivity 
shows how likely it is that the patient is withdrawing, when they have an SOS score ≥4.  
Sensitivity of SOS≥4 is 0.83.  Interpretation of sensitivity of the new test relies on the 
reference test being accurate, as this is what the new test is being measured against. 
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Screening instruments, such as SOS, prioritise high sensitivity to optimise detection of the 
condition being screened for (Traube et al 2014). 
Positive and negative predictive values are the proportions of positive and negative 
results that are true positive and true negative results, respectively.  The PPV of SOS≥4 is 
0.49, which means that SOS≥4 accurately reflects withdrawal in less than half of 
assessments. The low PPV was highlighted as a major flaw by Ista et al (2013), and was 
explained as the overlap of symptoms with pain, distress and delirium.  This justification 
highlights a fundamental flaw with SOS, as noted earlier “items must share one and only 
one underlying variable if they are to be combined into a scale” (DeVellis, 2012 p.159). 
The number of true and false positives and true and false negatives were not reported 
but these figures were calculated from the data reported in the study. The figures for 
false positives and negatives reflect the clinical utility of a scale and identify potential 
strengths and weaknesses.  False positives are also described as Type I errors, which 
indicate a diagnosis of withdrawal when withdrawal is absent. False negative are 
described as Type II errors, indicating a failure to detect withdrawal. 
The relationship between sensitivity, specificity, PPV and NPV can be demonstrated in a 
cross tabulation table of NRS≥4 with SOS≥4 and also shows how the missing values can be 
calculated (Figure 2.4).  The findings that were published by Ista et al (2013) are identified 
in bold. Calculations performed to identify missing accuracy statistics are shown in Table 
2.21. 
These calculations showed that SOS produced 56 false negatives and 258 false positives 
out of 3754 assessments.  These results suggest that nurse opinion (NRS≥4) is more 
accurate at screening for withdrawal that SOS is. 
The prevalence of withdrawal in this sample was 8%.  Ista et al (2013) reported the 
prevalence of withdrawal in the study sample as 48% by describing the population (N) as 
the number of patients who scored SOS ≥4 (the index test) out of the total of 154 patients 
in the study. The prevalence of 8% calculated in Table 2.21 reflects the statistical 
definition of prevalence which is based on the reference test number of true positive and 
false negative screens (n=303) out of the total number of assessments (n=3754).  
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 True condition 
NRS “Silver standard” 
  
NRS ≥4 
Present 
NRS ≤3 
Absent 
 
 P
red
icted
 co
n
d
itio
n
 
SOS ≥ 4 
Positive 
True positive  
(TP) 
False positive  
(FP) 
Type I error 
 
SOS≥4 
(TP+FP)  
= 505 
Positive predictive 
value 
=TP/ (TP+FP) 
=0.49 
SOS ≤ 3 
Negative 
False negative  
(FN) 
Type II error 
True negative  
(TN) 
 
SOS ≤ 3 
(FN+TN) 
Negative 
predictive value 
=TN/ (TN+FN) 
=0.98 
 
 
NRS≥4 (TP+FN) 
= 303 
NRS ≤3 
(FP+TN) 
 
Prevalence  
= (TP+FN)/  
(TP+FP+FN+TN)  
(3754) 
 Sensitivity 
=TP/(TP+FN) 
=0.83 
Specificity 
=TN/(TN+FP) 
=0.93 
 Figure 2.4 Cross tabulation of NRS ≥ 4 with SOS ≥ 4              Bold findings were published.  
 
Table 2.21 Calculations of false positives and false negatives for SOS 
 
 
 
 
 
 
 
 
2.9.3.2 Sensitivity to change and risk factors 
Sensitivity to change was evaluated in 156 paired SOS assessments in 51 patients before 
and after administration of sedatives or opioids to treat withdrawal symptoms. A mean 
decrease in SOS scores of 1.47 occurred, which was described as statistically significant. 
Clinical significance would also require the patient changed to “not withdrawing” (SOS ≤3) 
in response to the intervention.  No further details were provided about this cohort of 
patients.  Sensitivity to change may be more clearly understood if Ista et al (2013) 
published the range of SOS scores before and after rescue therapy and showed the trend 
in scores leading up to and after the high score. 
PPV = TP/(TP+FP) = 0.49 
TP+FP = 505 
Hence TP = 0.49 x 505 = 247 and FP=505-247= 258 
TP+FN=303 
Hence FN= 303-247 =56          
TN = 3754 – (TP+FP+FN) = 3754 -561 = 3193 
Prevalence = 303/3754 = 8% 
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Risk factors were analysed by comparing clinical data for those patients who had at least 
one score of SOS ≥ 4 during the weaning period with the rest of the sample.  The basis for 
comparing these two groups is debatable, given the extent of the disagreement between 
this cut-off score and nurses’ opinion of the diagnosis of withdrawal.  No information was 
presented on what impact a score of SOS≥ 4 had on weaning rates, that is, whether 
weaning was stopped, slowed or continued as a result. However, duration of weaning 
was more than twice as long in patients with SOS≥ 4 compared with SOS≤3. 
Ista et al (2013) presented risk factors for withdrawal in terms of clinically and statistically 
significant differences in patients with at least one SOS score ≥4 compared with patients 
with all SOS scores ≤3.  These factors or differences were duration of ventilation, the 
length of stay on PICU, duration of midazolam infusion, duration of midazolam weaning 
and cumulative dose of midazolam (Table 2.22). These factors are very similar to those 
reported by Franck et al (2008) in support of the construct validity for WAT-1. The 
relationship between these variables and their role as risk factors for withdrawal was not 
explicated by Ista et al (2013).   
Table 2.22 Clinically significant differences between patients with SOS ≥4 and SOS ≤3 
(median (Interquartile Range)) (reported by Ista et al 2013) 
Characteristic No withdrawal 
(n=80) 
(all SOS scores ≤3) 
Withdrawal (n=74) 
(≥ one SOS score ≥4)  
p 
Duration of ventilation 
(days) 
10 (6-15) 15 (8-29) 0.001 
Length of PICU stay (days) 
 
11 (8-19) 25 (16-44) <0.0001 
Midazolam duration 
(including taper) (days) 
9 (6-14) 17 (9-27) <0.0001 
Midazolam duration of 
weaning (days) 
3 (1-7) 7 (3-15) <0.0001 
Midazolam cumulative 
dose (mg/kg) 
34.8 (16.9-71.8) 77.9 (34.6-169.6) <0.0001 
 
Referring back to the model of the causal relationship between the variables (Figure 2.1); 
as these factors do not have a causal relationship with withdrawal, they are not risk 
factors for withdrawal.  These factors are risk factors for physical dependence 
(ventilation, drug duration, cumulative dose) or the consequence of duration of 
mechanical ventilation (length of PICU stay). The duration of taper for patients in the SOS 
≥4 group was nearly double that of patients in the SOS≤ 3 group. This finding suggests 
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tapering was slowed or stopped in consequence to the score or patient response, but 
these interventions were not reported by Ista et al (2013).  It may be possible that the 
speed of weaning may have been influenced by the initial SOS scores, rather than being 
an indication of the underlying construct of withdrawal, as conceded by Franck et al 
(2008). 
 
2.10 Discussion (WAT-1 and SOS) 
The rigor of both the WAT-1 (Franck et al 2008, 2012) and SOS (Ista et al 2009, 2013) 
studies suffers from the lack of an independent reference standard, thwarting the 
prospective design of these validation studies. The observational nature of a withdrawal 
assessment tool relies on the person applying the tool being familiar with their patient’s 
behaviours, which makes it difficult to undertake the concurrent, independent 
assessment.  The positive predictive value of SOS (0.49) was less than chance. The PPV for 
WAT-1 was not published, but was calculated by the researcher as 0.65, meaning it 
correctly identifies withdrawal 2 times out of 3.  Content validity of WAT-1 is flawed by 
the inclusion of a sedation/agitation assessment which has not been validated in patients 
who are withdrawing or in pain.  WAT-1 was only ever tested in a medical population, so 
it is not clear how the tool would perform in post-operative patients; whether it could 
discriminate pain behaviour from withdrawal behaviour. 
2.10.1 Opioid conversions  
One of the steps taken in both validation studies was the conversion of opioids to 
morphine equivalents to aid analysis and allow for inferences to be made in terms of 
construct validity of the index test.  Construct validity would be demonstrated if the index 
test performs as predicted in response to a change in a given variable: in this case a 
positive correlation between withdrawal tool scores and cumulative or peak opioid doses.  
Franck et al (2012) noted that peak opioid doses may be influenced by opioid conversions 
used, suggesting a calculation effect, rather than a clinical effect.  These studies used the 
conversion fentanyl 15 micrograms = morphine 1mg (1:66).  However, recent 
commentary on these conversion ratios casts doubt on the assumptions upon which this 
step was based.  The equianalgesic dosing guidance currently used has not been formally 
validated (Fine et al 2009) and was established on non-opioid tolerant adult patients, with 
no concurrent illness or comorbidities (Knotkova 2009, Patanwala 2007).  These findings 
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suggest a formulaic conversion between opioids of different potencies is an 
oversimplification (Patanwala 2007).  If, in clinical terms the conversion should be treated 
with caution, in validity terms, any inferences arising from the conversion should also 
then be treated with caution. 
This validation step also overlooks the inter-individual differences in opioid requirements: 
essentially a patient effect as well as a drug effect.  Katz et al (1994) reported that PICU 
patients may require a 10-fold variability in fentanyl infusion rates to achieve similar 
levels of sedation.  Anand et al (2010) noted that infants are susceptible to greater 
tolerance with fentanyl compared with morphine.  The impact of both conversion-effect 
and individual response was demonstrated in a trial of methadone tapering in PICU 
patients weaning from fentanyl (Bowens, 2011).  Patients were randomised to either a 
standard low dose weight-based methadone dose or a bespoke high dose, which also 
accounted for their most recent fentanyl dose.  Contrary to expectations, both regimes 
had similar efficacy, even in patients on high dose fentanyl and/or over a longer duration, 
but over-sedation was a risk in the high dose group.  Bowen and colleagues concluded 
that the methadone dose had to be personalised to each child’s response, to minimise 
the risk of over-sedation or withdrawal, the incidence of which could not be predicted 
based on the cumulative dose of fentanyl.   
Inferences would only be true if there was a clinically accurate conversion and no 
interpatient variability in dosing.  
 
2.11 Conclusion   
This chapter has summarised what is known about the assessment and management of 
withdrawal in critically ill children.  It has also highlighted the contextual complexity 
within which these assessments are performed; children may be weaning from more than 
one sedative agent and other differential diagnoses are common and share similarities in 
their behavioural presentation with withdrawal.  WAT-1 and SOS have been developed to 
standardise the assessment and recognition of withdrawal in PICU patients weaning from 
opioids and benzodiazepines.  However, this is not a homogeneous patient group in 
clinical practice and evidence from this critical consideration of the tools reveals little 
support for the diagnostic principle that a single summed score is sensitive enough to 
differentiate withdrawing and not-withdrawing patients.  
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Cut points for both tools have been identified but there was little evidence provided in 
support of these assertions.  In addition it is not clear what clinical utility this presents, as 
children with clinically significant withdrawal presented with a range of scores in both 
studies.  Useful cut points should distinguish between three patient states and treatment 
options:  
 No signs of withdrawal: continuing weaning.  
 Signs of withdrawal, some impact on the patient: stop weaning and review. 
 Signs of withdrawal, significant impact on the patient: stop weaning, increase / add 
sedation 
This review has also highlighted what is not known about withdrawal. This syndrome lacks 
a name, a definition and diagnostic criteria. Risk factors for withdrawal are confused with 
those for physical dependence. This may be because physical dependence and its variable 
onset in critically ill children are also poorly understood. The next chapter will address 
how the studies presented in this thesis were designed to increase the evidence base for 
the assessment and management of withdrawal in critically ill children. 
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Chapter 3:  Methodology and conceptual framework 
 
3.1 Introduction  
In this chapter I will present the conceptual framework for this thesis and the 
methodology and methods employed to answer the research questions.  The researcher 
perspective is also presented to demonstrate reflexivity. 
This thesis adds to this body of knowledge about withdrawal syndrome in critically ill 
children with four studies, each contributing a different perspective of this subject. Two 
evaluative studies of existing tools will be complemented by exploration of the nurse and 
parent perspectives of withdrawal assessment.  The nurse and parent perspectives will be 
viewed through the theoretical lens of judgement and decision making; theories which 
also provide an analytical framework for the clinical impact of the study findings.   
The findings from these different perspectives will be merged in a synthesis chapter.  
Merging these perspectives enhances and enriches the understanding and meaning of the 
existing single perspective (Creswell and Plano Clark 2011).  This process, called 
integration, is a key feature of mixed methods research (Fetter et al 2013).  
The choice of an interactive multiphase mixed methods design is explained and the 
purpose and design of the component studies articulated.  A pragmatic approach is taken, 
which does not commit to one philosophical view of reality and focuses on solutions to 
problems, rather than the abstract pursuit of knowledge (Creswell 2013; Morgan 2007).  
A thesis map is presented to demonstrate the interactive mixed methods design. 
 
3.2 Conceptual framework 
A conceptual framework in a mixed methods study is a framework that provides a general 
explanation as to what the researcher will find from the results (Greene 1989). This 
framework can be presented as a model, conceptual framework, theory or philosophy. 
To date, published research has focussed on one perspective of withdrawal assessment; 
the objective stance revealed in efforts to standardise the nurse’s assessment using a 
withdrawal assessment tool.  The attempt to standardise represents the positivist view 
that objectivity is truth (Onwuegbuzie and Leech 2005).  The underpinning assumption in 
this approach is generalisability – which means that all withdrawing patients present in a 
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similar fashion, or share sufficient signs in common, to be assessed by nurses applying a 
standardised assessment tool.   
3.2.1 A priori study conceptual framework 
The conceptual framework for withdrawal assessment upon which the a priori studies 
were based is shown in Figure 3.1. These studies were designed to demonstrate how the 
parental perspective contributed to recognition of withdrawal and could enhance the 
existing approach based on the assumption that the parent perspective contributed 
uniquely to the withdrawal assessment.  This represents the researcher’s view and the 
study hypothesis that the parental contribution augments an assessment based only on 
the nurse perspective by providing a more personalised withdrawal assessment, which 
enhances and enriches the meaning of equivocal behaviours.  
 
 
Figure 3.1 Conceptual framework for the a priori study  
The study design changed in response to analysis of findings from Study 1 (SWS 
evaluation). This interactive process reflects the models of research design presented by 
Maxwell and Loomis (2003) and Johnson (2014).  Both models place the research 
questions at the core and describe a non-linear or recursive process between the 
research questions and stages or steps in the research process.  For Maxwell and Loomis 
(2003) there is a continual interaction of the research questions, purpose, conceptual 
model, methods and validity the conceptual model, methods and validity.  For Johnson 
(2014) there are eight steps in a continual loop, including choice of and rationale for 
mixed methods, design, data collection, analysis, validation and interpretation and writing 
up.   
The conceptual framework for withdrawal assessment was modified recursively in 
response to the continual interaction between findings in the nurse and parent studies to 
SWS signs 
(nurse) 
Trend (parent) 
Typical 
behaviour 
(parent) 
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create a framework which demonstrated why the existing approach was incomplete and 
prone to error. 
3.2.2 Creating the conceptual framework for the studies presented in this thesis 
The idea for the structure of the framework was borrowed from the way clinical tools are 
evaluated by comparing, or cross tabulating results from the index test and the reference 
test. Cross tabulation by the researcher of the WAT-1 and SOS tools were presented in 
the literature review chapter (Figures 2.3 and 2.4).  Cross tabulation is a tool that allows 
comparison of the relationship between two variables or factors. The factors 
underpinning the conceptual framework comprise dualisms of perspective.  One 
perspective encompasses the person-based dualism of nurse and parent. This dualism 
contrasts the nurses’ expertise in assessing children and the parents’ expertise about 
their child; differentiating nurses “knowing children” and parents “knowing their child.” 
The second perspective encompasses the interpretive dualism of objectivity and 
subjectivity. This dualism contrasts the objective assessment of withdrawal using a 
withdrawal assessment tool with the subjective personalised assessment of the patient 
and their unique context; differentiating the parts of the assessment that are “agreed 
upon” from those that are “construed.” 
When two factors, each containing two levels are cross tabulated, a matrix is created with 
four cells.  The interactive conceptual framework for withdrawal assessment presents 
these four different combinations as a 2 x 2 factorial matrix with withdrawal signs, at the 
core (See Figure 3.2).  Cross tabulating the person-based dualism and interpretive dualism 
creates four different combinations; 
1. The nurse objective view; “nurse assessment” 
2. The nurse subjective view; “ nurse judgement” 
3. The parent objective view; “parent assessment” 
4. The parent subjective view; “parent judgement” 
The four combinations in the matrix characterise the multiple viewpoints of the pragmatic 
approach with the different approaches of interpretation or decision-making which frame 
this thesis. Each combination in the matrix represents a different view of withdrawal 
behaviour; the nurse’s objective view using a withdrawal assessment tool; the nurse’s 
subjective view interpreting the meaning or context of the behaviours; the parent’s 
objective view recognising SWS signs and the parent’s subjective view recognising 
changes in their child’s usual behaviour.  This framework demonstrates how each study 
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contributes a novel perspective to understanding this clinical phenomenon. The studies 
undertaken and presented in the thesis are mapped on the matrix. 
Figure 3.2 The conceptual framework  
 
3.3 The conceptual framework, the pragmatic approach and mixed 
methods research 
Pragmatism is the dominant worldview underpinning mixed methods research.   
In harmony with the world view of pragmatism, truth is what works at the time; which 
contends that whilst the positivist view is one view, other viewpoints exist (Onwuegbuzie 
and Leech 2005). This contrasts with the positivist view taken by existing withdrawal 
assessment studies (Franck et al 2008, 2012; Ista et al 2009, 2013).  The conceptual 
framework described above, embraces and transcends opposing philosophical dualisms, 
placing withdrawal signs at the core to be illuminated by all perspectives.  The mixed 
methods approach allows for problems such as withdrawal assessment to be viewed from 
multiple perspectives to enhance and enrich the meaning of the existing singular 
perspective (Bryman 2008).  
The existing singular perspective is the nurses’ objective view, using withdrawal 
assessment tools.  In terms of the objective/subjective dualism, objective decision-making 
is seen as standardised and predictable, whereas subjective decision-making is 
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contextual, personal and unpredictable.  In terms of the nurse/parent dualism, this 
relationship reflects the emic and etic viewpoints of ethnography (Lambert et al 2011). 
The etic, or nurse perspective is the scientific, outsider or observer view of reality (Spiers 
2000). The emic, or parent perspective is the insider view, reflecting multiple realities and 
is “silent in healthcare literature” (Spiers 2000, p 716).  
In terms of ontology, pragmatists consider objective and subjective viewpoints exist on a 
continuum; the chosen viewpoint depending on the research question being asked 
(Creswell, 2003).  Hypothesising that the nurse and parent may not make the same 
interpretation of a child’s behaviour, challenges the positivist view of truth.  Whilst 
positivists adopt the ontological view of an objective truth or “God’s-eye view” (Rorty, 
1990 p2), pragmatists accept the notion of practical truths, which describe a contextual, 
agreed truth (James, 1907).  This ontological view corresponds to the different 
perspectives, contexts and underlying condition which may impact uniquely on how each 
patient’s withdrawal presents and is perceived.   
3.4 Research methodology 
Pragmatism uses purposeful human inquiry as it focal point (Shields 1998) which 
emulates the primary focus of this thesis of improving withdrawal assessment.  A 
pragmatic research approach is concerned with finding solution to problems (Patton, 
1990) and it is achieved by using research methods that best meet this purpose (Creswell, 
2013).  A pragmatic epistemology underpinned the mixed methods approach taken, with 
component studies encompassing both quantitative and qualitative approaches and 
triangulation of data, research methods and theory. Each study contributed 
independently to new knowledge, from each of the viewpoints described in the 
conceptual framework.  Each study informed the subsequent studies. Equal contribution 
from both qualitative and quantitative studies represents an equivalent status design 
(Tashakkori and Teddlie, 1998).  Rorty (1982) supports the view that research should 
begin with and be guided by previous studies. The qualitative components of this thesis 
(Part 3 and 4) not only illuminated the nurse and parent perspectives, but also served to 
aid the interpretation of statistically significant findings from previous quantitative-based 
research studies. 
3.5 Researcher perspective 
In mixed methods research, the researcher presents their philosophical beliefs and 
assumptions about research. This enables the reader to identify the researcher’s potential 
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biases and predispositions and the influence these may have on the research process.  
Critical self-reflection by the researcher, called reflexivity, describes the process of 
recognising and minimise these biases (Creswell 2013).  The a priori study design 
reflected the researcher’s perspective, which was based on over a decade of clinical 
experience assessing and managing sedation withdrawal in critically ill babies and 
children.   
The SWS tool is central to the current approach to the assessment and management of 
sedation withdrawal.  The SWS score is assessed by the child’s nurse every six hours 
during weaning of sedative drugs.  Whilst clinically useful in identifying behavioural trends 
in response to sedative weaning rates in stable patients, it is less reliable in unstable 
patients with a range of differential diagnoses.  In these cases, the clinical context must 
be considered and other causes for behaviours should be excluded.   
Anecdotally, the parent perspective contributes a unique interpretation of behaviours to 
assist the specialist team in differentiating causes which share behavioural signs in 
common.  Parent’s knowledge about changes over the previous hours or days arises from 
their constant presence at the child’s bedside; insight which is missing from the formal 
withdrawal assessment undertaken by nurses.  The parent account of the onset and trend 
of equivocal behaviours also provides contextual insight which assists in identifying or 
excluding the diagnosis of withdrawal.  Alternatively, parents may describe behaviours as 
being typical of the child prior to critical illness, and which represent “usual behaviour” 
rather than emerging withdrawal syndrome; an interpretation which relying on familiarity 
with the child, is not available to nurses.  In these circumstances, the parent perspective 
helps to delineate withdrawal behaviours from other causes and assisted the diagnostic 
process. As the diagnosis directs the course of action, this assistance expedites the 
prompt treatment and relief of unpleasant withdrawal behaviours or facilitates optimal 
reductions of sedative drugs by preventing unnecessary delays or pauses to weaning 
regimes.   
In summary, the researcher believes there is an important role for parents in sedation 
withdrawal assessment due to their familiarity with their child’s usual behaviours and 
their insight into behavioural trends during critical illness.  This theoretical proposition 
formed the conceptual framework for withdrawal assessment in the a priori study.   
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3.6 The a priori research design 
This research project changed from a study to refine and validate a withdrawal 
assessment tool to the exploration and understanding of withdrawal assessment, in 
response to the interaction between study findings and the research question.   
The phases in the pre-planned study equated to a parallel mixed design; a typology 
proposed by Tashakkori and Teddlie (2003). The concurrent quantitative (QUAN) and 
qualitative (QUAL) strands of the study contributed to the mixed methods strand (MM) 
integrating the findings to design an updated tool (SWS v2), which would encourage 
parental input (Figure 3.3). 
 
 
 
 
 
 
 
Figure 3.3 The a priori study design for SWS tool development with parental input. 
 
3.7 The interactive multilevel mixed methods research design 
underpinning the studies  
The research design changed initially in response to the analysis and interpretation of the 
data in the first study (the retrospective evaluation of SWS).  Unexpected findings 
prompted the conceptualisation of sequential studies, to expand the breadth of the 
inquiry into other aspects of the current approach to withdrawal assessment.  Further 
research questions arose in response to the findings of succeeding studies, as new 
perspectives illuminated further challenges in the process of withdrawal assessment. 
Each new perspective prompted the recursive analysis and interpretation of existing data, 
the SOS and WAT-1 validation studies and the literature and extended the scope of the 
study beyond withdrawal syndrome to co-existing constructs such as PD and ADRs.  The 
interactive process of design describes how the study design is determine by interaction 
between study findings the research questions and the conceptual framework, an 
SWS evaluation 
 
Parent interviews 
Parent 
questionnaire  
 
Compare, 
contrast 
merge 
SWSv2 with 
parental input 
QUAN 
MM (QUAN –QUAL) 
QUAN 
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interaction reflected in the studies in this thesis, compared with a predetermined a priori 
design (Maxwell and Loomis 2003). 
The overall study design, having both parallel and sequential strands is defined as a 
multilevel mixed study (Tashakkori and Teddlie 2003). The thesis map showing the 
component studies and integration is shown in Figure 3.4.  Integration is a key feature of 
mixed methods research and occurs at the level of the research design, research methods 
and/or interpretation (Fetter et al 2013).  The consequence of integration at the analysis 
and inference stages is synergy of qualitative and quantitative data (Benz and Newman 
2008).  This approach was considered best able to illuminate and validate the multiple 
perspectives of the conceptual framework and synthesise a deeper understanding of 
sedation withdrawal assessment.  The order of the sequential studies (Studies 
1423) reflects a number of factors.  Chronologically, the data collection period of 
Study 3 spanned the publication of the WAT-1 and SOS validation studies (Franck et al 
2012, Ista et al 2013) through to the most recent publication by Best et al (2016); a 
timeframe that began shortly after the data collection period of Study 1 and finished after 
Study 4 had been written up and submitted for publication.  The order (Study 4 preceding 
Studies 2 and 3) also reflects the fundamental impact that the findings of Study 4 had on 
the study design and interpretation of data in Studies 2 and 3.   
The conceptual framework also provides the structure for the presentation of the studies 
in this thesis.  Studies 1, 2 and 3 considering the “nurse assessment” are presented in Part 
2 of the thesis; Study 3 investigating “nurse judgement” is presented in Part 3. Studies 4 
and 5 investigating parents’ assessment and judgement are presented in Part 4 and a 
synthesis of the study findings is presented in Part 5 of the thesis.  
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Figure 3.4 Thesis map; ovals show where integration has occurred and arrows show the points of interface in design. 
QUAN= quantitative,  QUAL= qualitative,  MM= mixed methods 
1Integration at design level case study 
2Integration at methods level; explaining, understanding connecting building merging embedding 
3Integration at interpretation level.
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Part 2: Nurse Assessment  
 
Part 2 of the thesis presents three studies which build on the existing body of knowledge 
about the nurses’ assessment of withdrawal using withdrawal assessment tools. This 
aspect of the conceptual framework introduced in Chapter 3, is the dominant perspective 
upon which the existing withdrawal tools have been developed and validated.  In 
harmony with the mixed methods approach, findings from these studies are integrated in 
the withdrawal signs synthesis chapter and with the findings of the other studies 
presented in this thesis, contributing to the meta-inferences about withdrawal signs.   
 
Figure Part 2.1 The conceptual framework showing the contribution of Studies 1, 2 & 3 
 
Chapter 4 (Study 1) is a retrospective evaluation of the Sedation Withdrawal Score (SWS) 
tool. 
Chapter 5 (Study 2) is a comparison of two studies which both characterise withdrawal 
signs in critically ill children.  The datasets were transformed to allow comparison.  
Comparing and contrasting the results of two studies is an example of integration, which 
is a key feature of mixed methods research (Fetter et al 2013).  Integrating results from 
two studies allows a comparison to be made and a more complete understanding to 
emerge, compared with what is provided by either study alone. 
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Chapter 6 (Study 3) presents a pragmatic critique of the WAT-1 dataset. The WAT -1 study 
is reviewed using a pragmatic framework proposed by Krathwohl (2009) prior to a review 
of three papers which each contribute a difference perspective of the same dataset. 
 
 
Figure Part 2.2 The thesis map showing Studies 1 and 2 highlighted 
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Chapter 4: Study 1: Retrospective evaluation of the Sedation 
Withdrawal Score (SWS); an audit of highest SWS scores in 
patients undergoing weaning of sedatives and/or opioids 
 
4.1 Introduction 
Two validated withdrawal assessment tools exist but neither has been able to identify the 
treatment cut-points necessary for clinical utility.  Exclusion criteria limit generalisability 
of these tools in a heterogeneous critical care population and flaws in the incomplete 
independence of the criterion and index tests in both tools, also cast doubt on their 
concurrent validity.  In the absence of a criterion standard, validation studies of both SOS 
and WAT-1 have relied on the views of the nurse completing the tools as the comparison 
measure. This is a significant flaw, as the association between criterion and index tests, as 
the basis for demonstrating concurrent validity, a component of construct validity, relies 
on the two measures being independent (Bowling 2004).  The withdrawal assessment 
tool used in the study hospital, the Sedation Withdrawal Score (SWS) (Cunliffe et al 2004), 
has not been formally validated. This study was the preliminary evaluative stage of 
refining the SWS tool prior to incorporating the parental perspective. 
 
4.2 Background 
The Sedation Withdrawal Score (SWS) has been embedded in clinical practice as the 
existing approach to withdrawal assessment in the study hospital since 2002 (See 
Appendix 1).  The SWS comprises 12 signs of withdrawal, each of which is scored 0, 1 or 2 
depending on whether the nurse perceives the behaviour as absent (0), mild (1) or severe 
(2) in the hours since the preceding assessment.  The SWS score is usually assessed every 
6 hours and determines subsequent treatment choices, according to the treatment 
protocol shown in Table 4.1.  This protocol delineates four levels of treatment according 
to withdrawal intensity, which broadly correspond to “no”, “mild”, “moderate” and 
“severe” withdrawal.  
A prospective study entails the independent concurrent comparison of the index test 
with a criterion standard; a condition which was not met in the validation studies of 
either WAT-1 (Franck et al 2008) or SOS (Ista et al 2009).  As the SWS tool was already 
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embedded in clinical practice, a retrospective evaluation was performed. This approach 
permitted an alternative approach to evaluation, exploiting and benefitting from 
hindsight; the opportunity to reflect on the consequence of the clinical decision in light of 
“what happened next.” This approach provides more evidence to retrospectively support 
or reject the choice of diagnosis or treatment, compared with the prospective nature of 
withdrawal assessment decision making in practice.    A similar approach has been 
applied in the evaluation of other clinical criterion standards, such as assessing degree of 
dehydration (Roland et al 2010).   
Table 4.1 SWS treatment protocol  
SWS score Treatment 
SWS ≤ 3  Continue with reducing regime 
SWS 4-6 Stop reductions 
SWS 6-10 Increase (revert to previous regime) 
SWS >10 Seek advice 
 
A diagnostic dilemma was revealed during the construction and piloting of the data 
extraction sheet, in relation to the retrospective allocation of withdrawal status at the 
time of the highest score.  The dilemma arose from assigning a dichotomous withdrawal 
status (withdrawing vs not withdrawing) in a complex situation where diagnostic 
uncertainty exists due to the co-occurrence of other causes for behaviours. 
With adverse drug reactions (ADRs) causality assessment is classified in terms of 
probability, rather than a rigid dichotomy, reflecting similar levels of uncertainty to 
withdrawal.  The ADR assessment criteria help to determine the likelihood that the 
patient’s condition is due to the drug implicated rather than the result of other factors.  
The likelihood rating is assigned according to aggregated evidence of a temporal 
relationship between the suspected drug and the reaction, the plausibility of the reaction 
and evidence of de-challenge/ re-challenge (Gallagher et al 2011).  Plausibility considers 
whether the response is a known drug reaction, whether there is a definitive laboratory 
test and whether there are other possible causes for the reaction.  De-challenge means 
the reaction improves on stopping the medication and re-challenge means the reaction 
returns when the medication is restarted.  The likelihood categories range from certain or 
definite, through probable and possible to unlikely (Gallagher et al 2011, WHO-UMC, Gill 
et al, 1995).  The ADR causality assessment criteria were considered to reflect the 
diagnostic uncertainty inherent in this population of critically ill patients.  The criteria 
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were adapted in order to identify predictive validity of SWS by retrospectively assigning a 
likelihood rating of withdrawal at the time of the highest SWS score in this audit. 
 
4.3 Purpose of Study 1 
To evaluate the following psychometric properties of SWS current approach to 
withdrawal assessment:  
1. Construct validity by examining 
a. The range of scores and component items of the highest SWS scores, 
b. The impact of respiratory status and likelihood of withdrawal on the 
highest SWS score; 
2. Content validity by identifying if other behaviours were described at the time of 
the score 
3. Predictive validity of the highest SWS score by cross-tabulating SWS ≥4 and SWS ≤ 
3 with the likelihood of withdrawal; 
4. Hypothesis testing of SWS≥4 as a cut point for withdrawal unlikely and 
possible/probable. 
 
4.4 Method 
The probability of withdrawal at the time of the highest SWS score was assigned 
objectively based on ADR causality assessment criteria.  This approach provided an 
independent standard against which the predictive validity of SWS and a cut point of 
SWS≥4 (Table 4.1) could be assessed.  Adaptations to the ADR criteria were made in 
recognition that withdrawal, as an end-of-use (Type E) ADR, is a consequence of stopping, 
rather than starting a drug, and only occurs in the context of physical dependence.  
Plausibility was labelled “physical dependence possible.” In terms of dechallenge and 
rechallenge, the actions and consequences of these interventions are reversed in 
withdrawal compared with other ADRs.  Rechallenge (restarting or increasing the drug) is 
linked to a reduction in withdrawal signs, due to an increase plasma levels and receptor 
occupancy. Dechallenge is the response manifested as withdrawal, which is provoked by 
weaning (decreasing plasma levels and reduced receptor occupancy). The terms 
dechallenge and rechallenge were labelled “temporal relationship with changes in dose” 
to reflect the relationship between changing drug levels and signs of withdrawal.   
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Of the four main categories of ADR likelihood that exist, “possible”, “probable” and 
“unlikely” were retained for this study (Table 4.2). The category “definite” was not 
included due to the lack of a definitive laboratory test and in light of the redundancy of 
this label, when in contrast with other ADRs, the causal drug may be reintroduced 
(rechallenge), rather than stopped, in response to the reaction.  
 
Table 4.2 Probability of withdrawal based on WHO–UMC causality assessment criteria 
(https://www.who-umc.org/media/2768/standardised-case-causality-assessment.pdf) 
Withdrawal 
likelihood 
Physical dependence 
possible 
Temporal relationship 
with change in dose 
Absence of 
differential diagnoses 
Probable Yes Yes Yes 
Possible Yes Yes No 
Unlikely No No No 
 
4.5 Setting 
The study was conducted in a large children’s hospital in the Northwest of England.  
Approximately 1000 patients are admitted to the 21-bedded PICU annually.  Sedation 
cycling is practised, whereby sedation drugs are changed (cycled) every five days, where 
the patient’s condition allows, in an attempt to minimise the development of physical 
dependence. The drug combinations cycled are fentanyl and midazolam, clonidine and 
promethazine and ketamine and diazepam.  In addition to these drugs, the use of chloral 
hydrate is common, with chlorpromazine and isoflurane used occasionally.  All patients 
referred to the pain team, the clinical team who oversee the sedation weaning of 
patients after discharge from PICU, were included in the audit until data on 100 cases had 
been collected.  Data were collected between January 2010 and June 2012.  
 
4.6 Ethics and governance 
This audit was registered with the clinical audit department in the study hospital and 
approved by the departmental audit lead.  Ethical approval was therefore not required. 
4.7 Data extraction 
A data extraction sheet was created (Appendix 5) to record patient data from a number 
of different sources; the case notes, electronic nursing records, the SWS assessment 
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sheet the PICU and ward drug prescription charts and the PICU fluid balance charts.   
During the timeframe of this audit, the SWS assessment, drug prescriptions and fluid 
balance charts were paper documents, which after use, were filed in the case notes or 
scanned onto the electronic patient record.  As each source of information was required 
to contribute the necessary data, patients were excluded from the audit if any of the 
paper documents was missing from the case notes. All data collection was performed by 
the researcher. 
4.7.1 Patient characteristics 
The following data were collected about the patient from the case notes and electronic 
nursing records; age, gender, underlying condition/s, the reason for PICU admission, and 
date and time of extubation (for respiratory status).  
4.7.2 Sedation Withdrawal Scores 
The withdrawal assessment chart is the document where nurses record the presence of 
the 12 component signs of SWS and assign an intensity score to each item.  The highest 
SWS score was identified from this document and the score, the date and time recorded 
and the breakdown of the score (the component signs and intensity scores) were 
collected.   
4.7.3 Drug therapy, other signs of withdrawal and differential diagnoses. 
Sedative drugs administered routinely in the study setting are opioids, benzodiazepines, 
chloral hydrate, clonidine and promethazine.  Changes in sedative therapy resulting in a 
reduction in any of these drugs in the 72 hours leading up to the highest score were 
noted, in order to identify a temporal link between sedation weaning and the highest 
SWS score.  An additional category of “other drug” was included to capture the 
administration of less commonly used sedatives.  In cases where withdrawal was 
suspected, the suspected causal drug was noted.  
Case notes and computerised nursing notes were checked to identify if any other 
withdrawal symptoms had been documented at the time of the highest SWS score and to 
ascertain whether other concurrent differential diagnoses may have contributed to the 
score.  
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4.7.4 Assigning the likelihood of withdrawal  
The diagnosis of withdrawal is based on a context of physical dependence, a temporal 
relationship to a reduction of sedative medication and exclusion of other possible causes 
for the behaviours.  These three criteria were assessed in order to assign the likelihood of 
withdrawal for each audit patient. Physical dependence was considered possible if 
patients had received at least five days drug therapy, either by continuous infusion or 
regular interval dosing (Franck et al 2004, 2008, Ista et al 2008, 2009) of one of more of 
the following drugs; opioids, benzodiazepines, chloral hydrate, clonidine, ketamine, 
promethazine and chlorpromazine.  
A temporal relationship with a change in dose was defined as any reduction in the 72 
hours prior to the highest score. Changes in sedative drugs and the possibility of other 
differential diagnoses were assessed from the drug prescription charts and 
documentation in the case notes and the electronic nursing record. 
The operationalisations of the criteria for assigning the likelihood of withdrawal at the 
time of the highest SWS score are summarised as follows (see Table 4.2);  
 Probable withdrawal was defined as physical dependence possible, reduction in 
sedative medication in the previous 72 hours and no other differential diagnoses. 
 Possible withdrawal was defined as physical dependence possible, reduction in 
sedative medication in the previous 72 hours, other differential diagnoses. 
 Withdrawal unlikely was defined as physical dependence unlikely or no reduction 
in sedative medication in the previous 72 hours, regardless of differential 
diagnoses. 
 
4.8 Analysis 
The audit results were analysed using descriptive and inferential statistics.   Descriptive 
statistics were calculated, including medians and interquartile ranges for the frequency of 
presentation and number of items in the highest SWS scores.  
Construct validity was evaluated by examining the range of scores and component 
behaviours of highest SWS scores across the entire sample and then by dividing the 
sample according to level of respiratory support and likelihood of withdrawal (probable, 
possible, unlikely), in order to identify any patterns or trends in presentation that 
differentiated levels of withdrawal or condition and to consider alternative diagnoses 
that might be driving the score (STARD 2015). 
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Content validity was evaluated by considering the impact of the presence of other 
behaviours reported in nursing records and case notes at the time of the highest SWS 
score, which were not part of SWS, but are recognised signs of withdrawal.  
Hypothesis testing of SWS ≥4 as a cut point for withdrawal, including identification of 
Type I and Type II errors, sensitivity, specificity and positive and negative predictive 
values for the highest SWS score.     
 
4.9 Results 
Of 188 patients referred to the pain team for management of sedation weaning during 
the study period, 97 complete sets of notes were retrieved and included in the study. The 
remaining 91 case notes were either unavailable or incomplete (one of more of the paper 
charts missing), so could not be included in the study. The sample of 97 patients 
comprised 59 males (61%) and 38 females (39%).  Sixty six children were aged under 1 
year of age (68%) of whom 13 (13%) were neonates. Twenty nine children (30%) were 
aged 1-5 years and two (2%) children were aged 6 years and over.  Forty six patients had 
an underlying cardiac condition requiring PICU care post-operatively. The remaining 51 
patients were admitted to PICU with a range of other medical conditions. One patient 
was treated for neonatal abstinence and did not require admission to PICU. 
4.9.1 Sedative drugs administered 
Sedative drugs were usually administered in combinations of two or more sedative drugs.  
Opioids were administered to 82 patients (85%); fentanyl 73%, morphine 26% and both 
1%. Benzodiazepines were administered to 66 patients (69%); midazolam 82%, diazepam 
11%, both 7%. In addition, patients received other sedatives including chloral hydrate 
n=70 (72%), promethazine n=31 (32%), clonidine n=24 (25%), ketamine n=16 (16%) and 
chlorpromazine n=5 (5%). Two patients had been recruited onto a clinical trial (SLEEPS 
study) and received a blinded study drug, which was either midazolam or clonidine. 
4.9.2 The likelihood of withdrawal  
At the time of the highest SWS score, withdrawal was probable in 61 (63%) cases, 
possible in 18 (18%) cases and unlikely in 16 (16%) cases.   
Where withdrawal was probable (n=61), the suspected causal drug was identified in 35 
cases (57%). Chloral hydrate was most commonly implicated (n=13), followed by opioids 
(n=9) (fentanyl n=5, morphine n=4) and benzodiazepines (n=6) (midazolam n=5, 
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diazepam n=1). In seven cases, withdrawal was precipitated in response to cycling of 
medication; fentanyl/midazolam to clonidine/promethazine (n=3), fentanyl/midazolam to 
ketamine/diazepam (n=2), promethazine/clonidine to ketamine/diazepam (n=1) and 
ketamine/diazepam to clonidine/promethazine (n=1). In these cases, the causal drug 
could not be identified because two drugs were changed concurrently.  Similarly, in the 
remaining cases (n=26), reductions in more than one drug meant the causal drug could 
not be identified (n=25) and one patient had neonatal abstinence syndrome.   
4.9.3 The range of highest SWS score  
The highest SWS scores ranged from 0-18 and were normally distributed (Figure 4.1).  The 
median (IQR) SWS score was 7 (5-9) and the number of items contributing to the score 
was median (IQR) 5 (4-6).  The number of items explains why, despite an SWS score range 
of 0-24, all but one of the peak scores fell in the lower half of the score range. 
 
 
Figure 4.1 Highest SWS scores by likelihood of withdrawal (all cases). 
The ranges of SWS scores for “probable” withdrawal was SWS 2-12, for withdrawal 
“unlikely” the range was SWS 0-12, and for “possible” withdrawal was SWS 5-18.  Every 
SWS score between the range of 2 and 12 was characterised by two or more levels of 
withdrawal.  All three levels of withdrawal were represented in the three modal SWS 
scores of SWS 5-7 inclusive.  The broad range of scores for each category of withdrawal 
points to the heterogeneous presentation of withdrawal whilst the overlap of scores is 
evidence of the similarities between withdrawal behaviour and other causes of behaviour 
in critically ill babies and children. 
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4.9.4 Symptom content of the highest SWS scores 
The twelve items in the SWS tool were analysed for frequency of presentation in the 
highest scores (see Table 4.3).  Three items, irritability, insomnia and diarrhoea, were 
present in ≥50% cases.  A further five symptoms, respiratory distress, sweating, high pitch 
cry, fever and tremor, were present in 25- 49% cases. The remaining four items occurred 
in <25% of highest SWS scores.   
It is of interest that irritability and insomnia, when documented, were more than twice as 
likely to be scored as 2 (severe) than 1 (present). The opposite was true with the 
remaining ten items, which were more frequently scored as 1 (present) than 2 (severe).   
Table 4.3 SWS signs represented in highest SWS scores (all cases) according to 
frequency of item presentation and individual item score. 
SWS signs Frequency of item in 
sample (%) 
Number of patients 
Score 0 Score 1 Score 2 
Irritability 90 10 27 60 
Insomnia 86 14 25 58 
Diarrhoea 50 48 34 15 
Respiratory distress 46 52 28 17 
Sweating 45 53 32 12 
High pitch cry 38 60 25 12 
Fever 30 68 24 5 
Tremor 25 73 17 7 
Vomiting 20 78 10 9 
Sneezing 16 81 15 1 
Hypertonicity 12 85 8 4 
Convulsions 2 95 2 0 
 
4.9.5 Hypothesis testing of SWS≥4 as a cut point for withdrawal  
A contingency table was constructed to cross tabulate the SWS scores, according to the 
treatment cut points, with the probability of withdrawal. This is shown in Table 4.4. Ticks 
denote cases where the treatment protocol is consistent with the withdrawal diagnosis.  
These data were used to calculate the false positive, or Type I errors and the false 
negative, or Type II errors (Figure 4.1).  False positives are those cases where the SWS 
score ≥ 4 but withdrawal is unlikely (n=10); with a potential for unnecessary slowing of 
the weaning regimes and possible delay in diagnosing the underlying cause for 
behaviours.  True positives occur where the SWS score ≥ 4 and withdrawal is possible or 
probable; withdrawal is suspected and treated.  False negatives are cases where SWS ≤ 3 
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but withdrawal is possible or probable (n=4); where the potential is for withdrawal to go 
untreated. True negatives occur when the SWS score ≤ 3 and withdrawal is unlikely; 
withdrawal is not diagnosed and weaning continues. 
Table 4.4 Contingency table showing SWS treatment cut points and the probability of 
withdrawal  
SWS 
score 
Intervention Total 
number 
Withdrawal 
probable  
Withdrawal  
possible  
Withdrawal  
unlikely 
≤3 Continue reducing 10 4 0 6 
4-6 Stop reducing 35 21 8 6 
7-10 Increase sedation 43 32 8 3 
>10 Seek advice 7 4 2 1 
Total 95 61 18 16 
This enables the sensitivity, specificity, positive predictive value and negative predictive 
value of the highest SWS score to be calculated, as shown in Figure 4.2.  
 True condition  
Withdrawal 
probable/possible  
Withdrawal 
unlikely  
 P
red
icted
 
co
n
d
itio
n
 
SWS ≥ 4 
75 
True positive (TP) 
10 
False positive (FP) 
Type I error 
Positive predictive 
value 
=TP/ (TP+FP)=0.882 
SWS ≤ 3 
4 
False negative (FN) 
Type II error 
6 
True negative (TN) 
Negative predictive 
value 
=TN/ (TN+FN)=0.6 
 
Sensitivity 
=TP/(TP+FN) =0.95 
Specificity 
=TN/(TN+FP) 
=0.375 
Prevalence  
= (TP+FP)/ 
(TP+FP+FN+TN)  
= 89% 
Figure 4.2 SWS cut points and rates of false positives and false negatives (Highest SWS 
score)  
The sensitivity describes the proportion of withdrawing patients (true positives) who are 
correctly identified as withdrawing by the test: Sensitivity = 0.95 
The specificity of describes the proportion of patients not withdrawing (true negatives) 
who are correctly identified as not withdrawing by the test: Specificity = 0.375 
The positive predictive value (PPV) is the probability of withdrawal in those testing 
positive (scoring SWS≥4): PPV = 0.882 
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The negative predictive value (NPV) is the probability of the absence of withdrawal in 
those testing negative (scoring SWS ≤3): NPV =0.6 
4.9.6 The impact of respiratory status and likelihood of withdrawal  
4.9.6.1 Respiratory status  
Forty five patients scored for respiratory distress as a component of their highest SWS 
score.  Four different levels of respiratory support were identified in this cohort; 
‘intubated and ventilated’, ‘non-invasive ventilation (CPAP* or BiPAP**)’, ‘extubated’ and 
‘not ventilated this admission’.  Intubated patients were more than twice as likely to 
score for severe respiratory distress as extubated patients were (Table 4.5).  Time since 
extubation was longer (median 46 hours) for those who scored ‘1’ (mild respiratory 
distress) compared with those who scored ‘2’ (severe respiratory distress) (median 20 
hours).   
Table 4.5 Respiratory support in patients scoring for ‘respiratory distress’ as part of the 
SWS assessment (n=45). 
Respiratory support Scored for SWS sign ‘respiratory distress’ Total 
Score 1 Score 2 
Intubated and ventilated 4 9 13 
Non-invasive ventilation 4 0 4 
Extubated 19 8 27 
Not ventilated 1 0 1 
Total 28 17 45 
*CPAP= Continuous positive airway pressure     **BiPAP = Bilevel positive airway pressure 
4.9.6.2 Likelihood of withdrawal 
The prevalence of signs was analysed in terms of items occurring in ≥ 50% of all cases and 
according to the likelihood of withdrawal.  Three items were present in ≥50% all cases; 
irritability (90%), insomnia (86%) and diarrhoea (50%).  In the ‘withdrawal probable’ 
group (n=61), there were four signs present in ≥50% cases; irritability (92%), insomnia 
(90%), diarrhoea (59%) and sweating (51%). In the ‘withdrawal possible’ (n=17), three 
signs were present in ≥50% cases: irritability (94%), insomnia (94%) and sweating (61%). 
In the ‘withdrawal unlikely’ group (n=19), two signs were present in ≥50% cases: 
irritability (79%) and insomnia (73%) (Table 4.6).   
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In all groups, irritability and insomnia were ranked first and second by prevalence 
respectively. With all other SWS signs, differences occurred in item presentation between 
groups, but not to an extent that could be considered clinically meaningful.   
Table 4.6 Top ranking SWS signs present in ≥ 50% by all cases and likelihood of 
withdrawal  
 
SWS Signs 
All 
cases 
Likelihood of withdrawal 
Probable Unlikely Possible 
n=97 n=61 n=19 n=17 
Irritability 90% 92% 79% 94% 
Insomnia 86% 90% 73% 94% 
Diarrhoea 50% 59% (32%) (41%) 
Respiratory distress (46%) (47%) (47%) (41%) 
Sweating (45%) 51% (32%) 61% 
(Bold shows signs with ≥ 50 % prevalence in one or more groups; bracketed results and 
respiratory distress (incidence<50%) for comparison). 
4.9.7 Other behaviours; additional withdrawal signs reported by clinicians 
The following signs were identified from the nursing or clinical notes; jittery n=4, agitated 
n=3,  and single episodes of the following; unsettled, inappropriate movement of arms 
and legs, lack of eye contact, not responding/interacting with family, doubly incontinent 
and ‘holding medication in mouth’.  
4.9.8 Evidence of something else going on 
Whilst assigning the likelihood of withdrawal, one of the steps in the causality assessment 
tool is considering the probability that the event was due to an underlying disease.  A 
number of cases stood out due to the unstable presentation of the child when the 
withdrawal assessment had been undertaken. This occurred in 11 cases, where there was 
clearly something other than withdrawal driving the behaviour being assessed. Patients in 
this cohort varied in terms of age, diagnosis and SWS score, as shown in Table 4.7.   
Six patients were ventilated; ventilator issues included the patient not synchronising with 
the ventilator, being ‘over-ventilated’ and patients becoming less tolerant of ventilation 
as sedation reduced in the time leading up to extubation.  One patient scored highest at 
the time of extubation but did not require additional respiratory support. Three patients 
required additional airway support between one hour and 24 hours after extubation; two 
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of whom were subsequently reintubated.  In two cases the underlying condition 
(bronchiolitis, meningococcal meningitis) may have driven the score.    
 
4.10 Discussion 
This retrospective study is the first to evaluate the SWS tool and the first study to use an 
objective test to assign probability of withdrawal to SWS scores.  The theoretical basis for 
the development of a generalisable withdrawal scale relies on two key factors. The first is 
a homogeneous presentation of withdrawal to enable comparison between patients and 
allow identification of treatment cut points.  The second factor is a clear distinction 
between the presentation of withdrawal and other possible differential diagnoses.  A 
number of findings in this study challenge these essential prerequisites for construct 
validity and hence the clinical utility of the SWS score as a marker for the diagnosis or 
treatment of withdrawal. The study findings and these challenges will be considered in 
light of the existing literature.  
4.10.1 Lack of homogeneous presentation 
The broad range of scores and indistinct characterisation of the likelihood of withdrawal 
points to a heterogeneous presentation. The median (IQR) peak SWS score was 7 (5-9) 
with a wide spread of likelihood of withdrawal.  This compares with a peak daily WAT-1 
score of 4 (3-6) in 126 patients reported by Franck et al (2012).  Ista et al (2013) did not 
report the SOS score range in their study of 154 patients. 
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Table 4.7 “Something else going on” (grouped by ventilation status; ventilated, at extubation, extubated) 
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Notes 
4 2 years Male Asthma 5 Probable 2 2     1     Ventilated 
 
Extubated 7h later. 
19 4  
months 
Male Respiratory  
failure 
6 Possible 2 2       2   Ventilated Intubated with HFOV 
31 3  
months 
Female Cardiac  
surgery 
12 Unlikely 2 2 2  2  1  2  1 Ventilated Not synchronising with the 
ventilator. 
45 6  
months 
Male Aspiration 
pneumonia 
7 Possible 1 2 1     2 1   Ventilated Extubated 14h later. 
56 8  
months 
Male Bronchiolitis 6 Unlikely  2 2   1 1     Ventilated Not weaning 
 
86 13 
months 
Male Cardiac  
surgery 
7 Possible 2 2  1    2    Ventilated Difficult to sedate, over-
ventilated. 
35 1 year Male Cardiac  
surgery 
4 Unlikely 1 1   1 1      At 
extubation 
 
14 24 days Female Closure 
gastroschisis 
9 Unlikely 1 2    2  2 2   Extubated  
19h before 
Reintubated and diagnosed 
with diaphragmatic hernia. 
24 8 weeks Male Bronchiolitis 4 Unlikely 1  1    1  1   Extubated  
1h before 
Required NPA, then BIPAP 
then reintubated. 
9 18 
months 
Male Respiratory  
failure 
5 Probable  1  1 1    1 1  Extubated  
24h before 
NPA reinserted. 
50 6 weeks Male Meningococcal 
meningitis 
10 Unlikely 2 2 1 2 1   1  1  Extubated  
52h before 
 
HFOV=high frequency oscillator ventilation   NPA=nasopharyngeal airway   BiPAP=Bilevel positive airway pressure 
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Although the range of scores was broad, this encompassed the lower half of the score 
range.  The lack of scores in the top half of the range was a consequence of the number 
of items contributing to each of these top scores. The median (IQR) number of items was 
5 (4-6), a range which demonstrates consistency in the number of items contributing to 
the top scores.  However, this range also highlights that even the “top score” behavioural 
presentation represented just 33% to 50% of available SWS items.  These figures point to 
a very loose association between the component signs of SWS, rather than the 
correspondence or convergence between items needed to demonstrate the theoretical 
relationship underpinning this operationalisation of withdrawal.  
4.10.2 No clear cut point for withdrawal 
In terms of episodes of withdrawal, Franck et al (2012) described 51 episodes of clinically 
significant withdrawal in 21 patients, whose median (IQR) WAT-1 scores before and after 
rescue therapy were 6 (4-8) and 2 (1-3) respectively.  Ista et al (2013) reported a mean 
reduction in SOS score of 1.47 in 51 patients after administration of sedative or opioids to 
treat withdrawal symptoms. This second result infers, if only by omission, that a range of 
scores existed, and that decision to treat was based on clinical opinion rather than the 
score, in common with the reported WAT-1 findings.  Despite the lack of transparency 
about clinically significant withdrawal, SOS and WAT-1 subsequently provided statistical 
support for cut points of SOS≥4 (Ista et al 2013) and WAT-1≥3 (Franck et al 2012).  It is 
not clear given the broad range of scores and overlap in scores between patients who are 
withdrawing and not withdrawing whether these cut points have clinical utility.  
The ADR causality assessment introduced a novel approach to labelling withdrawal, 
compared with the existing dichotomous depiction of the diagnosis, as “present” or 
“absent.” These terms portray a certainty that does not reflect the complexities of 
competing diagnoses and reliance on equivocal clinical signs in clinical practice.  Adopting 
the probability terms of “probable”, “ possible” and “ unlikely” to describe withdrawal 
may better reflect the level of uncertainty and the impact of withdrawal on co-existing 
conditions. 
4.10.3 Distinct from other differential diagnoses 
Other behaviours were noted at the time of the highest score.  Two of these signs ‘motor 
disturbance’ and ‘agitation’ appear in the SOS score (Ista et al 2009).  Agitation is a 
component of the SBS sedation assessment for WAT-1 (Franck et al 2008).  Two patients 
had communication disturbances similar to those described in the early literature 
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describing responses to sedation withdrawal (see Table 2.10 in Chapter 2). Whilst not a 
feature in WAT-1 or SOS, inattention is a criterion in the pediatric delirium (PD) tools 
(Traube et al 2014, Smith et al 2016). What is not clear is whether this is an overlapping 
feature of both PD and withdrawal. Integration of these findings on signs of withdrawal 
with the findings from subsequent studies will be presented in Part 5.   
In addition to the possible overlap of PD and withdrawal, the level of respiratory support 
in turn appeared to influence the respiratory distress component of the SWS score.  This 
has an impact on construct validity when the outcome is a summed score, as the changes 
in respiratory support may be driving the score rather than withdrawal (Streiner and 
Norman 2003).   The equivalent signs in SOS and WAT-1 are tachypnoea and respiration 
rate high for age respectively.  These findings demonstrate the challenge of delineating 
the causal impact of reducing ventilator support and withdrawal on respiratory distress.  
To be of value as a sign of withdrawal, the behaviour should be uncommon in patients 
who are not withdrawing.  Similarly the high prevalence of both irritability and insomnia 
in the SWS sample, including those patients classified as unlikely to be withdrawing may 
indicate that these behaviours are common to PICU patients, rather than specific for 
withdrawal.  Both behaviours feature in SOS but are absent from WAT-1.  Irritability and 
insomnia were the only SWS signs more likely to be interpreted as severe rather than 
present at the time of the highest score, implying that intensity of behaviour, rather the 
behaviour itself might indicate withdrawal.  This makes sense when considering the 
additional impact that an unpleasant ADR may have on the critically ill child’s underlying 
physical state.   
The positive predictive value is the probability of withdrawal in those testing positive 
(DeVellis 2012).  The low positive predictive value (PPV) of 0.49 for SOS ≥4 indicating 
withdrawal shows the poor diagnostic value of the SOS tool; at this cut point more 
patients who test positive are likely to be not withdrawing (51%) than withdrawing (41%). 
The PPV of WAT≥3 was not reported (Franck et al 2012) but could be calculated from the 
data presented (See Chapter 2). This gave a PPV value of 0.65; at the designated cut point 
of WAT-1≥3, the majority of patients are withdrawing (65 %) but this still means that 
more than a third of patients (35%) are not withdrawing. 
The PPV in this study is 0.882, which is higher than both WAT-1 and SOS, but this is a 
reflection of the higher prevalence of withdrawal in this cohort, where only the highest 
SWS scores were analysed, compared with the lower prevalence SOS and WAT-1 cohorts, 
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where all scores were considered (Franck et al 2008, Ista et al 2013).  Despite a PPV 
higher than WAT-1 and SOS, SWS figures still equate to an 11% error rate even in a high 
prevalence cohort.  
4.10.4 “Distribution of alternative diagnoses in those without the target 
condition”  
The distribution of alternative diagnoses is a STARD (2015) requirement when reporting 
the accuracy of clinical tools.  Ista et al (2013) attributed the low positive predictive value 
of SOS to overlap of withdrawal symptoms with pain, distress and delirium.  Franck et al 
(2008) did not report any consideration of alternative diagnoses. In this study, alternative 
diagnoses were demonstrated in the cohort of 11 patients.  These patients highlight the 
complexity of the clinical situation with a range of possible differential diagnoses with or 
without the suspicion of withdrawal.  In terms of speculating what had motivated the 
nurse to undertake a withdrawal assessment at these times, it may be the tool had been 
used as a “red flag” to highlight the nurse’s concerns over the child’s clinical condition, 
which could be described as “intentional false positive” (Van der Zwaan 2012).  
Alternatively, this may be due to overinflated confidence in the tool’s diagnostic ability 
(for example, If I get a score for withdrawal, then it is withdrawal).  Either way, these 
findings challenge the common assumption that nurses exclude other possible causes for 
behaviours prior to the withdrawal diagnosis being confirmed (Harris et al 2016, Ista et al 
2013).  This also casts doubt on the cogency of using nurses’ opinion as a reference 
standard in tool validation studies (Franck et al 2008, Ista et al 2013).   
4.10.5 Criterion validity 
When criterion validity is established retrospectively, as in this study, it is termed 
predictive validity (Streiner and Norman 2003).  SOS and WAT-1 established criterion 
validity by concurrently comparing the index tool to nurse opinion; this is termed 
concurrent validity (Streiner and Norman 2003).  Predictive validity of SWS was 
established by comparing SWS scores with an objective reference standard, in the form of 
adapted ADR causality assessment criteria.  This approach compares favourably with the 
“incomplete independence” (Franck et al 2008, p579) between the reference and index 
tests in the validation studies of both SOS and WAT-1; where the probability of 
withdrawal was assigned by the bedside nurse who also completed the study test (Ista et 
al 2009 and Franck et al 2008).  The reference (existing) and index (new) tests should be 
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independent of each other because the accuracy of the new test is based on the 
correlation with the existing test (nurse opinion).  If the nurse’s opinion is predicated in 
part on the results of the new test, or tempered by the process of performing the new 
assessment, then the reference test is based on the index test and the two measures are 
artificially correlated (Streiner and Norman 2003).  This is called criterion contamination 
(Streiner and Norman 2003).  Given the potential for criterion contamination and an 
inflated correlation between WAT-1, SOS and their respective reference tests, the PPVs of 
WAT-1 and SOS are surprisingly modest. 
The findings from this study contribute further insights into possible causes for the poor 
PPV of existing withdrawal assessment tools. 
If no clinically useful cut point exists, then consideration might be given to the impact of 
one diagnostic/statistical error over the other; these are false positive /Type I and false 
negative/ Type II errors.  False negative errors are benign, as the withdrawing child who 
shows minimal behavioural signs, is at risk of neither delayed diagnosis nor treatment.  
The negative predictive value (NPV) describes the probability of the absence of 
withdrawal in those testing negative (DeVellis 2012). The NPV of the withdrawal 
assessment tools are 0.6 (SWS), 0.96 (WAT-1) (Franck et al 2008) and 0.98 (SOS) (Ista et al 
2013).  In Type I errors the child’s behaviours score for withdrawal but the child is not 
withdrawing. As shown in the cohort of 11 patients, behaviours might signify the 
underlying condition, respiratory compromise or clinical deterioration.  There are two 
implications of a false positive diagnosis of withdrawal; 
1. delay in appropriate diagnosis and treatment, and  
2. unnecessarily prolonging the sedation regime due to slowing or stopping of weaning.   
Greater clinical concern arises from overlooking a more serious condition with a false-
positive diagnosis of withdrawal, rather than the unnecessary slowing of a weaning 
regime. However, unnecessary slowing may have a financial consequence by extending 
the duration of PICU and/or hospital admissions (Traube et al 2016).   
4.10.6 Treatment of withdrawal 
The treatment protocol linked to SWS describes four treatment levels; continue weaning; 
stop weaning; increase sedation to previously tolerated level; seek help (Cunliffe et al 
2004).  This step-wise approach contrasts with WAT-1 and SOS, where treatment of 
withdrawal relies on administration of rescue boluses of sedation (Franck et al 2008, Ista 
et al 2013).  Franck et al (2008) also used the term “clinically significant withdrawal” to 
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describe cases where withdrawal signs prompted the administration of rescue doses of 
sedation.  The median WAT-1 score for these cases was higher (SWS 6) than the reported 
threshold for withdrawal (SWS≥3) (Franck et al 2008).  The difference between these 
scores suggests an overlooked cohort of patients, who may be withdrawing but not to the 
extent that warrants administration of rescue boluses. As these patients fall below the 
threshold for rescue boluses of “clinically significant withdrawal”, this level of withdrawal 
might be described as “clinically insignificant withdrawal.” This term raises an interesting 
practice point in terms of management of withdrawal, about what constitutes the 
threshold for treatment.  Clinically insignificant withdrawal suggests withdrawal to an 
extent that is not hindering the patient’s clinical condition / recovery.  This might equate 
to the stage in the SWS treatment protocol, which advises stopping weaning.  The four 
steps in this protocol align to “no”, “mild”, “moderate” and “severe” withdrawal. This is a 
similar approach to the management of pain, where the intensity of pain determines a 
corresponding analgesic intervention (http://www.who.int/cancer/palliative/painladder 
/en/ accessed July 2017).  It is not clear how the cut points for WAT-1 and SOS align to 
the decision to treat “clinically significant withdrawal.” 
 
4.11 Conclusion 
The findings from this study cast doubt on the capacity for nurses to exclude other causes 
of behaviours when undertaking a withdrawal assessment, given the predominance of 
co-existent causes.  Further insight is needed into nurses’ decision-making when applying 
a withdrawal assessment tool in situations when the causes for behaviours may be 
unclear.  This finding prompted the design of a study to investigate nurse decision-making 
during withdrawal assessments.  This study will be presented in Part 3.  
This study did not demonstrate the clinical utility of the SWS score as a marker for 
diagnosis or treatment of withdrawal.  The range of scores representing withdrawal 
seems to be incompatible with the endeavour to identify treatment cut points. The 
heterogeneous presentations of withdrawal and the impact of underlying conditions 
contribute to a level of complexity that is not reflected in the current approach to 
withdrawal assessment. It may be that an individualised assessment of each case is 
required rather than the application of a standardised tool.  The criteria used in this study 
to assign probability of withdrawal may provide a suitable decision-making framework; 
the likelihood of withdrawal described as probable, possible or unlikely may also serve to 
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remind clinical staff of the elusive nature of this clinical construct and the need for 
ongoing consideration of other causes of behavioural concern.  The clinical utility of a 
decision-making framework will be explored in Part 4 and Part 5.  
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Chapter 5: Study 2: A characterisation of withdrawal based on 
OBWS and SBOWC.  
 
5.1 Introduction 
The existing body of research about withdrawal diagnosis is based on the association of 
equivocal behavioural signs and symptoms of withdrawal.  Although the WAT-1 (Franck et 
al 2008), SOS (Ista et al 2009) and SWS (Cunliffe et al 2004) tools share six items in 
common, these tools draws on a pool of 22 different signs and symptoms.   
The aim of Study 2 was to gain further insight into the characterisation and 
operationalisation of withdrawal in critically ill children, given the lack of agreement 
about the construct of withdrawal that these differences indicate.  Two existing papers 
provided the data for Study 2; the Opioid and Benzodiazepine Withdrawal Score (OBWS) 
(Franck et al 2004) and the Sophia Benzodiazepine and Opioid Withdrawal Checklist 
(SBOWC) (Ista et al 2008).  
Study 2 is an illustration of the interactive, emergent design of this thesis, as the impetus 
for this study emerged from iterative interpretation of the literature and of data and 
findings from the component studies in this thesis.  The lack of agreement about the 
manifestation of withdrawal, highlighted in the literature review and reinforced by the 
thesis studies, prompted further consideration of the manifestation of withdrawal.  Study 
2 is presented in Part 2 of the thesis because it considers the nurses’ objective 
perspective of withdrawal assessment, according to the conceptual framework (Figure 
3.2). 
5.2 Background 
Study 2 is an integrative study that investigated the behavioural signs of withdrawal in 
critically ill children undergoing tapering or stopping of drugs reported in two papers 
(Franck et al 2004, Ista et al 2008).  Franck’s and Ista’s studies shared a common purpose 
of establishing the frequency of withdrawal signs; each study representing the same 
stage of refining an item pool, in the development of a clinical scale.  The authors of these 
studies subsequently published validated withdrawal assessment tools; the WAT-1 
(Franck et al 2008) and the SOS (Ista et al 2009) respectively.  Once the definitive tool is 
published along with evidence of validity and reliability, a rationale for a direct 
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comparison of these item pool studies may not be indicated from a scale development 
perspective.  However, from a pluralistic perspective, these studies contribute valuable 
evidence about how the construct of withdrawal has been operationalised.  Comparing 
and contrasting two similar approaches also offers the opportunity to triangulate 
findings, identify areas of congruence and contention and lead to new insights and 
understanding of withdrawal.  The OBWS (Franck et al 2004) and SBOWC (Ista et al 2008) 
studies will be presented in brief to demonstrate their comparable design. 
5.2.1 The Opioid and Benzodiazepine Withdrawal Score (OBWS) (Franck et al 
2004) 
Fifteen patients (aged 6 weeks to 28 months of age) with complex congenital heart 
disease and/or respiratory failure were enrolled on the study. Inclusion criteria were 
opioid and/or benzodiazepine therapy for more than five days; exclusion criteria were 
children with significant neurological insult or seizure disorder.  Patients were weaned 
from opioids and benzodiazepines over a median of 11 days at a rate of 10-20% per day 
(Table 5.1).  The OBWS, adapted from the Children’s Hospital Oakland Opioid Withdrawal 
Flowsheet (Franck & Vilardi, 1995), was described as a 21-item checklist of which 17 
items were reported in the study.  OBWS assessments were performed every four hours 
until approximately two days after the drugs had been discontinued.  In total, 693 
assessments were recorded; 151 assessments in 13 children indicated withdrawal, as 
judged by the nurse caring for the child. Data were presented comparing the occurrence 
of symptoms in children judged to be experiencing withdrawal (n=151 assessments) and 
those judged not to be withdrawing (n= 542 assessments).  Incidence of withdrawal 
equated to 22% (n=151) of assessments in 87% (n=13) children (Table 5.1). 
5.2.2 Sophia Benzodiazepine and Opioid Withdrawal Checklist (SBOWC) (Ista et 
al 2008) 
Seventy nine patients (aged 0-15 years) with a range of medical and surgical diagnoses 
were enrolled on this study. Inclusion criteria were opioid and/or benzodiazepine therapy 
for at least five days: exclusion criteria were status epilepticus treated with midazolam, 
neuromuscular blocking agents and severely disturbed behaviour due to underlying 
neurology.  The duration of weaning was not reported in this study but weaning rates 
were described and equated to tapering and discontinuation in 24 - 48 hours for patients 
receiving median doses (Table 5.1). All patients weaned from midazolam and 92% (n=73) 
weaned from opioids.  The SBOWC contained 27 items derived from the literature, 
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purporting to include all signs of withdrawal.  Assessments were performed at 4am, 2pm 
and 10 pm, to ensure that the nurse had been caring for the patient in the 4 hours 
preceding each assessment.  Data collection ceased on discharge from PICU. In total, 
2616 assessments were recorded, of which 932 (42%) were within 24 hours of tapering or 
stopping drugs.  Ninety three observations in 27 children indicated withdrawal, which 
was defined as the need for increase in midazolam or opioids to counteract possible 
withdrawal symptoms.  Incidence of withdrawal equated to 0.04% of assessments in 34% 
(n=27) children (Table 5.1).  Data were presented in four groups for comparison, 
according to the following criteria;  
1. The total group: 2161 observations on 79 children, 
2. A weaning group: 932 observations in 76 children recorded less than 24 hours 
after reduction/stopping of sedatives, 
3. A high dose group (a subset of the weaning group): 496 observations in 19 
children with the highest total doses of midazolam, and 
4. An unsuccessful weaning group: 93 observations in 27 children prior to receiving 
sedatives in response to withdrawal behaviour. 
 
5.3 Purpose of Study 2 
The purpose of Study 2 was to explore the characterisation of withdrawal by critically 
examining the items, or signs included in OBWS (Franck et al 2004) and SBOWC (Ista et al 
2008), in order to; 
 Consider the construct validity of individual signs by identifying the changes in 
prevalence of signs between withdrawing and not withdrawing patients 
 Consider the generalisability of study findings by comparing and contrasting 
prevalence of signs across studies, where common items existed. 
 
5.4 Objectives of Study 2 
The objectives of Study 2 were to: 
1. Transform the data in each study to comparable “withdrawing” and “not 
withdrawing” groups, 
2. Identify the frequency with which signs present in the “withdrawing” and “not 
withdrawing” groups of OBWS (Franck et al 2004) and SBOWC (Ista et al 2008), 
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3. Identify the change in prevalence of signs between “not withdrawing” 
(baseline) and “withdrawing” groups of OBWS (Franck et al 2004) and SBOWC 
(Ista et al 2008) respectively, and 
3. For signs described in both studies, compare the similarities and differences in 
the frequency, and change in frequency from baseline, in the “withdrawing” and 
“not withdrawing” groups of OBWS (Franck et al 2004) and SBOWC (Ista et al 
2008). 
 
5.5 Method  
5.5.1 Sample characteristics 
Participants were the patients (n=15) in the OBWS study (Franck et al 2004) and the 
SBOWC study (n=79) (Ista et al 2008), who were weaning from at least five days opioid 
and/or benzodiazepine therapy. 
OBWS patients were assessed for withdrawal every 4 hours until two days after the drugs 
had been discontinued (Franck et al, 2004). SBOWC patients were assessed every 8 hours 
until discharge from PICU (Ista et al 2008). 
Patients were weaned according to the respective study protocols, which differed in 
terms of the rate of weaning. The median tapering period for patients in the OBWS was 
reported as 11 days (Franck et al 2004). A median tapering period for SBOWC (Ista et al 
2008) patients was not reported, but could be calculated from the data provided.  The 
median doses of opioids and benzodiazepines and the taper rates reported in the 
weaning protocol, suggests the tapering period was 24-36 hours, as shown in Table 5.1. 
5.5.2 Ethics and governance 
Ethical approval was not required for this study. 
5.5.3 Transforming the data 
The data from the assessments performed in the OBWS study (693 assessments) was 
presented as “withdrawing” (151 assessments) and “not withdrawing” (693 assessments) 
groups (Franck et al 2004). These diagnoses were designated according to the nurse’s 
clinical judgement of the child at the time of the assessment. The data from the 
assessments performed in the SBOWC study (2161 assessments) (Ista et al 2008) was 
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presented differently, so was transformed into two comparable groups to enable 
comparison of these datasets.   
The data from the SBOWC assessments was presented in four groups; the unsuccessful 
weaning group comprised assessments which were performed before increasing 
midazolam and/or opioids in response to perceived withdrawal (Ista et al 2008).  This 
group was considered to be comparable with the “withdrawing” group in OBWS.  A “not 
withdrawing” group was created by subtracting the “unsuccessful weaning group” data 
from the “total group” data.  This transformation of the SBOWC data created two groups; 
a “withdrawing” group comprising 93 assessments and a “not withdrawing” group 
comprising 2068 assessments. 
Table 5.1 Weaning protocols reported in OBWS (Franck et al 2004) and SBOWC (Ista et 
al 2008) and average duration of weaning. 
 Weaning protocol Sample weaning regime (showing 
average1,2 doses and infusion duration)  
OBWS 10 or 20% daily taper and slow 
or stop reductions /reinitiate 
treatment if needed.  
 
Midazolam 195 microgram/kg/hr1, 
tapered over 11 days. 
Morphine 40 micrograms/kg/hr1 for a 
median 9 days, tapered over 11 days. 
SBOWC Midazolam reduced by  
50 microgram/kg/hr  
every 8 hours. 
Midazolam 176 microgram/kg/hr2 for a 
median 10 days.  
Suggests taper completed over 24 hours. 
Morphine reduced by  
10 microgram/kg/hr  
every 24 hours. 
Morphine 14 microgram/kg/hr2 for a 
median 8 days.  
Suggests taper completed over 24-36 
hours. 
1 peak median dose 2 median of the mean continuous dose 
5.5.4 Identifying the change in the prevalence of signs between the “not 
withdrawing” and “withdrawing” groups. 
A way of categorising the frequency of reported signs was sought in order to 
demonstrate the change in prevalence of signs between the “not withdrawing” and 
“withdrawing” groups both within and across studies.   The incidence classifications used 
to describe drug side-effects in pharmacological product literature were selected to 
categorise any change (BNF 2016) (Table 5.2).  These categories provide labels to reflect 
the differing occurrence of side effects from the “very common” (greater than 1 in 10) to 
the “very rare” (less than 1 in 10 000).  In addition to standardising the incidence, this 
designation also helped to demonstrate the clinical significance that the change in 
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prevalence between the two groups might represent to the bedside nurse assessing and 
interpreting the behaviour.  
Table 5.2 The descriptions for incidence of drug side effects in product literature 
(developed from BNF 2016) 
Label  Incidence  Incidence (%) 
Very common greater than 1 in 10  greater than 10% 
Common 1 in 100 to 1 in 10  1% to 10%  
Uncommon  
(‘less commonly’ in BNF) 
1 in 1000 to 1 in 100  0.01% to 1% 
Rare 1 in 10 000 to 1 in 1000  0.001% to 0.01% 
Very rare less than 1 in 10 000  less than 0.0001% 
 
 
5.6 Results  
In the presentation of these results, the term “withdrawing” will be used to describe the 
“withdrawal present” and “unsuccessful wean” groups of OBWS (Franck et al 2004) and 
SBOWC (Ista et al 2008) respectively.  The term “not withdrawing” will be used to 
describe the “withdrawal absent” group in OBWS (Franck et al 2004) and all patients 
other than the “unsuccessful wean” group in SBOWC (Ista et al 2008). 
5.6.1 The frequency with which signs presented in the “withdrawing” and “not 
withdrawing” groups of OBWS (Franck et al 2004) and SBOWC (Ista et al 2008). 
In the OBWS study (Franck et al 2004), all signs were represented in patients in both the 
“withdrawing” and “not withdrawing” groups.  These signs were ranked in order of the 
frequency they occurred according to the drug side effects taxonomy (BNF, 2016) (Table 
5.3).  Signs occurred in three frequency categories; “very common”, “common” and 
“uncommon” in both the “withdrawing” and “not withdrawing” groups. The occurrence 
of 14 signs increased in the “withdrawing” group compared with the “not withdrawing” 
group. Three signs (frequent suction required, hyperactive Moro reflex and 
hallucinations) did not change in prevalence. No signs occurred less frequently in the 
“withdrawing” group compared with the “not withdrawing” group.   
Seven signs were very common in both the “withdrawing” and “not withdrawing” groups: 
temperature > 37.2C (82% vs 68%); sleeping <25% interval (52% vs 11%); diarrhoea (42% 
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vs 20%); pupils >4mm (36% vs 17%);  tremors (36% vs 17%); crying/agitated 25-75% of 
interval and frequent suction required (27% vs 26%).  Most signs were more prevalent in 
the “withdrawing” group, except for suctioning which stayed the same.  Temperature 
>37.2C was the most common sign in both groups and was also present in most patients 
in these groups.  The other three signs that were very common in the “withdrawing” 
group were either uncommon or common in the “not withdrawing” group. These signs 
were crying/agitated >75 % of interval (35% vs 0.2 %), movement disorder (16% vs 0.9 %) 
and sweating (11% vs 1.8%). 
Table 5.3 Comparison of OBWS signs in “withdrawing” and “not withdrawing” patients. 
OBWS signs ranked by  
prevalence  
Withdrawing 
(%, 2 sig fig) 
 OBWS signs ranked by  
prevalence  
Not with-
drawing  
(%, 2 sig fig) 
Temperature > 37.2C 82 ------V
ER
Y C
O
M
M
O
N
------- 
Temperature > 37.2C 68 --V
ER
Y C
O
M
M
O
N
-- 
Sleeping < 25% interval 52 Frequent suction required 26 
Diarrhoea 42 Diarrhoea 20 
Pupils >4mm 36 Tremors 17 
Tremors 36 Pupils >4mm 17 
Crying/agitated 25-75% of interval 34 Crying/agitated 25-75% of interval 12 
Frequent suction required 27 Sleeping < 25% interval 11 
Movement disorder 16 Nasal stuffiness 3.7 -CO
M
M
O
N
-- 
Crying/agitated >75% of interval 12 Sweating 1.8 
Sweating 11 Yawning 1.7 
Respiratory rate high for age 7.9 ---C
O
M
M
O
N
--- 
Hyperactive Moro reflex 1.5 
Nasal stuffiness 7.9 Respiratory rate high for age 1.3 
Yawning 5.3 Movement disorder 0.9 UN
C
O
M
M
O
N
 
Vomiting 3.9 Sneezing 0.7 
Sneezing 2.4 Hallucinations 0.4 
Hyperactive Moro reflex 1.3 Vomiting 0.4 
Hallucinations 0.7 * Crying/agitated >75% of interval 0.2 
*= uncommon    2 sig fig = 2 significant figures. 
In the SBOWC study (Ista et al 2008) most signs (25 of 27) occurred in both the 
“withdrawing” and “not withdrawing” groups.  Signs are shown ranked in order of the 
frequency they occurred according to the taxonomy for drug side effects (Table 5.4).  
Signs occurred in two frequency categories in the “withdrawing” group (“very common” 
and “common”) and in three frequency categories (“very common”, “common” and 
“uncommon” in the “not withdrawing” group.  The prevalence of 22 signs increased in 
the “withdrawing” group, three signs were equally or less prevalent and two signs did not 
occur compared with the “not withdrawing” group.  The three most frequently occurring 
signs were the same in both groups (“withdrawing” vs “not withdrawing”); these were 
 
 
 
 108 | P a g e  
 
sleeps 1-3 hours (60% vs 58%); agitation (46% vs 20%) and tachypnoea (31% vs 28%).  The 
prevalence of two of these behaviours (sleeps 1-3 hours and tachypnoea), however was 
relatively unchanged, with only agitation showing an increase in prevalence in the 
“withdrawing” group.   
Table 5.4 SBOWC signs ranked by prevalence in the “withdrawing” and “not 
withdrawing” groups  
(Signs in bold were considered to “stand out clearly” by Ista et al (2008)). 
SBOWC signs ranked by 
prevalence 
With- 
drawing (%, 
2 sig fig)) 
 SBOWC signs ranked by 
prevalence  
Not with-
drawing (%, 
2 sig fig) 
Sleeps 1-3 h 60 ------------------V
ER
Y C
O
M
M
O
N
-------------------------- 
Sleeps 1-3 h 58 --------V
ER
Y C
O
M
M
O
N
---------- 
Agitation 46 Tachypnoea 28 
Tachypnoea 31 Agitation 19 
Uncoordinated movements 29 Sweating 19 
Muscle tension 28 Fever 18 
Gastric residuals 26 Anxiety 15 
Anxiety 25 Muscle tension 15 
Fever 25 Diarrhoea  14 
Sweating 23 Sleeps < 1 h 14 
Sleeps < 1 h 22 Uncoordinated movements 13 
Diarrhoea  22 Gastric residuals 12 
Grimace 19 Grimace 9.4 --------------------C
O
M
M
O
N
-------------------- 
Tachycardia 16 Mottling 9.1 
Mottling 15 Hypertension 7.8 
Hypertension 14 Tachycardia 7.4 
Vomiting 12 Muscle jerks 6.9 
Inconsolable crying 11 Inconsolable crying 6.3 
Muscle jerks 8.6 -------C
O
M
M
O
N
-------- 
Vomiting 4.4 
High pitch crying 4.3 Yawning 2.9 
Yawning 4.3 High pitch crying 2.6 
Tremor, spontaneous 2.2 Tremor, spontaneous 1.9 
Pupils 2.2 Poor feeding 1.6 
Hallucinations 1.1 Pupils 1.4 
*Tremor, stimulation 1.1 Sneezing 1.3 
Sneezing 1.1 *Tremor, stimulation 1.1 
Poor feeding 0  Hallucinations 0.7 UC
 
Seizures 0 Seizures 0.3 
*Tremor in response to stimulation                                                          UC = uncommon 
In their analysis, Ista et al (2008) described seven signs as “standing out clearly” in the 
“withdrawing” group. It is not clear from the paper why these signs were considered to 
stand out.  These stand out signs were agitation, increased muscle tension, anxiety, 
grimacing, sleeping < 1hour, poor feeding and tachypnoea, which ranked 2nd ,5th ,7th ,11th, 
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14th and 21st and joint 26th out of 27 signs in order of prevalence in the withdrawing 
group.  Poor feeding was not noted in any patients in the withdrawing group.   
5.6.2 The change in prevalence of signs from baseline (“not withdrawing”) to 
“withdrawing” 
The change in prevalence of signs between the “not withdrawing” and “withdrawing” 
groups was calculated for each study in order to consider and explore the differences 
between withdrawal behaviour and critical illness behaviour (Table 5.5). Signs were 
ranked in order of the biggest changes in prevalence from baseline, in order to determine 
those signs, whose change in prevalence might be noticeable to the bedside nurse and 
therefore clinically significant in terms of withdrawal.   
In the OBWS study (Franck et al 2004), ranking the signs by increase in prevalence from 
baseline produced five “stand out” signs. These signs (crying/agitated >75% of interval, 
movement disorder, vomiting, sneezing and sweating) showed increases of between 5 
and 10 times that of baseline levels, which also prompted a change in their frequency 
classification. Two behaviours (“crying/agitated >75% of interval” and “movement 
disorder”) showed a more than ten times increase in prevalence in the “withdrawing 
group” compared with the “not withdrawing” group and changed in classification from 
uncommon to very common.  In this analysis, “crying/agitated >75% of interval” moved 
from being the least prevalent sign at baseline (0.2%) to being at the top of the table, as 
the sign with the biggest increase in prevalence in the “withdrawing group” (12%).  
Movement disorder had the next biggest increase from 0.9% at baseline to 16% in the 
“withdrawing” group.  Two further signs were worthy of comment due to their increase 
in prevalence, although this was not sufficient to change their classification. Respiratory 
rate high for age increased by more than five time baseline, but remained common; 
sleeping < 25 % interval increased by just under five times baseline, but as a very 
common sign,  became prevalent in just over half of all withdrawing patients.  No other 
signs changed their classification due to either no change or modest changes from 
baseline.   
The change in prevalence of signs in the SBOWC study (Ista et al 2004) was less striking, 
with most behaviours being less than twice as likely in the “withdrawing” group (Table 
5.6). The sign with the greatest change was vomiting, which was nearly three times more 
likely in the “withdrawing” group.  Despite the difference in the extent of the change 
between the two datasets, it is interesting to note that the three signs showing the 
 
 
 
 110 | P a g e  
 
biggest increase between “not withdrawing” and withdrawing groups are the same in 
both studies: these being agitated, movement disorder and vomiting. 
Table 5.5 OBWS signs ranked by increase in prevalence from baseline (“not 
withdrawing”) to “withdrawing” 
OBWS signs  Prevalence (Frequency using drug 
side effect taxonomy) 
Increase in 
prevalence 
Not withdrawing 
(%) 
Withdrawing  
(%)  
Crying/agitated >75% of 
interval 
0.2  
(Uncommon) 
 12 
(Very common) 
> 10 times 
increase 
Movement disorder 0.9  
(Uncommon) 
16  
(Very common) 
Vomiting 0.4   
(Uncommon) 
3.9  
(Common) 
 
> 5 times 
increase but  
< 10 times 
Sneezing 0.7  
(Uncommon) 
2.4  
(Common) 
Sweating 1.8  
(Common) 
11  
(Very common) 
Respiratory rate high 
for age 
1.3 7.9  
 
 
 
 
 
 
> 2 times 
increase but  
< 5 times 
Common 
Sleeping < 25% interval 11 52 
Very common 
Yawning 1.7 5.3 
Common 
Crying/agitated 25-75% 
of interval 
12 34 
Very common 
Nasal stuffiness 3.7 7.9 
Common 
Pupils >4mm 17 36 
Very common 
Diarrhoea 20 42 
Very common 
Tremor 17 36 
Very common 
Hallucinations 0.4  0.7  
 
Similar rates  
(< 2 times 
increase)  
or no change 
Uncommon 
Temperature > 37.2C 68 82 
Very common 
Frequent suction 
required 
26 27 
Very common 
Hyperactive Moro 
reflex 
1.5 1.3 
Common 
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Table 5.6 SBOWC signs ranked by increase in prevalence from baseline (“not 
withdrawing” group) (Signs in bold were considered to “stand out clearly” by Ista et al 
(2008)). 
SBOWC signs  Prevalence (Frequency using drug 
side effect taxonomy) 
Increase in 
prevalence 
Not withdrawing (%) Withdrawing (%) 
 Vomiting 4.4 
(Common) 
 12 
(Very common) 
 
 
 
 
 
> 2 times 
increase 
 
 
 Tachycardia 7.4 
(Common) 
16. 
(Very common) 
Grimace 9.4 
(Common) 
19 
(Very common) 
Agitation 19.2 46 
Very common 
Uncoordinated 
movements 
13 29 
Very common 
Gastric residuals 12 26 
 Very common 
Inconsolable crying 6.3 11  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Similar rates / 
no change 
Common Very common 
Hypertension 7.8 14 
Common Very common 
Mottling 9.1 15 
Common Very common 
Muscle tension 15 28 
Very common 
High pitch crying 2.6 4.3 
Common 
Anxiety 15 25 
 Very common 
Pupils 1.4 2.2 
Common 
Hallucinations 0.7 1.1 
Uncommon Common 
Sleeps < 1 h 14 22 
Very common 
Diarrhoea  14 22 
Very common 
Yawning 2.9 4.3 
Common 
Fever 18 25 
Very common 
Sweating 19 23 
Very common 
Tremor, 
spontaneous 
1.9 2.2 
Common 
Muscle jerks 6.9 8.6 
Common 
Tachypnoea 28 31 
Very common 
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Sleeps 1-3 hours 58 60 
Very common 
Tremor, in response 
to stimulation 
1.1 1.1 
Common 
Sneezing 1.3 1.1 
Common 
Seizures 0.3 0 
Uncommon  
Poor feeding 1.6 0 
Uncommon  
 
5.6.3 Comparison of prevalence of shared items between the OBWS and SBOWC 
Of the 25 and 21 items examined by SBOWC and OBWS respectively, 13 items were 
investigated by both teams (Table 5.7).  Similarities in the prevalence of these behaviours 
during these studies might be expected.  This was not the case.  Apart from three low 
prevalence items; sneezing, yawning and hallucinations, there was incongruence in the 
prevalence of behaviours between the “withdrawing” groups or “not withdrawing” 
groups”.   Sleeping < 25% interval had a similar prevalence in the “not withdrawing” 
groups (11% OBWS vs 14% SBOWC) but this connection was not maintained in the 
“withdrawing” group (52% OBWS vs 22% SBOWC).  
Table 5.7 Prevalence of items common to OBWS (Franck et al 2004) and SBOWC (Ista et 
al 2008) 
Item OBWS (%, 2 sig.fig) SBOWC (%, 2 sig.fig) 
Withdrawing Not 
withdrawing 
Withdrawing Not 
withdrawing 
Crying/agitated 12 0.2 46 19 
Movement disorder 16 0.9 29 13 
Vomiting 3.9 0.4 12 4.4 
Resp rate high for age 7.9 1.3 31 28 
Sweating 11 1.8 23 19 
Sleeping < 25% interval 52 11 22 14 
Sneezing 2.4 0.7 1.1 1.3 
Yawning 5.3 1.7 4.3 2.9 
Pupils >4mm /dilatation 36 17 2.2 1.4 
Diarrhoea 42 20 22 14 
Tremor 36 17 3.3 3 
Hallucinations 0.7 0.4 1.1 0.7 
Temperature (OBWS > 
372C/ SBOWC > 384C) 
82 68 25 18 
2 sig. fig = 2 significant figures. 
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However, there was an unexpected correlation in the prevalence of three behaviours 
between the “withdrawing group” in OBWS and the “not withdrawing group” in SBOWC. 
These items were agitation (12% OBWS vs 19% SBOWC), movement disorder (16% OBWS 
vs 13% SBOWC) and vomiting (3.9% OBWS vs 4.4% SBOWC) (identified in bold in Table 
5.7).  These were also the three items that had shown the biggest increase in prevalence 
between the “not withdrawing” and “withdrawing” groups in their respective studies.  
This finding is unexpected as the size of the change in the prevalence of these items 
suggests a meaningful difference between the “not withdrawing” and “withdrawing” 
states in the respective studies: it does not explain why the prevalence of these items in 
“withdrawing” OBWS subjects then compares with the prevalence of these items in “not 
withdrawing” SBOWC subjects.  
 
5.7 Discussion  
This exploration compared two studies showing how behaviours differed in critically ill 
children weaning from opioids and benzodiazepines.  Data from two studies, Franck et al 
(2004) and Ista et al (2008), with similar inclusion and exclusion criteria were compared.   
Critically examining OBWS and SBOWC has delivered new insights into existing data and 
in so doing has demonstrated the value of triangulation and the mixed methods approach 
to inquiry. Considering the difference between withdrawing and not withdrawing groups 
from two perspectives; prevalence and change in prevalence, gave insight into the extent 
to which each of these equivocal signs may differentiate between withdrawal and critical 
illness.  Compared with more ubiquitous signs, those that increase from uncommon to 
common/very common may have a discriminant diagnostic value that is clinically 
meaningful in identifying withdrawal.  
These two studies have provided two perspectives of the characterisation of withdrawal.  
Results showed aspects of both congruence and dissonance, both of which are valued 
outcomes in a pragmatic approach (Mathison 1988).  Triangulation as a mixed methods 
approach, affords greater confidence in the inferences that can be made in congruent 
results from more than one perspective.  In pragmatic epistemology, divergent results are 
held in equal regard to congruent results, as consistent with the ideology of difference 
(Greene 2007), these different outcomes offer a dialectic perspective of withdrawal.  The 
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dissonance invokes further scrutiny and analysis leading to new insights and 
understanding (Cook, 1985).   
The impact of this study in terms of assessing withdrawal will be discussed first in relation 
to the diagnostic accuracy of WAT-1 and SOS, prior to a consideration of how differences 
in operationalisation of withdrawal may account for the dissonance in results.  
5.7.1 Differentiating between withdrawal and critical illness behaviour 
OBWS comprised 17 signs, most of which were very common (n=7) or common (n=5) in 
the “not withdrawing” group.  This finding demonstrated the equivocal nature of these 
signs by showing that they are already prevalent in critically ill children who are “not 
withdrawing”.  Most signs (n=13) showed an increase in prevalence between the 
“withdrawing” and “not withdrawing groups”.  Only four signs showed little or no 
increase in the “withdrawing” group: these signs were temperature >37.2C, 
hallucinations, frequent suction required and hyperactive moro reflex.   
The “stand out” signs in OBWS were four signs that were uncommon in “not 
withdrawing” patients and became common (sneezing) or very common (movement 
disorder, vomiting and crying/agitated > 75% of the interval).   As these signs are 
uncommon in critically ill children, their manifestation may act as a red flag to prompt 
consideration of withdrawal, particularly the two signs (crying/agitated >75% of interval 
and movement disorder) that increased in prevalence by more than 10 times that of not 
withdrawing patients. A fifth sign, sweating, although common in the “not withdrawing” 
group, also stood out, due to a five times increase in prevalence in the “withdrawing” 
group.  It might be that these signs are more discriminant items for withdrawal compared 
to other more equivocal signs.  This is important since a withdrawal assessment tool 
relies on clinically meaningful differences in the presentation of withdrawal, compared 
with no withdrawal or other differential diagnoses (DeVellis 2012).   
The item content of WAT-1 (Franck et al 2008) was examined in light of these findings. Of 
the 11 signs in WAT-1, only two signs; startle to touch and muscle tone were not derived 
from the OBWS checklist.  The five “stand out” signs were all included in WAT-1, although 
“crying/agitation > 75% of interval” was changed to a snapshot assessment of the child’s 
state during each assessment.  Of signs that did not change in prevalence, only 
temperature was retained in the subsequent WAT-1 tool; albeit with an increase in 
threshold to temperature > 37.8C (Franck et al 2008).  The remaining three signs; 
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loose/watery stools, tremor and yawning, were signs whose prevalence more than 
doubled in the “withdrawing” group compared with the “not withdrawing group”.   
SBOWC comprised 27 signs, most of which were very common (n=11) or common (n=14) 
in the “not withdrawing” group.  This finding, similar to the OBWS study also 
demonstrated the equivocal nature of these signs, given their prevalence in critically ill 
children who are “not withdrawing”.  Only six signs showed an increase in prevalence in 
the “withdrawing” group, but to a much lesser extent than the changes noted in the 
OBWS study.  These signs, which more than doubled their “not withdrawing” prevalence, 
were vomiting, tachycardia, grimace, agitation, uncoordinated movements and gastric 
residuals. No signs “stood out” due to their change in prevalence between the groups. 
The item content of SOS (Ista et al 2009) was examined in light of these findings.  All 15 
signs in SOS were derived from the SBOWC checklist.  This included five of the six signs 
which had the greatest change in prevalence; gastric residuals was not included. The 
other ten signs included showed similar rates or no change in prevalence between the 
withdrawing and “not withdrawing” groups. 
These findings point to a possible explanation for the poor positive predictive value of 
SOS: PPV=0.48 (Ista et al 2013). Ten of the 15 signs in SOS showed similar rates of 
prevalence in the “not withdrawing” and “withdrawing groups.”  Put another way, these 
behaviours are as likely to occur in critically ill children who are not withdrawing, as they 
are in those who are withdrawing. 
5.7.2 The operationalisation of withdrawal 
Consistent with the concept of dialectic, the dissonance in findings between the two 
groups offers the opportunity to reconcile these conflicting perspectives in the pursuit of 
synergy. Dissonance may be a consequence of the differences of the operationalisation of 
withdrawal, a consequence of different perceptions of behaviours or a reflection of 
differences in the severity of withdrawal.  Differences between the two datasets included 
the frequency of assessment, how withdrawal was designated, the incidence of 
withdrawal and the speed of weaning.  These aspects and their possible impact on the 
differences in presentation will be considered.  
5.7.2.1 Frequency of assessment  
SBOWC had a less frequent assessment schedule (8-hourly / three times a day) compared 
with OBWS (4-hourly / 6 times a day). The assessment schedule is a fundamental 
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operationalisation of the construct of withdrawal. It is not clear which of these schedules 
best identifies the withdrawing patient. 
5.7.2.2 How withdrawal was designated  
In OBWS, withdrawal was designated according to the clinical judgement of the bedside 
nurse. In SBOWC however, withdrawal was designated according to the decision to 
administer rescue therapy. These may not be comparable delineations for withdrawal 
and may possibly indicate different levels of withdrawal severity. For example, mild 
withdrawal signs might be classified as “withdrawing” in the OBWS study, as judged by 
the nurse. However, the same level may not prompt the administration of rescue therapy 
in the SBOWC study, so might be classified as “not-withdrawing”.  There is little evidence 
for, or agreement regarding the treatment threshold of withdrawal. Without a clear 
operationalisation, the association between behavioural signs of withdrawal and rescue 
therapy may reflect individual decision-making rather than the construct of withdrawal.  
Rather than delineating “withdrawing” and “not withdrawing” patients, these differences 
suggest a spectrum of withdrawal severity, as implied by the stages in the SWS treatment 
protocol (Cunliffe et al 2004).  
5.7.2.3 The prevalence of withdrawal by observation and by patient  
The OBWS cohort had more than twice the incidence of withdrawal by number of 
children (87% OBWS vs 34% SBOWC) and considerably higher incidence per observation 
(22% OBWS vs 0.04%).  The OBWS incidence equates to 1 in 5 assessments being judged 
as withdrawal. With an assessment schedule performed every 4 hours (6 times per day) 
this amounts to a frequency of just under one positive assessment per day. 
The SBOWC incidence of withdrawal (0.04%) equates to 1 in 25 assessments being judged 
as withdrawal. With an assessment performed every 8 hours, or 3 times a day, this 
amounts to an average of less than one positive assessment per week.   
The difference in the rates of diagnosis between the two studies suggests that the OBWS 
patients were withdrawing throughout the weaning process, compared with the SOS 
patients who had infrequent and transient episodes of withdrawal.  
5.7.2.4 The speed of weaning  
When physical dependence is suspected, sedative drugs are weaned, rather than stopped 
abruptly in an attempt to prevent or minimise withdrawal syndrome. Weaning rates 
differed considerably between the two studies, with OBWS taking an average of 11 days 
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and SBOWC appearing to take less than 48 hours, given the doses and reductions 
reported in the study (Ista et al 2007). The median number of 8-hourly SBOWC 
assessments was 14 over 6 days. A rapid wean in a physically dependent patient could be 
expected to cause signs of withdrawal for the duration of the weaning period and for 
about 72 hours after completion; a timeframe comparable to the SBOWC median 
assessment period. 
If the closest association exists between behaviour rates in the “withdrawing group” in 
OBWS (Franck et al 2004) and the “not withdrawing group” in SBOWC (Ista et al 2008), 
then one of the possibilities is that the SBOWC (Ista et al 2008) group were wrongly 
classified, and were really withdrawing.  Whether the patients in the SBOWC “not 
withdrawing” group were withdrawing or not, there appears little in common in the 
presentation of patients in different settings. This also implies that the change in 
behaviour which prompts a diagnosis and/or treatment of possible withdrawal may also 
differ across settings. Given the difference in weaning rates between the two studies, it 
might be expected that the incidence of withdrawal was higher in the SBOWC group, who 
had experienced the more rapid wean.  This was not the case, as the reported incidence 
of withdrawal was much lower in the study with the more rapid wean, a finding that 
suggests that the interpretation of behaviours varies to such an extent between different 
settings that comparison is futile and findings cannot be generalised. 
 
5.8 Conclusion  
When the difference in presentation between the “withdrawing” and “not withdrawing” 
groups was determined, the three signs which showed the greatest change were the 
same in both studies.  It might be that these signs -agitation, movement disorder and 
vomiting- are more discriminant items for withdrawal compared to other more equivocal 
signs.  These findings also conclude that most of the signs examined do not helpfully 
differentiate the withdrawing and not withdrawing groups. This brings into question the 
practice of summing behaviours to provide a global score indicative of a diagnosis of 
withdrawal if these behaviours are also common to those patients without the diagnosis.   
Rather than providing evidence in support of the current approach to withdrawal, this 
study highlighted the dissonance between OBWS and SBOWC and prompts further 
consideration.  Fundamentally, this incongruity points to the differences in the 
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 respective operationalisation of the construct of withdrawal in critically ill children; the 
speed with which weaning should occur to prevent withdrawal, the frequency with which 
an assessment of withdrawal should be performed and the delineator for diagnosing 
withdrawal.  It is not known which operationalisation better represents the construct. 
Further examination of the complexities of withdrawal assessment from different 
perspectives may offer different insights or possible solutions. 
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Chapter 6: Study 3: Pragmatic critique of the WAT-1 dataset 
 
6.1 Introduction 
Study 3 presents a pragmatic critique the WAT-1 dataset which offers a different 
perspective to the realist critique of the WAT-1 construction and validation studies 
(Franck et al 2008, 2012) which was presented in Chapter 2.  The evaluative framework of 
internal integrity will be described first. This will be followed by a pragmatic critique of 
the WAT-1 construction and validation studies.  The WAT-1 data analysis is reviewed in 
light of three additional studies which present analysis of the same dataset used in the 
WAT-1 study secondary analysis papers. The chapter concludes with the implications of 
this critique for the operationalisation of withdrawal. 
 
6.2 Background 
The process of critiquing WAT-1 commenced in the development stages of the studies 
underpinning this thesis.  Subsequent insights gained from the findings and analysis of 
Studies 1 and 2 and a focus on the perception and meaning of withdrawal behaviour for 
nurses and parents, prompted recursive interpretation of the tool validation studies.  
Further perspectives came from publications which undertook secondary analysis of the 
WAT-1 dataset (Grant et al 2012, 2013, Best et al 2016). The different perspectives that 
the Grant and Best studies bring to the WAT-1 validation study corresponds to the 
pragmatic philosophical position of this thesis.  Triangulation of the findings and analysis 
of these papers, for the purposes of obtaining corroboration or finding contradictions, is 
another key feature of mixed methods (Green et al 1989). 
The STARD checklist (2015) provided the framework for the critique of WAT-1 in Chapter 
2.  A different framework was sought to reflect the emergent approach to evaluation of 
this literature, mirroring the emergent design of the thesis and drawing on the theoretical 
framework of reasoning.  A pragmatic framework which focuses on “internal integrity” 
was selected and is suitable for evaluating both qualitative and quantitative research, 
(Krathwohl, 2009).   
Internal integrity is a judgement on the decision-making processes which underpins the 
assurance of a causal relationship being studied (Krathwohl, 2009).  In the WAT-1 and 
SOS validation papers, the use of inferential statistics to demonstrate validity relies on 
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the correct translation of constructs into operationalisations.  The lack of agreement 
between WAT-1 and SOS about how the construct of withdrawal syndrome is 
operationalised was another reason why further analysis of the WAT-1 validation study 
was undertaken and an alternative approach taken to evaluation.   
 
6.3 Aim of Study 3 
The aim of Study 3 was to critically evaluate the operationalisation of withdrawal 
underpinning the construction and validation studies of WAT-1 (Franck et al 2008, 2012).  
 
6.4 Objectives of Study 3 
The objectives of Study 3 were to;  
1. Apply the pragmatic evaluative approach proposed by Krathwohl (2009) to the 
WAT-1 validation paper (Franck et al 2012). 
2. Evaluate the operationalisation of withdrawal presented in the WAT-1 validation 
paper in light of findings from publications which undertook secondary analysis of 
the WAT-1 validation dataset (Grant et al 2012, 2013, Best et al 2016).   
 
6.5 Method 
6.5.1 A pragmatic approach to tool evaluation 
Internal integrity is defined by five standards which provide both conceptual and 
empirical support for the conclusions reached in a study (Krathwohl, 2009).  According to 
Krathwohl, conclusions, as new knowledge, equate to a reduction in uncertainty in the 
topic that has been studied.  The extent to which conclusions reduce uncertainty is a 
product of the internal integrity of the study.  Conceptual support for internal integrity is 
provided by “explanation credibility” and “translation validity.”  Empirical support is 
shown by “demonstrated result”, “rival explanations eliminated” and “credible result” 
(Krathwohl, 2009).  A brief description of each of these standards is presented followed 
by the findings of the evaluation of the WAT-1 validation study according to these 
standards. Ethical approval was not required for this study. 
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6.5.1.2 Explanation credibility  
Described as “plausibility” by Tashakkori and Teddlie (2009), explanation credibility 
focuses on the relationship between the explanation or rationale for the study and the 
hypothesis and research questions. This includes defining the constructs involved in the 
study and describing their interrelation. 
6.5.1.3 Translation validity 
Described as “quality of implementation” by Tashakkori and Teddlie (2009), translation 
validity focuses on how the study was carried out (whether the study design and 
processes are appropriate to answer the research questions). 
6.5.1.4 Demonstrated results 
Described as “congruence of evidence and explanations” by Tashakkori and Teddlie 
(2008), a demonstrated result, where the explanation provides an accurate prediction, 
has the following attributes;  
1. Authenticity of evidence.  Inferential statistics rely on authenticity of evidence, 
2. Precedence (or concomitance) of cause, and 
3. Presence of effect.  An effect occurred as expected in terms of the relationship 
described by the hypothesis. 
6.5.1.5 Rival explanations eliminated  
This is described as “lack of other plausible explanations” by Tashakkori and Teddlie 
(2008). The researcher should anticipate any rival explanations for the study effect and 
demonstrate how the causes have been ruled out. 
6.5.1.6 Credible results 
This is a culmination of the four standards needed to make good inferences in the study.  
These standards which characterise good inferences in both qualitative and quantitative 
research were applied critically by the researcher to the construction and validation 
studies of WAT-1 and SOS.   
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6.6 Results 
6.6.1 Explanation credibility 
The aim of the Franck et al (2012) study was to further evaluate the psychometric 
properties and generalisability of the WAT-1 tool, and to identify cut-points for 
diagnosing withdrawal.  Initial psychometric testing had demonstrated that a WAT-1 
score ≥3 predicted a nurse numeric rating (NRS) score >4, with a sensitivity of 0.87 and 
specificity of 0.88 (Franck et al 2008). This relationship may have been due to these 
paired assessments (WAT-1 then NRS) being performed by the same nurse. This 
interrelation limits the extent to which we can be confident that WAT-1 score ≥3 
indicates withdrawal syndrome.  WAT-1 requires further evaluation to demonstrate that 
it is a valid and reliable measure of withdrawal syndrome. 
6.6.2 Translation validity 
This feature considers whether the study has been carried out in a way that will provide 
evidence in support of WAT-1 as a valid and reliable withdrawal assessment tool.  
Translation validity considers the following aspects of the study design;  
 Focus (what is being studied), 
 Study setting (when and where) and participants (who), and 
 How is it demonstrated that something of interest occurs.  
6.6.2.1 What is being studied  
The objectives of the study were to demonstrate three aspects of the construct validity of 
WAT-1 (as an operationalisation of withdrawal); these were known groups validity, 
concurrent and predictive validity. These aspects all demonstrate how accurately the 
WAT-1 tool (including item content, the assessment process and the assessment 
schedule) measures the construct of withdrawal (Streiner and Norman 2003). 
Known groups validity is demonstrated if WAT-1 is sensitive enough to discriminate 
between groups of patients who are known to be withdrawing and groups who are not 
withdrawing, or between groups who have differing levels of withdrawal severity.  
Concurrent validity is demonstrated if a WAT-1 score provides the same result 
(withdrawal – yes/no) as other measures of withdrawal when scored at the same time. 
Predictive validity is demonstrated if WAT-1 scores in patients who have a greater 
number of risk factors for withdrawal are higher than WAT-1 scores in patients with 
fewer risk factors. 
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6.6.2.2 The study setting and participants 
The WAT-1 validation study (Franck et al 2012) was undertaken during the baseline phase 
of the parent study; the RESTORE study (Curley et al 2015).  The RESTORE study was 
designed to compare a sedation protocol, which directed decisions about sedation, 
analgesia and withdrawal, to usual care.  The aim of the baseline phase was reported as 
the implementation of valid and reliable instruments to measure the secondary 
outcomes of the RESTORE study (Curley et al 2015); the incidence of withdrawal was one 
of the secondary outcomes.   
Children (aged 2 weeks to 18 years) with acute respiratory failure supported on 
mechanical ventilation exposed to at least five days continuous opioids participated in 
the study.  The study schedule planned WAT-1 assessments for patients from the start of 
opioid tapering until 72 hours after the last opioid dose, at 8am and 8pm daily, and at 
other times if clinically indicated.  Compliance with this schedule could not be assessed in 
the published results, which reported that WAT-1 was recorded once daily for 23% days, 
twice daily for 29% of the days and more than twice daily for 48% of the days (Franck et 
al, 2012). Explanation for non-compliance with the schedule was not reported or 
discussed. 
This was a multisite study in 21 PICUs in the USA.  Eligible PICUs did not have a sedation 
protocol in place and prior to participation in the trial, only 8 of the 22 sites had a 
standard of care for withdrawal assessment.  Aside from the introduction of assessment 
tools for pain, sedation and withdrawal, all sites continued with usual care during this 
study.  The usual care of participating PICUs was not described.  The lack of 
standardisation in treatment for participants across the sites impacts on inferences that 
can be gained from the findings.  In terms of making the decision to treat withdrawal 
signs, it is not clear whether the newly introduced WAT-1 tool featured in the decision-
making. It is not known if staff were aware of the hypothesised cut-point of WAT -1≥3 for 
withdrawal or whether there was a temporal link between the WAT-1 score and decision 
to treatment withdrawal signs.  As subjects continued to receive usual care, the range of 
treatment options for withdrawal was not reported.  A causal relationship between WAT-
1 scores and treatment decisions cannot be inferred from the data presented.  
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6.6.2.3 How is it demonstrated that something of interest occurs 
Demonstrating that a WAT-1 score ≥3 indicates withdrawal due to a causal relationship, 
rather than due to chance, entails evaluation of the reliability and validity of findings.  To 
be assured of a causal relationship rather than a chance occurrence, the researcher must 
demonstrate interrater reliability (IRR), showing that all subjects were assessed in a 
standardised way. Each site completed three rounds of IRR testing before and during the 
study. Support for IRR was reported as an overall concordance rate for WAT-1 score <3 
and WAT-1 score ≥3 (97.4%); the Spearman rank correlation coefficient between 
simultaneous WAT-1 scores (0.93) and the frequency with which pairs of nurses recorded 
identical scores (83.1%).  It is not clear from these data that IRR was sufficiently 
established prior to the start of the study; presenting results for each round of testing 
rather than the aggregate result may have provided assurance that this was the case.  
Subjects in this study were being weaned from ≥5 days opioids, so all were at risk of 
withdrawal.  When demonstrating known groups validity, concurrent and predictive 
validity the study compared scores across groups expected to differ and examined the 
association between WAT-1 scores and variables hypothesised to be indicative of 
withdrawal (amount of drug exposure, length of weaning). The approach to 
demonstrating each of these aspects of validity will be considered. 
6.6.2.3.1 Known groups validity  
This study did not compare scores across groups expected to differ, so known groups 
validity was not demonstrated.  Subjects who ever had a WAT-1 score ≥3 were compared 
with those with lower WAT-1 scores in relation to three factors thought to contribute to 
the likelihood of withdrawal; analgesia and sedative treatment during weaning, peak and 
cumulative opioid and benzodiazepine exposure and duration of pre weaning and 
weaning phases.  Splitting the group according to the WAT-1 score does not show the 
discriminatory power of the score.  This is called criterion contamination (Streiner and 
Norman 2003). To demonstrate discriminatory power, the group should be split 
according to one of the contributing factors before comparing the WAT-1 scores of 
patients in these groups.   
Given the similar behavioural presentation between pain, under sedation and 
withdrawing, demonstrating that WAT-1 can discriminate between patients who are 
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withdrawing and patients who are under-sedated would provide even stronger support 
for construct validity.  
6.6.2.3.2 Concurrent validity  
Concurrent validity was not demonstrated in this study as no other measures of 
withdrawal were applied to assess withdrawal at the same time as the WAT-1 tool. 
6.6.2.3.3 Predictive validity  
Predictive validity is demonstrated if WAT-1 scores are higher in patients who have a 
greater number of risk factors for withdrawal than WAT-1 scores in patients with fewer 
risk factors. This could not be demonstrated by splitting the group according to WAT-1 
score, rather than according to a risk factor for withdrawal.   
Contrary to the claims of statistical support for construct validity presented by Franck et 
al (2012), this pragmatic approach does not provide evidence that the stated construct 
validity aims were achieved in the WAT-1 validation study. 
6.6.3 Demonstrated results 
Demonstrated results show whether explanations prove to be good predictors of the 
construct of withdrawal and considers authenticity of evidence, precedence of cause and 
presence of effect.  Each of the aspects of demonstrated results will be considered in 
turn.  
6.6.3.1 Authenticity of evidence 
The discrepancy between the number of subjects who ever scored WAT-1≥3 (n=97) and 
the number reported to have clinically significant withdrawal (n=21) was not explained.  
Clinically significant withdrawal as a construct was not defined at the start of the study, 
but first appeared in the results section as “any patient receiving rescue therapy (an 
opioid or benzodiazepine bolus or an increase in opioid or benzodiazepine infusion) to 
manage an increase in WAT-1 symptoms after the start of weaning (not for treatment of 
new pain or new sedation needs).”  This definition came from the RESTORE trial protocol 
(Curley et al 2015), but is not clear whether this protocol directed the management of an 
increase in WAT-1 symptoms in this study (the baseline phase).  Franck et al (2012) 
reported in the study design that subjects would receive usual care during the baseline 
phase, at the discretion of the medical team, rather than according to the study protocol.   
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It is also not clear whether the proposed cut-point of WAT-1≥3 was known to nurses 
applying the tool in this study.  If this was known, then the WAT-1 score, rather than the 
child’s presentation and/or clinical opinion, might have driven the decision to treat.  Even 
if the cut-point was not known, the introduction of a scoring system is a change which 
may impact on usual care.  The rationale underpinning the decision to treat or not treat is 
not reported or explained, so may not have been consistent across the 21 sites of this 
study.    
Of the 97 subjects who ever had a WAT-1 score ≥3, 21 subjects received rescue 
medication.  It follows therefore, that the majority of patients who ever had a WAT-1 
score ≥3 (n=76 patients, 78%) were not treated for withdrawal.  
The findings presented do not support the study conclusion that a WAT-1 score ≥3 
appears to be a reasonable designation of clinically significant withdrawal symptoms.  
6.6.3.2 Precedence of cause   
A demonstrated result shows a precedence or concomitance of cause.  This would be 
demonstrated in this study if reductions in sedative dosing preceded an increase in WAT-
1 scores.  However, this temporal link pertains to all subjects in this study, who were all 
being weaned from opioids during the study period.  The reduction in sedatives does not 
differentiate patients whose WAT-1 scores increased compared with those whose scores 
did not increase.  A causal relationship could be better established by comparing WAT-1 
scores in patients who were weaning sedatives and those who were not weaning 
sedatives. 
6.6.3.3 Presence of effect 
Einhorn and Hogarth (1986) described contiguity of cause and effect and congruity of the 
effect of the cause. The former refers to the proximity of, or association between the 
reduction in opioid dosing and the WAT-1 score ≥3.  This was not presented in the results. 
Congruity means the size of the cause and effect should correspond; a larger reduction in 
opioids should manifest as a greater WAT-1 score compared with a smaller reduction in 
opioids.   This was also not presented in the results.   
Presence of effect can also be demonstrated if rescue treatment was administered in 
response to a WAT-1 score ≥3 and the WAT-1 score reduced in response to this 
treatment.  Such an effect was reported in 21 subjects who had 51 episodes of 
withdrawal and received rescue therapy (a bolus of opioid or benzodiazepine or an 
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increase in infusion rate) to manage an increase in WAT-1 symptoms. The median (IQR) 
WAT-1 score of these patients before and after rescue therapy was 6 (4-8) and 2 (1-3) 
respectively (Franck et al, 2012).  The temporal link between rescue therapy and the 
before and after WAT-1 assessments was not reported, so the strength of the association 
is not known.  
6.6.4 Rival explanations eliminated 
This standard considers other possible reasons for the patient to score WAT-1 score ≥3. 
Exclusion of these possible causes supports the diagnostic capacity of this cut point. 
The definition of clinically significant withdrawal reported in the previous section was 
contingent on the administration of rescue therapy to manage an increase in WAT-1 
symptoms.  However, this rescue therapy may also have been administered to treat 
unmet sedation or pain needs. The sedation and pain scores of patients who received 
rescue therapy for an increase in WAT-1 scores were not reported in this study, both of 
which are plausible explanations for the administration of rescue therapy.  Sedation was 
assessed using the State Behaviour Scale (SBS) (Curley et al 2006) at least every 4 hours 
(hourly if the patient was agitated), pain was also assessed at least every 4 hours and 
withdrawal was assessed at least every 12 hours (Curley et al, 2015).  
The SBS is a component of WAT-1, contributing 3 points of the 12-point range in a child 
who is awake/ distressed at the start of the assessment and then takes more than 5 
minutes to settle once the assessment was completed.  In these circumstances the 
patient would score for withdrawal (WAT-1 = 3) and under sedation (SBS ≥+1).  The pain 
scale used in non-verbal children under 6 years was the Faces, Legs, Activity, Cry and 
Consolability Scale (FLACC) (Merkel et al 1997).  The behavioural parameters of this tool 
also overlap with those of SBS: an SBS+1 or +2 could score as FLACC 4 (due to difficulty to 
console, squirming and restless or kicking legs.  
The interdependence of SBS, WAT-1 and FLACC challenges the capacity to differentiate 
pain, under sedation and withdrawal, any of which might be plausible diagnoses in this 
cohort.  This study did not provide assurance that rival explanations had been eliminated. 
6.6.5 Credible results 
Franck et al (2012, p 147) concluded “WAT-1 score ≥3 a reasonable designation of 
clinically significant (withdrawal) symptoms.” The design and presentation of the study 
did not support this conclusion. The following changes would be required to produce 
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evidence that links the variables in a causal relationship and reduce the uncertainty 
inherent in this study.  The demonstrated results attributes of “authenticity of evidence” 
“precedence of cause” and “presence of effect” were not established in this study. 
Demonstrating these attributes would require;  
 Evidence of the causal link between the WAT-1 score and decision to treat 
withdrawal with a rescue bolus or an increase in withdrawal, 
 Evidence of a clear temporal relationship between reduction in sedative and WAT-
1, demonstrating congruity where bigger reductions in sedative result in higher 
WAT-1 scores than smaller reductions do, and 
 Evidence of a clear temporal relationship between the administration of the 
rescue therapy in response to a high WAT-1 score and the lower WAT-1 score on 
reassessment   
“Elimination of rival explanations” was also not established in this study. Demonstrating 
this attribute would require; 
 Elimination of pain and under-sedation as rival explanations for patients with 
WAT-1 scores ≥3 by undertaking concomitant assessment of pain and sedation.  
 
6.7 Discussion 
The findings of the pragmatic evaluation of the WAT-1 validation study (Franck et al 2012) 
will be discussed in light of the studies which undertook and published secondary analysis 
of the WAT-1 validation dataset.  The different perspectives are provided by Grant et al 
2012, Grant et al 2013 and Best et al 2016.  The RESTORE trial was a multicentre 
prospective sedation trial (Curley et al 2015).  The same data set of patients enrolled in 
baseline pre-randomisation phase of this trial was described and analysed in two further 
studies relating to withdrawal, in addition to the WAT-1 study (Franck et al 2012). Grant 
et al (2012) prospectively evaluated sedation-related adverse events and subsequently 
published operational definitions of sedation-related adverse events (Grant et al 2013).  
Best et al (2016) characterised sedation weaning patterns in patients who received at 
least five consecutive days of opioids (Table 6.1). These studies were reviewed in order to 
examine the different perspectives they might afford the WAT-1 validation study. 
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6.7.1 RESTORE trial (Curley et al 2015) 
PICUs without an existing sedation protocol were eligible to participate in RESTORE 
(Curley et al 2015).  All 22 participating units had a standard of care for pain assessment, 
but fewer had standards for sedation/agitation assessment (55%, n=12) or withdrawal 
assessment (36%, n=8) (Curley et al 2015).  Standardised assessments for pain, sedation 
and withdrawal were introduced in the baseline phase but study subjects continued to 
receive usual care. This meant that sedation and pain control were managed at the 
discretion of the care team; no recommendations were made by the RESTORE team.  
WAT-1 was used to assess opioid withdrawal in patients receiving at least five days 
opioids. 
Table 6.1 RESTORE studies by author, purpose of study and year of publication 
Author and year Purpose of the study 
Franck et al 2012 Further evaluate the psychometric properties and generalisability of 
WAT-1 in children recovering from acute respiratory failure. 
Grant et al 2012 Define and estimate sedation-related adverse events 
Grant et al 2013 Test operational definition and estimate the rate and site to site 
heterogeneity of prospectively collected sedation-related AEs in 
patients intubated and mechanically ventilated for acute respiratory 
failure at 22 PICUs.  
Best et al 2016 Characterise sedation weaning patterns in patients who received at 
least 5 consecutive days opioids.   
 
6.7.2 RESTORE trial sedation-related adverse events (Grant et al 2012, 2013) 
Grant et al (2012, 2013) published two papers relating to sedation-related adverse 
events.  The first was a prospective evaluation of adverse events in the RESTORE baseline 
phase, to test operational definitions and estimate the incidence of inadequate pain and 
sedation management in mechanically ventilated paediatric patients (Grant et al 2012). 
The second paper published estimates for sedation-related adverse events for the 
RESTORE trial (Grant et al 2013) (Table 6.2).   
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Table 6.2 Specified event definitions and estimated rate of events (Grant 2013) 
Clinically significant iatrogenic withdrawal is defined in patients weaning from ≥5 days of 
continuous infusion or round-the clock narcotics as; any patient receiving rescue therapy 
(defined as an opioid or benzodiazepine bolus or an increase in opioid or benzodiazepine 
infusion) to manage an increase in WAT-1 symptoms after the start of weaning and not 
for treatment of new pain or sedation needs.  Available evidence identifies iatrogenic 
withdrawal as a WAT-1 score ≥3.  Event rate: < 75% patients. 
Inadequate sedation management is defined as; agitation defined by an SBS>0 (or 
assumed agitation in patients receiving neuromuscular blockade) for 2 consecutive hours, 
not related to a planned extubation attempt. Event rate: <10% patients 
Inadequate pain management is defined as; pain score >4 (or assumed pain present) for 
2 consecutive hours not related to a planned extubation event.  Event rate: < 20% 
patients. 
 
The rate of two adverse events (withdrawal and sedation) reported in the baseline trial 
(Grant et al 2012) differed substantially to the event rates published in the subsequent 
paper (Grant et al 2013). During the baseline phase of the trial, clinically significant 
iatrogenic withdrawal was reported at 8.7%, which was nearly ten times than the chosen 
estimated rate for the trial (Table 6.3).  
Table 6.3 Actual event rates (Grant 2013) 
308 subjects / 594 AEs 
Withdrawal incidence = 54 events in 24 subjects (8.7 %) subjects.   
Although reported as 8.7 % in paper, the calculation 24/308 gives the incidence as 7.8% 
This is out of 308 subjects/ 594 AEs (not all of whom were > 5 days opioids).  
In patients≥ 5 days opioids (n=141 or 142);  
Withdrawal incidence equates to 24/(141 or142) = 17 % subjects. 
Inadequate sedation management = 242 events in 93 (30 %) subjects  
Inadequate pain management = 173 events in 83 (27 %) subjects  
Subjects with inadequate sedation and pain= 56 (18 %) subjects (number of events not 
provided). 
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This figure was calculated inaccurately in the published paper, as the denominator used 
was the number of patients in the trial (n=308) but should have been the number of 
patients receiving at least 5 consecutive days of opioids, which was reported as 46% 
participants (n=141 or 142). This gives an incidence of withdrawal of 17%, which is still 
considerably lower than the estimate for the RESTORE trial (Grant et al 2013). Cases of 
inadequate sedation were three times more prevalent during the baseline study, than the 
estimated rate and inadequate pain management which was the same as the estimated 
rate.   
Prior to entering the trial, all PICUs undertook pain assessments, one half (55%, n=12) 
undertook sedation/agitation assessments and one third (36%, n=8) undertook 
withdrawal assessments (Curley et al 2015).  The differences between estimated 
prospective rates and actual rates for adverse events in the baseline study appear to be 
inversely proportional to the presence of existing assessments prior to the study. The 
biggest difference between actual and expected rates was for withdrawal, which had only 
been assessed in one third of PICUs prior to this study. This compared with no difference 
between expected and actual rates for inadequate pain, for which all PICUs had an 
existing assessment. Despite the intention to continue with usual care, the introduction 
of a new assessment may have led to an altered interpretation of the patient’s behaviour 
and an inadvertent change in usual care.  
Due to the anticipated potential for site to site heterogeneity in the reporting of 
sedation-related AEs, statistical analysis methods allowed for clustering of observations 
within a site (Grant et al 2013). The events with the largest intraclass coefficient (ICC) 
were inadequate sedation management (0.13), clinically significant iatrogenic withdrawal 
(0.088) and inadequate pain management (0.08).  These values represent moderate site-
to-site heterogeneity for these adverse events. The ICCs measuring the proportion of 
variation in outcome attributable to the natural variation between sites rather than 
between subjects in sites was 7.8% to 13%. 
Grant et al (2013) concluded that there was moderate variation in event reporting, 
despite clear operational definitions, training, monitoring and adjustment for the age of 
the child, severity of condition and functional health.  This conclusion diminishes the 
reliability of the findings in the WAT-1 study (Franck et al 2012).  
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Reliability is the ratio of subject variance to subject + error variance (Streiner and 
Norman, 2004).  Reliability appears to improve when the extent of the variance between 
participants is increased relative to the error variance.  Administering the scale in a 
heterogeneous population artificially inflates variance, giving a flawed impression of the 
reliability to discriminate patients at risk of withdrawal.   
6.7.3 Characterising sedation weaning patterns (Best et al 2016)  
The purpose of this study was to characterise sedation weaning patterns in patients who 
received at least 5 consecutive days of opioids.  Two weaning patterns were identified 
from the data. Intermittent wean described patients with a 20% or greater increase in 
daily opioid dose after the start of weaning and steady wean described all other patients 
(Table 6.4).  In the steady wean group, opioid weaning was completed in median (IQR) 2 
(1-5) days. Fifty patients (63%) in this group had WAT-1 scores performed, of whom 23 
(46%) scored WAT-1 score ≥3.  The same number (n=50, 63%) also had opioid boluses and 
forty-nine (62%) had benzodiazepine boluses during opioid weaning.  Seventy-two 
patients (91%) required other sedatives during opioid weaning. Fifty-nine patients (75%) 
received two or more classes of sedatives during this period.  In the intermittent weaning 
group, opioid weaning took longer 10.5 (8-13) days, and a higher proportion of patients 
had WAT-1 scores performed (94%, n=62), scored WAT-1 score ≥3 (85%, n=53), received 
opioid (86%, n=57) and benzodiazepine (85%, n=56) boluses and required two or more 
additional classes of sedatives (94%, n=62) during the weaning period. 
The assessment method and frequency of adverse event assessments was dictated by the 
RESTORE team but all subjects received usual sedation and pain control at the discretion 
of the care team in the 22 different sites.  The study protocol scheduled (at least) 12-
hourly WAT-1 scores during opioid weaning, but 23% patients (n=33) did not have any 
WAT-1 assessments performed during this time (Best et al 2016).  Of the remaining 
patients who had one or more WAT-1 assessments performed (77%, n=112), these 
patients made up a greater proportion of the intermittent wean group compared with 
the steady weaning group (94% versus 63%) respectively.   
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Table 6.4 Patient characteristic by pattern of weaning (Best et al 2016) 
Characeteristic Steady wean  
n=79 (54%) 
Intermittent wean  
n=66 (46%) 
Opioid weaning duration  
median (IQR) days  
2 (1-5) 10.5 (8-13) 
Opioid boluses during weaning  n=50, 63% n=57, 86% 
Benzo bolus during op weaning n=49, 62% n=56, 85% 
≥ 2 additional classes of sedatives*  n=59, 79% n=62, 94% 
WAT-1 assessments performed n=50, 63% n=62, 94% 
WAT-1 ever ≥3 n=23 patients/50 (46%) n=53 patients/62 (85%) 
Peak WAT-1 score, median (IQR) 2 (1-5) /50 assessments 5 (4-6) /62 assessments 
 *Required during opioid weaning 
 
6.7.3.1 What predicts administration of boluses or prompts a withdrawal 
assessment? 
The number of patients in each group who required rescue therapy (additional opioid 
boluses and/or benzodiazepine boluses) is very closely correlated with the number of 
WAT-1 assessments undertaken, rather than with the number of assessments defined as 
clinically significant withdrawal (WAT-1 score ≥3) (Table 6.4).  This correlation raises the 
possibility that the patient’s state typically prompted both a WAT-1 assessment and 
treatment with opioids and sedatives, rather than adhering to the assessment schedule in 
the study screening schedule.  It is not clear from the data, however, whether the 
assessments and interventions related to the same patients. Insufficient information is 
provided to understand the relationship between assessments, scores and bolus 
administration.  
These findings cast doubt on the assertions of construct validity made in the Franck et al 
(2012) study as this level of information about interventions and the trend in scores was 
absent in the analysis of that study (Franck et al 2012). There are also differences in the 
figures reported.  Franck et al (2012) reported 51 episodes in 21 patients, defined as “any 
patient receiving rescxue therapy defined as an opioid or benzodiazepine bolus or an 
increase in opioid or benzodiazepine infusion” (p 146). Best et al (2016) reported that 107 
patients received opioid and/or benzodiazepine boluses during weaning, but did not 
report the number of episodes. The figures reported by Best et al (2016) that correspond 
most closely to those reported by Franck et al (2012) are the cohort of patients (n=50) in 
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the steady wean group (n=79). This cohort had a WAT-1 assessment performed during 
weaning, of which 23 had a WAT-1≥3. However 50 patients in this group received opioid 
and benzodiazepine boluses over a median (IQR) of 1(1-2) and 2 (1-3) days respectively 
(Best et al 2016). 
6.7.3.2 Risk factors of withdrawal 
Best et al (2016) described these patients as steady and intermittent wean. Intermittent 
wean patients had a pattern of weaning including a 20% or greater increase in the total 
daily opioid dose at any time during the weaning period (Best et al 2016).  Graphs of two 
representative patients were presented by Best et al (2016) (Figure 6.1).  
Patient A had lower daily doses of opioid and benzodiaepines than Patient B with a peak 
opioid dose of 4.5 mg/kg on day 9. The opioid was weaned at consistent rates over 11 
days, as shown by the steady slope of the dose graph. 
Patient B had higher daily doses of opioids and benzodiazepines than Patient A with a 
peak opioid dose of 7.5 mg/kg on day 6. The opioid and benzodiazepine was weaned 
rapidly by at least 30% of the peak dose on day 7 as shown by the steep slope of the dose 
graph. Opioid weaning then slowed on day 8 and the rate was increased on day 9. 
 
Figure 6.1 Dose curves presented by Best et al (2016) 
6.7.3.2.1 Interpretation by Best et al (2016) 
Best et al (2016) described tolerance as a doubling of the day 2 opioid dose  prior to the 
start of weaning; according to this definition, both patient A and B are tolerant.  All 
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patients in this study are also at risk of physical dependence as the inclusion criteria 
required patients to have received at least 5 days continuous opioids (Best et al 2016). 
Patients with intermittent patterns of weaning were reported to have received 
significantly more doses of sedatives during the weaning period, had higher  total 
cumulative opioid and benzodiazepine doses and experienced longer durations of 
mechanical ventilation and PICU and hospital lengths of stay when compared with 
patients who were weaned steadily (Best et al 2016). 
Conversely, steadily weaned patients tolerated rapid decreases in opioid and 
benzodiazepine doses with a lower incidence of withdrawal (Best et al 2016).  
Best et al (2016) concluded that higher cumulative doses, peak doses of opioids and 
benzodiazepines and longer exposures are associated with  withdrawal (Best et al 2016). 
6.7.3.2.2  My interpretation (An alternative proposition) 
The basis for these assertions can be challenged by the extent to which these variables 
are causal factors of withdrawal or are the cause or consequence of other related factors.  
The researcher would argue that the only causal factor for withdrawal is the rate of 
weaning.  From this perpective, the increase in opioid dose used to define the  
intermittent weaning, is a response to  withdrawal signs provoked by too fast a rate of 
weaning. 
According to this model, if patient B was weaned at the rate of patient A, then B may not 
have withdrawn. If patient A was weaned at the rate of patient B then A might have 
withdrawn.  Changing the rate of weaning changes the risk of withdrawal. By changing 
rate of weaning; the factors related to the duration of mechanical ventilation are 
unchanged but the factors related to treating withdrawal – more sedative doses during 
weaning and a longer wean would be changed.  
The propositional model, devised by the researcher as a means of clarfying  and 
illustrating the causal relationship between variables, presented earlier (Chapter 2), is 
shown in figure 6.2.  The model has been adapted slightly to incorporate all variables and 
consequences described by Best et al (2016) but the cause and effect relationships they 
represent are unchanged.  Additions to the model presented earlier include the role of 
peak dose, which contributes to cumulative dose and the onset of physical dependence 
(Ambigoni et al 2014, DaSilva et al 2016). The terms “too fast” and “optimal”  delineate 
the speed of weaning in relation to the patient’s response to the chosen rate.   
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In patients who are physically dependent, the risk factor for withdrawal is the rate of 
weaning prescribed by the clinical team.  All other factors are a consequence of the 
length of mechanical ventilation.  In support of my proposition, Best et al (2016) reflected 
that patients with intermittent patterns of weaning experienced greater frequency and 
severity of WAT-1  scores, concluding;  
“The question whether intermittent weaning patterns are the outcome of 
preweaning risk factors or a contributory cause of higher WAT-1 scores and more 
intense or protracted weaning remains unanswered” (Best et al 2016, p 10). 
 
Figure 6.2 A proposition of the causal relationships between factors linked to physical 
dependence and withdrawal syndrome. 
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6.7.4 Flow of participants (STARD, 2015) 
One of the STARD criteria includes the flow of participants through the study.  As each 
study shared the same patient population, the flow of participants through the three 
studies (Franck et al 2012, Grant et al 2012, Best et al, 2016) was expected to be the 
same.  Studies reported differences in enrolment, inclusions and exclusions (Table 6.5).  
Table 6.5 Flow of participants 
 Franck et al 
2012 
Best et al 
2016 
Grant et al 
2012 
R
ecru
ited
 
Approached 348 NR 468 
Refused 11 NR 160 
Enrolled 308 308 308 
Exposed to ≥ 5 days opioids 206*  186* 141/142* 
Exclu
sio
n
s 
Total excluded 80 41 NR 
Did not start weaning during 
study period 
16 0 NR 
Did not complete weaning in 
28-day study period 
0 36 NR 
Lost to follow up 0 1 NR 
Died 3 4 NR 
No WAT-1 assessment 61 (excluded) 33 (included) NR 
 Final sample 126* 145*  141/142 
Total WAT-1 score ≥3 97 WAT-1≥3 76 WAT-1≥3 NR 
Total WAT-1 score <3 29 WAT-1<3 36 WAT-1<3 NR 
Episodes of withdrawal 
(number of patients) 
51 (21) NR 54 (24) 
*Differences in flow of participants  NR = not reported 
The number of patients enrolled in the study was the same across the three studies. 
However, differences occurred in the number of patients who had at least five 
consecutive days of opioids, ranging from 206 (Franck et al 2012) to 141/142 (Grant et al 
2012). Reasons for exclusion also differed between teams, impacting on differences in 
the final sample size and the proportion of WAT-1 scores ≥ 3 (Table 6.5)  
The study protocol defined clinically significant iatrogenic withdrawal as WAT-1 score ≥3 
and requiring rescue therapy (Curley et al 2015).  Reporting of this differed between 
studies. In Franck et al (2012) the median (IQR) WAT-1 score associated with clinically 
significant withdrawal was 6 (4-8) in 51 scores and 21 patients, compared with WAT-1 
score of 6 (4-7) in 54 scores and 24 subjects (Grant et al 2013).  Best et al (2016) did not 
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report episodes of clinically significant withdrawal, but did report the number of patients 
(n=107) who required opioid and benzodiazepine boluses during weaning.  
These differences imply failure in translation validity (Krathwohl, 2009), a standard which 
underpins the credibility of the inferences made. 
6.7.5 Missing data (STARD 2015) 
The extent of missing data has implications for validity and reliability and should be 
presented in the study. The flow of participants’ data in Table 6.4 shows that 61 patients 
who were recruited did not have any WAT-1 scores performed, leaving a sample size of  
126 patients (Franck et al 2012); this figure implies compliance with the assessment 
schedule was poor.  The study protocol required WAT-1 assessments to be performed 
twice daily from the first day of opioid weaning until 72 hours after the last dose of 
opioid, up to a maximum study period of 28 days.   
Franck et al (2012) reported 836 assessments in 126 children; the number of assessments 
per child was not reported, but these figures equate to a mean of 6.6 assessments per 
child.  WAT-1 was performed once daily for 23% study days and at least twice daily for 
the remaining 77% study days, proportions which suggests reasonable compliance with 
the assessment regimen. 
As the extent of missing data was not published, an approximation was inferred from 
data presented about the number of assessments, the length of participation in the study 
and the assessment schedule (Table 6.6).  The median opioid wean was 9 days (Franck et 
al 2012) and assessments continued until 72 hours after the last opioid dose the median 
duration of study participation should be 12 days, or 24 WAT-1 assessments per child.  In 
126 participants this equates to 126 x 24 = 3024 expected assessments.  With 836 actual 
assessments, this equates to a response rate of 28%, which demonstrates poor 
compliance with the assessment regimen.  In the absence of published data, these figures 
have been calculated using median data points, so whilst not precise, should be 
representative.  On average, WAT-1 assessments were performed for only 50 % of both 
the expected frequency and duration. The extent of the missing data has implications for 
validity and reliability and might explain why the prevalence of withdrawal was lower 
than anticipated.  
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Table 6.6 Inferred data in the absence of published findings (Bold findings published) 
 
 
 
 
 
 
 
Bold findings were published 
 
 
6.7.6 Differential diagnoses 
Grant et al (2013) acknowledged that differentiating pain and sedation is difficult in this 
population. The operational definitions of sedation/agitation and withdrawal both 
comprised an SBS score ≥1 and the lack of validity of SBS in withdrawing patients and 
patients in pain, has been highlighted earlier in this chapter.  
The difference between these WAT-1 scores and the operational definition are not 
explained, do not equate to the operational definitions of WAT-1 score ≥3 and do not 
compare to the figures in Best et al 2016 regarding the number of patients requiring 
opioid or benzodiazepine boluses and are nearly ten times less prevalent than the 
estimated event rate (8.7% vs 75%). 
Patients (n=109) who took more than 5 minutes to settle would score WAT-1 score 2 
from this alone and WAT-1 score 3 if they had also been distressed (SBS ≥1) during the 
pre-stimulus (Franck et al 2012).  In these withdrawal assessments, similarities exist with 
the operational definition of inadequate sedation; SBS ≥ 0 for 2 consecutive hourly 
assessments.  Patients were ventilated for median (IQR) 9.4 (5.9-13.3) days, opioids were 
administered for 7 (5-11) days and benzodiazepines for 6 (4-9) days. The duration of 
weaning was a median of 9 days, for both opioid and benzodiazepines. These figures 
suggest opioid weaning was commenced 2.4 days prior to extubation and weaning was 
completed about a week after extubation. 
WAT-1 assessments were performed for a median of 6 days (Franck et al 2012) which was 
50% of the expected study period.  These figures differ from those presented in Best et al 
Median opioid wean = 9 days (Franck et al 2012) 
Median duration of study participation = 12 days 
Number of assessments expected; 
Two assessments per day for 126 patients over 12 days = 2 x 126 x 12  
= 3024 assessments (expected) 
Number of assessments performed = 836 (actual) 
Compliance with study schedule = 836/3024 = 28%  
Mean number of assessments per child = 836/126 = 6.6 assessments. 
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(2016).  Patient data included in analysis differed due to inclusion of patients without 
WAT-1 assessments in Best et al (2016). The impact of including the patients without 
WAT-1 scores is surprising; weaning duration reduced to a median of 2 days for the 
steady wean half of the group, of whom only 63% had any WAT-1 scores performed 
during weaning.  This implies weaning rates were slowed in patients who had withdrawal 
assessments.  An alternative explanation is that the child’s agitated state prompted a 
withdrawal assessment.  The correlation between number of withdrawal assessments 
and the frequency of administration of opioid or benzodiazepine boluses suggests that 
the patient’s agitation was the motivation for both undertaking a withdrawal assessment 
and administering boluses.  No details were provided about patients who had their opioid 
or sedative infusion rates increased.  
 
6.7.7 The majority of WAT-1 scores are low 
The WAT-1 score range was not comprehensively described. Overall, the median (IQR) for 
836 assessments was 2 (0-4) and in the 92% (n=769) patients who did not score for 
yawning/sneezing the WAT-1 median (IQR) was 1 (0-3).  These ranges indicate that 25% 
scores were WAT-1 score 0, 50% scores were WAT-1 score ≤2 and 69% scores were WAT-
1 score ≤3, showing that most of the scores were skewed in the bottom quarter of the 
possible WAT-1 score range 0-12.  Although good from the clinical perspective as there 
appears to be minimal withdrawal, from a statistical perspective, if the majority of scores 
are low, approaching the ‘floor’, it means that many items are being wasted (Streiner and 
Norman 2003). The solution is to introduce items that will result in scores near the 
middle of the scale, or alter the threshold at which existing items count. This is a 
legitimate way of increasing true variance and reliability (Streiner and Norman 2003).   
The proportion of missing assessments may be partly explained by the potential for low 
or no WAT-1 scores.  If most assessments are WAT-1 =0, this might have limited nurses 
motivation for documenting non-scores. Equally, the opposite might be true, whereby 
nurses had more time to document trial data when the patient was calm. Some 
acknowledgement and explanation for the high number of missing assessments would 
contribute to the interpretation of the clinical utility of the WAT-1 scale.  
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6.8 Conclusion 
The pragmatic approach using Krathwohl’s Internal integrity framework (2009) to 
evaluate the WAT-1 validation study (Franck et al 2012) established that conclusions 
reported in the study were not supported by the data.  The components of Internal 
integrity which afford conceptual and empirical support for the WAT-1 tool demonstrated 
the lack of both conceptual and empirical evidence.  No evidence was provided that a 
WAT-1 score ≥3 was a reasonable designation of withdrawal; neither was psychometric 
evaluation of the WAT-1 confirmed or extended.  
Different perspectives of the WAT-1 dataset were provided by an additional three papers 
(Grant et al 2012, Grant et al 2013, Best et al 2016).  These studies were reviewed to 
determine to what extent they supported or refuted the findings of Franck et al (2012).  
Although different approaches were taken to analysing the data, these approaches only 
served to undermine the conceptual basis for the WAT-1 tool. Episodes of clinically 
significant withdrawal were poorly defined and there appeared to be a risk that these 
might have been interpreted as episodes of under-sedation or pain.  That extubation was 
routinely performed during the weaning period may also have confused the clinical 
picture regarding the cause of agitation.   
Although efforts were made to standardise the assessment performed during data 
collection, there was no standardisation of the treatment that patients received.  Each 
study attempted to demonstrate associations between scores of the index tool being 
validated (WAT-1) and clinical factors prescribed by the clinical teams including drug 
dosing and duration of mechanical ventilation.  Although there appeared to be a positive 
correlation between the WAT-1 assessment and an extended weaning regime, there is no 
evidence that the care children received across the 22 units was comparable and 
therefore any associations between clinical factors and WAT-1 scores may be due to 
chance. 
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Part 2 Summary and conclusions 
This chapter has highlighted the absence of an articulated theory for withdrawal 
syndrome.  The attempts to demonstrate the construct validity of any of the existing 
scales (SWS, WAT-1 or SOS) has been hampered by the lack of “a formal description of 
the construct, how it will manifest itself objectively and how it is related to other 
constructs and behaviours” (Streiner and Norman 2003, p182). 
In the exploration of how the nurses’ objective assessment of withdrawals syndrome, 
contributes to the theoretical basis for withdrawal syndrome, Studies 1 and 2 were 
undertaken. A retrospective review of the SWS tool concluded that the heterogeneous 
presentation of withdrawal seemed incompatible with the existing approach of assigning 
a summed score to aid diagnosis of withdrawal. The use of a summed score relies on an 
homogenous presentation of the underlying construct.  This study also revealed the 
complexity of the clinical conditions in which withdrawal assessment are performed. This 
finding prompted the design of Study 2 to investigate nurse decision which is presented 
in Part 3. The level of complexity also prompted the development of three criteria upon 
which to assign the probability of withdrawal. These criteria are; the likelihood of physical 
dependence, a temporal association between the reduction or stopping of drug(s) with 
onset of behavioural signs and an exclusion of other causes for the behaviours. The utility 
of the criteria will be examined further in Parts 4 and 5. 
Study 2 transformed data to enable comparison of the characterisation of withdrawal 
from two existing studies. Many of the equivocal signs of withdrawal were common or 
very common in “not withdrawing” patients, so an increase in prevalence in 
“withdrawing patients” may not be recognised as clinically significant. This study 
demonstrated differences in the characterisation of withdrawal which may be a 
consequence of the different rates of weaning, differences in the assessment schedules 
or differences in the way withdrawal was assigned.  Despite all these differences, the 
data from both studies demonstrated that three signs – agitation, movement disorder 
and vomiting – showed the greatest change in prevalence between “withdrawing” and 
“not withdrawing” groups, differences in prevalence that may be recognised as clinically 
significant.   
In Study 3 a pragmatic critique of the WAT-1 validation study (Franck et al 2012) was 
undertaken. Three peer reviewed papers presenting secondary analysis of the same 
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dataset from which WAT-1 was validated were also reviewed. The critique could not 
support the conclusions made by Franck et al (2012) that WAT-1≥3 is a reasonable 
designation of clinically significant withdrawal. The analysis of these three papers 
provided further evidence to challenge this assertion and no evidence in support of this 
construct. 
The findings in these chapters are predicated on the lack of theoretical underpinning for 
the assessment, risk factors and assessment of withdrawal syndrome. Without an 
articulated theory, the assessment tools cannot be validated. Theory must precede the 
development of a tool as it underpins the content of the tool and is the basis for 
determining the performance of the tool (Cronbach and Meehl 1955).  
In the absence of existing theoretical concepts for withdrawal, the propositional model 
presented in Chapter 2 (Figure 2.2) has been further developed (Figure 6.1) to 
demonstrate the relationship between the constructs of withdrawal and physical 
dependence and the associated variables of duration of mechanical ventilation and drug 
dosing and duration (Figure 6.1).  This model will be extended in subsequent chapters in 
this thesis.  
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Part 3 Nurse Judgement  
 
Introduction  
Part 3 of the thesis presents a study of nursing judgement (Study 4), which was prompted 
by the findings in Study 1 which highlighted instances when behaviours caused by 
competing diagnoses drove the withdrawal score.  It has been assumed that nurses 
exclude other causes for equivocal behaviours (Ista et al 2013, Harris et al 2016) but in 
some instances where differential diagnoses coexist, it may not be possible to exclude 
other causes.   
 
Figure Part 3.1 The conceptual framework highlighting the contribution of Study 4 
Study 4 investigates nurse decision-making under experimental conditions, allowing the 
researcher to control the information received by nurses in a way that would not have 
been possible in the naturalistic clinical setting.  
 
Figure Part 3.2 The thesis map showing Study 4 highlighted. 
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Chapter 7: Study 3:  Cognitive interviews with children’s nurses: 
decision-making during the assessment and management of 
sedation withdrawal. 
 
7.1 Introduction 
A brief review of the literature regarding judgement and decision-making is presented; 
terms which are used synonymously with the term clinical reasoning in this chapter. In 
the method section, the rationale for the choice of cognitive interviewing is presented 
along with other approaches to minimise research participation effects. 
Results are presented according the different stages of decision-making and different 
aspects of the withdrawal assessment. The discussion reviews these results in the context 
of the literature and the existing knowledge about the subject. Study conclusions are 
followed by an integration of the findings of this study with the findings of Part 2. 
 
7.2 Background 
The assessment of withdrawal syndrome in children is complex. Structured and 
repeatable assessments are recommended to assist detection, but it is often unclear how 
these are applied by nurses.  Three published tools have been developed to monitor 
withdrawal in children; the Sedation Withdrawal Score (SWS) (Cunliffe et al 2004), the 
Withdrawal Assessment Tool (WAT-1) (Franck et al 2008) and the Sophia Observation 
Score (SOS) (Ista et al 2009). Each is a checklist of non-specific signs that, in combination, 
appear to support a diagnosis of withdrawal. The SWS is the withdrawal assessment tool 
and treatment protocol used in our hospital since 2004. The SWS has proven clinically 
useful in identifying withdrawal signs in PICU and ward-based patients, but has not been 
validated (Macqueen & Bruce 2012). Both WAT-1 (Franck et al 2008, 2012) and SOS (Ista 
et al 2009, 2013) have been validated but the studies excluded patients whose existing 
behaviour might confound the withdrawal assessment and clinical utility is further limited 
by the lack of linked treatment protocols.  
The assessment of sedation withdrawal is complex due to the multiple drug and patient 
factors to be considered. Drug factors include the likelihood of physical dependence, 
which varies depending on drug dose and duration of therapy  (Amigoni et al 2014; Da 
Silva et al 2016) but also appears highly individualised (Best et al 2016) and may be 
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further complicated by concurrent tapering of more than one sedative or analgesic drug 
(Best et al 2016).  Patient factors include the highly individualised effects of withdrawal 
on the child’s recovery (Franck et al 2008) and the confounding effect of the patient’s 
primary medical condition on withdrawal intensity (Franck et al 2008).  Findings in 
Chapter 4 (Study 1) highlighted that assumptions that nurses will modify the assessment 
to ensure the underlying condition or any external factors do not skew the withdrawal 
score (Franck & Vilardi 1995, Ista et al 2013, Harris et al 2016) may be flawed.  Complex 
tasks like this demand a degree of cognitive effort and focussed attention on the part of 
the nurse, to make correct judgments and decisions.  Given that the judgement of the 
bedside nurse has been described as both a ‘tin standard’ (Franck et al 2008) and a ‘silver 
standard’ (Ista et al 2009) in tool validation studies, it is important to understand how 
nurses think when undertaking withdrawal assessments and making treatment choices 
(Easley & Nichols 2008).  
Two key theoretical approaches to clinical decision-making are reasoning and intuition 
(Banning 2008).  Different academic disciplines including the airline industry, medicine, 
education and information studies have investigated the analytical, rational approach of 
reasoning.  Models have emerged, which describe similar key stages of the process (Table 
7.1).  Endsley (1995) and Tanner (2006) each describe a three stage process- situation 
awareness- that comprises perception, comprehension and projection (Endsley 1995). 
These stages are described as noticing, interpreting and responding by Tanner (2006).  
Remaining open minded throughout these stages is vital, as relevant cues can be subtle 
and may be overlooked, particularly if the situation is changing quickly or there is too 
much to take in simultaneously (Gaba et al 1995).  Knowing how to filter tenuous cues 
and focus on relevant ones is a feature of expert nursing practice (Harbison 2006).   
Intuition is defined as “a way of knowing something immediately as a whole that 
improves with experience” (Rew & Barrow 2007, p. E25).  This enables the clinical expert 
to process and identify key diagnostic components subconsciously (Lyneham et al 2008).  
In high-pressure situations, the rational approach is somewhat idealistic as clinical 
decisions are often required despite incomplete knowledge of the situation (Graber et al 
2002).  Under these conditions, experienced clinicians rely on intuition to “think fast” 
(Kahneman 2011, p. 13), using pattern recognition (Berner & Graber 2008; Gobet & 
Chassy 2008) and heuristics ( Elstein 1999; Cranley et al 2009).  However, intuitive 
processing can be flawed (Graber et al 2005), especially in an unpredictable environment 
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(Kahneman & Klein 2009) such as critical care.  The intuitive heuristic describes 
circumstances where clinicians faced with a complex clinical problem resolve a simpler 
issue instead, without realising they have done so (Kahneman 2011).  
Table 7.1    The key stages of decision-making  
Model Disciplinary  
background 
Stage 1 Stage 2 Stage 3 
Situation Awareness 
(Endsley 1995) 
Airline industry 
Medicine 
Perception Comprehension Projection 
Thinking like a nurse 
(Tanner 2006) 
Nursing Noticing Interpreting Responding 
Bruner’s phases of 
interpretation  
(Kuhlthau 1993) 
Learning and 
education 
Perception Process of 
recognising 
patterns 
Making 
inferences 
Prediction 
Cognitive Model of 
Response Processes 
(Tourangeau et al 2000) 
Information 
studies 
Comprehension Retrieval Judgment Response 
 
No published papers were identified that considered how nurses make decisions about 
the assessment and management of withdrawal in children. This study sought to fill this 
knowledge deficit by attending to the three stages of decision making; noticing, 
interpreting and responding. 
 
7.3 Aim of Study 4 
The aim of the study was to explore registered children’s nurses’ decision-making during 
the assessment and management of sedation withdrawal in children by examining the 
three stages described by Tanner (2006). The stages equated to; 
1. Noticing; the nurses’ recognition and understanding of four clinical signs from the 
SWS tool, 
2. Interpreting; the meaning of an SWS score, in terms of a diagnosis of withdrawal,  
presented in two clinical vignettes, and 
3. Responding; the treatment choices made in response to the withdrawal diagnosis. 
 
7.4 Method 
Recognising the value of the nurse perspective in identifying ways to improve the existing 
approach to withdrawal assessment fits with a pragmatic approach that focuses on 
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finding the solutions to problems (Creswell 2013).  The nurse using the assessment tool in 
clinical practice could be viewed as the emic, or insider perspective contrasting with the 
etic perspective presented by the formal tool validation studies.  Cognitive interviews 
were undertaken using clinical vignettes to explore the study aim.  
7.4.1 Validity and reliability 
Validity and reliability were considered carefully in design and implementation of the 
study. A challenge in studying usual behaviour is how to do this without observation bias 
or research participant effects (McCambridge et al 2014). In decision-making studies, the 
ideal research method has minimal impact on typical, subconscious reasoning and does 
not lead to an altered, more conscious level of reasoning.  Research participant effects - 
the change in behaviour as a consequence of being studied (McCarney et al 2007) have 
been demonstrated  in observational studies investigating antibiotic prescribing 
behaviour in paediatricians (Mangione-Smith et al 2002) and compliance with hand 
hygiene  in clinical settings (Eckmanns et al 2006; Maury et al 2006).  In these studies, 
participants were more likely to demonstrate or take a best practice approach. In studies 
investigating decision-making, the manner of questioning may also stimulate new 
thinking (McCambridge et al 2014) or change the effort paid to the cognitive task 
(Sitterding et al 2012). These effects may limit the generalisability of clinical research to 
routine practice (McCarney et al 2007). The cognitive interview technique is inherently 
suited to this study as it is not considered to alter the effort or attention paid to the task 
and is also widely used in psychometric testing of survey instruments (Sofaer, 2002).   
Cognitive interviews are a recognised approach to explore cognitive processing in relation 
to decision-making (Willis 2005, Ross et al 2012). The fundamental features of cognitive 
interviews are think aloud and verbal probing; these techniques permit the researcher to 
listen in to the complex and usually hidden evolution of (clinical) reasoning without 
interfering with the cognitive processes being uncovered (Fonteyn et al 1993).  Verbal 
probing delivered in a neutral manner enables the interviewer to drill down on the issues 
under investigation, so clinical expertise in the subject area is necessary to recognise 
when a response needs further probing (Sofaer 2002). All other interaction between 
researcher and participant is minimised to reduce biasing participants’ responses (Sofaer 
2002).  
The cognitive interview approach has been employed in other studies investigating nurse 
decision-making (Cioffi 1998; Simmons et al 2003; Twycross & Powls 2006; Hoffman et al 
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2009); these are now presented in brief. Cioffi (1998) investigated the effects of 
experience and uncertainty on triage assessments made by emergency nurses and 
Simmons et al (2003) described cognitive processes used by experienced nurses during 
their patient assessments in elderly care. Work by Twycross and Powls (2006) explored 
how children’s nurses made clinical decisions and Hoffman et al (2009) compared clinical 
cues collected by novice and expert nurses in intensive care. The cognitive interview 
approach has also been applied to the psychometric testing of self-report clinical 
assessment tools, to check that terminology is understood and interpreted consistently 
by patients (Sofaer, 2002; DiBenedetti et al 2013).  
7.4.2 Measures 
An experimental setting, using vignettes, was chosen over a naturalistic setting in order 
to control the clinical data provided to participants and allow comparison between them 
(Willis 2005, Berner and Graber 2008).  By standardising the data, the only variable lay in 
the nurses’ decision making processes (Cook and Rumrill 2005), enabling focus on the 
abstruse stages of ‘noticing’ and ‘interpreting’ rather than simply the outcome or 
response (Veloski et al 2005).  
Two clinical vignettes were developed by the researcher (an experienced pain/sedation 
nurse specialist) to illustrate a typical, complex clinical situation featuring a patient with 
severe neurological disability (Figure 7.1).  The vignettes were based on a real case from 
clinical practice to enhance believability (Endacott et al 2010).  Face and content validity 
was undertaken to check that the vignettes were comprehensible and contained 
sufficient detail to prompt participants to think about the scenario. This was assessed by 
piloting the vignette and the explanation about cognitive interviewing with four senior 
clinical nurses (members of the pain team and an Advanced Nurse Practitioner in critical 
care) experienced in withdrawal assessment. This process did not prompt any changes to 
either the vignettes or the introductory explanation. The sensitivity and specificity of the 
vignettes was subsequently evident in that they generated data that identified both 
cognitive errors and correct decisions. 
Typical levels of cognitive stimulation were prompted by using developmental vignettes 
(Barrows & Feltovich 1987, Veloski et al 2005), to measure nurses’ usual or ‘everyday’ 
practice (Peabody et al 2004).  Developmental vignettes present a scenario that unfolds 
in stages (Jenkins et al 2010). The first vignette (V1) supplied minimal information, to 
reflect initial interpretation at the moment when the SWS score is completed. A diagnosis 
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at this stage would indicate the inclination to ‘make do’ with limited information, thus 
uncovering the usually hidden assumptions which are made to fill in knowledge gaps.  
The second vignette (V2) provided additional clinical details reflecting the range of 
information required to underpin a more considered, contextual interpretation of the 
same assessment.   
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
*Codeine was included in the list of interventions as this study took place prior to restrictions in the use of 
codeine in children under 18 years of age, were issued by the Medicines & Healthcare products Regulatory 
Agency (MHRA, 2013). 
Figure 7.1  Vignettes and Intervention(s) 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Vignette  1  
18 month old boy admitted to ICU 18 days ago in respiratory failure (Lower 
respiratory tract infection secondary to tracheomalacia).  
His SWS score is 5 (insomnia 1, irritability 1, tremor 1, respiratory distress 1 and 
hypertonicity 1) 
  
] Vignette  2         
History of presenting condition 18 month old boy admitted to ICU 18 days ago in 
respiratory failure (Lower respiratory tract infection secondary to tracheomalacia). 
Past Medical History severe hypoxic ischaemic encephalopathy, chronic lung 
disease, epilepsy. 
Past Surgical History Aortopexy 6 days ago. 
He was extubated 4 days previously but within 24 hours required insertion of NPA 
and CPAP.  NPA removed 24 hours ago.  
Sedation fentanyl and midazolam infusions for 48 hours post op stopped 4 days 
ago. Regular chloral hydrate and codeine started 3 days ago.  Chloral hydrate 
weaning started yesterday and codeine stopped. 
His SWS score is 5 (insomnia 1, irritability 1, tremor 1, respiratory distress 1 and 
hypertonicity 1) 
 
Intervention(s) 
What intervention would you recommend? You can provide one or more answers. 
 Give codeine* 
 Stop weaning chloral hydrate 
 Increase dose of chloral hydrate 
 Restart fentanyl 
Restart midazolam 
 No intervention 
 Other intervention – please state 
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7.4.3 Sample/ participants 
The study was conducted in a large children’s hospital in the Northwest of England.  The 
study participants were registered children’s nurses, who undertook withdrawal 
assessments in their clinical role.  Purposive sampling was employed to recruit nurses 
from the clinical areas where patients experiencing withdrawal were usually nursed (the 
Paediatric Intensive Care Unit (PICU), the High Dependency Unit (HDU) and the cardiac 
ward).  Nurses were eligible for inclusion if they undertook withdrawal assessments 
regularly and considered themselves familiar with the SWS tool.  Nurses were recruited 
by poster or by word of mouth by the researcher during clinical rounds and they gave 
written consent to participate (See Appendix 7 for study information and consent forms).  
Interviews took place in Autumn 2013 in quiet rooms adjacent to the clinical areas (see 
also Ethical considerations section). 
7.4.4 Data collection 
The interviews were conducted by the researcher (who had training in cognitive 
interviews and clinical expertise in the recognition and management of withdrawal 
syndrome). The interviews were audio-recorded with the participant’s permission.  
Demographic data included gender and experience, in years, of applying the SWS tool in 
practice was collected from participants at the start of the interview. No further 
demographic data were collected, as the relationship between factors such as years since 
qualification, level of expertise and level of educational attainment on decision-making is 
unclear (Lauri & Salanterä 1998; Hoffman et al 2004; Fick et al 2007).  Consideration was 
given to the sequence of the interview to minimise the potential impact on typical 
thought processes by unintentionally problematising aspects of nursing care that may be 
relatively routine (Jenkins et al 2010).   
The first part of the interview: interpreting SWS scores and responding with treatment 
choices, aimed to replicate routine clinical practice using the SWS tool and reflect the 
largely subconscious and automatic synthesis of information nurses undertake.  V1 was 
presented followed by V2.  After reading each vignette, the participant was asked to 
‘think aloud’ whilst responding to the pre-set questions and scripted probes e.g., “Is this 
patient withdrawing?” and “How easy or difficult is it to decide whether the patient is 
withdrawing?”  A list of treatment options for the patient in V2 was then presented and 
the participant was reminded to ‘think aloud’ whilst they made a decision.  Options 
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included all drugs mentioned in V2 in addition to ‘no intervention’ and ‘another 
intervention’.   
The second part: noticing (recognising and understanding) individual withdrawal signs 
was anticipated to be more cognitively taxing, possibly causing participants to critically 
reflect on their current approach to, and alter subsequent, withdrawal assessments. 
Consequently, participants were asked not to discuss their interview experience with 
colleagues until the study was completed.  In order to encourage deeper reflection on 
issues raised by the vignette, the participant was then asked to define four pre-selected 
SWS terms (‘insomnia’, ‘irritability’, ‘respiratory distress’, ‘hypertonicity’). These terms 
were selected due to the equivocal meaning of the behaviours in terms of withdrawal or 
critical illness.  The participants were also asked how easy or difficult it is to decide when 
a patient displayed one of these four behaviours.  
7.4.5 Ethical considerations  
The study was approved by the Liverpool East Research Ethics Committee, REC number 
12/NW/0681. 
Ethical issues pertinent to this study included minimising the risk of coercion, freedom to 
stop or withdraw from the study, maintaining confidentiality and protecting anonymity. 
These issues were covered in the participant information leaflet (PIL)(See Appendix 6).  
The researcher’s clinical role as a member of the pain team that oversees sedation 
weaning meant she was known to nurses prior to their participation in the study.  To 
minimise the risk of coercion, nurses self-selected to participate and contacted the 
researcher to express their willingness to participate.  Information provided to potential 
participants included verbal information about the purpose of the study, and assurances 
of confidentiality, that participation was voluntary and that non participation would not 
affect their working relationship with the researcher.  The PIL reinforced the mitigation of 
these ethical issues in writing, provided assurance that the study posed no risk to them 
and identified the process for raising any concerns about any aspect of the study. Written 
consent was gained from nurses who agreed to participate by the researcher. 
7.4.6 Data analysis 
The interviews were transcribed by a professional transcriber and checked by the 
researcher for accuracy and completeness.  “Informal analysis”, the approach proposed 
by (Willis 2005, p. 156) was used to identify cognitive problems with decision-making.  
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Subjective interpretation is key to informal analysis, which rather than a formal coding 
scheme, relies on expert judgement to identify problems (Fonteyn et al 1993).  The 
conceptual framework used with this analysis incorporates the dualisms of objective 
decision-making and subjective decision-making described in Chapter 3.  These opposing 
perspectives were used as the analytic structure for categorising the decisions made by 
nurses.  Identifying and examining cognitive challenges arising from the existing approach 
to withdrawal assessment is the basis for considering how to minimise errors and aligns 
with the overall purpose of the thesis to improve sedation withdrawal assessment. 
Analysis involved two stages; firstly the identification of the decision-making processes 
including cognitive errors made when noticing, interpreting and responding within 
individual interviews and secondly, comparison across interviews to elucidate trends. The 
term cognitive error is used to describe any flawed judgement or inaccurate decision 
made by the participants.   
For the purpose of this study, the putative diagnosis of withdrawal syndrome was based 
on two core features drawn from the literature:  
1. Physical dependence on a drug therapy administered continuously for at least five 
days or sooner if administered at high doses (Macqueen & Bruce 2012, Harris et al 2016),  
2. Behavioural signs of withdrawal, in response to the drug(s) stopping or reducing 
that are not better explained by other physical, illness or environmental causes 
(Macqueen & Bruce 2012, Ista et al 2013, Harris et al 2016). 
These features are comparable with the criteria adapted from the ADR causality 
assessment tool, which was used to assign the probability of withdrawal in Study 1 
(Chapter 4).   Provision of incomplete, equivocal information in the vignettes was 
designed to reflect the “fuzziness of unstructured real life situations” (Benner and Tanner 
1987, p.24).  V1 provided no data on either of the core features of withdrawal. V2 
provided data about the likelihood of physical dependence, but in the absence of a 
baseline SWS score or trend, insufficient information was available to establish the cause 
of behavioural signs. 
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7.5 Results 
Twelve registered children’s nurses participated in the interviews; four from the PICU, 
four from the Cardiac Ward and four from the HDU.  All participants were female.  The 
nurses had been undertaking withdrawal assessments for between 4 and 13 years 
(median 10 years) so were experienced in this aspect of their clinical role. Interviews 
lasted between 21 and 47 minutes. 
7.5.1 Interpreting the meaning of an SWS score 
In both vignettes, nurses drew on all three options: ‘withdrawing’, ‘not withdrawing’ and 
‘unsure’ (Table 7.2).  In V1, two nurses recognised there was insufficient information 
upon which to make any judgement.  Responses to ‘How easy or difficult was it to 
decide?’ ranged from ‘easy’ to ‘very difficult’ with one nurse commenting that it “should 
be easy with more information”.  All nurses who found the diagnosis ‘easy’ made a 
definite diagnosis.  In V2, the responses to ‘How easy or difficult was it to decide?’ ranged 
from ‘quite easy’ to ‘very difficult’.  Some nurses found V2 “easier than previous 
[vignette]” and one thought it was “harder with more information”.  Again, those finding 
the diagnosis ‘easy’ all made a definite diagnosis.  Those who found it “easier than 
previous” each gave a different diagnosis of withdrawal.  The nurse finding V2 “harder 
with more information” was ‘unsure’ in both vignettes.  In terms of consistency of 
opinion across the vignettes, three people who made a diagnosis in V1, persisted with 
their diagnosis in V2 (‘yes’ n=2, ‘no’ n=1). Four nurses were ‘unsure’ in both vignettes.  
The two nurses who could not comment in V1 were ‘unsure’ in V2 and found the decision 
‘difficult’.  Diagnosis of withdrawal was commonly based on the SWS score in V1, 
although the child’s underlying condition was recognised as a possible cause for the score 
(Table 7.3).  In V2, more nurses recognised that the SWS score might reflect either the 
child’s underlying conditions or their normal behaviour. Some nurses recognised that the 
duration of sedation described was too short to cause physical dependence and hence 
withdrawal symptoms.  The three nurses who diagnosed ‘not withdrawing’ made this 
observation along with one nurse who still diagnosed the patient as ‘withdrawing’. Four 
nurses made explicit assumptions during their deliberations in V1. Three of these nurses 
diagnosed withdrawal; one was ‘unsure’. 
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Table 7.2      Participant demographics, results of vignette diagnosis and intervention 
 
 
Nurse 
 
Ward 
Experience 
(years) 
Vignette 1 Vignette 2 Intervention 
Patient 
withdrawing? 
Ease of decision 
Patient 
withdrawing? 
Ease of 
decision 
Give 
codeine 
Stop weaning 
chloral 
Increase  
chloral 
No 
intervention 
Other intervention 
N1 
 
PICU 5 Yes 
 
Easy Yes Not difficult Maybe Yes Maybe  Distraction 
N2 
 
HDU 7 Yes 
 
Not easy Don’t know Difficult Yes Yes    
N3 
 
HDU 5 No 4/10 easy No Easier than 
previous 
   No 
intervention 
Investigate tremor 
N4 
 
HDU 10 Probably Quite easy Don’t know Harder with 
more info 
 Yes   Paracetamol, speak 
to mum 
N5 
 
PICU 5 Don’t know 
Possible 
Difficult (v) Don’t know 
 
Very difficult    No 
intervention 
Monitor 
N6 
 
Cardiac 
ward 
13 Yes 
 
Easy Yes Quite easy Yes Yes Maybe   
N7 
 
PICU 10 Don’t know Very difficult Don’t know 
Yes 
Easier than 
previous 
Yes Yes    
N8 
 
Cardiac 
ward 
13 Yes 
possible 
Should be easy 
with more 
information 
No Quite easy Maybe    Paracetamol, oral 
morphine, pain 
team, neurology 
N9 
 
Cardiac 
ward 
13 Can’t 
comment 
 Maybe Difficult Yes Yes Maybe  Paracetamol, physio, 
neurology 
N10 
 
PICU 10 Can’t 
comment 
 No Quite 
difficult 
Maybe    Speak to parents 
N11 
 
HDU 13 Yes Quite hard Don’t know 
No 
Not asked Maybe Maybe   Paracetamol 
N12 
 
Cardiac 
ward 
4 Don’t know 
 
DNA Yes Easier for 
this one 
Yes Yes Maybe  Paracetamol 
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Table 7.3    What nurses considered when deciding about withdrawal 
V1 (Insufficient information provided) 
 N1 N2 N3 N4 N5 N6 N7 N8 N9 N 
10 
N 
11 
N 
12 
Diagnosis W W N ? ? Y ? ? C C W ? 
SWS Score              
Underlying condition/ 
pain/environment 
            
Need info about  
SWS  score trend (T)/  
drug therapy (D) 
       D TD   D 
Made assumptions             
W = Withdrawing    N = Not withdrawing ?= Unsure C = Can’t comment 
 
V2 (Information provided about co-morbidities and potential for physical dependence) 
 N1 N2 N3 N4 N5 N6 N7 N8 N9 N 
10 
N 
11 
N 
12 
Diagnosis W ? N ? ? W ? N ? N ? W 
Underlying condition/ 
normal behaviour 
            
Drug therapy             
Not physically dependent             
Made assumptions             
Two nurses made assumptions in V2. One nurse made assumptions in both vignettes, and 
diagnosed ‘withdrawal’ in both cases. The second nurse was ‘unsure’ in both vignettes, 
but found V2 “easier than previous”. The common assumption in V1 was based on the 
length of ICU stay and related to possible sedatives the child might have received. One 
nurse reflected that ‘he’s been on ICU eighteen days and I’m assuming he’s been receiving 
some kind of sedation for that long.’ (N5) Another nurse thought ‘there’s a possibility that 
he may have failed extubations and been re-ventilated so he’s been awake and asleep 
quite a few times within those eighteen days possibly.’ (N1) 
7.5.2 Response to the withdrawal diagnosis 
Treatment choices corresponded to the diagnosis when the diagnosis was definite but 
varied amongst nurses who were “unsure” (Table 7.3 and Figure 7.2).  Nurses who 
diagnosed ‘withdrawing’ chose to stop weaning chloral hydrate and ‘maybe’ increase 
chloral and give codeine (‘yes’ n=2, ‘maybe’ n=1).  In contrast, nurses who diagnosed ‘not 
withdrawing’ chose to continue weaning chloral hydrate. Two nurses considered giving 
additional analgesia including codeine, paracetamol and oral morphine.  Nurses who 
were ‘unsure’ chose a range of interventions, including stop weaning chloral hydrate, 
increase chloral, give codeine and no intervention.  Paracetamol was chosen as ‘another 
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intervention’ by five nurses who had varied opinions about whether the child was 
withdrawing.  Failed heuristics and biases were identified during protocol analysis and 
these cognitive errors were categorised according to definitions cited by Croskerry (2003) 
(Table 7.4). Cognitive errors occurred during the decision-making processes involved in 
both the interpretation of and response to the SWS score.  Every nurse made cognitive 
errors: the number ranging between 1 and 4 errors per nurse. Not all cognitive errors led 
to diagnostic errors, as two nurses made assumptions during their deliberations in V1, 
but these did not translate into an inaccurate diagnosis. No nurse made errors at every 
stage of the decision-making process. 
7.5.3 Noticing (recognising and understanding) SWS behaviours 
Nurses shared an accurate understanding of the terms ‘insomnia’ and ‘respiratory 
distress’ and were confident and succinct in their definitions.  They found ‘irritability’ 
harder to define, but it was usually described as difficulty in consoling the child despite 
trying the usual comfort measures and parental presence. ‘Hypertonicity’ was the most 
problematic term with one nurse unable to offer a definition and another giving an 
inaccurate definition; “being unable to relax, quite tense, they often have trouble staying 
still, their little arms and legs keep going” (N8).  Although the remaining nurses offered a 
definition of “increased tone”, half of them expressed doubt or lacked confidence about 
their explanation.   
 
 
 
 
 
 
 
 
 
 
Figure 7.2     Withdrawal diagnosis and Interventions chosen 
No  
n=3 
Don’t know  
n=6 
Yes 
n=3 
No intervention 
Analgesia only 
Increase chloral 
Stop weaning chloral 
+/- analgesia 
n=1 
n=3 
Definite intervention Possible intervention 
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When talking about the definitions, there was a tendency for nurses to blur the 
boundaries between signs, describing the co-existence or overlapping of some 
behaviours. Two nurses described the interdependence of insomnia and irritability. 
During a definition of ‘irritability’, one nurse explained “it’s linked a bit to the insomnia 
where you can see that they are tired and want to sleep”(N5).   Another nurse’s definition 
of ‘irritability’ appeared to overlap with ‘insomnia’; “you sort of think they are settled, 
they sort of shut their eyes and they go still and then two minutes later they’re awake you 
know, they’re off again” (N10).  
Inaccurate mapping of other behaviours to SWS signs was identified as another 
perceptual problem.  Descriptions of motor disturbance were made by half of the nurses 
during their definitions of insomnia, irritability or hypertonicity.  When defining 
‘insomnia’ one nurse commented that “They may be active, arms, legs, head, generally 
moving so they’re not peacefully asleep” (N10). A definition of ‘irritability’ included 
“thrashing their arms and legs around or their head around” (N9). ‘Hypertonicity’ was 
described as: 
 “Just constant moving of arms and legs, inability to stay still really, some of 
the babies they look like they’re riding bikes lying in their cot because their 
legs just keep going round and their arms keep waving.” (N8)      
 
Table 7.4  Cognitive errors identified during protocol analysis 
Cognitive error Example Nurse 
Commission 
bias 
Stopping chloral hydrate despite being unsure about 
withdrawal. 
2,4,7,9 
Administering analgesia. 4,8,9,12 
Confirmation 
bias 
Diagnosing withdrawal despite recognising the duration of 
sedation was too short. 
12 
Overconfidence 
bias 
Acting on incomplete information or intuitions. Any definitive 
diagnosis in V1. 
1,2,3,6,11 
Making assumptions. 1,2,5,7,11 
Availability 
heuristic 
Accepting a diagnosis that springs easily to mind. Relying on the 
SWS score alone to make a diagnosis without considering the 
wider context. 
1 
Anchoring 
heuristic 
Choosing to stick with one’s original diagnosis despite more 
information becoming available. 
1,3,6 
 
 ‘Insomnia’ presented challenges for nurses in terms of both recognising and interpreting 
this behaviour.  Lack of familiarity with the patient made it difficult to know if the 
patient’s behaviour was different to normal, as one nurse described “unless you know 
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exactly what they’re like without any of the illness, medication and what have you” (N4). 
Trying to making sense of current behaviour by ascertaining recent trends was also 
complicated by the perceived subjective nature of the assessment “if you look at the 
previous 12 hours, you’ve only got the chart to go from, so when somebody’s marked 
down awake or asleep, you don’t know if they’ve really been asleep for a whole hour or is 
it just 10 minutes” (N7). However, confidence grew throughout the shift “because you’ve 
done a whole day with them….” (N10) and nursing a child on consecutive days was also 
viewed positively, because “then you’ve got a better comparison as to whether they are 
more or less alert than they were the previous day” (N9). Environmental factors were also 
identified as possible causes of insomnia, as one ICU nurse described, “ICU is noisy, it’s 
loud, we forget and our colleagues talk and have to be shushed a lot of the time 
throughout the night, the monitors are always bleeping…” (N5).  
The main challenge with interpreting ‘irritability’ related to deciding whether this 
behaviour was a result of withdrawal or other co-morbidities.  Nurses talked about 
undertaking a process of eliminating other possible causes of ‘irritability’ before 
attributing it to withdrawal. As one nurse described “it’s never the first thing I think when 
they’re crying, they might be hungry or I’ll check their nappy, and when I’ve covered all 
the bases then I’ll be like actually they’re irritable  (N12). 
Lack of familiarity with the patient was voiced but some nurses described working with 
parents to interpret the child’s behaviour, because “they know them better than us” (N2). 
In children with neurological impairment, nurses described relying on parents to identify 
whether behaviours differed from normal, as one nurse explained; “I walk into the 
situation and I don’t know the child I might think – ‘oh my word this baby’s really 
agitated’. But the parent’s might go – ‘well that’s him when he’s well’” (N8).  Nurses 
appeared to be most confident in recognising ‘respiratory distress’ but found the 
challenge was judging whether it was a sign of withdrawal or another co-morbidity.  One 
nurse commented “It’s hard with the respiratory distress side of things, because if he’s 
chronic lung disease, it’s like Catch 22 isn’t it?” (N6).  
                             
7.6 Discussion 
No published studies have been identified that describe the use of cognitive interviews 
and vignettes to examine the stages of decision-making undertaken by nurses in the 
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assessment and management of withdrawal syndrome. This study showed that nurses 
used a variety of approaches alone or in combination including intuition, reasoning, 
biases and heuristics, as reported by Tanner (2006).    The use of SWS did not standardise 
nurses’ assessment of withdrawal and cognitive challenges arose in each stage (noticing, 
interpreting and responding) of decision-making examined. These stages will be discussed 
in light of the overarching clinical goal of improving the assessment and management of 
withdrawal syndrome.  As SWS shares a similar format and content to SOS and WAT-1, 
these findings suggest that cognitive challenges may also exist for nurses using SOS and 
WAT-1.  As all nurses in the study made at least one cognitive error, there did not appear 
to be a relationship between quality of decision-making and either their experience or 
their clinical specialism. These results support the view that “simply possessing clinical 
experience is no predictor of high quality decision-making” (Thompson et al 2009, p. 610).  
The noticing stage - identifying and describing individual withdrawal behaviours - 
presented the greatest cognitive challenge for nurses and the widest variation in 
responses. When asked to describe withdrawal signs, nurses could plainly visualise a 
withdrawing child, demonstrating the “pattern recognition” of expert judgement and 
decision-making (Berner & Graber 2008, p. S12).  Difficulty arose in separating the 
component behaviours to fit a list of withdrawal signs, leading to a blurring of boundaries 
between terms and inaccurate mapping of other signs.  Although deconstruction of 
withdrawal syndrome into an item pool of component behaviours may be a necessary 
stage in scale development (DeVellis 2012), within the experimental conditions of this 
study, this step appears to add complexity rather than simplifying the assessment.   
Nurses recognised that they lacked knowledge needed to interpret some SWS items 
presented in the vignette, as they were mostly not cognisant of the child’s normal 
behaviour.  Knowing the patient and their pattern of responses is considered 
fundamental to sound clinical judgement (Tanner 2006) promoting a corresponding sense 
of salience (Benner & Tanner 1987), whilst less knowledge impacts on the capacity to 
notice subtle cues or changes.   
Interpretation of the vignettes differed widely, despite every nurse being presented with 
the same information and clinical cues. This variation in decision-making in the face of 
identical information mirrors other studies involving nurses and pain assessment 
(Hodgins 2002), nurses and critical event risk assessment (Thompson et al 2009) and 
triage assessments made by emergency nurses (Cioffi 1998).  These findings support the 
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view that clinical judgements are influenced more by what nurses bring to the situation 
than by the clinical data available to them (Tanner 2006).  The effort required to reach a 
diagnosis also varied widely: nurses who made a definite diagnosis found the decision 
easier than those who were unsure. For some nurses in V1, the score alone gave a clear 
diagnosis of withdrawal, abnegating the cognitive burden of interpreting the meaning of 
ambiguous clinical signs. Indeed Benner & Tanner (1987, p28) warned against the over-
reliance on assessment tools, which could encourage a complacent “checklist mentality” 
rather than the rigour of “active enquiry”. 
The ability to see some aspects as more important than others has also been described as 
a sense of salience by Sitterding et al (2012): this sense of salience was lacking amongst 
the nurses who overlooked the fundamental importance of recent drug history as the 
context for a withdrawal assessment.  In the face of such complexity, and the need to 
consciously consider the context of drug dependence, the role for the subconscious 
cognitive processing characteristic of intuitive thinking is unclear.  Nurses who were 
unable to reach a diagnosis found the task harder, reflecting their recognition of the 
ambiguities, complexity and incompleteness of the available information; this 
demonstrated what (Brannon & Carson 2003) would consider being superior decision-
making.  This quality was also suggested by  nurses who made probability judgements 
(possibly, probably or maybe withdrawing), which appeared to acknowledge the 
contextual challenge and  inferred a cognitive flexibility to modify their opinion in light of 
further information (Szolovits & Pauker 1978).  Whether as a result of complacency, 
overconfidence or a checklist mentality, the findings from this study suggest that some 
nurses have a misplaced confidence in the diagnostic capacity of SWS, which if they were 
directed primarily by the score, may consequently limit further enquiry.  The potential for 
cognitive errors during this interpretive phase highlights the importance of learning 
clinical reasoning skills, ideally during nurse training (Levett-Jones et al 2010, 2015). 
The responding stage was the most consistent phase of decision-making with treatment 
decisions corresponding to nurses’ definite diagnoses. Cioffi (1999) describes the 
relationship between cues and inferences as decision rules or “if…then” rules. For 
example, “If a patient is withdrawing (cues) then the drug reductions should cease 
(inference)” or “If a patient is not withdrawing, then drug weaning should continue.”  
However, when nurses were unsure of the diagnosis, an inclination towards ‘doing 
something’ meant the most common intervention was to stop weaning chloral hydrate.  
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This tendency towards action rather than inaction, despite no supporting evidence for 
the decision, is known as commission bias (Croskerry 2003).  However, such bias can 
result in poorer outcomes as the unnecessary slowing of weaning regimes should be 
avoided, as prolonging sedative treatment may prolong recovery and hospitalisation.  
Administration of analgesics was another common treatment choice made by nurses, 
regardless of withdrawal diagnosis, perhaps reflecting an ‘obligation towards 
beneficence’ another example of commission bias (Croskerry 2003) - despite no 
supporting evidence within the vignette of the need for analgesia.  
7.6.1 Content validity  
Content validity relies on a common understanding of the terms used in the tool. Results 
demonstrated inconsistencies in the understanding of some of the items in the score, 
with nurses describing recognised withdrawal behaviours but attributing them 
inaccurately to another withdrawal term.  This occurred most frequently with ‘motor 
disturbance’, a behavioural sign included in the SOS (Ista et al 2009) and WAT-1 (Franck 
et al 2008) tools but not in SWS. It is to the nurses’ credit that they noticed this behaviour 
in withdrawing patients and recognised it as part of the constellation of withdrawal.  In 
this respect, they were demonstrating “pattern recognition”, a feature of expert 
judgement and decision-making (Berner and Graber, 2008, p. S12). A robust scoring tool 
for withdrawal syndrome must limit item content otherwise the resulting tool would 
model many clinical conditions and result in low specificity for withdrawal.  The 
consequence of limiting signs, in a complex condition such as withdrawal, is that nurses 
can only log those signs included in the tool, and may inadvertently ‘fit’ other observed 
behaviours into the available signs.  The interdependence of some behavioural signs (e.g., 
insomnia causing irritability) highlighted another weakness in terms of the content 
validity of SWS.  Ensuring a common understanding requires either a clear definition of 
each of the items included in the tool or the exclusion of some behavioural signs on 
pragmatic grounds.   
7.6.2 Construct validity 
Construct validity of the tool came under scrutiny as a result of the cognitive challenge 
presented by the interpretation of behavioural signs. Where similar behavioural 
responses may also be a consequence of the child’s underlying medical condition, their 
current illness or an environmental artefact, this may confound withdrawal assessment.  
The SWS was based on the Neonatal Abstinence Syndrome (NAS) tool (Finnegan et al 
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1975).  However, the major difference between the two patient cohorts is in the meaning 
of these non-specific signs, which have much greater sensitivity and specificity for NAS in 
the newborn population than they do for withdrawal in the critical care population.  An 
additional personalisation of the measure is required for critical care patients who 
unwittingly “score for withdrawal” by nature of their underlying or pre-existing condition; 
an outcome described as a false positive or Type 1 error in statistical testing.   Patients 
with severe neurological disability may be excluded from tool validation studies for 
psychometric convenience (Ista et al 2009).  The vignette patient represented such a child 
and these findings suggest that assuming nurses will modify their assessment in light of 
underlying behaviours, is wrong. The ipsative nature of withdrawal scores in some critical 
care patients is a phenomenon also  recognised in self-assessment pain scoring in 
children (Connelly and Neville, 2010). This means changes in scores in the same patient, 
over time, may provide a more personalised assessment for withdrawal, and minimise 
unnecessary treatment, rather than attempting to identify standardised cut-points for 
pharmacological intervention.  
Tools are only ever tested under ideal conditions, whereby the tool developer has 
dictated the way in which the tool is applied through a robust training programme for 
participants.  Once a tool becomes established, it is not unreasonable to imagine it will be 
applied differently by different users. This is an example of the false consensus effect, 
whereby tool developers make inaccurate assumptions about the performance of the 
users applying their tool.  They expect the tool to be applied as they have designed it to 
be applied and this may not be true for the inexperienced or untrained user (Roland et al 
2010).  
 
7.7 Limitations 
Study 4 has a number of limitations. This was a small sample of nurses from one hospital 
who volunteered for the study, so may not have been a representative sample.  However, 
whilst the cognitive interview technique is unique in revealing cognitive processes in 
participants, results are not generalisable to a wider population. The use of a 
developmental vignette under experimental conditions to reproduce the conditions of 
clinical practice and illuminate the judgements and decisions nurses make may be flawed.  
Equally the efforts made to minimise observation bias and prompt typical levels of 
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reasoning may have been unsuccessful. Nonetheless, the range of diagnoses in the 
results and the evidence of a range of cognitive errors both suggest that research 
participant effects were minimised.  The interviewer works as a nurse specialist in the 
hospital where the study took place and was known to the nurses participating in the 
interviews; this relationship may have been a source of bias 
The bedside treatment schedule of withdrawal in the study hospital includes guidance to 
stop weaning with SWS scores between 3 and 6. The treatment schedule was not 
presented or discussed but it may be that some nurses recalled that a score of 5 linked to 
guidance to stop weaning. The number of withdrawal diagnoses in V1 may have been 
influenced by the fact that the participants were aware that the study was addressing 
sedation withdrawal; this might have created a diagnostic strategy of ‘going for the 
obvious’ that may not reflect typical decision-making.   
 
7.8 Conclusion 
This study using cognitive interviews with vignettes has provided insight into nurses’ 
judgement and decision-making in a complex and ambiguous clinical situation.  Focussing 
on the whole decision-making process (noticing, interpreting and responding) identified a 
significant cognitive burden and the potential for cognitive error at each stage.  Nurses 
perceived and interpreted the scenario differently and gave a range of diagnoses in 
response to the same clinical information.  The conditions necessary for withdrawal to be 
a possible diagnosis were not considered consistently.  Nurses also demonstrated a 
blurring of boundaries between different behaviours, in an inadvertent effort to fit 
behaviours to the available signs.  These findings do not support the existing approach to 
withdrawal assessment.   
Key areas for improvement are in recognising the clinical context necessary for 
withdrawal and minimising the use of biases and failed heuristics.  A structured approach 
to withdrawal assessment which focuses on the core features of withdrawal rather than 
the identification of ambiguous behaviours may reduce the likelihood of cognitive errors.  
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Conclusions to Part 3: Integration of findings from Study 4 with Parts 1 
and 2. 
Study 4 showed that the stages of decision-making aligned with different aspects of the 
withdrawal assessment and illuminated the potential chances for cognitive error.  This 
discourse will consider two ways in which the findings of this study illuminate the existing 
approach to withdrawal. The first consideration is the extent to which the existing 
approach to withdrawal assessment is underpinned by the principles of decision-making. 
The second consideration is the integration of the stages of decision-making into the 
propositional model of the causal relationship between factors linked to physical 
dependence and withdrawal. 
The existing approach to withdrawal assessment and decision-making 
The effort required to interpret the child’s behaviours was a salient finding from a 
decision-making perspective.  The SWS tool exists to aid diagnosis, but inadvertently 
focuses effort on the inconsistent, unique and equivocal presentation of withdrawal 
rather than the more consistent core features of withdrawal.  Cognitive effort was 
expended in both deconstructing the child’s presentation into component behaviours to 
fit the tool and in interpreting the meaning of these equivocal behaviours. What might 
have naturally been System 1 intuitive thinking of pattern recognition is changed to 
effortful System 2 thinking at the detriment of considering whether the conditions for 
withdrawal had been met.  The consequence of focusing the cognitive effort on this one 
equivocal aspect of withdrawal assessment is to “effectively blind” (Kahneman 2011, p34) 
nurses to other aspects of the assessment. 
Consider the intuitive System 1 observation of “This child is behaving like they might be 
withdrawing.”  The next step depends on which decision-making system is engaged.  One 
option is to apply the SWS tool to see if you are right, a biased process which confirms 
what you already suspect. The alternative option, which is assumed rather than 
supported by the current approach, is to consider whether the core features of 
withdrawal exist.  This second approach acknowledges the possibility of other causes for 
the behaviours, which initially prompted the intuitive impression of withdrawal. 
The motivation for Study 4 was the finding from Study 1 that highlighted occasions when 
nurses undertook a withdrawal assessment when something other than withdrawal was 
driving the patient’s behaviour.  Decision-making theories explain how intuitive, System 1 
thinking offers immediacy, which may be expert intuition or heuristic intuition 
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(Kahneman 2011).  Heuristic intuition may have reflected the decision-making in the 
complex context of the deteriorating critically ill child, reflected by the eleven cases 
reported in Study 1 where withdrawal and other causes coexisted.  The nurse when faced 
with the difficult question of ‘What is the cause of the child’s deterioration?’ 
unintentionally answers an easier question – ‘Does the child score for withdrawal?’  
Encouraging the System 2 thinking of deliberation (Kahneman 2011) supports the nurse 
to ask the pertinent question; ‘Are the conditions right for withdrawal to be a possible 
cause of behaviours?’   
Integrating the stages of decision-making into the propositional model 
The conditions for withdrawal have been discussed previously in the literature review 
(Chapter 2), Study 1 (Chapter 4) and Study 3 (Chapter 6) and a model of the relationship 
between these variables has been introduced in this thesis.  This model was reviewed in 
light of the stages of decision-making illuminated by Study 4, to examine how these 
stages might be integrated in the model (Figure Part 3.3).   
The first condition is the onset of physical dependence. The risk of physical dependence is 
50% after 5 days of continuous sedative drugs, but may occur sooner at higher doses (Ista 
et al 2007).  If physical dependence is suspected, then the next condition is a reduction in 
the drug or drugs, whether planned or inadvertent, which links to the onset of a 
behavioural response indicative of withdrawal. 
The noticing phase of decision-making involves perception of the risk factors for physical 
dependence, followed by interpreting the likelihood of dependence. The likelihood of 
dependence should determine the speed of weaning.  The cycle of decision-making then 
continues recursively, with a response to the speed of weaning being an indicator of how 
well the child tolerated weaning. No behavioural response supports the chosen rate 
whereas a behavioural response indicative of withdrawal indicates the speed of weaning 
is too fast and contributes to the interpretation of the risk of physical dependence and 
influences the response in terms of modifying the speed of weaning.   
This model demonstrates how the desired pattern of reasoning when determining the 
cause of equivocal signs follows a top-down deductive approach based on the premise or 
condition of physical dependence. By contrast the abductive bottom-up style of heuristic 
intuition which seeks to find the simplest explanation for an observation may result in an 
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erroneous diagnosis.  This discourse will be expanded upon in the conclusions section in 
Part 4. 
 
Figure Part 3.3 Propositional model linking the stages of decision making performed 
during a withdrawal assessment to the proposition of the causal relationships between 
factors linked to physical dependence and withdrawal syndrome.  
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Part 4  The parent perspective 
 
 
This section presents Study 5 (Chapter 8) and Study 6 (Chapter 9) that explore the parent 
perspective of withdrawal in critically ill children.  In the absence of existing evidence, 
these studies were exploratory in design; evolving abductively in response to the data 
collected. 
The hypothesis that parents contribute a novel and valuable perspective to withdrawal 
assessment relies on two assumptions; 
1. Parents recognise behaviour changes indicative of withdrawal in their critically ill 
child, and 
2. Parents are willing to participate in their critically ill child’s withdrawal 
assessment. 
Study 5 was designed to answer the first assumption; to identify parents recall of, and 
distress evoked by SWS withdrawal signs during their child’s sedation weaning.   
Study 6 was designed to fulfil two aims; 
1. Identifying parental willingness to participate in the withdrawal assessment. 
2. Exploring the parents experience of their child’ withdrawal.  
  
 
Figure Part 4.1 The conceptual framework showing the contribution of Studies 5 and 6 
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Figure Part 4.2 The thesis map showing Studies 5 and 6 highlighted 
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Chapter 8: Study 5: Mixed methods study of parent’s 
recollection of, and distress evoked by, signs of withdrawal in 
children aged less than 5 years. 
 
8.1 Introduction 
In the researcher’s clinical role overseeing the management of sedation withdrawal in 
critically ill children, seeking the parent’s opinion about trends in their child’s behaviours 
aids clinical decision-making. This anecdotal evidence of the value of the parent 
perspective underpinned the design of a study to examine parents’ recollection of, and 
distress evoked by signs of withdrawal.  
 
8.2 Background 
The theoretical basis for the assessment and management of withdrawal syndrome is 
sparse.  As a consequence, there is little evidence to delineate withdrawing and not- 
withdrawing patients.  Some authors refer to clinically significant withdrawal symptoms, 
requiring administration of rescue medication, but it is not clear how this is construed 
(Franck et al 2012, Grant et al 2012, Curley et al 2015).  In adults, the diagnostic criteria 
for drug withdrawal describes a behavioural change that causes clinically significant 
distress of impairment (DSM, 2013).  These terms imply a sub-syndromal category of 
withdrawal, where withdrawal signs may be present but not to an extent that is deemed 
to require pharmacological intervention.  There is evidence in the tool development 
studies that such a cohort exists (Franck et al 2012, Ista et al 2013).  When undertaking 
withdrawal assessments in conditions of uncertainty, there is evidence that nurses may 
stop weaning sedation as a cautionary measure, despite no evidence of a worsening 
trend (Craske et al 2017).  This published paper reports the findings from Study 4 
(Appendix 7). 
There is an assumption that nurses elicit the view or opinion of parents during the 
withdrawal assessment on PICU (Harris et al 2016, Ista et al 2013): in pediatric delirium, 
the opinion of caregivers is sought to assist in evaluation of the child’s behaviour 
(Schieveld et al 2009).  Nurses report that they seek the parent’s opinion to assist in the 
interpretation of a child’s withdrawal behaviours (Craske et al 2017), but the parents 
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perspective has not been explored.  It is not known whether parents recognise 
behaviours indicative of withdrawal in their critically ill children and if so, how distressing 
these behaviours are from the parents’ perspective.  
 
8.3 Aims of the study 
The a priori aims of this study were to  
 Examine the parent perspective of withdrawal by examining recall and distress 
evoked by SWS signs.  
 Triangulate SWS data and nursing notes with the parent perspective to determine 
likelihood of withdrawal at the time of the highest SWS score.  
A further aim evolved in response to the findings from Study 1, to  
 further evaluate the SWS tool by examining the item content and the influence of 
differential diagnoses at the time of the highest SWS score for the patients in this 
study.  
 
8.4 Objectives of the study  
The specific objectives were to; 
1. Explore parental recall of behavioural signs consistent with withdrawal syndrome in 
their critically ill child. 
2. Explore the parental view of how distressing these behaviours are to observe. 
3. Compare parental recollections of items with those recorded prospectively by nursing 
staff at the time of the highest SWS score. 
4. Retrospectively categorise the likelihood of withdrawal at the time of the highest 
score 
5. Identify differential diagnoses in cases where the likelihood of withdrawal was 
possible or unlikely. 
 
8.5 Method 
A convergent mixed methods design (questionnaire and retrospective chart review) was 
employed to address the aims of the study.  A questionnaire was used to elicit parent 
recall of SWS signs and the distress these signs evoked. The convergent design enabled 
integration by merging of results from the questionnaire and from a retrospective chart 
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review, so that a comparison could be made and a more complete understanding of the 
parental perspective could emerge than what was provided by the questionnaire data 
alone. 
These data sources were triangulated in two ways;  
1. Parent recall of SWS signs was compared and contrasted with their child’s highest 
SWS score.  
2. The distress evoked by the recalled signs was validated as a reflection of their 
child’s withdrawal, rather than in response to clinical deterioration or other 
differential diagnoses, by triangulation with clinical records.   
 
8.5.1 Study population 
The study was conducted in a large children’s hospital in the Northwest of England.  Data 
were collected between December 2012 and December 2014.  Parents whose child had 
completed sedation weaning during their inpatient stay were recruited.  A purposive 
sample frame was used to select parents with two characteristics; the nature of the 
circumstances of the PICU admission (planned or emergency) and previous experience of 
PICU.  It was anticipated that these two features may impact on parents’ recollections 
and views of how distressing they found their children’s behaviours to be. This produced 
four groups;  
 Elective admissions with no previous experience of PICU 
 Elective admission with previous experience of PICU 
 Emergency admissions with no previous experience of PICU 
 Emergency admissions with previous experience of PICU. 
Inclusion criteria were parents of children aged birth to five years. This age range 
encompasses the majority of PICU admissions; the majority of whom are preverbal or 
non-verbal, so represent a group of patients for whom parental experience is a proxy 
measure of the child’s experience. Exclusion criteria were parents of children aged six 
years or older and parents where neither parent was sufficiently proficient in English to 
complete the questionnaire.   
8.5.2 Procedure 
Parents were invited to participate in the study during their child’s hospital admission, 
after weaning of sedation had been completed and they were no longer under the care of 
the Pain and Sedation Service overseeing sedation withdrawal.  Potential participants, 
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identified by the Pain and Sedation Service were approached by a member of staff not 
directly involved in the child’s care and provided with verbal and written information 
about the study. Written consent was gained from parents who agreed to participate by 
the researcher (See Ethics section later).   
A questionnaire was developed to collect data on parents’ recall of and distress evoked 
by the component signs of withdrawal in the Sedation Withdrawal Score (SWS), when 
their child was withdrawing.  The twelve SWS signs were listed and additional descriptors 
were included for terms which might be perceived as unfamiliar (Appendix 8).   Parents 
identified their recall of the sign by circling one of three responses; yes /no / don’t know.  
For each sign recalled, the parents also rated how distressed they had felt, when seeing 
their child display that behaviour. This was identified using an 11-point Likert scale of 0-
10 (0 = not distressing, 10 = extremely distressing).  Face and content validity were 
checked prior to data collection, by pilot-testing the questionnaire on two parents who 
met the inclusion criteria, to ensure comprehension of the terms used and acceptability. 
One questionnaire was completed per child.  The questionnaire was labelled with 
hospital unique study number to allow triangulation with nursing and medical 
documentation of withdrawal behaviours. Completed questionnaires were sealed in a 
pre-addressed envelope and returned via hospital mail or collected from the ward.   
8.5.3 Measures 
8.5.3.1 Parent characteristics 
Demographic data were not collected from parents who participated in this study.  This 
was an exploratory study and insufficient is known about the relationship between 
parental characteristics and parental participation in PICU care to identify sample 
characteristics, which may impact on the generalisability of findings. 
8.5.3.2 Patient characteristics 
The following data were collected about the patient from nursing and medical records; 
age, gender, underlying condition/s, the reason for PICU admission, the date and time of 
extubation and the duration of PICU admission. The date and time of the highest SWS 
score was identified and recorded along with the component items and their severity 
scores.  Data were recorded on an Excel spreadsheet. 
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8.5.3.3 Likelihood of withdrawal 
An indication of the likelihood of withdrawal at the time of the highest score (probable, 
possible, unlikely) was made using the same method described in Study 1; an adaptation 
of the WHO-UMC causality assessment criteria for adverse drug reactions (WHO-UMC) 
(Table 8.1).   
Table 8.1 Classification of the probability of withdrawal, adapted from ADR causality 
tool 
Probability of 
withdrawal 
Physical dependence 
possible 
Temporal relationship 
with change in dose 
Absence of 
differential diagnosis 
Probable Yes Yes Yes 
Possible Yes Yes No 
Unlikely No No No 
The temporal relationship was defined as any reduction or stopping of sedative or opioid 
drugs in the 72 hours prior to the highest score. Differential diagnoses were defined as 
any other concomitant causes for the behaviours documented in the highest withdrawal 
score. Data regarding drug administration and the child’s clinical condition were collected 
from nursing and medical records.   
8.5.4 Analysis 
The questionnaire results were analysed using descriptive statistics, including median and 
interquartile range.   The pragmatic approach of triangulation was taken to demonstrate 
these findings were not due to other underlying causes.  
 A comparison of the frequency of parent and nurse-reported SWS behaviours was made 
in an attempt to establish some degree of concordance, and thereby validate the parents 
reporting of behaviours as signs of withdrawal. 
Assigning a retrospective probability of withdrawal in this study legitimised the parents’ 
experience and view of withdrawal, by ascertaining the extent of uncertainty at the time 
of the highest score, in case the child’s clinical instability or deterioration was driving the 
distress rating, rather than withdrawal.   
The further evaluation of the current approach to withdrawal assessment, included 
analysis of the highest SWS scores in terms of frequency of presentation of component 
signs and the cumulative contribution of each sign to the highest scores across study 
patients. 
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8.5.5 Ethics 
The study was approved by the Liverpool East Research Ethics Committee, REC number 
12/NW/0681. 
Ethical issues pertinent to this study included minimising the risk of coercion, maintaining 
confidentiality and protecting anonymity. These issues were covered in the participant 
information leaflet (PIL) (Appendix 8).  The researcher’s clinical role as a member of the 
team that oversees sedation weaning meant she may have been known to parents, prior 
to their participation in the study.  To minimise the risk of coercion, parents were not 
approached until sedation weaning had been completed, so the researcher’s possible 
clinical involvement with the child was complete.  The initial approach to the parents was 
also made by another member of staff; either the nursing shift co-ordinator or another 
member of the Pain and Sedation Service.  Information provided to potential participants 
included verbal information about the purpose of the study, and assurances of 
confidentiality, that participation was voluntary and that non –participation would not 
affect their child’s care.  The PIL reinforced the mitigation of these ethical issues in 
writing, provided assurance that the study posed no risk to the child and identified the 
process for raising any concerns about any aspect of the study. The questionnaire 
(Appendix 8) was included with the PIL, so that parents could see what their potential 
participation entailed.  Written consent was gained from parents who agreed to 
participate by the researcher. 
 
8.6 Results 
Twenty parents completed the questionnaire (Table 8.2).  For ten parents, this was the 
first time their child had been admitted to PICU; five were planned admissions and five 
were emergency admissions. Of the ten parents with previous experience of PICU, seven 
admissions were planned and three were emergency admissions.  
Table 8.2 Parent characteristics by nature of PICU admission and previous experience.   
 First PICU admission Previous PICU admission 
Elective admission 5 7 
Emergency admission 5 3 
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8.6.1 Patient Characteristics  
The children, whose behaviours were ranked by their parents, ranged in age from 27 days 
to 44 months at the time of their highest SWS score (Table 8.3). Seventeen patients (85%) 
were aged less than 36 months, 13 patients (65%) were aged less than 12 months. Twelve 
patients (60%) were male.  This sample is representative of the European PICU 
population (80% < 36 months, 50% <12 months, Schieveld 2013). 
All planned admissions (n=12) were post-surgery (cardiac surgery n=11, general surgery 
n=1). Most emergency admissions (n=8) were due to respiratory infections (n=5), 
(bronchiolitis n=2, lower respiratory tract infection=2 and adenovirus n=1). Other reasons 
for admission were diaphragmatic hernia (n=1), undiagnosed cardiac condition (n=1) and 
sepsis (n=1).  The median (IQR) length of stay on PICU was 19.5 (11.5-33) days.  The 
median (IQR) highest SWS score recorded was 9 (8-10).  
8.6.2 Recall of SWS signs  
Parents recalled a median (IQR) number of 6 (5-7) SWS behaviours during their child’s 
withdrawal (Table 8.4).  In their ranking of SWS signs, ‘insomnia’ and ‘irritability’ were 
recognised most frequently (n=18), followed by ‘sweating’ (n=14), ‘diarrhoea’ and 
tremor’ (n=12), ‘respiratory distress’ (n=10), ‘sneezing’ (n=9), ‘vomiting’ (n=8), ‘fever’ and 
‘high pitch cry’ (n=6), ‘hypertonicity’ (n=5) and ‘convulsions’ (n=2). 
Most parents (n=15) were confident about their recollection of SWS signs, providing 
definitive responses. Five parents were less sure and responded with “don’t know” in 
relation to two or more of the items listed.  These items were sweating (n=1), diarrhoea 
(n=3), respiratory distress (n=2), sneezing (n=1), vomiting (n=1), fever (n=2), high pitch cry  
(n=2) and hypertonicity (n=2). Each of the four groups defined by nature of admission and 
previous experience of PICU were represented in the parents who responded “don’t 
know. 
8.6.3 Distress caused to parents 
Most items (n=11) were moderately (median scores 5-7) or severely (median scores 8-10) 
distressing to observe; only sneezing was not distressing (median 0) (Table 8.5).  Ranked 
from most distressing to least distressing were convulsions, respiratory distress, 
irritability, tremor, high pitch cry, hypertonicity, insomnia, fever, sweating, diarrhoea and 
vomiting.  It is noteworthy that the least prevalent sign was also the most distressing sign. 
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Nine parents gave one of more SWS items a maximum score of 10. Three parents 
represented the “planned/previous” group; the remaining six parents were spread evenly 
across the other three groups. Two parents gave a maximum score of 10 for more than 
half of the items they recalled; these parents represented the “planned/ previous” and 
“emergency/ 1st” groups. 
8.6.4 Likelihood of withdrawal and differential diagnoses 
The likelihood of withdrawal at the time of the highest score was classified according to 
the adapted ADR causality assessment tool (Table 8.1).  Withdrawal was classified as 
probable in 13 patients, possible in 6 patients and unlikely in 1 patient.  In patients who 
were probably withdrawing (n=13), the median (IQR) highest SWS score was 9 (8-10), 
which matched the figures for the whole, heterogeneous sample.  
In the cases where withdrawal was considered either possible or unlikely, further details 
regarding weaning regimes and other differential diagnoses demonstrated the complexity 
in distinguishing withdrawal from other causes of distress (Table 8.6).  The only patient 
who was considered unlikely to be withdrawing had not been weaned in the 96 hours 
preceding the highest SWS score. Their score of SWS 7 may have been due to the effect 
of his underlying cardiac condition and/or an adverse drug reaction to prostaglandin.  
Six patients were categorised as possibly withdrawing; these patients had been weaned 
within 72 hours of the highest score. The presence of other differential diagnoses 
however, meant it was not possible to definitely differentiate the cause of behavioural 
distress. In two cases, where patients were weaning fentanyl (P9, P20), a bolus of 
fentanyl did not reduce behavioural signs, which would be expected if they were 
experiencing fentanyl withdrawal.  In another two cases patients had tolerated weaning 
at a consistent rate (P4, P16), which they subsequently did not tolerate; respiratory 
support was increased in both cases.  These four cases demonstrate clinical 
circumstances where, although weaning was taking place, the underlying condition may 
have had a greater influence on the SWS score, or on the child’s capacity to tolerate the 
weaning regime.  
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Table 8.3 Patient demographics including highest SWS score and likelihood of withdrawal 
 
 
Planned/ 
emergency 
1st/ 
previous 
Age M/F 
Reason for PICU admission Co-existing conditions Nu
m
b
er 
d
ays P
IC
U
 
Highest SWS 
score, day (D), 
location 
Withdrawal 
suspected 
1 Planned 1st 3 years F Cardiac surgery  
(Atrial septal defect closure) 
None 31 9 
D30 PICU 
Probable 
2 Planned Previous 1 year M Cardiac surgery  
(RV-PA conduit) 
VACTERL Association 19 8 
D3 ward 
Probable 
3 Planned Previous 9 months M Cardiac surgery  
(Fallots repair) 
None 28  10 
D5 HDU 
Probable 
4 Planned Previous 10 
months 
F Cardiac surgery  
(Cavopulmonary anastamosis) 
None 98 10 
D60 PICU 
Possible 
5 Planned Previous 1 year M Cardiac surgery  
(RV-PA conduit) 
None 10 8 
D7 PICU 
Probable 
6 Planned 1st 5 weeks M Cardiac surgery  (Transposition of the 
Great Arteries, septostomy) 
None 35 8 
D30 PICU 
Possible 
7 Planned 1st 5 months M Cardiac surgery  
(Tetralogy of fallot) 
None 7 5 
D6 PICU 
Possible 
8 Planned Previous 5 months M General surgery  
(Roux en y) 
Neurodevelopmental delay 19 10 
D16 PICU 
Probable 
9 Emergency 1st 8 weeks F Diaphragmatic hernia Congenital cardiac anomaly 104 11 
D62 PICU 
Possible 
10 Emergency 1st 6 months M Lower respiratory tract infection None 11 11 
D10 PICU 
Probable 
11 Emergency 1st 5 months M Bronchiolitis Ex 34 week premature birth  6 10 
D2 ward 
Probable 
12 Emergency Previous 9 weeks M Respiratory collapse Congenital cardiac anomaly 20 9 
D20 PICU 
Probable 
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13 Emergency 1st 4 months F Bronchiolitis Trisomy 21, Congenital cardiac 
anomaly, 
Tracheobronchomalacia,  
12 10 
D8 PICU 
Probable 
14 Planned Previous 5 months M Cardiac surgery  
(Redo hypoplastic aortic arch) 
Williams syndrome 6 8 
D0 ward 
Probable 
15 Planned 1st 3 months F Cardiac surgery  
(Truncus) 
None 40 9 
D23 PICU 
Probable 
16 Emergency 1st 2 years F Adenovirus Kabuki syndrome 20 10 
D3 HDU 
Possible 
17 Planned 
 
1st 27 days M Cardiac surgery  
(Transposition of the Great Arteries) 
None 38 7 
D27 PICU 
Unlikely 
18 Emergency Previous 3 years M Sepsis Cerebral Palsy, TPN dependent, 
Developmental Delay  
Tracheomalacia  
13 8 
D11 PICU 
Probable 
19 Emergency Previous 10 
months 
F Lowe respiratory tract infection Chronic Lung Disease,  
Ex 26 week premature birth 
29 11 
D12 PICU 
Probable 
20 Planned Previous 2 years F Cardiac surgery  
(Redo RV-PA conduit) 
Bronchomalacia, recurrent LRTIs 19 8 
D11 PICU 
Possible 
 
M=male   
F= female    
RV-PA = right ventricle – pulmonary artery conduit surgery 
LRTI = lower respiratory tract infection 
TPN = total parenteral nutrition 
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Table 8.4 SWS signs recalled by parents 
 Parent Y 
() 
No 
(x) 
? 
SWS sign 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 
Insomnia 
 
   x  x               18 2 0 
Irritability 
 
     x       x        18 2 0 
Sweating 
 
 x   x      x      ?  x x 14 5 1 
Diarrhoea 
 
 x      ? ?     x x  ? x   13 4 3 
Tremor 
 
 x x        x  x x x x   x  12 8 0 
Respiratory 
distress 
x     x x  ?   Md x x    x ? x 10 7 2 
Sneezing 
 
 x x x x  x   x  Md    x  x ? x 9 9 1 
Vomiting 
 
 x     x ? x x  Md  x  x  x x x 9 9 1 
Fever 
 
 x  x x x Md  ? ?  Md x x x   x x x 6 10 2 
High pitch cry 
 
x  x x x x  ? ?  x  x  x x x x  x 6 12 2 
Hypertonicity 
 
x x  x x x x   ? x Md x x  x ?  x x 5 12 2 
Convulsions 
 
x x x x x x x  x x x Md x x x x  x x x 2 17 0 
Signs recalled 
 
8 4 8 6 6 5 6 9 6 7 7 6 5 5 7 6 8 5 4 4 ? = don’t know 
Md =missing 
data 
 
Don’t know        3 4 2       2  2  
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Table 8.5 SWS signs ranked by distress caused to parents 
 Parent Distress 
score 
SWS sign 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 Median 
(IQR) 
Convulsions        10         10    10 
Respiratory 
distress 
 5 10 9 2   10  9 8    9 9 8    9 (8-9) 
Irritability 6 8 8 7 2  6 10 10 10 7 10  8 9 7 5 7 10 8 8 (7-10) 
Tremor 7   7 5 8 8 10 8 10  7     8 9  2 8 (7-8.5) 
High pitch cry  6     8   10  8  2     9  8 (6-9) 
Hypertonicity   2     9 8      9   4   8 (4-9) 
Insomnia 3 9 2  2  10 10 10 10 4 10 4 10 7 7 4 7 7 5 7 (4-10) 
Fever 8  3     8   5     3 8    6.5 (3-8) 
Sweating 7  6 5  0 5 7 4 5  5 2 0 8 5  7   5 (4-7) 
Diarrhoea 6  10 5 5 0 8   5 2 5 4   7   3 4 5 (4-6) 
Vomiting 5  10 5 1 3     7  3  7  7    5 (3-7) 
Sneezing 0     0  4 3  0  0 0 5  3    0 (0-3) 
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Table 8.6 Differential diagnoses in cases where withdrawal categorised as possible or 
unlikely 
Patient  Withdrawal 
likelihood 
Sedation, weaning and other possible causes of behaviours 
4 Possible 
 
Intubated, long term ketamine and diazepam at consistent doses 
for the last 3 weeks. Chloral reduced daily for the previous 7 days. 
No changes for the following 6 days. Weaning ventilation 
support, previous 12h alternating between BIPAP and CPAP. 
6 Possible Increased work of breathing, ventilation support increased from 
CPAP to BIPAP, resolving sepsis. Fentanyl weaned and stopped 
90h before. Midazolam changed to diazepam 6 days ago, reduced 
48h before. Vomited diazepam dose prior to high score, so given 
IV diazepam, lungs wet, diuresis, settled. 
7 Possible Midazolam stopped 36 h previously after 4 ½ days. Fentanyl 
stopped a few hours earlier. Insomnia previous night.  Possible 
episode of Junctional Ectopic Tachycardia requiring alteration to 
pacemaker. 
9 Possible 19h post extubation. Fentanyl weaning, bolus of fentanyl 
administered with no effect. Settled after diazepam (but had not 
been on midazolam). 
16 Possible 
 
Weaning fentanyl and midazolam at rates previously tolerated. 
Respiratory acidosis, commenced CPAP, pyrexial, blood cultures 
taken, fluid overloaded. 
17 Unlikely Cycled after 5 days clonidine and promethazine 96h before to 
oral morphine and diazepam. Dose unchanged. 30h post 
extubation. Milrinone stopped 7h previously, prostaglandin in 
progress, respiratory acidosis, flow increased. Clonidine restarted 
66h prior due to tachycardia and pyrexia after prostaglandin 
restarted (possible ADRs to prostaglandin) 
20 Possible Weaning fentanyl for the previous 2 weeks with minimal signs of 
withdrawal. Opisthotonos, agitated.  Clonidine, promethazine 
and ketamine unchanged. Bolus of fentanyl no effect, bolus of 
ketamine settled for 3 mins. Diazepam 0.4 mg given, settled 
quickly and pulse and BP recovered over the next 30 mins. 
Extubated previous day to non-invasive ventilation.  
CPAP/ BiPAP = continuous/ bilevel positive airway pressure non-invasive ventilation. 
 
8.6.5 Component items of highest SWS scores 
Nurses documented a median (IQR) number of 5.5 (5-6) behaviours at the time of the 
highest score.  The component items of the highest SWS scores are shown in Table 8.7. 
Eleven of the 12 behaviours were identified in this sample: convulsions did not feature in 
any of the highest scores.  Insomnia, the most prevalent item, was a component of every 
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score and scored a maximum intensity of ‘2’ in most (n=16) cases.  Irritability (n=18) was 
also highly prevalent and scored ‘2’ in most (n=15) cases.  Of the two patients who did 
not score for irritability, one was probably withdrawing and one was possibly 
withdrawing. The remaining SWS signs identified, in order of the frequency they occurred 
were respiratory distress (n=14), diarrhoea (n=12), sweating (n=11), fever (n=8), vomiting 
(n=7), tremor (n=7), high pitch cry (n=7), sneezing (n=4) and hypertonicity (n=2). 
The frequency at which SWS signs were recalled by parents during the course of their 
child’s withdrawal was compared to the frequency behaviours were documented by 
nurses in the child’s highest recorded SWS score (Table 8.8).  Although not directly 
comparable, it was anticipated that parents would be most likely to recall their child’s 
behaviour when the child had been most agitated or distressed; the time which was likely 
to also be captured by the highest SWS score. The frequencies at which behaviours were 
recalled by parents corresponded with nurses’ documentation. The similarities between 
the two columns provide a degree of support for both the capacity for parents to 
recognise SWS behaviours in their child and the construct validity of the SWS tool.   
Table 8.8 Comparison of frequency at which SWS signs were noted by nurses and 
recalled by parents 
Frequency 
n (% of sample) 
Parents recall  
(n=20) 
Nurse documentation 
(n=20) 
16-20 (76-100%) Insomnia, irritability Insomnia, irritability 
11-15 (51-75%) Sweating, diarrhoea, tremor Sweating, diarrhoea, 
respiratory distress 
6-10 (26-50%) Sneezing, vomiting, fever, 
high pitch cry, respiratory 
distress 
Tremor, vomiting, fever,  
high pitch cry 
0-5 (up to 25%) Hypertonicity, convulsions. Sneezing, hypertonicity, 
convulsions. 
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Table 8.7 Component items of highest SWS scores ranked by frequency documented. 
 Patient ID Scores 
SWS item 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 2 1 0 
Insomnia 
 
2 2 1 2 2 2 2 2 2 2 2 2 2 2 2 1 1 1 2 2 16 4 0 
Irritability 
 
2 2 2 2 2 1 0 1 2 2 2 2 0 2 2 2 1 2 2 2 15 3 2 
Respiratory 
distress 
0 2 2 1 1 0 0 1 2 1 2 1 1 0 0 2 2 0 2 2 8 6 6 
Diarrhoea 
 
0 1 1 0 1 1 1 2 0 2 0 1 1 0 0 1 0 0 2 2 4 8 8 
Sweating 
 
1 0 2 1 0 1 0 0 0 2 2 1 0 2 2 2 0 0 1 0 6 5 9 
Fever 
 
0 1 0 1 2 0 0 2 0 0 0 0 2 0 0 2 1 0 2 0 5 3 12 
Vomiting 
 
2 0 2 2 0 2 1 0 0 0 0 0 2 0 2 0 0 0 0 0 6 1 13 
Tremor 
 
2 0 0 1 0 0 1 2 2 0 0 0 0 0 1 0 0 2 0 0 4 3 13 
High pitch cry 
 
0 0 0 0 0 1 0 0 1 1 2 2 0 1 0 0 0 2 0 0 3 4 13 
Sneezing 
 
0 0 0 0 0 0 0 0 0 1 0 0 2 1 0 0 2 0 0 0 2 2 16 
Hypertonicity 
 
0 0 0 0 0 0 0 0 2 0 0 0 0 0 0 0 0 2 0 0 2 0 18 
Convulsions 
 
0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 20 
SWS score 9 
 
8 10 10 8 8 5 10 11 11 10 9 10 8 9 10 7 8 11 8 71 39 110 
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The cumulative contribution that each of the SWS items made to the highest SWS score 
was calculated in all 20 patients (Table 8.9 and Figure 8.1).  The extent of the impact that 
individual signs had on the cumulative score varied considerably between the greatest 
influence (insomnia, 20%) and the least influence (convulsions, 0%).  Three signs 
(insomnia, irritability and respiratory distress) contributed 50 % of value of the highest 
scores; a further four items (sweating, diarrhoea, vomiting and fever) contributed 33% 
and five signs contributed the remaining 17% of the score. 
Table 8.9 The cumulative contribution of the frequency and intensity rating of SWS 
items to the highest SWS scores. 
 Inso
m
n
ia 
Irritab
ility 
R
esp
. d
istress 
D
iarrh
o
ea 
Sw
eatin
g 
Fever 
V
o
m
itin
g 
Trem
o
r 
H
igh
 p
itch
 cry 
Sn
ee
zin
g 
H
yp
e
rto
n
icity 
C
o
n
vu
lsio
n
s 
To
tal 
Score “2” (n) 16 15 8 4 6 5 6 4 3 2 2 0 142 
Score “1” (n) 4 3 6 8 5 3 1 3 4 2 0 0 39 
Combined  
score (n) 
36 33 22 16 17 13 13 11 10 6 4 0 181 
% cumulative 
contribution 
20 18 12 9 10 7 7 6 6 3 2 0 100 
 
 
Figure 8.1 The percentage contribution of component items to the highest SWS scores 
in 20 patients 
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8.7 Discussion 
Study 5 has demonstrated that parents recalled SWS signs during their child’s critical 
illness. This was a main aim of this study, and reflects an important first step in the 
process of including the parent perspective in the withdrawal assessment. This study has 
also highlighted the distress evoked by these signs. These findings will be discussed in 
turn. 
8.7.1 Parent recall of SWS behaviours 
This is the first study to demonstrate that parents recalled their child displaying SWS signs 
during weaning from sedation. Most parents were definitive in their recall or otherwise of 
the twelve SWS signs. However, a minority were not sure about some signs. These items 
included sneezing, diarrhoea and sweating, these are familiar terms which suggest the 
lack of confidence may be simply due to recall rather than an unsolicited burden to 
interpret behaviours.  
The similarity in findings between parents’ recall of signs and the nurses’ prospective 
withdrawal assessment at the time of the highest score shows fit of data integration 
which by confirming the results of the other, affords the results greater credibility 
(Fetters et al 2013).  Validation of the congruence of parent and nurse assessments 
supports a role for parents and opposes the assumption that parents are too 
overwhelmed to participate in their child’s care (Campbell-Yeo et al 2008).  Even away 
from the critical care environment there is little evidence of parent participation in 
clinical assessment, despite parents knowing the child best (Roland 2015). 
Although there may be anecdotal evidence to support the inclusion of the parent 
perspective in clinical assessments, there is a dearth of literature about this topic.  
Parental concern is a component of a minority of Pediatric Early Warning Scores (PEWS) 
in recognition that the person who knows the child best may improve recognition of the 
deteriorating child (Roland 2015).  The parent perspective has been described in a 
primary care setting.  A study comparing parental and medical perceptions of the 
symptoms of childhood asthma, found differences between parental reporting and 
clinician expectations of the influence of symptoms on perception of severity (Yoos et al 
2005).  Twenty percent of parents used none of the standard symptoms when describing 
an exacerbation of their child’s asthma and even fewer (16%) reported a symptom 
considered to be a hallmark by clinicians.  Another study about parental assessment of 
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pain in children with profound special needs found parents relied on knowing their non-
pain child, to recognise the unique changes in response, activity and behaviour, which 
indicated pain (Carter et al 2002). 
Distress evoked by SWS signs SWS signs varied in the level of distress they evoked and only 
one of the signs; sneezing did not evoke some degree of distress.  Of the remaining SWS 
signs, the median distress ratings were in the top half of the 0-10 rating scale.  That the 
majority of withdrawal signs evoke medium to high levels of distress for parents is a 
finding with clinical relevance.  It is known that the child’s behaviour is a source of stress 
for parents in PICU (Board and Ryan-Wenger 2000, Siederman et al 1997) and seeing 
their child suffer causes suffering in parents (deWeerd 2015).  The parents’ sense of 
helplessness can be moderated when clinicians help them to understand their child’s 
behaviours (Ames et al, 2011). However, the provision of parent information is ranked 
more highly by parents than by PICU nurses (Latour et al 2011).  Demonstrating that 
parents recognised and were distressed by signs of withdrawal, highlights the importance 
of telling parents when their child is being assessed for withdrawal syndrome.  
It was expected that parents who were unfamiliar with the PICU environment or whose 
child had been admitted as an emergency may have had higher levels of stress, be less 
likely to recall their child’s behavioural signs or more likely to perceive behaviours as 
distressing. There appeared to be no association or impact between these factors and 
parental capacity to either recall SWS signs or the distress these signs evoked.  
8.7.2 Prevalence of SWS signs 
The prevalence with which SWS signs were documented by nurses and recalled by 
parents was similar. The dominance of insomnia and irritability, which were the highly 
prevalent signs in Study 1, the SWS evaluation study (Chapter 4), was corroborated by the 
parental perspective in this study.  This finding both supports and challenges the validity 
and reliability of SWS, depending on the perspective taken.  The parental view provides 
independent, concurrent validity on the one hand, of the behavioural presentation at the 
time of the highest score.  However, internal consistency is unclear given the unequal 
contribution to the SWS score of the component behaviours (DeVellis, 2012).  The three 
signs with the highest combined prevalence and intensity contributed as much to the 
cumulative score as the remaining nine signs (insomnia, irritability and respiratory 
distress).  These signs are present in SOS (Ista et al 2009) but not present in WAT-1 
(Franck et al 2008). The uneven contribution of the dominant items to the SWS score and 
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the absence of these items from one of the validated scales challenge the theoretical 
concept of withdrawal underpinning these scales (Streiner and Norman 2003).  
Component items are attempting to measure different underlying characteristics or 
factors of withdrawal; it is not clear how the dominant manifestations in one tool can be 
absent from another tool.  
The purpose of withdrawal assessment tools is to discriminate withdrawal (from non-
withdrawal), component items should be answered differently by the withdrawing group 
(Streiner and Norman 2003).   In this small sample the use of the ADR causality 
assessment tool did, however, provide a measure that discriminated likelihood of 
withdrawal due to component criteria that were answered differently by these groups 
(Table 8.1).  It may be that this structure provides an alternative approach to withdrawal 
assessment, compared with the existing approach based on manifestation alone. 
8.7.3 Likelihood of withdrawal 
Assigning a likelihood of withdrawal was designed to highlight the diagnostic complexities 
inherent in the diagnosis of withdrawal and in this study to identify the influence of 
withdrawal as the driver for the parent distress ratings.  Three categories of withdrawal 
likelihood at the time of the highest score were identified retrospectively.  In most cases 
the child was probably withdrawing, but in a third of cases the child’s underlying 
condition may have driven the score. This finding has two implications for this study.  
From a scale development perspective, it challenges both the specificity and positive 
predictive value of SWS (DeVellis, 2012).  From a parental perspective, the distress 
evoked by observed behaviours may have represented times when their child was 
clinically unstable and/or mirrored a sense of clinical uncertainty.   
Further study is needed to determine why parents find these signs distressing. 
 
8.8 Limitations 
This study has a number of limitations. This was a small sample of parents from one 
hospital so may not have been a representative sample and results may not be 
generalisable.  This study investigated parents’ recall of their child’s behaviours during 
weaning of sedation. However, these behaviours may have been a result of withdrawal, 
or the child’s clinical condition, or a combination of both.  
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The child’s highest SWS score was used to validate both parent recall of signs and to 
identify withdrawal as the causal diagnosis for the distressing items.  It might be a flawed 
assumption that parent recall is most likely to reflect the time of the highest SWS score. 
Some parents’ recollections may have been influenced by discussions with nursing or 
medical staff about the likelihood of withdrawal at the time the behaviours occurred.  
The recall and ranking questionnaire was undertaken at the earliest opportunity, once 
weaning was complete, to optimise accurate recall.  However, there is a possibility of 
both false positive and negative recall.  
 
8.9 Conclusions 
Study 5 has shown that parents recalled signs displayed by their critically ill child, which 
were synonymous with withdrawal syndrome. Although varying in the levels of distress 
they evoked, most signs caused high levels of distress. Parents’ recall and scoring did not 
appear to be effected by previous experience of, or the nature of admission to PICU. 
Clinical staff may be able to reduce parental anxieties with proactive information about 
prevention, assessment and treatment of withdrawal behaviours. Study 6 will further 
explore the causes of distress. 
As parents recognised signs of withdrawal, they may be able to contribute to and 
enhance behavioural assessments during their child’s stay on PICU.  Study 6 (Chapter 9) 
also explores parents’ views about participating in these assessments.  
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Chapter 9: Study 6: A multiple case study of parents’ 
experiences of their child’s withdrawal syndrome  
 
 
9.1 Introduction 
A role for parents during the assessment of withdrawal has been presented in the 
literature and/or assumed by healthcare professionals (Chapter 7), but the parent 
perspective has never been studied.   
Using a nested sample of parents from the participants of Study 5, a multiple case study 
approach sought to explore parents’ experiences of withdrawal and acceptability of a 
potential role for parents in withdrawal assessment.  Triangulation of data using nursing 
and medical record served to explain the parents’ perspective and provide an in-depth 
understanding of the case.  Parent interviews were matched to the questionnaires from 
the previous study, with withdrawal assessments of the child and documentation in the 
child’s medical and nursing records, with the overarching aims of exploring parental 
recognition of withdrawal signs, their feelings about their child’s withdrawal event and 
their willingness to participate in withdrawal assessments.  
  
9.2 Aim of the study 
The study aimed to explore parents’ perceptions of their child’s withdrawal and the 
acceptability of a potential role for parents in withdrawal assessment in light of their 
actual experiences.  
 
9.3 Objectives of the study 
The specific objectives of the study were to: 
1. Identify what behaviours parents recognised whilst their child was withdrawing 
and compare with behaviours documented in clinical data. 
2. Ascertain whether parents would be willing to participate in withdrawal 
assessments during their child’s critical illness.  
 
 
 
 191 | P a g e  
 
3. Explore parent’s experiences and perceptions of having a child undergoing 
withdrawal syndrome.  
4. Explore how parents felt about seeing their child suffering withdrawal.  
 
9.4 Method 
Case studies can be explanatory, exploratory or descriptive and can be used to capture 
the complexity, temporal changes and context of a case (Yin 2009).  In this study, the a 
priori rationale for the case study approach was to explain the parent perspective and 
experiences of withdrawal, using a combination of qualitative and quantitative methods.  
This approach fits with the pragmatic approach as “… case study is defined by interest in 
individual cases, not by the methods of inquiry used.” Stake (2003, p 134).   
A longitudinal approach was taken encompassing the time period of 72 hours before and 
after the highest SWS score.  This timeframe allowed insight into the possible causes for 
the behaviours; identifying the likelihood of withdrawal or other differential diagnoses, 
and response to interventions or changes to the weaning regime.   Within-case analysis 
provided validation of the individual parent perspective in each case (Yin 1994).  Cross 
case analysis synthesised the shared components of the parent experience (Yin 1994).  
During the course of the study, the design evolved iteratively due to integration at the 
interpretation level (Fetters et al 2013). Integration with the findings of Study 1 and 
abductive reasoning led to a collective case study approach (Stake 2003).  Hammersley 
defines abduction as “the development of an explanatory or theoretical idea, resulting 
from close examination of particular cases” (2005, p5).  The nascent utility of the adapted 
ADR causality assessment tool, as a withdrawal causality assessment tool (W-CAT) was 
demonstrated in Study 1.  Using abduction, the emergent theoretical proposition was 
that the contingency of sedation withdrawal is better described by the probability terms 
in W-CAT, than the dichotomy of WAT-1 and SOS.   
Case studies can be undertaken to test such an explanatory framework, or proposition 
(Thomas and Myers 2015).   The unit of analysis, or subject of the study is the case.  The 
object of the study is the analysis, or theorisation by which the case is explicated. 
the theme on which the study intends to shed light, in this case withdrawal assessment, 
A multiple case study design was used in recognition of the heterogeneity of the sample, 
which was highlighted in the findings of the previous study.   
This methodology utilises multiple sources of information (Creswell, 2013). In this study, 
these sources included parent interviews, the questionnaire responses from Study 5 and 
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nursing and medical observations and documentation.  The use of multiple sources 
increases rigour by contributing to completeness of data and by demonstrating 
concordance between sources (Knafl and Breitmayer 1991). 
9.4.1 The interviews 
A pragmatic approach was ideally suited to this study, using a descriptive qualitative 
approach and thematic analysis.  The researcher sets aside, or brackets their own beliefs 
and perceptions to facilitate an open approach to the parents lived experience of 
withdrawal and elicit rich and descriptive data.  The participants’ children may have been 
patients of the interviewer prior to recruitment to the study, so the interviewer may have 
been cognisant of the course of the child’s weaning and withdrawal.  Fundamental to the 
bracketing of these experiences was the acknowledgement that the parent and clinical 
perspectives of a shared experience may be fundamentally different; both perspectives 
are valid and with neither having supremacy over the other.  The conceptual framework 
values the diversity of views.  This framework contends that these multiple perspectives 
and the richness of data they afford enhance the rigour of the study findings.  
The etic (outsider) and emic (insider) perspectives are assigned in relation to the 
expertise and knowledge of the individual child rather than expertise and knowledge of 
sedation withdrawal. In this respect, the etic view is assigned to the researcher and the 
emic view to the parent, as the expert of their child.  This approach is congruent with 
pragmatic ontology, which holds that truth and reality are subjective constructs, which 
vary depending on the perspective through which they are experienced.   
9.4.2 Study population 
This study followed on from Study 5 (see Chapter 8).  Parents who completed the 
questionnaire were then given the option of a follow-up interview to discuss their 
experiences further by ticking a box at the bottom of the sheet.  Inclusion and exclusion 
criteria, study setting and period of data collection were the same as described in Study 
4.  Purposive sampling was used again to select parents for interview with both prior PICU 
experience and no prior experience, elective and emergency admissions.  
9.4.3 Procedure 
Interviews took place at the child’s bedside or in a quiet room adjacent to the ward, 
according to the parents’ preference after weaning had been completed and prior to 
their discharge home.  This time frame aimed to minimise recall bias by interviewing 
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parents as soon as weaning was completed.  A semi-structured interview protocol was 
constructed to meet the aims of the study. During the development stage of the study, 
the researcher presented an overview of the study to a parent support group at the local 
branch of the Children’s Heart Federation.  The purpose was to gain feedback regarding 
the acceptability of the study design and face validity for the proposed interview 
questions from parents who had experienced PICU care after their child’s cardiac surgery.  
Parents supported all aspects of the study discussed.   
Pre-determined interview questions covered aspects of withdrawal assessment, where 
responses would confirm or refute the proposed participation of parents in future 
assessments: parents were asked about their recognition of and feelings evoked by 
behaviours displayed by their withdrawing child and their views on the option of 
including the parental perspective in future assessments (Table 9.1).  Questions exploring 
the parent perspective were open –ended in order to prompt discussion, to afford the 
opportunity to explore themes or responses further and to allow participants to discuss 
and raise issues that had not been considered. The existing approach to withdrawal was 
evaluated by examining parent’s experiences of their child’s withdrawal syndrome, 
ascertaining the relative impact of this aspect of their child’s critical illness and the extent 
to which they were aware of or had been involved in withdrawal assessments.  
9.4.4 Ethics 
Ethical approval was granted by the Liverpool East NHS Ethics committee (12/NW/0681). 
Parents volunteered to participate in this part of the study by ticking a box at the end the 
questionnaire. This method of recruitment allowed parents to self-select as potential 
participants for the second, more in depth phase of the study after completion of the 
brief questionnaire. Whilst this approach minimised the risk of coercion, parents were 
assured they could withdraw from the study at any time. The approach to maintaining 
confidentiality and protecting anonymity was described in the previous study. In addition, 
parents were informed that any names mentioned in interviews would be removed 
during transcription.   
Consideration was given to the risk that parents might get upset when recalling their 
child’s critical illness. If this occurred, the interview would be paused and opportunity 
given to continue after a suitable break or stop the interview.  Additional support from 
their child’s clinical team was also offered.  Written information about these issues was 
contained in the participant information leaflet (PIL).  Written consent was gained from 
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parents who agreed to participate by the researcher in audio-recorded interviews (See 
Appendix 9 for study paperwork including information leaflets and consent forms).   
Table 9.1 Interview guide 
1. How is [child’s name] getting on now? 
 
2. Please tell me about why [child’s name] was admitted to Intensive Care. 
 
3. Please tell me about what sedation [child’s name] was given. What were you 
told about the drugs? (and who told you this)? 
If not mentioned in response to this question: Were you told about weaning or 
withdrawal? 
 
4. Thinking back to when [child’s name] was in Intensive Care, please can you tell 
me about their withdrawal and what symptoms s/he had. Take your time and 
tell me as much as you can remember. I am interested in the little things you 
might not think are important. [The researcher will write down the symptoms 
on small cards]. When did you become concerned? What were the first things 
you noticed about [child’s name]? 
[After the parent has completed their description, the researcher will show 
them their completed questionnaire].  
 
5. Apart from the symptoms you’ve already described, did [child’s name] have 
any other symptoms?  
 
6. For any symptoms identified in Q4 or Q5; what is your description of each of 
these symptom in your own words?  
 
7. How did you feel about seeing [name of child] withdrawing?  How did it 
compare with other stressful aspects of [child’s name]’s hospitalisation? 
 
8. Using cards with [child’s name] symptoms, could you rate each of these 
symptoms on a ladder?  Put the worst one/s at the top of the ladder and the 
less distressing ones further down. 
 
9. Your child’s nurse would have scored [name of child] four times a day for 
withdrawal.   
a. Was this score or [name of child]’s symptoms discussed with you?   
b. Was there a discussion about how [name of child]’s symptoms 
would be managed?  Were you involved in this discussion? 
c. Who talked to you about sedation withdrawal while you were on 
ICU? 
d. How would you feel about participating in the withdrawal 
assessment in partnership with the nurses caring for your child? 
 
10. Is there anything else you want to tell me about you and your child’s 
experiences, that you feel is important, and that we haven’t covered already? 
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9.4.5 Data analysis 
The interviews were professionally transcribed and checked by the researcher for 
accuracy and completeness. Quantitative data were analysed using descriptive statistics. 
The median and interquartile ranges were calculated for the frequency of withdrawal sign 
recall across the sample and the number recalled per participant.  In Study 5, 
concordance between the frequency of signs in the highest SWS score and parent recall 
had validated parent reporting of SWS signs. In this study, parent recall of non-SWS signs 
was triangulated with nursing and medical notes, in order to interpret the parents’ 
recollections of their child’s behaviours and characterise individual experiences of 
withdrawal.  Recall of withdrawal signs was presented as individual cases.  Preference for 
parent participation in withdrawal assessment was presented as a percentage.   
Qualitative data were subjected to a thematic analysis and presented as cross-case 
themes (Yin 1994). Thematic analysis is not tied to a particular theoretical position, so can 
be applied across the range of theoretical approaches (Braun and Clarke 2006).  
The steps taken in analysing the data were modelled on the phases of thematic analysis 
described by Braun and Clarke (2006).  In the first phase; familiarisation with the data, all 
transcripts were read several times to obtain an overall feeling for them.  Preliminary 
notes were made of initial impressions.  Significant statements were identified from each 
transcript which related to the lived experience of parenting a child who was 
withdrawing; these statements generated the initial codes for phase two.  In the third 
phase of searching for potential themes across the data set, shared meanings and themes 
emerged from the significant statements.  Emergence of themes was predicated by the 
underpinning aim to synthesise lessons from all cases, in order to inform advances in 
withdrawal assessment by optimising parental participation.  Validation of the themes 
was verified by presentation of the thematic map to a team of clinical psychologists who 
support children and their families in PICU, and who verified them as resonant with the 
concerns typical of parents with a child in PICU.  This process reflecting refinement of the 
themes was phase four of the analysis. The fifth phase; defining and naming the themes 
identified one metatheme and three subthemes to the stress and challenge of being a 
parent of a child with withdrawal syndrome.  The process of data analysis was more 
iterative than these distinct steps suggest, reflecting Krathwohl’s (1998) account of three 
phases; observing [immersive reading of the transcripts], coding and interpreting, which 
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occur concurrently but with different emphasis throughout the study.  The write-up of 
the study constituted the concluding phase of analysis. 
Quotes from individual interview transcripts are identified by the codes P1 through to 
P11; a following “M” refers to mothers and “F” to fathers. 
 
9.5 Results 
Of the 20 parents who participated in Study 5, 13 parents of 11 children participated in 
interviews.  Eleven interviews were held; six with the mother only, three with the father 
only and two with both parents present.  Interviews lasted between 23 and 68 minutes. 
For five parents this was the first time their child had been admitted to PICU; two were 
planned admissions and three were emergency admissions. Of the six parents with 
previous experience of PICU, four admissions were planned and two were emergency 
admissions (Table 9.2).  Suspected withdrawal at the time of the highest scores was 
“probable” in nine cases, “possible” in one case and “unlikely” in one case.    
Results will be presented in three parts, starting with quantitative data, followed by the 
individual case studies and then the qualitative data. 
 
9.6 Quantitative results 
9.6.1 Parental recognition of their child’s withdrawal behaviours 
During the weaning of sedative and analgesic drugs, parents recalled a median of 10 (IQR 
7-11) behaviours per patient, of which 3 (IQR 1-5) were non-SWS behaviours (Table 9.3).  
Parents were asked if the behaviours noted were improving or had resolved to support 
their association with withdrawal; the majority (n=10, 91%) did.  The non-SWS signs 
identified by parents fitted most of the categories of signs identified in the early case 
reports describing withdrawal in the literature review (Chapter 2, Table 2.5); abnormal 
movements, communication disturbances, neurological instability, symptoms and other 
signs (Table 9.4). Communication disturbances were recognised by seven parents and 
described in different ways, but most commonly as “not recognising me” (n=3) “vacant” 
(n=2) and “not focusing” (n=2).  Motor disturbances were recognised by four parents 
describing 13 behaviours, including most commonly “lip smacking” (n=3) and “moving 
arms about” (n=3).  
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Table 9.2 Patient demographics including highest SWS score and likelihood of withdrawal 
C
ase stu
d
y 
 
Parent 
interviewed 
Child demographics Study 
number in 
previous 
study 5 
Plan/ 
Emergency 
1st/ previous 
Age Gender Reason for PICU admission  
and underlying condition 
Number 
of days 
on PICU 
Highest SWS 
score, day 
(D), location 
Withdrawal 
suspected 
1 Mother Planned 
1st 
3 years Female Cardiac surgery  
 
31 9 
D30 PICU 
Probable 1 
2 Both 
parents 
Planned 
Previous 
1 year Male Cardiac surgery  
VACTERL Association 
19 8 
D3 ward 
Probable 2 
3 Mother Planned 
Previous 
9 months Male Cardiac surgery  
 
28  10 
D5 HDU 
Probable 3 
4 Father Planned 
Previous 
5 months Male General surgery  
Neurodevelopmental delay 
19 10 
D16 PICU 
Probable 8 
5 Father Emergency 
1st 
5 months Male Bronchiolitis  
Ex premature 34/40 
6 10 
D2 ward 
Probable 11 
6 Mother Emergency 
Previous 
9 weeks Male Respiratory collapse  
Cardiac patient 
20 9 
D20 PICU 
Probable 12 
7 Mother Emergency 
1st 
4 months Female Bronchiolitis, Trisomy 21, AVSD 
Tracheobronchomalacia, 
12 10 
D8 PICU 
Probable 13 
8 Both 
parents 
Planned 
Previous 
5 months Male Cardiac surgery  
Williams syndrome 
6 8 
D0 ward 
Probable 14 
9 Father Emergency 
1st 
2 years Female Adenovirus  
Kabuki syndrome 
20 10 
D3 HDU 
Possible 16 
10 Mother Planned 
1st 
27 days Male Cardiac surgery  38 7 
D27 PICU 
Unlikely 17 
11 Mother Emergency 
Previous 
3 years Male Sepsis Cerebral Palsy, TPN dependent, 
Developmental Delay, Tracheomalacia 
13 8 
D11 PICU 
Probable 18 
M=male, F= female TPN =Total parenteral nutrition AVSD= atrial ventricular septal defect 
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Table 9.3 Parent recall of withdrawal behaviours, ranked in order of the distress they evoked.  (Bold = non SWS signs) 
P1M P2 (Both) P3M P4F P5F P6M P7M P8 (Both) P9F P10M P11M 
Insomnia 
Irritability 
Sweating 
Diarrhoea 
Vomiting 
Tremor 
Fever 
Sneezing 
Jittery 
Jumping 
about 
Distressed 
Hallucinations 
Shaky 
Floating 
hands 
Twitchy head 
Vacant 
Not 
engaged/ 
focussing 
Insomnia 
Respiratory 
distress 
Irritability 
Moving 
arms about 
Reaching 
out to grab 
things 
Scratching 
and itching 
HP cry 
Lip 
smacking  
Dilated 
pupils 
Restlessness 
Uncertainty 
of 
neurological 
damage 
Not 
recognising 
me 
Different 
baby 
Irritability 
Insomnia 
Lip smacking 
Jerky 
movements 
Rubbing face 
and nose 
Hypertonicity 
Sweating 
Respiratory 
distress 
Fever 
Convulsion 
Respiratory 
distress 
Insomnia 
Tremor 
Hypertonicity 
Irritability 
Rapid eye 
movement 
Not 
focussing 
Fever 
Sweating 
Sneezing 
Eyes  
looking 
down 
Respiratory 
distress 
Irritability 
Agitated 
Looking 
through me 
(not there) 
Fever 
Vomiting 
Insomnia 
Diarrhoea  
Sneezing 
Insomnia 
Irritability 
Diarrhoea 
Sweating 
Tremor 
HP cry 
Looked 
dazed 
Sore 
bottom 
Insomnia 
Diarrhoea 
Sweating 
Sneezing 
Vomiting 
Insomnia 
Irritability 
Sweating 
HP cry 
Sneezing 
Stiff arms 
and legs 
Tongue 
protruding 
Lip 
smacking 
Respiratory 
distress 
Diarrhoea 
Blank canvas/ 
not 
communicating 
HP cry 
Irritability 
Insomnia 
Hallucinations/ 
throwing arms 
about 
Swimming 
movements 
with arms 
Fever 
Sweating 
Convulsions 
Tremor 
Fever 
Respiratory 
distress 
Insomnia 
Irritability 
Vomiting 
Sneezing 
Sweating 
Not 
recognising 
me 
Irritability 
Tremor 
Hypertonicity 
Insomnia 
Sweating 
Hallucinations 
P= parent M= mother F= father 
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Table 9.4 Non-SWS behaviours recalled by parents 
Abnormal movements Communication disturbance Neurological instability Symptoms Other signs 
Floating hands 
Twitchy head 
Moving arms about 
Lip smacking 
Jerky movements 
Rubbing face and nose 
Rapid eye movement 
Stiff arms and legs 
Tongue protruding 
Swimming movements with 
arms 
Vacant 
Not engaged or focussing 
Not recognising me 
Not focussing 
Eyes looking down 
Looking through me 
Looked dazed 
Blank canvas/not 
communicating 
Jittery 
Jumping about 
Shaky 
Restlessness 
Agitation 
Hallucinations 
Reaching out to grab thing 
Distressed 
Scratching and itching 
Dilated pupils 
Sore bottom 
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‘Hallucinations’ were also reported by four parents.  Only one of these children could 
verbalise and she had described to her parents, how she “was swimming with mermaids” 
without “mummy and daddy” and that she had been “dropped in the water with no arm-
bands and she couldn’t float” (P1).  In the other cases the presence of hallucinations was 
based on parents’ interpretation of behaviours suggesting visual hallucinations, including 
“reaching out to grab things” (P2), “sort of treading water, as if she was swimming with 
her hands, as if she was batting things away” (P9) and “sometimes he’d lie there and have 
a little giggle” (P11).  Parent descriptions of signs are further reported in the case studies 
section of the results and in the sign synthesis chapter.  
9.6.2 Parent participation in withdrawal assessments 
The majority (n=10/11, 91%) of parents were receptive to the idea of active participation 
in the withdrawal assessment. Qualitative findings about this objective are presented in 
the qualitative section of the results. 
 
9.7 Qualitative results 
9.7.1 Stress and challenge of being a parent of a child with withdrawal 
syndrome 
While the primary aim of this study sought to identify a role for parents in sharing their 
insider knowledge to benefit withdrawal assessments, this contrasted sharply with the 
dearth of communication that parents received about withdrawal: it was striking how 
alone and/or vulnerable parents seemed with their concerns at times.  The parents 
described their concerns about the meaning of their child’s behaviours and their 
occasional unsolicited participation in decisions about weaning.  Parents revealed that 
the overall experience of parenting a child with withdrawal syndrome was stressful and 
challenging, and differed from other challenges presented by their child’s critical illness.   
This sense of “stress and challenge” became the overarching metatheme and comprised 
of three subthemes (Figure 9.1); 
1. Withdrawal was an unexpected part of their child’s critical illness, which caused 
distress (the burden of withdrawal).  
2. Parents noticed changes in their child’s behaviours and did not know what these 
changes signified (parents’ recognition of their child’s withdrawal behaviours and 
parental distress).   
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3. The parents’ sense of powerlessness and their preferred role in the assessment and 
management of withdrawal;  
 
Although open visiting for parents on PICU affirms the parent’s place at their child’s 
bedside, their role appears to resemble that of “passive bystander” (Glasper 2015, p73) 
rather than partners in care.  This etic role parents experienced in practice contrasted 
sharply with the emic role they were assigned in the research design. The three 
subthemes will be presented in turn. 
 Figure 9.1 Diagram showing the metatheme and subthemes of the stress and challenge 
of being a parent of a child with withdrawal syndrome. 
 
9.7.1.2 Subtheme 1: The burden of withdrawal  
Parents described withdrawal as a distinct part of their child’s critical illness “It’s like a 
separate issue, like being sick again” (P5F).  Another parent described how “you don’t 
realise it can be quite an ordeal and that it brings a different set of problems” (P9F); 
another described it as “a horrendous 24 - 48 hours” out of a 20-day PICU admission, 
(P6M).  Comparing withdrawal to all the other stressful aspects of their child’s PICU stay, 
parents expressed a range of views. Although all parents found aspects of withdrawal 
stressful, one parent summed up the typical feeling that although distressing, it  was “not 
in the same way as the operations and the bad news” and that the most distressing thing 
was “the fact you might not be taking your child home” (P1M).  Other parents expressed 
other views during their interviews. In one case, a parent explained “I wouldn’t say 
overall it was a mega issue, but the factors in it, like insomnia, I found as stressful as 
Stress and challenge of 
being a parent of a 
child with withdrawal 
syndrome 
The burden of 
withdrawal  
Parental recognition of 
their child’s  
withdrawal behaviours 
and parental distress 
Parents’ sense of 
powerlessness and 
preferred role 
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seeing them do stuff on PICU, it was on a par with that” (P8M).  Another parent explained 
how, in one respect “It’s not as distressing as what we went through on PICU because we 
thought he was going to die……but it was an unexpected part.” However, this parent 
subsequently explained that “This [withdrawal] has probably been one of the most 
distressing bits – this last two weeks has been a huge thing” (P2M).  Similar sentiments 
were expressed by another parent who declared “compared to being told there was a 
possibility he might die, the withdrawal was nothing really,” then later explained that “In 
the grand scheme of things, it’s nothing, at least he’s alive, but on a day to day basis it’s 
everything” (P3M). 
One father described how the reality of his child’s suffering evoked a different response 
to the anguish of not knowing if his child would survive, which possibly explains the 
paradox;  
“When they’re on a ventilator they look very peaceful… if you look deeper 
they’re very poorly. When they wake, you see their distress and they’re 
struggling to breathe, you see withdrawal and pain – it’s a different kind of 
emotion.” (P9F)   
In some cases seeing their child undergo withdrawal ranked very highly in terms of 
stressful events during the child’s critical illness.  A father whose son had had multiple 
PICU admissions explained 
“The thing I dread every time is withdrawal…… I dread it every time……It’s 
just a nightmare as a parent to see your child go through that….. it’s heart-
breaking, it’s absolutely awful” (P4F).   
However, a contrasting view was held by a mother whose son had also had multiple PICU 
admissions;  
“I didn’t worry about it each time……He was so poorly that everything else 
sort of takes over, all you want them to do is get better.” (P11M) 
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9.7.1.3 Subtheme 2: Parental recognition of their child’s withdrawal behaviours 
and parental distress  
Parents found some withdrawal behaviours more distressing than others. One parent 
differentiated between distressing signs where “you can see there is something wrong 
with him” (P5F) and others that were not distressing, because they were “just side 
effects” (P5F).  Another parent described the basis upon which she perceived each sign as 
distressing or not, as “I understand why these sort of things happen, so they are less 
scary” (P2M).  In some cases, the child’s underlying condition dictated which signs were 
more distressing because “we knew some were more serious than others” (P9F).  Parents 
expressed concern that some signs might compromise the child’s recovery, as one parent 
explained; “Restlessness and irritability I don’t like to watch, especially when you’ve got a 
child with a heart problem, you are worrying that they’re going to get tired.” (P2M). 
Other behaviours evoked distress because they were not typical of their child, so parents 
were concerned about what these  might mean, as one parent explained “It’s just not his 
normal behaviour and so it’s upsetting, you just don’t know what’s going on” (P11M). 
Communication disturbances ranked highly amongst these atypical signs as one mother 
explained, “Not recognising me was the most upsetting really, because they didn’t know 
if there was something wrong with his brain” (P11M).  This was a rational concern, 
because, as one parent explained, “it could be a sign of neurological problems, which is a 
part of what we signed on the consent” [form before heart surgery as a risk of the 
operation] (P2M).  Despite attempts by staff to reassure parents about the temporary 
nature of withdrawal signs, one mother worried that 
 “it could be that it’s never going to go away…..that’s more distressing than 
insomnia, because hopefully that can be reversed”(P2M).   
Concerns about neurological injury  were also shared by staff, as one parent explained; 
“the nurse thought there was something wrong with his brain and they took him for a 
scan at 9 o’clock at night, because they didn’t know what was wrong with him” (P11M).  
The spectre of neurological damage was pervasive; “It’s probably more upsetting than 
anything else really” (P11M).  A mother of a 3-year-old daughter explained 
“You’d speak to her and she’d just look right through you….. It was like 
there was nothing there; there was no light, there was no sparkle and that 
upset me” (P1M).  
 
 
 
 204 | P a g e  
 
This caused her to think; “Am I going to get the same child back? Those first few days 
were really worrying.  That was one of my major concerns” (P1M).  Another mother 
described how living with the uncertainty of neurological damage was “like waiting for 
heart surgery, it’s a massive albatross round your neck” (P3M). 
 
9.7.1.4 Subtheme 3: The parents’ sense of powerlessness and their preferred 
role in the assessment and management of withdrawal 
The immediate impact of altered communication on the parental comforting or nurturing 
role was described by other parents. One parent described; “You want your child to know 
who you are, that’s all you want back when they’ve been so poorly, and then you wait 
ages for them to realise that ‘mummy’s here’” (P11M).  Another mother, who was able to 
lip-read, described how upset she felt when her daughter, who was still intubated and 
ventilated, kept repeating over again ‘I want my mummy, I want my mummy’ because “I 
can’t do anything to help you, I can’t pick you up” (P1M).   
Subsequently, when she was first allowed to cuddle her daughter, she described how “I 
sat her on my knee and she just literally kicked off. It was like – I don’t want you” leading 
this parent to think “she really doesn’t like me” (P1M).  The ineffectiveness of parental 
nurturing was also shared by fathers. One father summed up a sense of helplessness that 
was common;  
“You can’t control it, there’s no control over it, all you can do is sit there 
and be with them, and watch them go through it. But there’s no 
comforting him, no matter what you do” (P4F).  
In addition to the sense of helplessness, not being able to comfort their child caused 
frustration, “you can’t do anything for him, can’t understand what he wants” (P5F), and 
stress; “why can’t he sleep?” “Why can’t I get him to sleep?” (P8M).   One mother, whose 
son had been ventilated from birth, felt it was “reflecting on me, my skills as a mother, 
that I obviously wasn’t good enough yet at comforting him” (P6M).  This made her feel 
“like I was a bit of a useless mother” (P6M).  This sense of despair was also shared by a 
more experienced mother whose baby was a few months old and had previous PICU 
experience, who described her inability to comfort her baby as what “upset me the most” 
(P8M). 
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Parents were asked whether they were aware of, or had participated in the nurses’ 
clinical withdrawal assessments.  Awareness was mainly predicated on parental enquiry 
rather than nurses volunteering information.  One parent explained; “You’d hear the 
discussions and so naturally ask what’s going on” (P5F).  When parents were informed 
about the purpose of the withdrawal assessment they reported feeling “more 
comfortable” (P10M) and “more relaxed” (P2M) as they were reassured that this was 
expected behaviour and “what other children do” (P2M).  However, some parents were 
not informed and felt “left in the dark” (P4F) or had to be “nosey” (P8M).  This was seen 
to be detrimental as “it’s a scary time for parents” (P4F) and they would have preferred 
to have known about the “score… or what the next stage is going to be.” (P4F) 
In terms of parental participation, there appeared to be an inconsistent approach to 
including or involving parents in the withdrawal assessment.  One father explained how 
although he “didn’t participate in scoring,” he found “it was interesting as a parent to 
look down the list and keep an eye out for things.” (P9F).  Parents acknowledged that 
their constant presence at the bedside gave them a different insight than the nurses into 
their child’s behaviour. This was manifested by reporting behaviour the nurse might not 
have seen; “you missed this bit where she was happy and singing” (P1M) or by 
recognising subtle changes in behaviour because “they’ve [nurses] got nothing to 
compare to, there’s no consistency, people can’t work 24/7” (P9F).  One parent noticed 
how her daughter’s behaviour altered during the nursing assessment and this might lead 
to an inflated score;  
“They were saying she was really agitated and he [father] disagreed. I think 
because nurses are in uniform, she thinks “what are they going to do?” She 
would only really become agitated when they were approaching her” 
(P1M).   
Conflicting opinions about withdrawal scores were highlighted by some parents who felt 
the nurse score was higher than their own view.  Despite parents feeling the child had 
had a “really good day” (P8M), lack of familiarity with the patient meant the nurse scored 
behaviours on face value, despite the mother explaining “He does that anyway, it’s just 
how he is” (P8M).  The withdrawal score determines treatment changes and one parent 
described how they were successful in asserting their opinion; “She’s not a ‘6’ and we 
want that turning down tonight.” (P1M)  
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There was also evidence that parents acted as gatekeepers to stop too many reductions 
occurring simultaneously.  One mother described how; “I started waiting by his bed ready 
to pounce on anyone if they wanted to change 2 or 3 things” (P10M), after her son 
experienced a “very bad” withdrawal and was “just in a mess really” after a number of 
concurrent treatment changes to medication, sedation and respiratory support had made 
it difficult to determine the cause of his distress. Another mother commented on the 
frequency that her son’s sedative infusion was being reduced at, as “Even I know it takes 
ages to get out of your system.” This was frustratingly described as the staff  being 
“trigger happy” in contradiction to the weaning plan suggested by the pharmacist, 
resulting in her son being in “a right state” (P11M). 
At times, a more collaborative approach was described by parents, with evidence of both 
staff and parents talking to achieve a consensus about decisions to omit sedative drugs. 
One mother described how the nurse involved her in the decision-making;  
“They started telling me what he [child] was scoring. One night they said 
“We’re onto ‘6’ and they said should we ride it out, should we not?” 
Whether they were really involving me or not, I felt like they were and I felt 
like I was part of the decision” (P10M).   
In another example, the parent appeared to instigate the discussion and described the 
exchange using language suggestive of an equal partnership; 
“Last night we [nurse and mother] managed to hold off. She said “He’s 
doing really well, he’s not distressed and he’s asleep.” So I said “If he’s 
asleep when it’s due and not upset, can we skip that dose and see how he 
goes?” The nurse said “Yes, that’s great.” And we managed to do it” 
(P8M).   
One mother explained succinctly why a collaborative approach should be endorsed; “I 
think if parents want to be involved they should be.  I’m not an expert on sedation, but I 
am on my son and that’s the same for every parent, isn’t it?” (P11M). 
The majority of parents were receptive to the idea of active participation in the 
withdrawal assessment, but qualified that this might not suit all parents.  Only one parent 
did not like the idea of participating and felt that being asked about the presence or 
absence of specific behaviours might “cause worry to a parent unnecessarily” (P7M).  
Other parents felt involvement would help them feel “competent” (P1M) and 
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“comfortable with what’s going on” (P4F) or “reassured” (P6M).  They felt it could assist 
the clinical assessment by establishing “the norm” (P8) and assist nurses if parents “keep 
an eye out” (P3M) for signs.  However, one parent recognised the responsibility involved 
in participation and expressed concern about the impact of the accuracy of their 
assessment;  
“I wouldn’t want to score him too high and have someone put something 
back up that actually we are trying to get him off, or I wouldn’t want to 
miss something that would mean he should actually have it taken back 
up.” (P10M) 
Although one parent felt the nurses’ objective view “is probably better” (P5F) and 
another parent recognised that they may have a “differing opinion” (P9F) to the nurse, 
overall a collaborative approach was endorsed, as summarised by one father; 
“Knowledge is power and once you get that little bit of knowledge, once 
you’ve learned that little bit you can help a lot more, but you can’t learn 
until somebody tells you what’s going on.” (P4F) 
 
9.8 Discussion 
This is the first study, to describe parental perceptions of the signs and experiences of 
their child’s withdrawal syndrome.  Parents recognised behaviour changes in their 
children and most felt that a partnership approach to withdrawal assessment would 
benefit both them and their child.  This study has also highlighted the suffering and 
distress arising from the weaning of sedative and analgesic drugs in PICU. Findings will be 
discussed in light of the existing literature and then consider ways to ameliorate this 
experience by changes in the existing approach to withdrawal assessment. 
This study demonstrates that parents varied in how distressing they perceived each sign, 
depending on the meaning or interpretation of the sign for them.   In common with the 
findings of other studies, behavioural signs ranked high for parental distress if they were 
perceived as potentially exacerbating the child’s underlying condition, if they were 
indicative of neurological damage or if they prevented the parent from being able to 
comfort their child (Board and Ryan-Wenger 2000, Carter 1985, Siederman et al 1997, de 
Weerd 2015).  These behaviours may matter more to parents than the staff and be quite 
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divergent from clinical causes for concern.  The typical timeline for withdrawal syndrome 
is during recovery from critical illness, as the child’s condition improves, is extubated and 
then discharged to the ward (Cunliffe et al 2004). This is when the child poses less of a 
clinical challenge to staff, and more care may be delegated to parents and is known to be 
an anxious time for parents, despite the obvious improvements in the child’s condition 
that this step represents (Keogh, 2001).  This study has emphasised that, even though 
their child is recovering, this might be a tough time for parents.  The parental 
perspectives of distress, recall of behaviours and participation in the withdrawal 
assessment will be discussed in light of the broader literature on parental participation in 
care.  Insights that that the parental perspective brings to the current approach to 
withdrawal assessment will also be discussed. 
 
9.8.1 Parents’ distress 
Using parents as a surrogate measure highlighted how, whilst the behaviour itself might 
not cause physical suffering to the child, the meaning a parent attaches to the behaviour 
might cause existential suffering for the parents (deWeerd et al 2015).  Many of the 
parents did not feel that they had been adequately prepared for the signs of withdrawal 
their child might develop. Studies have shown that parents on PICU value being kept up 
to date with their child’s condition, having explanations for the behavioural changes they 
see in their child (Siederman et al 1997), being reassured of the normalcy of their child’s 
behaviour (Ames et al 2011), and being prepared for what to expect as the child’s 
condition progresses (Shudy et 2006).  These explanations help to moderate the parents’ 
emotional reactions.  A striking finding of this study was the stress parents experienced 
due to uncertainty much of which, albeit an inherent feature of PICU, could potentially 
have been allayed by better communication between the staff and parents (Latour et al 
2010, 2011).    Whilst some parents in this study described instances where the nurse-
parent partnership was effective and provided reassurance, this was an inconsistent 
feature.  This may be a consequence of the extent to which individual nurses consider or 
dismiss a parent’s perspective (Callery and Luker, 1996) or the positive or negative impact 
of communicating uncertainty on parental trust and confidence in the health care team 
(Latour 2011, Carnevale et al 2016). 
The rationale for relieving withdrawal signs matches the rationale for using sedation - to 
minimise the child’s distress and suffering (Cunliffe et al 2004).  Behaviours synonymous 
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with distress are also known to be a major stressor for family members of adult patients, 
not just parents of children in PICU. In the case of delirium, family members are more 
distressed about the delirium episodes experienced by their adult loved ones, than the 
patients themselves (Breitbart et al 2002).  From the parents’ perspective, the alteration 
in the parental role (de Weerd 2015, Board and Ryan-Wenger 2000, Siederman et al 
1997, Franck 2004, Carter et al 1985) also causes distress. These stressors may be 
exacerbated when parents are unable to hold or comfort their child in response to their 
physical distress (de Weerd 2015, Ames et al 2011), or do not know how to help their 
child (Siederman et al 1997).   
 
9.8.2 Parents’ recall of behaviours 
Parents’ insights and perceptions into the behavioural signs of withdrawal provide an 
opportunity to reflect on the behaviour content of the SWS tool. Parents recalled a range 
of behaviours, including all signs contained in the SWS as well as some that are not 
currently scored for. These additional signs included motor disturbance, which features in 
both the SOS (Ista et al 2009) and WAT-1 (Franck et al 2008), hallucinations, which 
features in SOS (Ista et al 2009) alone and one sign, communication disturbances, which 
does not appear in any of the three tools.  The challenge in identifying hallucinations, 
which is a patient-reported symptom, rather than a sign, relies on interpretation of 
behaviour in a non-verbal patient, which may be based on the assumption that 
uncoordinated movements are in response to a visual hallucination, rather than simply 
being motor disturbance.  Only one patient in this study was old enough (aged 3 years) to 
subsequently describe hallucinatory symptoms.  Concurrent self-report is the only 
reliable way to confirm presence of hallucinations prospectively during a withdrawal 
assessment, because symptoms are experienced by the individual. This study does not 
provide any evidence that the parents’ perspective offers any benefit over that of the 
staff.  
Parents used a range of words, in addition to ‘irritability’, to describe an agitated state. 
These terms included ‘restlessness’, ‘agitated’, ‘jittery’, ‘shaky’ and ‘scratching and 
itching’, sometimes distinguishing between them, by identifying more than one of these 
behaviours in their child. The subjective nature of these terms may complicate the 
assessment, which the SOS tool (Ista et al 2009) has simplified by using the global term of 
‘agitation’ to cover the behaviours ‘irritable, restless, agitated, fidgety.’  Using an 
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umbrella term that incorporates a range of similar, overlapping and subjective behaviours 
might enhance interpretability, but only if all terms reflect the same underlying factor of 
withdrawal (Streiner and Norman 2003). 
Communication disturbances, recognised by more than half of parents, do not feature in 
any of the published withdrawal tools but were described in original case reports 
describing withdrawal syndrome (Hughes and Choonara 1998, Lane et al 1991, Miser et al 
1986). The absence of this sign may reflect the way in which these tools were developed, 
based either on the Neonatal Abstinence Score (Finnegan et al 1975) where recognition 
of the caregiver is a redundant behaviour, or on the opinion of an expert panel of 
clinicians, who may overlook this behaviour compared with parents.   
 
9.8.3 Construct validity and the meaning of behavioural signs  
Scoring tools must limit their item content otherwise the resulting tool would model 
many clinical conditions and result in low specificity for withdrawal.  However, the 
findings of this study suggest that recognition of communication disturbance, and the 
consequent loss to the patient of reassurance from parental presence, may be important 
behavioural indicators of withdrawal that the parent can uniquely contribute to a clinical 
assessment of withdrawal syndrome. 
Another possibility for the presence of communication disturbances is that parents have 
detected signs of pediatric delirium (PD), which is not currently assessed for in the study 
hospital.  The most common signs of PD in children under 3 years of age are impaired 
attention, sleep disturbance, irritability and agitation (Turkel et al 2013).  Delirium may 
result from infection, drugs and toxins, metabolic dysfunction, malignancy or other 
serious illness (Turkel and Hanft 2014).  Recognition of inattention in a preverbal child is 
complicated in a person not known to the child, such as a nurse, who would not expect to 
be acknowledged. A parent would be much better placed to recognise this sign than 
nurses. 
 
9.8.4 Parents’ participation in care 
There may be an assumption that parents in PICU are too overwhelmed to participate in 
their child’s care (Campbell-Yeo et al 2008), yet this study demonstrates that, in addition 
to being willing participants, they offer a unique perspective to complement the clinical 
assessment of withdrawal. Although parental participation in care is widely advocated, 
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parents’ role is often described in terms of resuming their usual parenting role (Ames et 
al 2011, Latour et al 2005, Siederman et al 1997). This study suggests that parents may 
enhance the clinical assessment of withdrawal due to their privileged knowledge of their 
child’s typical behaviour and their constant presence at the bedside, as also seen in other 
situations such as pain assessment (Carter et al 2002, Hunt et al 2004). 
Where parental influence on withdrawal assessment and management was evident, this 
appeared to be in the direction of lower SWS scores, compared to nurses, and 
concomitant parental inclination to continue with sedative tapering.    The Shared 
Decision-making Continuum (Koh 2010) describes five points between 100% patient 
responsibility for decisions and 100% physician responsibility for decisions, in the adult 
patient – physician relationship.  Adapted for the PICU setting, these five points would 
equate to 100% parent-driven, nurse recommendation (predominantly parent decision), 
equal partners, informed non-dissent (predominantly nurse-decision) and 100% clinician-
driven.  These levels of shared decision-making were evident in this study although 
decisions were predominantly nurse-driven.  If partnership in decision-making is 
beneficial, strategies to increase partnership should be considered.  If parent-driven 
decisions prevent the unnecessary slowing of sedative weaning regimes, this is a 
demonstrable benefit of parental participation; similar to the benefits demonstrated by 
parent-driven decisions about the use of antibiotics for otitis media in primary care 
(Merenstein et al 2005) and  family activation of a medical emergency team in tertiary 
care (Brady et al 2015).  
Being present, participating in care and being kept informed of their child’s condition 
have been shown to help parents to cope with the stress of PICU (Carnevale et al 2016, 
October 2014, Ames et al 2011, Shudy et al 2006, Siederman et al 1997).  Evidence about 
what parental participation means in practice ranges from a passive role (Glasper et al 
2015, Franck and Callery 2004, Simons et al 2001) through aspects of their usual 
caregiving role, such as washing, changing nappies and comforting the child (Latour et el 
2005, Siederman et al 1997) to participation in clinical assessments (Carter et al 2002) 
and decision-making (Lipstein et al 2012).   
9.8.5 Reciprocity in sedation withdrawal assessment 
It was striking how alone and/or vulnerable parents seemed with their concerns at times.   
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Vulnerability describes “experiences of being unprotected and open to damage from 
threatening environments (Stevens et al 1992, p758).” Unmet communication needs for 
these participants led to parents being unprotected from the threat posed by their child’s 
distress. The unfamiliar behaviours, with their unknown meaning were also threatening 
due to their possible impact on recovery or an implication of brain damage. 
The parents’ described their unmet needs to understand the meaning of their child’s 
behaviours and their occasional unsolicited participation in decisions about weaning.   
These findings contrast with the nurses reports in Study 4 of the challenges they faced 
when interpreting equivocal behaviours and deciding when to alter weaning regimes in 
response to the child’s state.  Both parties had unmet information needs, which could be 
fulfilled through dialogue with the other party.  This exchange of information, being 
mutually beneficial to both parent and nurse, and moreover to the patient, describes 
“reciprocity.”  A reciprocal relationship between nurses and parents focussed on 
withdrawal syndrome has been diagrammatised (Figure 9.2).   
 
  Figure 9.2 Benefits of reciprocity (nurse-parent collaboration) in withdrawal syndrome. 
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A reciprocal relationship may promote partnership and parental participation, enabling 
the parent to contribute their unique knowledge of the child in the identification of 
behavioural signs and the nurse to reciprocate with reassurance, explanation and 
information about the behaviours.  A reciprocal relationship regarding decisions about 
weaning of sedation may speed the duration of weaning if nursing caution about the 
meaning of behaviours is balanced by parental assurance that current behaviours 
represent an improving trend or are normal behaviours. 
Partnership may not suit all parents and parents’ preferences for participation in care 
may vary during the course of their child’s PICU admission depending on both personal 
and situational factors.  In keeping with the mutual benefits of reciprocity, it is therefore 
vitally important that nurses establish and review the level of participation that meets the 
expectations of parents (October 2014).  The Shared Decision Making Continuum (Kon 
2010) could be adapted to encompass any level of reciprocity and demonstrate different 
levels of participation according to parent preference.  
 
9.9 Strengths and limitations 
There are a number of limitations in this study to acknowledge. The questionnaire listing 
the SWS signs may have biased parents to ‘recognise’ these behaviours at interview.  
There is also a risk of bias as parents self-selected for interviews, which may have 
resulted in parents who were more distressed with withdrawal and other aspects of the 
PICU experience, agreeing to take part.  
However, a strength of this study is that interviews were undertaken as soon as weaning 
was completed, to minimise the parents’ recall bias. 
 
9.10 Conclusion 
Study 6 has shown that withdrawal signs are a source of distress for parents due to 
uncertainty about the meaning of the signs and their impact on both their child’s 
immediate and long term recovery.  Parental awareness of the performance of 
withdrawal assessments was not consistent; despite this parents recalled a range of 
withdrawal behaviours, which was broader than represented in the SWS assessment tool.  
Parental participation in withdrawal assessments was viewed as a positive potential role 
by most parents.  Parents described how being present, participating in care and being 
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kept informed of their child’s condition helped them cope with the stress of their child’s 
critical illness.  Enabling parental participation in withdrawal assessments may encourage 
these aspects of care.  A collaborative relationship between nurses and parents with a 
two-way flow of information may be beneficial to both parties; providing a timely flow of 
information and reassurance to parents, aiding nurses understanding of the child’s 
behaviours and increasing confidence to continue weaning sedation. 
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Conclusions to Part 4: Integration of findings from Studies 5 and 6 with 
Parts 1, 2 and 3. 
Studies 5 and 6 showed that parents recalled a broader range of withdrawal signs than is 
reflected in the item content of the SWS tool.  Having sought the parent perspective with 
the aim of improving withdrawal assessment, instead this insight has cast doubt on the 
validity of the existing approach.  The impact of this finding will be integrated into the 
discourse regarding withdrawal assessment and decision-making, which was begun in the 
conclusions to Part 3.  This discourse will consider the ways in which the findings of 
Studies 5 and 6 illuminate the existing approach to withdrawal and how integrating a 
potential role for parents might expand on the propositional model of withdrawal 
assessment and decision-making.  
The existing approach to withdrawal assessment 
The range of behaviours recalled by parents was broader than the item content of the 
SWS tool, which guides the existing assessment of withdrawal.  In a similar way to how 
the focus of effort on deconstructing and interpreting equivocal behaviours effectively 
blinds the nurse to other aspects of the assessment, so limiting the “noticing” stage of 
decision-making to behaviours listed in the SWS tool, also effectively blinds the nurse to 
other behavioural changes.   
In Study 6 parents demonstrated that they intuitively recognised behaviour changes in 
their critically ill child, typically without either the SWS tool as a prompt or the contextual 
awareness to understand the meaning of behaviours. The ability to recognise these 
behaviour changes in the absence of a prompt or contextual understanding supports the 
idea that the “noticing” stage naturally aligns with System 1 intuitive thinking of pattern 
recognition (Kahneman 2011).  Parents recognised changes because they know their child 
and are usually a consistent presence at their critically ill child’s bedside, so notice 
behavioural trends.  These findings support a collaborative role for parents in the 
withdrawal assessment, of noticing behaviour changes.   
Integrating a potential role for parents into the propositional model 
If the ‘noticing’ stage in the withdrawal assessment is a role that might be performed by 
parents (Figure Part 4.3), the nurses’ role and expertise can focus on the other two 
decision-making stages;  
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 ‘interpreting’ the meaning of the behaviour change in light of the likelihood of 
physical dependence and the temporal relationship with reductions in sedative 
drugs, and  
 ‘responding’ with decisions regarding weaning or the need for medical review. 
 
Figure Part 4.3 Propostional model integrating a role for parents in the decision-making 
stages performed during a withdrawal assessment. 
A different approach, which is less prescriptive in terms of identifying specific behaviours 
and focuses on changes in behaviour may represent a more individualised approach to 
withdrawal assessment. An approach focussing on the child may be more empowering 
for parents, as it emphasises the parents’ role in being most able to recognise their child’s 
behavioural trends.  The parents’ contribution to the assessment would support the 
nurses’ interpretation of the likelihood of physical dependence and underpin changes to 
the weaning regime.  
Parents described behaviours indicative of inattention, which is a clinical features of PD. 
This finding reflects the clinical context within which the withdrawal assessment takes 
place; a context which is missing from the propositional model.  It is not known whether 
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the children who were inattentive were also delirious or to what extent the features of 
withdrawal and delirium overlap.  Parents did however highlight the interaction between 
features of withdrawal and their child’s critical illness. The impact of the critical illness 
and other coexisting conditions on withdrawal assessment will be discussed in the next 
chapter. 
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Part 5  Towards a theory of withdrawal in critically ill children  
 
Introduction 
The aim of the studies in this thesis was to improve the assessment of withdrawal by 
including the parent perspective; the studies focussed on operational aspects of 
withdrawal.  The lack of a theoretical basis supporting the existing operationalisations of 
withdrawal became apparent during the literature review and studies 1-6 when seeking 
to compare results to previously developed theories or propositions. As a consequence, a 
propositional model and withdrawal causality assessment tool were developed from the 
research literature, against which to consider and evaluate the study findings.   
This concluding part of the thesis will identify gaps in the existing evidence base and then 
integrate and synthesise the findings of studies 1-6 in an attempt to fill these gaps. Part 5 
of the thesis consists of three chapters.   
In Chapter 10, the adapted ADR Causality Assessment Tool is renamed the Withdrawal 
Causality Assessment Tool (W-CAT).  The clinical utility of W-CAT is evaluated using case 
studies from Study 5 as test cases.  An in depth consideration of the substruction of 
physical dependence in each case will seek to illuminate the relationship between the 
features of physical dependence and withdrawal. 
In Chapter 11 a synthesis of the findings from Studies 1-6 in relation to signs of 
withdrawal will be undertaken and the epistemic assumptions that link these behavioural 
variables with withdrawal will be considered. 
In Chapter 12, the conclusions, original contributions to knowledge and implications for 
practice and policy are presented. 
 
Figure Part 5.1 The thesis map showing Part 5 highlighted. 
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Background 
Theoretical substruction will provide a framework for the integration and synthesis 
chapters and identify the contributions of these studies towards a theory of withdrawal 
syndrome in critically ill children.  Theoretical substruction is a process that demonstrates 
the hierarchical relationship between the constituent constructs, concepts, variables and 
indicators of a theory (Franck and Callery 2004, Hinshaw, 1979).  This framework was 
selected due to the lack of an explicit theoretical basis for withdrawal in critically ill 
children.  Theoretical substruction also demonstrates the link between the theoretical 
and operational components of a construct (Trego 2009) and the structure of the 
substruction model can then be used to identify gaps in the evidence base (Dulock and 
Holzemer 1991).   
Theoretical substruction of physical dependence and withdrawal syndrome 
The hierarchical relationship between the constructs, concepts, variables and indicators 
of physical dependence and withdrawal are shown in Figure Part 5.2. Table Part 5.1 
provides definitions for the terms used in Figure Part 5.2.  The relationship between 
physical dependence, withdrawal syndrome and signs of withdrawal in critically ill 
children was first described in case reports more than thirty years ago (Miser et al 1986).  
Three withdrawal assessment tools have since been published, which operationalise this 
theoretical relationship (Cunliffe et al 2004, Franck et al 2008, Ista et al 2013). 
However, these tools, as empirical indicators were constructed and tested based on the 
statistical association between variables, rather than by examining the theoretical 
association between variables and the empirical indicator as shown in Figure Part 5.2. 
The consequence of a statistical, rather than theoretical basis for the operationalisation 
of withdrawal is manifest by the differences between the assessment tools.  From an 
item pool of 22 withdrawal signs, the three withdrawal assessment tools share only six 
items in common. Study 6 (Chapter 9) highlighted behaviours recalled by parents that 
were over and above this item pool.  The statistical basis for the withdrawal tools also did 
not account for the heterogeneous presentation of withdrawal or the equivocal nature of 
some of the behaviours which are very common in critically ill children, who are not 
withdrawing (Franck et al 2004, Ista et al 2008).  
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Figure Part 5.2 Theoretical substruction of physical dependence and withdrawal 
 
 
Table Part 5.1 Definitions of theoretical substruction terms (Franck and Callery 2004, 
Bekhet and Zauszniewski 2008, Dulock and Holzemer 1991) 
Construct is a highly abstract notion that can be partially defined 
Concept is a word that expresses a mental image of some phenomenon 
Variables are dimensions of the phenomenon 
Empirical indicators are instruments or other observable evidence of the phenomena of 
interest 
Postulate is a relational statement between construct and concept 
Epistemic assumption is the assumption made to link the concept with the variable.  
Transformational statement is the relationship between variables and empirical 
indicators which are logically derived. 
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Identifying the gaps 
The element of the theoretical substructions; “construct”, “concept” and “variable” were 
mapped onto the propositional model introduced in Chapter 2, to examine the 
theoretical basis for withdrawal (Figure Part 5.3). 
The theoretical aspects of substruction include the identification of the construct, 
concept and variables and a description of the relationships between them, according to 
the theory (Hinshaw 1979).  The construct of physical dependence and the concept of 
withdrawal syndrome in critically ill children are not well defined. The theoretical 
relationship between physical dependence and withdrawal (the postulate) and between 
withdrawal and the signs of withdrawal (the epistemic assumption) are also poorly 
defined.  The synthesis studies in Chapters 10 and 11 will seek to fill these gaps by 
introducing a new definition for withdrawal syndrome in critically ill children; “Paediatric 
Withdrawal Syndrome” and describing the epistemic assumptions and transformational 
statements that link the construct, concept and variables. 
 
Figure Part 5.3 Mapping of theoretical substruction terms onto the propositional 
model. 
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Chapter 10: Case studies as test cases 
 
10.1 Introduction 
A different approach to withdrawal assessment was devised during Study 1 as a reference 
standard with which to evaluate the SWS tool and to retrospectively assign the likelihood 
of withdrawal in an objective manner. The tool was adapted from an ADR causality 
assessment tool (WHO-UMC) and contained criteria which were similar to the DSM-5 
substance withdrawal diagnostic criteria (DSM, 2013).  This adapted tool was also used in 
Studies 5 and 6 in order to ascertain the likelihood that withdrawal rather than another 
cause was driving the behaviours recalled by parents.  This tool differs from existing 
withdrawal assessment tools by considering contextual features of withdrawal, including 
the likelihood of physical dependence and a temporal relationship between the onset of 
signs of withdrawal and reductions of sedative drugs, rather than just the child’s 
behavioural presentation.  Another feature was the assigning of probability of withdrawal 
rather than the dichotomous yes/no of WAT-1 (Franck et al 2008) and SOS (Ista et al 
2013).  This tool will be called the Withdrawal Causality Assessment Tool (W-CAT). 
Table 10.1 The Withdrawal-Causality Assessment Tool (W-CAT) based on WHO–UMC 
causality assessment criteria (https://www.who-umc.org/media/2768/standardised-
case-causality-assessment.pdf) 
Withdrawal 
likelihood 
Physical dependence 
possible 
Temporal relationship 
with change in dose 
Absence of 
differential diagnoses 
Probable Yes Yes Yes 
Possible Yes Yes No 
Unlikely No No No 
 
 
10.2 Purpose of the chapter 
The purpose of this chapter is; 
1. To consider the utility of the Withdrawal Causality Assessment Tool (W-CAT) 
retrospectively in five case studies, and  
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2. An in depth consideration of the substruction of physical dependence in each case 
to illuminate the characteristics of, and the theoretical relationship between, 
physical dependence and withdrawal. 
 
10.3 Method 
Three types of instrumental case studies were developed for the purpose of analytic 
generalisation, which is a measure of generalisability or transferability of findings (Yin 
2003).  Rather than drawing inferences from data to a population, as in statistical 
generalisation, analytic generalisation generalises to a previously developed theory or 
theoretical proposition.  The theoretical proposition is the use of the W-CAT to assign 
clinically meaningful levels of withdrawal probability.  
Five individual cases are presented from Study 6 to demonstrate the different levels of 
withdrawal probability; three cases of probable withdrawal which highlight the impact of 
patient and contextual factors and one case each of possible withdrawal and withdrawal 
unlikely.  These five cases challenge the clinical utility of the existing, dichotomous 
approach and provide evidence for analytic generalisation of the W-CAT approach to 
withdrawal assessment (Yin 2010).  Each case is presented as a test case to “confirm, 
challenge, or extend the theory” (Yin 2003, p40). 
Yin (2010) emphasises the following points to increase the analytic generalisation of the 
cases presented, which have been adhered to in this chapter; 
 The theory should be presented at the beginning of the case study, which is the utility 
of W-CAT as an empirical indicator of withdrawal, 
 The theory should be grounded in research literature. W-CAT is adapted from an 
existing ADR causality assessment tool, 
 Findings should show how the results of the case study either support or challenge 
the theory,  
 Examining rival hypotheses will strengthen claims of analytical generalisation, and 
 Generalisability increases if similar results are found with other case studies 
 
10.3.1 Subject 
Five cases were selected from Study 6 to test the clinical utility of W-CAT; these cases 
were selected to reflect the complexity and variety of cases in clinical practice.  These 
cases included the one ‘withdrawal unlikely’ case, the one ‘withdrawal probable’ case and 
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three ‘withdrawal possible’ cases. The subject of each study is the clinical case in the 72 
hours both leading up to and following the highest SWS score.  The object of the study is 
the W-CAT, which provides the theoretical frame through which each case is viewed and 
explicated (Thomas and Myers, 2015).  
Each subject will be presented as an integration of data and findings from Study 5, 
presented consecutively. After a brief introduction of the case, the following subheadings 
will organise the presentation and discussion of the data; 
Sedative drug therapy 72 hours before and after the highest SWS score, presented 
and discussed in terms of interpreting the likelihood of withdrawal and/ or other causes, 
or rival hypotheses  
Highest SWS score, presented as table showing component scores and as a graph 
showing the trend of scores in the 72 hours leading up to and following the highest score 
Probability of withdrawal according to the W-CAT criteria 
Identifying a causative agent by considering the drug therapy, weaning rates and any 
changes in drug therapy in response to the highest SWS score and interpreting the 
meaning for the likelihood of withdrawal. 
Parent perspective presents an excerpt from the transcripts of the interview where this 
contributes further insight. 
Withdrawal signs from nurse documentation and parent interviews, presented as pie 
chart (Nurse documentation) and a table (parent-reported signs) 
Discussion of the utility of W-CAT as an empirical indicator of withdrawal. 
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10.4 Case study 1 (Withdrawal probable) 
A 3 year old girl underwent cardiac surgery (ASD repair) and spent the following 31 days 
on PICU. During this time she returned to theatre twice, had a cardiac arrest and spent 8 
days on ECMO.   
10.4.1 Sedative drug therapy 
The patient was sedated with fentanyl and midazolam throughout her PICU stay.  Peak 
doses were fentanyl 4.6 micrograms/kg/hr and midazolam 288 micrograms/kg/hr prior to 
slow weaning of both infusions (10 % wean per day) commencing on day 12.  
Promethazine (1mg/kg every 6 hours) was commenced to facilitate weaning of fentanyl 
and midazolam.  A ketamine infusion was also commenced to facilitate the weaning of 
fentanyl and midazolam on day 17: starting at 15 micrograms/kg/minute and increasing 
to 30 micrograms/kg/min within 24 hours. Promethazine was stopped and 
chlorpromazine (0.5 mg/kg every 6 hours) commenced on day 22 due to high SWS scores. 
The patient was extubated on PICU day 27.  
Perception and interpretation 
This patient required high doses of sedatives for a prolonged period and weaning was 
very slow despite the addition of other high dose sedatives. This picture describes a “hard 
to sedate” patient; the causes of which may not be recognised or identified during the 
critical illness but could include their underlying condition, an ADR or pediatric delirium. 
10.4.2 Highest SWS score 
The highest withdrawal score, SWS 9, occurred on PICU day 30, three days after 
extubation (Table 10.2). SWS scores had increased six hours prior to the highest score 
from a modal score of SWS 3 to SWS 6.  The nursing documentation described the patient 
as agitated, very unsettled, withdrawing severely, large pupils, tremors, constantly rolling 
in the bed and severe twitching.   
Scores remained at a modal score of SWS 6 for a further 57 hours prior to declining.   
 
Interpretation 
Schieveld et al (2010) described pediatric delirium (PD) as “refractory agitation.” This 
child was diagnoses with “severe withdrawal” as pediatric delirium was not assessed in 
this PICU, so was not a diagnostic option.  
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Table 10.2 Highest SWS score components (Case study 1, SWS score 9) 
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10.4.3 Probability of withdrawal  
Likelihood of withdrawal was probable at the time of the highest score (Table 10.3) in the 
absence of PD as a possible differential diagnosis. 
Table 10.3 Likelihood of withdrawal (Case study 1) 
Criterion Case 1 
Physical dependence possible Fentanyl and midazolam for > 5 days 
Temporal relationship with change in dose Fentanyl and midazolam weaning by less 
than 10% per day 
Absence of differential diagnosis Yes 
 
10.4.4 Identifying a causative agent 
10.4.4.1 Drug therapy and weaning rates 
The patient was sedated with four sedative agents at the time of the highest score; 
fentanyl, midazolam, chlorpromazine and ketamine.  Chlorpromazine continued at the 
the same dose of 0.5 mg/kg every 6 hours throughout this period.  Three drugs had been 
reduced in the 72 hours prior to the highest score so were possible causes of withdrawal.   
Fentanyl  
Weaning of the fentanyl infusion had recommenced five days prior to the highest SWS 
score, after no changes for the preceding 4 days (in response to an SWS score 5). The 
weaning rate was 0.05 micrograms/kg/hr every 12 hours.  
Midazolam 
The midazolam infusion had been reducing fairly consistently by 0.05 micrograms/kg/hr 
every 12 hours for the 10 days preceding the highest score.  Reductions had paused for 
48 hours a week prior to the highest score (at the same time as fentanyl reductions had 
paused) and had been increased for 24 hours, 1-2 days prior to the highest score.   
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Ketamine 
Ketamine reductions had been commenced 60 hours prior to the highest score, were 
recorded as not tolerated (although the SWS score was 3 at each assessment that day) 
and were increased back to the original rate of 30 micrograms/kg/minute.   
10.4.4.2 Changes in drug therapy in response to the highest SWS score 
In response to the SWS score, fentanyl was increased from 1.4 to 2 micrograms/kg/hr, an 
increase equivalent to 3 days’ worth of reductions. The midazolam infusion was increased 
from 54 to 60 micrograms/kg/hr, equivalent to one 12-hourly reduction, a modest 
reduction considering the dose 72 hours previously had been 102 micrograms/kg/hr.  The 
difference in the extent of these dose increases suggests that fentanyl withdrawal was 
blamed for the cause of the withdrawal score. Figure 10.1 shows changes in fentanyl and 
midazolam rates in relation to the SWS scores.   
During the 24 hours following the high score, the ketamine infusion (30 microg/kg/min) 
was stopped (hence no temporal relationship with highest SWS score) and choral hydrate 
25 mg/kg every 3-6 hours as required was commenced.  Fentanyl and midazolam 
continued unchanged for the following 72 hours.   
 
 
Figure 10.1 Sedative drug weaning and SWS scores (Case study 1) 
 
Interpretation 
As SWS scores remained high and the increase in fentanyl failed to relieve the SWS signs, 
fentanyl withdrawal was unlikely to be driving the SWS score. This implicates either 
midazolam as the likely cause of withdrawal or another cause, such as PD.   
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10.4.5 Parent perspective 
This excerpt, taken from the interview transcripts in Study 6 gives the mother’s 
perspective on which drugs caused issues for her daughter during the weaning of 
sedation: 
“Then they decided to change her over to the Ketamine which it did seem to 
make quite a big difference if I’m honest because she was more comfortable 
with that and rather than the absolute jumping about she was just more 
shaky which we found a bit easier to deal with. I think although the 
Ketamine wasn’t a sedative we did see a difference once that came off.  I 
think that was the right decision because she wasn’t handling coming off the 
sedation at all while she was still on Ketamine because there was vomiting 
and diarrhoea as well.  We found that the worst withdrawal we’ve seen was 
coming off Ketamine and then it’s been a nice smooth process coming from 
the Fentanyl and the Midazolam since that’s come away.  So that’s been a 
big difference for us and I do think that the Chlorpromazine has made things 
a little bit more comfortable for her as well, because we did find that when 
she became distressed and they’ve administered that she was fine within a 
few minutes and stuff so that has made a difference.” (P1M) 
Prior to ketamine stopping, SWS scores had increased and the highest SWS score had 
occurred, so there was no temporal relationship with the change in ketamine dose and 
the highest SWS score.  Ketamine is not considered to cause physical dependence, 
although this patient had been on a continuous high dose infusion of ketamine for 13 
days.  The mother’s report suggests another possible cause, as when ketamine was 
started, there was an improvement in comfort and a reduction in jumpiness. It may be 
these behaviours re-emerged in response to a diminishing therapeutic response as 
ketamine was reduced, rather than due to a withdrawal response. The therapeutic 
response to chlorpromazine also implies an undiagnosed and underlying contributing 
cause for distress, as this treatment would be unlikely to improve signs of fentanyl or 
midazolam withdrawal, in the manner that the child’s mother describes.  
Interpretation 
Although midazolam withdrawal is probable, a coexisting undiagnosed cause for 
behavioural signs is also possible.  In the absence of delirium or ADR assessment tools, 
this interpretation is based on the mother’s retrospective description of behaviours. 
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10.4.6 Withdrawal signs 
10.4.6.1 Nurse documentation 
All SWS scores over the timeframe were collated and the contribution of component 
signs was presented in a pie chart (Figure 10.2). This shows that two signs; irritability and 
tremor contributed over half of the SWS score during this time frame. 
 
Figure 10.2 Contribution of component SWS signs (Case study 1) 
10.4.6.2 Parent interviews 
The two dominant SWS behaviours from the nurses’ withdrawal assessments 
encompassed seven distinct behaviours recalled by the patient’s mother (Table 10.4). The 
SWS item “tremor” was matched to “jittery”, “jumping”, “shaking” and “floating hands.” 
The mother’s description of “tremor” referred to parkinsonism-type movement disorder.  
The SWS item “irritability” was matched to “distressed.” The mother’s description of 
“irritability” described severe tantrum-like behaviour. 
These behaviours, along with hallucinations and inattention (“not recognising me”), 
describe features of other differential diagnoses, including PD and ADRs; (extrapyramidal 
side effects from chlorpromazine, hallucinations from ketamine). 
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Table 10.4 Parent report of behaviours during weaning (Case study 1) 
Jittery “Her legs were sort of lifting up and her hands were like shaky.  When 
you picked her hand up she was really like ‘tremory’.” 
Jumping “Like when you jump in your sleep but it was more sort of violent. 
When you just see someone jump in their sleep it’s just a little like 
‘bounce’, she just seemed to lift up that little bit more.  It frightened us 
because it was such a sudden movement.  It was like –  I think I was 
more distressed, even though I knew she was sedated, [thinking] what’s 
happening to her?  Is she ok? Is she experiencing anything that’s 
upsetting her or can she feel any pain?   She just seemed to jump, but 
obviously there was no sound.”    
Distressed “When she had periods of being a little bit more lucid with her eyes 
open, although we couldn’t hear what she was saying I can lip read 
because I’m deaf and she was just repeating over and over again – “I 
want my mummy, I want my mummy, I want my mummy”.   That upset 
us because I couldn’t do anything to help her, because I couldn’t pick 
her up and things like that.  You could clearly see sometimes you would 
be talking to her, and I don’t know whether it was just because of her 
eyes being like closed for so long, but to us when she started having a 
tear down her face that upset us to think - is she crying because is she 
aware what’s going on?  It might just be her eyes were aching but it just 
seemed like an emotional reach for some comfort and stuff.  We felt so 
helpless with her.” 
Shaking “If you tried to pick her up and move her up the bed, her body, it was 
just that little bit shaky.  Her hands it was like, if you put a cup or 
something in her hand you just knew she wouldn’t be able to hold it.” 
Hallucinating “Her eyes frightened me sometimes because it was like she was looking 
at something that we can’t see and she was screaming.”   
“She’s been telling us that she was swimming with mermaids and that 
me and daddy weren’t there, and she’s been dropped in the water with 
no arm-bands and she couldn’t float.”  
“I had red hair when I came in and I did find that when (name of child) 
was first coming off it I couldn’t go near her.  I changed my hair colour 
and she’s been absolutely fine so I’m wondering whether it’s been 
‘clowns’ or something like that because it’s been so red.  But she was 
screaming quite a lot when I was coming near her as well and she 
wouldn’t entertain me.  She was fine with dad, I’m just assuming it’s 
because he’s always had the same colour and his face looked more 
familiar.” 
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Irritability “Tantrums, screaming, she’s been a bit violent towards me.  She won’t 
entertain you when you try to reason with her, things like that.  I know 
a normal three-year old has tantrums, but these are literally screaming 
and throwing herself about the bed.  She’s tried to pull her lines out.  
She tried to wrench the sides off the bed.  Her heart rate would shoot 
up and we just didn’t want her to make herself [ill].” 
Tremor “Like someone with Parkinson’s at first because her hands were really 
shaking.  She was struggling to hold things in her hands.” 
Floating 
hands 
“We called it the floating hand, because she’d just bring her arm up. I 
used to say to her – “Are you doing the backstroke?”  She’d be on her 
back and just bring this arm up.  It was almost like a twitch of the head, 
but it was like when you start to bring your shoulder up and twitch your 
head.  She does still do that from time to time, but we make a joke of it 
and she just laughs so it’s not a major thing.” 
Not 
recognising 
me 
“You’d speak to her and she’d just look right through you.  It was like 
there was nothing there and she just looked like horrible, terrible, like 
the eyes were out, there was like no light there, no sparkle, and that 
upset me more because– am I going to get the same child back?  Those 
first few days were really worrying.” 
 
 
10.4.7 Discussion 
This patient demonstrates the complexities of a withdrawal assessment, which relies on a 
fixed number of equivocal behaviours and assumes, rather than encourages the exclusion 
of other possible causes of these behaviours.  The W-CAT provides this structure. 
Assessing the causal indicators for physical dependence encourages a consideration of 
previous drug therapy and endorses the option of withdrawal as a possible diagnosis.  
The temporal relationship between behaviour change and the change in drug dose 
supports a rational consideration of the conditions. In this case the failure in a recent trial 
of reducing ketamine may have biased subsequent judgement despite the absence of a 
temporal relationship. 
The absence of a differential diagnosis may not be an accurate reflection of the case, but 
reflects the diagnostic options available to clinical staff at the time.  The similarities in 
presentation between withdrawal, pediatric delirium and adverse drug reactions (ADRs) 
has recently been highlighted (Madden et al 2017).  Whether in this case, behaviours 
were driven by withdrawal, delirium or ADRs cannot be determined retrospectively.  The 
W-CAT category “absence of differential diagnoses” does not reflect the possibility of the 
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co-existence of withdrawal and other causes; the context of critical illness may mean it is 
not possible to exclude other causes.  Rather than assigning probable or possible 
withdrawal according to the absence or otherwise of other causes, differentiating the 
main driver for the behaviours, rather than excluding other causes, may better reflect the 
context of critical illness.  
Although the existing (SWS) approach to withdrawal assessment provided a structure for 
regular assessment of this patient and an opportunity to demonstrate trends in scores, 
the complexities of this case may have been better supported by the W-CAT criteria and a 
PD assessment tool.  
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10.5 Case study 2 (Withdrawal probable) 
A 5 month old boy (twin 1) was admitted to PICU with RSV positive bronchiolitis, 
rhinovirus and parainfluenza virus. He was born at 34 weeks gestation and this was his 
third episode of lower respiratory tract infection, due to mild tracheomalacia and 
moderate right bronchomalacia.  He was intubated for 5 days and spent 6 days on PICU.   
Two days later he required increasing ventilatory support, was transferred to HDU for 
CPAP and was diagnosed with Haemophilus influenza four days later. 
10.5.1 Sedative drug therapy 
The patient was sedated with morphine and midazolam whilst intubated on PICU.  Peak 
doses were morphine 40 micrograms/kg/hr and midazolam 116 micrograms/kg/hr in the 
first 24 hours prior to reducing to 20 micrograms/kg/hr and 75 micrograms/kg/hr 
respectively for the following 4 days.  Both infusions were stopped without weaning 
between 2 hours (morphine) and 7 hours (midazolam) prior to extubation on PICU day 5.  
Perception and interpretation 
After five days sedation, this patient had a 50% risk of being physically dependent. Peak 
doses were neither high nor administered for prolonged periods, so weaning was not 
indicated.  
 
10.5.2 Highest SWS score 
The highest withdrawal score, SWS 10, occurred on ward day 2, three days after 
extubation (Table 10.5). SWS scoring commenced 10 hours after extubation, were SWS 4-
7 for the first 48 hours, rising to SWS 7-10 the following day.   SWS scores gradually 
reduced to SWS 4 over the following 3 days, then remained SWS≤4 for the following 
week. (See Figure 10.3).  
Table 10.5 Highest SWS score components (Case study 2, SWS score 10) 
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10.5.3 Probability of withdrawal  
Likelihood of withdrawal was probable at the time of the highest score (Table 10.6). 
Table 10.6 Likelihood of withdrawal (Case study 2) 
Criterion Case study 2 
Physical dependence possible Morphine and midazolam for  5 days 
Temporal relationship with change in dose Stopped 72 hours previously 
Absence of differential diagnosis Yes 
 
10.5.4 Identifying a causative agent 
10.5.4.1 Drug therapy and weaning rates 
Morphine and midazolam were administered for 5 days and stopped without weaning 
within 6 hours of each other. Both drugs are possible causative agents. 
10.5.4.2 Changes in drug therapy in response to the highest SWS score 
Diazepam was commenced regularly on the day of the highest score having been 
administered “as required” since the previous day. Chloral hydrate was administered 
intermittently in the 48 hours prior to the highest score with brief effect. 
 
 
Figure 10.3 SWS scores  (Case study 2) 
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Interpretation 
As SWS scores remained high and starting diazepam failed to relieve the SWS signs, 
midazolam withdrawal was unlikely to be driving the SWS score. This implicates either 
morphine as the likely cause of withdrawal or another cause.   
10.5.5 Parent perspective 
This excerpt, taken from the interview transcripts in Study 6 gives the father’s perspective 
on issues for his son during the weaning of sedation: 
“My feeling was he wasn’t well enough yet to start the weaning process.  I 
think maybe he needed, I might have got this wrong, but I think we started 
getting him off the oxygen and the drugs at the same time and he couldn’t 
handle it.  I think maybe we needed to do one and then do the other or 
leave him in ICU a little bit longer or give him more support with the oxygen 
a little bit longer before.”(P5F) 
10.5.6 Withdrawal signs 
10.5.6.1 Nurse documentation 
All SWS scores over the timeframe were collated and the contribution of component 
signs was presented in a pie chart (Figure 10.3). This shows that two signs; irritability and 
respiratory distress contributed over half of the SWS score during this time frame. 
 
Figure 10.4 Contribution of component SWS signs (Case study 2) 
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10.5.6.2  Parent interviews 
The two dominant SWS behaviours from the nurses’ withdrawal assessments were also 
reported by the father and described as being linked.  A further behaviour that was 
described as “panic attack/agitated” was also linked to irritability (Table 10.7).  This 
parent also described his son “looking through him.” 
Table 10.7 Parent report of behaviours during weaning (Case study 2) 
Looking 
through you 
“Even when he was awake though he’s not properly awake for me, he’s 
not really there. For me he obviously wasn’t himself, he’s not there.  I 
mean if he’s looking at you he’s looking through you.  His eyes weren’t 
focusing, I don’t think it mattered if it was me or a nurse or a doctor I 
don’t think he was focusing on anybody or anything, he had his eyes 
open but looking through you as such.” 
“He had a strange thing where he did this thing where his eyes 
disappeared, he’s looking down and his pupils are like disappearing.”   
Panic attack / 
agitated 
“He was having a bit of a funny turn where he didn’t like being 
touched.  His eyes were kind of like flicking and his eyes were 
disappearing down, and it’s a very bizarre thing.  He’d be ok if you kind 
of left him alone I think but because he needed medication and 
treatment as soon as you did anything with him, change his bum, he 
starts getting, he starts like hyperventilating, he’s getting more and 
more agitated and his throat’s going and then I think he just winds 
himself up.”  
Irritability “He’s very irritable, he didn’t want to be touched which – I mean he’s a 
premature baby and I think you know he’s not been a big fan of being 
faffed about with anyway.  But in particular when he’s kind of like 
whimpering or whatever and you want to pick him up but every time 
we did that it made him worse so you leave him alone.  So he got very 
irritable with any kind of intervention at the height of it.  He’s got 
better as time’s gone on but he’s still a little bit moany!”   
Respiratory 
distress 
 
“Linked to the being irritable that’s the whole body going, the chest, his 
whole tummy and the chest going up and down. They were the ones 
(along with eyes) that were probably the most distressing because you 
can see there is something wrong with him.”   
 
10.5.7 Discussion 
This patient demonstrates the complexities of differentiating withdrawal from the child’s 
critical illness. In this case, the child deteriorated and required additional respiratory 
support. The gradual increase in behavioural distress occurred during the time 
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withdrawal would be expected, so the patient may have been withdrawing. The highest 
SWS score was temporally linked to the patient’s deterioration. The prevalence of 
respiratory distress and irritability in his withdrawal assessments point to his underlying 
condition driving both the scores and his behaviour.  The parent perspective was 
illuminating, identifying the additional burden that even mild withdrawal might have 
posed for his son. The parent also linked irritability with respiratory distress and agitation, 
which in combination, would indicate hypoxia and collapse rather than withdrawal.   
Similarly to the previous case, the W-CAT did not reflect the possibility of this co-
existence of withdrawal and other causes.  In this case, it appears that the underlying 
condition was the main driver for the behaviours, possibly exacerbated by the presence 
of withdrawal. 
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10.6 Case study 3 (Withdrawal probable) 
A 5 month old boy was admitted to PICU following cardiac surgery (hypoplastic aortic 
arch). He has William’s syndrome.  He was intubated for 4 days and spent 6 days on PICU.   
10.6.1 Sedative drug therapy 
The patient was sedated with fentanyl and midazolam whilst intubated on PICU.  Peak 
doses were fentanyl 3 micrograms/kg/hr and midazolam 170 micrograms/kg/hr. Fentanyl 
continued at this dose for 72 hours and was then weaned and stopped over 48 hours. 
Midazolam was reduced every 24 hours and stopped after 72 hours. The patient was 
extubated on the PICU day 4.  
Perception and interpretation 
After four days sedation, this patient had less than a 50% risk of being physically 
dependent. Peak doses of fentanyl were high however and administered for 72 hours.  
10.6.2 Highest SWS score 
The highest withdrawal score, SWS 8, occurred on the day of discharge from PICU, two 
days after extubation (Table 10.8).  SWS scoring was commenced when the patient was 
transferred to the ward.  SWS scores gradually reduced to SWS ≤3 over the following 2-3 
days (Figure 10.5).  
Table 10.8 Highest SWS score components (Case study 3, SWS score 8) 
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10.6.3 Probability of withdrawal  
Likelihood of withdrawal was probable at the time of the highest score (Table 10.9). 
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Table 10.9 Likelihood of withdrawal (Case study 3) 
Criterion Case study 3 
Physical dependence possible Fentanyl at high dose for 4 days. 
Temporal relationship with change in dose Stopped 48 hours previously 
Absence of differential diagnosis Yes 
 
 
 
Figure 10.5 SWS scores (case study 3) 
 
Interpretation 
Motivation for initiating a withdrawal assessment was possibly perception of behavioural 
signs indicative of withdrawal. 
 
10.6.4 Identifying a causative agent 
 
10.6.4.1 Drug therapy and weaning rates 
Fentanyl was the likely causative agent due to the high doses administered, despite less 
than 5 days therapy. 
10.6.4.2 Changes in drug therapy in response to the highest SWS score 
Clonidine 15 micrograms every 6 hours and chloral hydrate 120 mg every 3 hours were 
commenced after extubation but SWS scores did not cover this time frame. 
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10.6.5 Withdrawal signs 
10.6.5.1 Nurse documentation 
All SWS scores over the timeframe were collated and the contribution of component 
signs was presented in a pie chart (Figure 10.6). This shows that one sign; irritability 
contributed over one third of the SWS score during this time frame.  
10.6.5.1 Parent interviews 
The dominant SWS behaviour from the nurses’ withdrawal assessments was also 
reported by the parents. The severe breath-holding attacks described by the parents and 
the PICU nursing notes covered the time when SWS assessments were not undertaken.  
(Table 10.10).  Additional clinical details from nursing documentation are presented in 
Table 10.11. 
 
 
 
Figure 10.6 Contribution of component SWS signs (Case study 3) 
 
Table 10.10 Parent report of behaviours during weaning (Case study 3) 
Insomnia “I noticed it that last night in Intensive Care because he was just so, so 
tired you could see he was absolutely shattered, his eyes were rolling 
round his head and he just couldn’t sleep.  And every noise that went 
off, every sound - there was someone coughing over the way - would 
make him jump and it was just horrendous and I was starting to think – 
right there’s something not quite right.  But I’m thinking - oh no maybe 
he’s just coming round and he’s feeling more aware and that’s why he 
can’t sleep.  Then I think he was awake for about six to eight hours and 
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then finally, every time he closed his eyes you’d think he was starting to 
fall asleep and then he’d hear a noise and he would be jumping and 
waking back up again.  His eyes were red raw all along the bottom rim 
and he had one eye just had loads of bloodshot in it, it was horrible and 
he just looked wired, he looked strange, he didn’t look normal because 
he was all funny.  And I said it’s not normal for him to not sleep at all for 
his age from six o’clock in the morning we are coming onto four o’clock 
in the afternoon now.” 
Tongue had a 
mind of its 
own 
“But when he was having withdrawal, his tongue was wild.  Like his 
tongue had a mind of its own.  It was like he didn’t actually want to keep 
his tongue in his mouth.  For a baby who normally at home has his 
dummy 24/7 he couldn’t keep it in his mouth.  And I was saying – “Why 
can’t he keep his dummy on his tongue?”  At first we thought, he’s 
getting teeth at the bottom and we thought maybe it’s that because his 
tongue was just constantly out of his mouth. He was moving it so much.” 
“I was thinking he’s not going to be able to catch his sleep if he can’t 
suck properly because it was like he wanted a dummy and then he’d - 
wah, wah, wah - (Mother makes a sound to indicate baby not able to 
hold onto dummy) and then he’d be looking for it and then you’d put it 
in and then it would just be over and over again.” 
Irritability “And when I was trying to comfort him, to cuddle him in he was pushing 
me away, but it was like he didn’t know what he wanted because when I 
put him in the pram he didn’t want to be there.  Pick him up he didn’t 
want to be picked up so it was strange.”   
“There was just nothing you could do to settle him because you have 
many things you do, she picks him up and has him up on her chest but 
that wouldn’t work, he was just constantly moving about and he 
wouldn’t keep his dummy in. He was just constantly irritable for hours. 
Even after he started to sleep he was still irritable when he was awake.” 
Sweating “All his back, it was all his back and the back of his head and you could 
feel it on his forehead he had like little beads on his forehead. He 
doesn’t sweat like that normally.  It was really, really wet so I changed 
his babygro a few times.  And when I picked him up and put his face 
close to me his face was wet, it was cold and it was like a clammy 
sweat.”  
Sneezing and 
yawning 
“Every day he has some sort of sneezing fit and he yawns all the time.  
But they were saying they were signs of you know – because he’d had 
the operation then so I don’t know if they thought he was having a bit of 
withdrawal then but I was like “No, I really know that’s nothing to do 
with that, that’s just how he is.””   
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Breath holding “When he went through his rough period when we were letting the 
sedation wear off and try and let him come round.  Then he’d have 
these big paddies and every new nurse was having the full panic and 
like, you know, “Ring the bell and get the doctors.”  But we knew 
what he was doing and we know he would hold his breathe and he 
would make his heart rate drop to zero but he would eventually stop but 
obviously the nurses were coming in like “Oh my god this baby is blue. 
get someone!””   
“Yes and that was just his temper so the nurses instantly were bolus 
this, bolus this, because they like couldn’t handle that fact that he was 
getting so distressed which obviously none of us wanted him to do.” 
High pitch cry “It was a bit more prolonged and there was a slight difference to it. It 
had a different tone to it and it stayed at that tone instead of reaching a 
high and then a low, it stayed at that same level which was different.  So 
it wasn’t like he’d get upset and it would be a wail, wail, wail (wailing 
sound from Mother) and go down it sort of stayed, it was a weird cry.” 
Hypertonicity “When I was picking him up, when I was trying to comfort him I suppose 
he was in a sense doing it but it wasn’t just his hands and arms it was his 
whole body.  Like when I’m trying to do something with him he’d sort of 
do it with everything as if to say – you are not doing anything to me.  
And that was something he was doing when I was trying to either hold 
him, or put him back down, he was holding his body in a stiff way which 
was a bit more unusual because it wasn’t a behaviour that he does a 
lot.” 
 
10.6.7 Discussion 
This case study demonstrates the potential for withdrawal to be overlooked when the 
duration of drug treatment falls below the expected threshold for causing withdrawal.  
PICU did not perform withdrawal assessments. This may be because withdrawal was not 
expected or that the main cause of behavioural distress was severe breath-holding 
episodes, which do not appear in the SWS assessment, so may have been overlooked as a 
sign of withdrawal. 
Another key feature of this patient’s withdrawal was lip smacking, which the mother 
described as issues with her baby’s tongue. This caused parental distress due to the 
consequent impact on the baby’s ability to suckle on a dummy and settle to sleep. 
Physical dependence in this case occurred in less time than the threshold assigned during 
the adaptation of the ADR causality assessment tool. The W-CAT would need to reflect 
the possibility of physical dependence occurring in less than five days.
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Table 10.11 Additional clinical details from nursing documentation (Case study 3) 
PICU day 4 PICU day 5 PICU day 6/Ward day 1 Ward day 2 Ward day 3 Ward day 4 
Extremely agitated at times, 
wakes angry. Grumpy and 
agitated. Hypertensive systolic 
190 when upset and breath-
holding.  Esmolol started and 
increased post extubation. 
Normal when asleep, high 
even if awake and settled.  
Breath-holding, going purple, 
bradycardic 1st time to 80, 2nd 
time to 30 requiring bag and 
mask ventilation. CPR not 
required. 
Upset when urine bag 
removed, HR 80, desaturated 
to 60%, hand ventilated, but 
remained very unsettled. 
Fentanyl bolus no effect. MDZ 
bolus good effect. Nappy 
changed, bradycardic to 70, 
sucrose and fentanyl bolus to 
settle.  
Overnight. 
 3 episodes of 
desaturation to 40%, 
bradycardic to 80, 
purple, hand-bagged, 
bolus fentanyl and 
MDZ. Settled after PRN 
chloral. 
Not very happy when 
awake.  
Regular chloral given. 
Fentanyl stopped. 
Overnight. 
 Unsettled ? wind, settled 
with Infacol. 
Slept for a few minutes 
and v unsettled again. PRN 
chloral. 
Bradycardic to 84, no 
desaturation, self-
correcting. 
Hypotensive, 5 am 
clonidine not given.  
Unsettled at times. 
Overnight.  
V irritable at start 
of shift. 
Paracetamol 
given, feeds 
increased, only 
settling with 
chloral. 
Overnight.  
Irritable at times. 
Medication good 
effect. 
Overnight.  
Irritable when chloral 
due, otherwise settled. 
Day  
Quite unsettled 
throughout the day, no 
chloral needed. CVL 
and art line out. 
Mum able to settle 
baby down. 
Day PICU.  
Mum trying to soothe 
baby. Very agitated. 
Paracetamol as required. 
 
Ward. Unsettled and 
unable to sleep since 
Day.  
More settled but 
waiting for next 
dose of chloral. 
Day.  
Much more 
settled since 
yesterday.  
Sleeping for 
periods. 
A little unsettled 
Day.  
Much better again 
since yesterday. Grizzly 
for ½ h before chloral 
due, otherwise settled. 
Smiled at mum. Family 
feels he’s more like 
himself. Unsettled 
Bowels open loose ++++ mum 
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says this is normal One episode of 
bradycardia at 6pm. 
yesterday, lip smacking, 
irritable, restless. 
Restarted chloral, much 
more settled.  
at times. periods but parents 
advise this is no 
different from home. 
Extubated 11.00 and PD cath 
removed 
To ward 11.40 
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10.7 Case study 4 (Withdrawal possible) 
A 2 year old girl was admitted to PICU with a chest infection (adenovirus). She has Kabuki 
syndrome.  She was intubated for 17 days and spent 20 days on PICU.   
10.7.1 Sedative drug therapy 
The patient was sedated with midazolam and ketamine on admission to PICU.  On PICU 
day 4, ketamine was stopped and fentanyl was commenced.  In addition, chloral hydrate 
and promethazine were cycled every five days for the duration of the PICU admission.  
The peak dose of fentanyl was 3 micrograms/kg/hr and for midazolam was 183 
micrograms/kg/hr. Fentanyl was administered for 8 days before reaching peak dose on 
PICU day 12-15 and was then weaned gradually over 11 days. Midazolam was at peak 
dose for two 48 hour periods (PICU days 3-4 and 12-13) and was then also weaned over 
11 days.  Both drugs were converted to oral equivalents due to loss of IV access and 
weaning continued for a further 5 days to completion. The patient was extubated on the 
PICU day 17.  
Perception and interpretation 
The patient will be physically dependent after 20 days continuous administration of 
fentanyl and midazolam. Tolerance occurred over the first two weeks resulting in 
increasing doses to maintain optimum sedation. Slow weaning commenced shortly 
afterwards as the child’s condition improved.   
 
10.7.2 Highest SWS score 
The highest withdrawal score, SWS 10, occurred on HDU day 3, six days after extubation 
(Table 10.12). Apart from this episode SWS scores ranged from SWS 1-5 (Figure 10.7).  
Table 10.12 Highest SWS score components (Case study 4, SWS score 10) 
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Figure 10.7 SWS scores (Case study 4) 
10.7.3 Probability of withdrawal  
Likelihood of withdrawal was possible at the time of the highest score (Table 10.13). 
Table 10.13 Likelihood of withdrawal (Case study 4) 
Criterion Case study 4 
Physical dependence possible Fentanyl and midazolam for > 5 days. 
Temporal relationship with change in dose Weaning consistently for the previous 9 
days. 
Absence of differential diagnosis No 
 
10.7.4 Identifying a causative agent 
10.7.4.1 Drug therapy and weaning rates 
Fentanyl and midazolam infusions were being weaned slowly every 12 hours at 
consistent rates; these rate reductions had been tolerated over the previous 9 days with 
SWS score ranging from SWS 1-5, with a modal score of SWS 2. 
10.7.4.2 Changes in drug therapy in response to the highest SWS score 
There was no change in drug therapy in response to the high score. 
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Interpretation 
Not tolerating a previously tolerated weaning regime suggests that either the child’s 
condition has changed or that the sedation was having an inadvertent therapeutic effect, 
which is diminishing as drug levels reduce.   
 
10.7.5 Withdrawal signs 
10.7.5.1 Nurse documentation 
All SWS scores over the timeframe were collated and the contribution of component 
signs was presented in a pie chart (Figure 10.8). This shows that four signs; diarrhoea, 
respiratory distress, irritability and insomnia contributed to most of the SWS score during 
this time frame. 
 
Figure 10.8 Contribution of component SWS signs (Case study 4) 
10.7.5.2 Parent interviews 
The SWS behaviour from the nurses’ withdrawal assessments was also reported by the 
parent. There was a differentiation between signs which appeared more indicative of 
being unwell with a chest infection; insomnia, irritability and diarrhoea and signs which 
were more likely to indicate withdrawal; hallucinations, high-pitch noise and inattention 
(blank canvas) (Table 10.14).  Additional clinical details from nursing documentation are 
presented in Table 10.15. 
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Retrospective interpretation 
Indications that the SWS score was driven by the child’s underlying condition rather than 
withdrawal are that the SWS score varied despite ongoing slow weaning and other than 
the peak dose, there was no trend in scores (either increasing or decreasing).  The 
dominant component of the SWS score was diarrhoea, which the father reported was a 
pre-existing condition. 
 
10.7.6 Parent perspective 
This excerpt, taken from the interview transcripts in Study 6 gives the father’s perspective 
on issues for his daughter’s during the weaning of sedation: 
“So I think she did show signs of withdrawal but I also think that the plan in 
terms of the weaning off was managed effectively to probably reduce those.  
But again the difficult is knowing she may have had no withdrawal at all 
and just had those side effects which was just – I’m trying to think what  
(the child) scored high on which was diarrhoea, irritability, not being able to 
go to sleep.  Well we’ve spoken about (the child) teething in the last month 
all of those three things could be the result of teething so there is a 
possibility that she didn’t  withdraw at all but from a nurse’s point of view 
when they are scoring they can only score what’s in front of them” (P9F) 
 
Table 10.14 Parent report of behaviours during weaning (Case study 4) 
Diarrhoea “She had chronic diarrhoea for four weeks before she came in here.” 
Insomnia “Not being able to get to sleep and when she did finally get to sleep 
not being able to stay asleep for periods of time.  Her sleep pattern 
was all over the place. I found that when she is sleeping for long 
periods during the day she will then be awake for three hours during 
the night, so I just think she was all of a mix up in terms of day and 
night and trying to deal with that.  She was on a pump feed and that 
was making her poo in the night.  As soon as she pooed her bottom 
was so sore it was waking her up in pain and then she couldn’t get back 
to sleep and we were back in the same situation, so she was never into 
a deep sleep because she was pooing every half-hour.”   
Irritability “She was permanently irritable because she was so poorly and I think 
in terms of eating she seemed to have, you know lots of things like 
wind makes her irritable and she was a very windy baby.  So yes I 
would say she was irritable for a couple of weeks but you would expect 
that given the fact that she was poorly and at times now she still does 
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get irritable, you know with her breathing she still gets irritable you can 
see.  But certainly there was a link between the insomnia and the 
irritability, she became irritable because she couldn’t go to sleep, she 
wasn’t irritable at other times of the day.” 
Hallucinations “This was at night-time and with a child this age you can’t 
communicate with them to find out what they are experiencing but 
there were times when she was sort of treading water, as if she was 
swimming with her hands, as if she was batting things away. I think it 
looked like something was there and she was sort of batting it away 
with her hand or it was distressing her in some way.  It’s a movement 
which I’ve never seen her do before.”   
High-pitched 
noise 
“They were noises that I’d never heard  (child’s name) make before in 
terms of pitch, in terms of – this is very early, this is when she first 
came off her vent.  But I think her throat was very sore so I think her 
normal cry didn’t sound like her normal cry.  (child’s name) wasn’t like - 
I remember I had this conversation - (child’s name) wasn’t like (child’s 
name) in terms of the noises she made they were completely different 
but she was sort of throwing her arms and was irritable.” 
Blank canvas “There was nothing at first because I was asking the doctor is there 
something wrong with her, has there been some sort of event that’s 
made her [like this]?  I was thinking the worst, I was thinking is there 
something wrong with her brain or something because she was 
conscious but there was nothing coming back in terms of no smiles.  I 
did think, does she know who I am?  She was a blank canvas, there was 
no personality at all and it was difficult to explain to the doctors 
because obviously they don’t know what her personality was before.”  
 
10.7.7 Discussion 
This case study presents a patient with possible withdrawal, assigned due to the 
possibility that the child’s underlying condition was driving the behaviour rather than the 
sedation weaning regime. 
The W-CAT provides a diagnostic framework which emulates the uncertainty inherent in 
some withdrawal assessments. The temporal relationship criterion may not reflect cases 
such as this one, where a previously tolerated weaning rate is no longer tolerated, 
indicating a change in the relative impact of the underlying condition, or another cause.  
Using the weaning regime as a heuristic (the child is weaning, so a behavioural change 
indicates withdrawal) is prone to error in circumstances such as this case. 
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Table 10.15 Patient details from electronic nursing records 
HDU 
day 2 
HDU 
day 3 
HDU 
day 4 
HDU 
day 6 
HDU 
day 7 
Overnight 
T 383, bowels 
open x4 
bottom sore, 
retching.  
Slept well 
Overnight 
Agitated  
2 x chloral,  
1 x 
promethazine 
Overnight settled  Restless 
Tolerated 
weaning 
Overnight 
Tachycardic 
at times, 
mainly 
when 
upset. 
Agitated, 
restless. 
Awake and 
looking round, 
not upset. 
Agitated 
around 
lunchtime. 
Settled and 
slept pm. 
 Increased WOB 6 
am.  
Blood gas OK, 
lactate raised,  
Airvo to CPAP. 
T 388, rash,  blood 
cultures 
SWS score 7 and 10 
however difficult to 
assess due to 
symptoms 
associated with 
pyrexia. 
 Settled pm 
Airvo 
ventilation 
Alert and responsive 
interacting with 
family in the 
morning. 
18.00 Sleeping, once 
established on CPAP 
and had chloral. 
No documentation HDU day 5 
 
The withdrawal signs described by the father portray the equivocal nature of these 
behaviours. At face value this child scores for withdrawal.  The father’s perspective 
however views some of these signs (diarrhoea, insomnia and irritability) in the light of his 
daughter’s underlying condition. Other signs (high pitch cry, hallucinations and blank 
canvas) rely on a level of interpretation based on knowing the child’s usual behaviour. 
This case highlights the value of the parent perspective when interpreting behaviours. 
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The items in the SWS did not cover all this patients behaviour changes, which impacts on 
the construct validity of the SWS tool.  
Similarly to previous case studies, the likelihood in this case is a co-existence of 
withdrawal and the underlying condition. Treatment decisions depend on the relative 
impact of these clinical issues, determining whether increased respiratory support will 
reduce behaviours and permit the continuation of weaning, or whether stopping weaning 
will improve the child’s respiratory status. 
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10.8 Case study 5 (Withdrawal unlikely)  
A newborn baby boy was admitted to PICU on the first day of life following complications 
after an emergency atrial septostomy. He had an antenatal diagnosis of a congenital 
heart defect (Transposition of the Great Arteries). A prostaglandin infusion, to improve 
blood flow, was stopped on day 16 but recommenced on day 23 due to a drop in oxygen 
saturations despite an increase in ventilatory support. A scan confirmed narrowing of the 
ductus arteriosis and prostaglandin was continued (until surgery six weeks later).  An 
infusion of milrinone, an inotrope, was stopped on day 20 and recommenced on day 24 
for 48 hours.  He was extubated onto Optiflow on PICU day 25.  Six days later, a chest X 
ray revealed an enlarged left ventricle. He was discharged to the ward 2 days later prior 
to further cardiac surgery.  The highest SWS score was on PICU day 26.  
10.8.1 Sedative drug therapy 
The patient was cycled every 5 days in combinations of fentanyl and midazolam, 
morphine and chloral and ketamine and midazolam in an attempt to prevent physical 
dependence.  The fourth cycle (clonidine 1 microgram/kg/hr and promethazine 1mg/kg 
every 6 hours) was stopped on PICU day 21.  Enteral sedation was commenced on day 21 
with diazepam 0.1 mg/kg every 8 hours; oral morphine 50 micrograms/kg every 6 hours 
was added on day 23.  On day 24, an IV clonidine infusion was recommenced at a rate of 
0.1 microg/kg/hr. No changes were made to the enteral sedation regime for the following 
8 days. Clonidine rates varied between 0.1 and 0.5 microgram/kg/hr for the first 4 days 
and were then weaned by 0.1 microgram/kg/day over 5 days until stopped. 
10.8.2 Highest SWS score 
The highest withdrawal score, SWS 7, occurred on PICU day 26, one day after extubation 
(Table 10.16).  SWS scores varied between SWS 1 and SWS 6 over the following 5 days. 
(See Figure 10.9) 
Table 10.16 Highest SWS score components (Case study 1, SWS score 7) 
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Figure 10.9 SWS scores (Case study 5) 
10.8.3 Probability of withdrawal  
Physical dependence possible 
The patient was at low risk of physical dependence after cycling sedation every 5 days. 
Enteral sedation doses were within the normal range.   
Temporal relationship with change in dose 
There was no temporal link to changes in sedation, as the patient appeared very settled 
after cycling from clonidine and promethazine to a low dose of enteral diazepam.  
Absence of differential diagnosis 
In the hours prior to the highest SWS score, milrinone was stopped and the baby was 
described as “working harder, tachypnoea and had respiratory acidosis. The ventilation 
flow rate was increased in response and an IV fluid bolus administered. The temporal link 
is to reductions in inotrope support, the patient’s clinical deterioration and the adverse 
effects of prostin (tachycardia, pyrexia, vomiting (BNF 2016)).  
 
The likelihood of withdrawal was categorised as unlikely at the time of the highest score 
(Table 10.17). 
Table 10.17 Likelihood of withdrawal (Case study 5) 
Criterion Case study 5 
Physical dependence possible Unlikely. 
Temporal relationship with change in dose Five days since change in sedation. 
Absence of differential diagnosis No. 
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10.8.4 Identifying a causative agent 
10.8.4.1 Drug therapy and weaning rates 
No causative agent for withdrawal was suspected.  
10.8.4.2 Changes in drug therapy in response to the highest SWS score 
There was no change in sedative drug therapy in response to the high score. 
10.8.5 Withdrawal signs 
10.8.5.1 Nurse documentation 
All SWS scores over the timeframe were collated and the contribution of component 
signs was presented in a pie chart (Figure 10.10). This shows that two signs; fever and 
respiratory distress contributed over half of the SWS score during this time frame. These 
signs are likely to be a consequence of the child’s clinical condition and ADR to prostin.  
 
 
Figure 10.10 Contribution of component SWS signs (Case study 5) 
 
10.8.5.2 Parent interviews 
The SWS behaviour from the nurses’ withdrawal assessments was also reported by the 
parent. There was a differentiation between signs which appeared more indicative of 
being unwell with a chest infection; insomnia, irritability and diarrhoea and signs which 
were more likely to indicate withdrawal; hallucinations, high-pitch noise and inattention 
(blank canvas) (Table 10.18).   
Insomnia 
9% Irritability 
11% 
Sweating 
1% 
Tremor 
4% 
Sneezing 
4% 
Diarrhoea 
5% 
Vomiting 
11% 
Fever 
20% 
Respiratory 
distress 
35% 
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10.8.6 Parent perspective 
This excerpt, taken from the interview transcripts in Study 6, gives the mother’s 
perspective on her son’s condition: 
“One of the sedations he was on he had a very bad sort of like case of 
withdrawal from that and we had seizure movements, he went grey, he was 
very sick, the diarrhoea and constant sneezing, and it was all from obviously 
the product.  They checklist then and at that point they said because his 
heart rate started going nuts and the numbers started beeping and all this, 
and we were thinking – oh what’s this, this time, what’s happened now – 
and then they started ticking off lists and said – “Oh look we’ve got this 
green sheet and he’s actually scoring quite high on the withdrawal”.  At that 
point I think they were trying to wean his midazolam off quite quickly and 
put him onto clonidine.  The midazolam time he was still on the ventilator, 
nowhere near being extubated and that was the worst one.  And his second 
worst one he’d just been extubated and then they changed so many things 
at once, including the extubating him within the first twelve hours I 
think.”(P10M) 
 
10.8.7 Discussion 
This case study presents a patient who was unlikely to be withdrawing at the time of the 
highest score. There was no temporal link to changes in sedation and there was a 
possibility that the child’s underlying condition was driving the behaviour. The mother 
described two episodes of withdrawal; the second episode relates to the highest score 
reported here. The earlier episode linked to reducing midazolam, but did not have a 
corresponding SWS score, so could not be included in the analysis.  At that point 
withdrawal was possible due to a temporal link with changes in midazolam dose. 
However, other causes could not be excluded as prostin had been stopped and the baby 
was described as “grey, clammy, gasping and fighting the ventilator” in the nursing notes. 
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Table 10.18 Parent report of behaviours during weaning (Case study 5) 
Fever “He’d had a fairly high temperature throughout the day, despite being 
barely warm his temperature just sky rocketed. They did all the bloods, he 
was being sick and a bit restless. His heart rate was like two-hundred-and-
five, two-hundred-and-ten because it was racing, manic racing.  He was 
just dripping with sweat and really, really hot.” 
“We had a few nights of restlessness and a high temperature but he 
wasn’t as upset as he had been before and his colour didn’t change as 
much and it was some of the same symptoms but just on a lower grade if 
you like.” 
Insomnia “Going from being quite sleepy to suddenly fighting it and almost not 
wanting to sleep. He was restless and taking ages to get to sleep - I think 
it was probably about two or three hours and that was the longest he’d 
been awake and when he finally did go to sleep then he started doing 
seizure type tremor movements.  But then he just seemed uncomfortable 
and he still had his tubes in at the time, he was making like flapping 
movements.  Like at the time he still had his tubes, his ventilator through 
his nose rather than through his mouth so he could move his mouth 
whilst he was crying but obviously no sound came out so there’d be some 
lip trembling movement.”   
Irritability “The arms flapping and not being able to settle, he was trying to move 
himself a bit more yet he still didn’t have enough – like now he can turn 
himself from side to side roughly, he couldn’t do that because he still 
didn’t have the full use of his limbs but he was trying to move.  At that 
point nothing would settle him, so stroking his face didn’t work or 
touching his bum and stuff.  Obviously I couldn’t lift him at the time which 
would be my normal instinct to pick him up.” 
Tremor “I think there was the sort of seizure but then I think the next morning 
they said he’d had a couple of little tremor- like movements, a shiver and 
a bit of shaking.” 
Respiratory 
distress 
“He chokes anyway because of his condition but his heart rate would fly 
up and he was like (sharp intake of breath by mother to illustrate) you 
know.  He seemed to be struggling sometimes and gasping in air. They 
were saying – “He was working very hard” but again sometimes that was 
tied in with changes to some of his heart medication.” 
Convulsions “His right shoulder just started twitching; it was quite a violent sort of 
movement like that on the right side of his body. It lasted about a minute 
or two and tied in with that his colour started to change and then his 
heart rate went up and more sick came out. They gave him anti-seizure 
medication but then there’s not been anything since then. He just had 
one dose I believe in the early hours of that morning.”  
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Table 10.19  Additional clinical details from nursing documentation 
PICU day 23 PICU day 24 PICU day 25 PICU day 26 PICU day 27 PICU day 28 PICU day 29 PICU day 30 PICU day 31 PICU day 32 
Intubated Intubated Extubated to 
Optiflow  
Optiflow  
 
Optiflow  Optiflow  
 
Optiflow  Optiflow  
 
Optiflow  
 
Optiflow  
 
Oxygen 
saturations 
<50% 
Ventilation 
increased. 
 
Tachycardic, 
Pyrexial, ? 
due to 
withdrawal  
or to prostin 
Blood gases x 
2, indicating 
over -
ventilation 
Oxygen 
saturations  
> 70%. 
Plan to 
extubate, 
ventilation 
weaned. 
Working 
harder, 
tachypnoea 
pm 
Respiratory 
acidosis 
Flow 
increased 
 
Frequent 
episodes of 
being 
unsettled 
and crying, 
settles with 
comfort 
measures. 
? withdrawal 
 Does not like 
being 
disturbed, 
but is easily 
comforted 
and settles 
 Respiratory 
effort 
increased 
tachypnoea, 
nasal flaring, 
moderate 
recession. 
Vomiting 
overnight x 
5; medical 
review – due 
to 
withdrawal. 
Prostin 
restarted 
and  
increased. 
Gelofusin 
bolus 
Milrinone 
restarted. 
Prostin rate 
reduced and 
temperature 
reduced. 
Prostin then 
increased as 
scan showed  
narrowing in 
duct. 
Gelofusin 
bolus x 3 
Milrinone 
continues 
Prostin 
continues 
Milrinone   
stopped 11h 
Prostin 
continues.  
 
Fluid bolus 
(10% 
dextrose) 
Prostin 
continues  
 
 
Prostin 
continues  
 
 
Prostin 
continues  
 
Prostin 
continues  
 
 
 
 
Prostin 
continues 
Tachycardia, 
CXR shows 
enlarged R 
ventricle.  
 
? seizures as 
eyes appear 
to be rolling 
back when 
in/out of 
sleep. 
Prostin 
continues  
 
 
 
 
 
Eyes rolling 
back at 
times. 
 
BO x 10  
Vomited x 2 
BO x 7 
Vomited  x 1 
BO x 4 
 
BO x 5 
 
BO x 3 BO x 4 
Vomited x 1 
BO x 5 
Vomited x 2 
BO x 5 BO x 4 
Vomited x 3 
BO x 3 
Vomited x 5 
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Chloral 
100mg PRN 
x2 
Chloral 
100mg PRN 
x2 Clonidine 
infusion 
started . 
Clonidine 
continues 
Clonidine 
reduced but 
not 
tolerated.  
Clonidine 
reduced 
daily  
 
Clonidine 
reduced 
daily  
Clonidine 
reduced 
daily 
Clonidine 
reduced 
daily 
Clonidine 
stopped. 
 
Oral 
morphine 
250 microg 
6h 
Oral 
morphine 
250 microg 
6h 
Oral 
morphine 
250 microg 
6h 
Oral 
morphine 
250 microg 
6h 
Oral 
morphine 
250 microg 
6h 
Oral 
morphine 
250 microg 
6h 
Oral 
morphine 
250 microg 
6h 
Oral 
morphine 
250 microg 
6h 
Oral 
morphine 
250 microg 
6h 
Oral 
morphine 
250 microg 
6h 
Diazepam  
0.5 mg 8h 
Diazepam  
0.5 mg 8h 
Diazepam  
0.5 mg 8h 
Diazepam  
0.5 mg 8h 
Diazepam  
0.5 mg 8h 
Diazepam  
0.5 mg 8h 
Diazepam  
0.5 mg 8h 
Diazepam  
0.5 mg 8h 
Diazepam  
0.5 mg 8h 
Diazepam  
0.5 mg 8h 
BO= bowels opened. 
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10.9 Discussion of the utility of W-CAT in light of five case studies 
These cases demonstrated the differences in the presentation and likelihood of 
withdrawal that exists in a small sample of patients. These differences presented 
challenges for the existing approach to withdrawal assessment and each of these cases 
was diagnosed as withdrawing, based on behaviours alone.  Reflecting on the different 
presentations of these cases helps to illuminate the relationship between dependence 
and withdrawal. However, the W-CAT criteria offer a link between the construct of 
physical dependence and the concept of withdrawal providing the basis of a theoretical 
relationship, which is missing from the existing approach.  
This discussion will address the utility of the W-CAT by considering the component 
diagnostic criteria and their clarification of the theoretical relationship between physical 
dependence and withdrawal in critically ill children. 
 
10.9.1 W-CAT diagnostic criteria  
10.9.1.1 Physical dependence  
The likelihood of physical dependence is generally accepted to be 50% after five days of 
continuous sedative infusions (Ista et al 2007), occurring sooner at higher doses. One 
patient in this study was dependent after 4 days of fentanyl and another after 5 days of 
morphine and midazolam. The speed of onset of physical dependence in critically ill 
children is in direct contrast with the adult patients for whom the DSM diagnostic criteria 
were developed. The criterion for likelihood of physical dependence refers to signs of 
withdrawal after heavy or prolonged use (DSM, 2013).  The DSM criteria also refer to a 
substance-specific syndrome relating to a single pharmacological agent, whereas critically 
ill children may be at risk of withdrawal from more than one concurrent sedative drug.   
10.9.1.2 Temporal relationship  
The diagnostic insight gained from considering the temporal relationship between onset 
of behaviours and sedative weaning may assist in the identification of causal 
relationships. This relationship is not a feature in the existing approach, which was 
highlighted in two cases. In case 1, the child’s behaviour was linked to ketamine 
withdrawal despite the highest score occurring before the ketamine was stopped.  In case 
5, the child’s agitation was linked to clonidine withdrawal, despite clonidine being started 
in response to the child’s agitation.   
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10.9.1.3 Differential diagnoses 
Excluding the possibility that other causes might explain the behavioural response is an 
assumption made in the ADR causality assessment tool (WHO-UMC), the DSM-5 criteria 
for substance withdrawal in adults (DSM, 2013) and the literature regarding withdrawal in 
critically ill children (Ista et al 2013, Harris et al 2016). However, this proved a challenge in 
some of the cases, due to the context of critical illness within which withdrawal occurs.  In 
case 1, weaning stopped due to the SWS score, despite the score remaining high. In case 
2, the baby’s underlying condition was impacting on the opportunity to wean; if he had 
not been so unwell he may have weaned sooner.  In case 4 the child had tolerated 
weaning at a consistent rate and then had a high SWS score; in retrospect this responded 
to changes in medical management including an increase in respiratory support. In case 5, 
withdrawal was consistently diagnosed, despite no risk of dependence and no temporal 
link to a change in dose.   
A more pertinent consideration, rather than excluding other causes, may be whether 
withdrawal or critical illness is driving the behaviour; a dichotomy underpinning whether 
withdrawal or critical illness should be treated.  In four cases in this sample, where other 
possible causes for the behaviours existed, the impact of these behaviours varied.  As 
withdrawal exists in the context of critical illness, then a continuum exists whereby the 
clinical impact of behaviours is due to the combined effect of withdrawal and the critical 
illness.  At one end of the continuum, behaviours will be 100% driven by withdrawal, with 
no impact from critical illness. At the other end of the continuum, behaviours will be 
100% driven by the critical illness, with no impact from withdrawal.  The point where each 
case lies on the continuum reveals whether clinical intervention should focus on treating 
withdrawal or treating the critical illness.  A proposed withdrawal- critical illness 
continuum is presented in Figure 10.11.   
 
This continuum also illustrates the impact that ongoing critical illness may have on 
withdrawal severity.  A dominant influence of critical illness would indicate underlying 
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illness or deterioration was limiting the capacity to wean, such as case 2; whereas a 
dominant influence of withdrawal would indicate sedative weaning had been too rapid, 
such as case 3. 
10.9.2 Signs of withdrawal 
The contribution of component behaviours in the SWS scores in the 72 hours before and 
after the highest score demonstrated the dominance of a minority of signs in some 
patients; signs which may have been driven by the child’s underlying condition. This was a 
retrospective review, so in some cases the patients were being assessed for withdrawal 
before subsequent diagnoses were known. One child who was diagnosed with influenza 
after the highest score had the greatest contribution to his cumulative SWS score from 
the items, respiratory distress and irritability (case 2).  Respiratory distress accounted for 
one third of another child’s cumulative SWS score, who was subsequently diagnosed with 
heart failure (case 5).  The child who withdrew after 4 days of fentanyl exhibited 
irritability predominantly.  These cases reflect the broader findings from Study 1 that 
showed the median number of items contributing to the highest SWS score was 5.  Each 
of these findings supports the heterogeneous presentation of withdrawal, which 
challenges an implicit assumption scale development, that items contribute equally to the 
total score (Streiner and Norman 2003).  
In addition to these cases where one or two SWS items dominated and possibly drove the 
withdrawal assessment score, parents described a range of other signs which were not 
accounted for in the score.   The parental perspective suggests that the possible 
behaviour combinations may far exceed the range that is possible in any single tool.   
There was no evidence that a summed score aided assessment of withdrawal in this small 
sample, given the impact of underlying condition and the possibility of overlooking other 
behaviours that do not feature in the SWS tool.   
10.9.3 W-CAT diagnostic features as the structure of a new definition of 
withdrawal in critically ill children 
The complexity of the clinical context may be better interpreted using diagnostic criteria, 
which focus on the shared diagnostic features of withdrawal rather than focussing on the 
unique heterogenous aspects of the individual’s presentation. The diagnostic criteria in 
W-CAT focus on the shared diagnostic features of withdrawal and may support decision-
making by providing a structure to the assessment. The assigning of a probability term to 
the withdrawal diagnosis may provide a more accurate reflection of this diagnosis in light 
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of other possible causes for behaviours, than the existing definitive diagnoses of SWS, 
WAT-1 and SOS do.    
The diagnostic features of W-CAT (Table 10.1) describe the relational statement, or 
postulate, between the construct of physical dependence and the concept of withdrawal. 
This postulate is the rate of reductions of sedative drugs in the context of physical 
dependence.  The W-CAT features can also form the basis of the characterisation of 
withdrawal in critically ill children as a clearly defined syndrome.  It is proposed that the 
newly defined syndrome is termed Paediatric Withdrawal Syndrome (PWS).  The 
diagnostic criteria for Paediatric Withdrawal Syndrome (PWS) are; 
Table 10.20 The diagnostic criteria for Paediatric Withdrawal Syndrome 
Criterion A A change in behaviour causing distress or impacting on the child’s clinical 
condition which develop after stopping or reducing one or more sedative 
or analgesic infusions, or regular medications, which have been 
administered for at least four days. 
Criterion B Withdrawal signs develop within minutes to two days after Criterion A. 
Criterion C The behavioural signs are not due to the critical illness or deterioration and 
are not better explained by another medical condition or drug effect e.g 
pediatric delirium, adverse drug reactions. 
Criterion D Behaviours improve when the drug is restarted or increased to the 
previously tolerated dose, if clinically indicated. 
 
10.10 Conclusion 
The W-CAT demonstrated clinical utility in this retrospective evaluation, using case 
studies as test cases.  The W-CAT criteria, focussing on the shared features of withdrawal 
syndrome appear to support and reflect the stages of clinical reasoning shown on the 
propositional model (Figure Part 5.1). Plotting the terms ‘construct’ and ‘concept’ on the 
model identified the relationship between the construct of physical dependence and the 
concept of withdrawal. This relationship; the rate of reductions of sedative drugs in the 
context of physical dependence, is a diagnostic criterion in the W-CAT. The discussion of 
the five case studies supported the relationship, or postulate and provided preliminary 
evidence of the utility of W-CAT criteria as both the defining, and diagnostic criteria for 
paediatric withdrawal syndrome (PWS).   
Chapter 11 will consider the behavioural signs of withdrawal (Criterion B) and seek to 
identify a logical relationship between these variables and the concept of withdrawal.  
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Chapter 11: An interpretive synthesis of signs of withdrawal   
 
11.1 Introduction 
The conceptual framework that guided the studies presented in this thesis featured 
withdrawal signs at the core.  These signs have been studied from a range of 
perspectives.  These perspectives have identified flaws in the current approach to 
withdrawal assessment.  Study 1 demonstrated that the three modal SWS scores of SWS 
5, 6 and 7 comprised patients with three different likelihoods of withdrawal, which cast 
doubt on the diagnostic reliability of a summed score.  Study 2 demonstrated that many 
withdrawal signs were common in children who were not withdrawing, but also revealed 
three signs which are much more prevalent in withdrawing patients.  Study 3 revealed 
how the lack of a formal definition or description of withdrawal and how it manifests has 
hampered the validation of withdrawal assessment tools. Study 4 revealed the challenges 
nurses face distinguishing individual signs in a constellation of behaviours and then 
interpreting the meaning of these behaviours.   Study 5 revealed that parents recalled 
SWS signs and found them distressing. Study 6 showed that parents recognised other 
signs of withdrawal that are not included in the SWS tool.  The literature review and 
pointed to a heterogeneous presentation of withdrawal, resulting in a high proportion of 
false positive diagnoses of withdrawal (33% WAT-1 (Franck et al 2008), 51% SOS (Ista et al 
2013)).  
 
11.2 Purpose 
The purpose of the interpretive synthesis presented in Chapter 11 is to: 
1. Integrate the multiple sources of data presented in Studies 1-5 regarding the 
manifestation of withdrawal syndrome, to consider the ease of interpretation and 
clinical utility  of signs of withdrawal, and  
2. Consider the epistemic assumptions, or underlying physiological mechanisms that 
link these behavioural variables to withdrawal.  
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11.3 Method 
All SWS signs and those signs identified by at least one parents were included in the 
synthesis. The following features were collated and considered for each sign; 
1. A definition of each sign along with a comparison of similar signs, 
2. The pathophysiological mechanism for the behaviour in withdrawal syndrome,   
3. The inclusion of the signs in SWS, WAT-1 and SOS,  
4. Results from the SWS evaluation (Study 1),  
5. Nurses recognition and scoring for the four behaviours: insomnia, irritability, 
respiratory distress and hypertonicity (Study 4),  
6. Parents’ descriptions of behaviours and their intensity ratings (Study 5 and 6)  
7. Additional description of behaviours from computerised nursing notes. 
 
11.4 Insomnia 
Insomnia is not formally defined in the SWS tool (Cunliffe et al 2004) but was defined as 
“sleeps for no more than 1 hour at a stretch” in SOS (Ista et al 2009) and similarly as 
“sleeping less than 1 hour in the previous 4 hour period” in the OBWS study (Franck et al, 
2004). 
Insomnia is a recognised sign of opioid and benzodiazepine withdrawal (Ista et al 2007), 
features in one of the pediatric delirium (PD) tools as “sleep-wake cycle disturbance” and 
is also a known feature in ICU patients.  Recent studies have investigated the impact of 
the different factors of critical illness, drugs and the ICU environment on sleep. The ICU 
environment has features which interfere with sleep, such as noise and light, which 
results in sleep fragmentation, with nearly half of sleep occurring during daytime, even in 
healthy adult volunteers (Drouot 2008).  Sleep and waking is regulated by many 
neurotransmitters, including noradrenaline, serotonin, acetylcholine, dopamine, 
histamine, gamma-aminobutyric acid (GABA), the pituitary hormones and melatonin. Any 
drugs that alter the balance of these neurotransmitters, as opioids and benzodiazepines 
do, may affect sleep (Benyamin 2008).  The pathogenesis of either primary or withdrawal-
induced insomnia is not clear. Primary insomnia is thought to be a consequence of 
hyperarousal, which is exhibited as hypervigilance during the day and difficulty initiating 
and maintaining sleep at night (Bonnet and Arand 1997).   
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11.4.1 Presence of insomnia as an item in withdrawal assessment tools 
Insomnia is included in SWS (Cunliffe et al 2004) and SOS (Ista et al 2009) and featured in 
OBWS (Franck et al 2004).  Insomnia was highly prevalent in the SWS evaluation (Study 1), 
occurring in 86% of cases and was the most frequently observed behavioural sign in the 
OBWS study (Franck et al 2004) occurring in 52% of withdrawing patients.  Subsequent 
refining of OBWS in the WAT-1 study (Franck et al 2008) however, did not include 
insomnia and gave no rationale for its omission.   
11.4.2 Nurse perspective 
Nurses found assessment and scoring for ‘insomnia’ challenging because it was difficult to 
decide whether the patient had insomnia (N1), whether insomnia was due to withdrawal 
(N3,5) and the subjective nature of the intensity scoring (N2,4,7,8). Two nurses admitted 
to always scoring patients ‘1’ (N6,12), whilst another felt limited by the choice of only two 
intensity options (N4). Nurses’ definitions of ‘insomnia’ sometimes included features of 
‘irritability’ or ‘motor disturbance.’  
11.4.3 Parent perspective 
Eighteen of 20 parents who completed questionnaires identified insomnia in their child, 
which they gave a median (IQR) rating of 7 (4-10) for distress.  Ten of 11 parents who 
were interviewed, described insomnia.  These descriptions covered absence of sleep 
(n=6), broken sleep (n=4) and delayed onset of sleep (n=1) (Table 11.1). 
Table 11.1 Parents’ descriptions of their child’s insomnia 
Parent Description of insomnia 
P1 Broken sleep 
P2 Three and a half days without sleep. Sleep disturbance for 3 weeks. 
P3  36-48h without sleep. And irregular sleep patterns. 
P4 No sleep at all for 3-4 days. 
P5 Broken sleep 
P6  Slept only about 3h in a 48 hour period 
P8  24h with very little sleep; only sleeping for a few minutes at a time 
P9 Broken sleep, sleeping during the day. 
P10  Taking ages to get to sleep. 
P11  Just not being able to sleep ?24h 
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11.4.4 Summary 
It is important to differentiate the sleep disruption typical to most ICU patients and 
insomnia as a sign of withdrawal, which is the striking absence of sleep described by 
parents.  The high prevalence of insomnia in the SWS audit may represent a blurring of 
these two states, limiting the diagnostic value of this sign. Blurring of boundaries between 
SWS signs also occurred in the nurses’ definitions. 
Lack of sleep, to the extent described by parents, was distressing; not only to see their 
child going so long without sleep but also their concern that this might have a detrimental 
impact on their child’s recovery. Absence of sleep to this extent did not appear to 
translate to nursing documentation.  This may be a consequence of the nursing shift 
pattern, which may impose a diurnal interpretation, with sleeplessness at night being 
more noticeable than that occurring during the day, consequently obscuring the 
cumulative impact over successive shifts. “Sleeps for no more than 1 hour at a stretch” 
(SOS, OBWS) is objective and elegantly distinguishes between sleep disruption, insomnia 
and other SWS behaviours.  
 
11.5 Irritability/irritable (agitation, restless, fidgety) and anxiety (and 
inconsolable) 
Irritability describes a broad concept rather than a specific behaviour and a range of 
definitions exist; the medical, paediatric and colloquial definitions may each be relevant 
to withdrawal assessments (Table 11.2). The overlapping definitions and terms are shown 
in bold in Table 11.2 to demonstrate how these terms intermingle.  The clinical impact of 
interpreting the meaning of irritability as a broad behavioural concept is further 
demonstrated, by the occurrence of two of the terms in the overlapping definitions; 
“restlessness” and “inconsolable” featuring in the PD tools. Restlessness and 
inconsolability encompass four of the five delirium domains; cognition, psychomotor 
activity, affect/ distress and orientation in the CAPD tool (Traube et al 2014) and 
disorganised brain in psCAM-ICU (Smith et al 2016). 
11.5.1 Presence of irritability as an item in withdrawal assessment tools 
Irritability occurs in SWS and in SOS, as “irritable”; which is a component of agitation 
(with restless and fidgety).  Once again, the clinical utility of SOS is enhanced with the  
inclusion of four similar terms, which captures the broad-spectrum of behaviour that is 
sought, compared with the more restrictive use of a single term.  SOS also includes the 
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similar term of “anxiety”, which is defined as “unrest or anxious face (eyes wide open, 
eyebrows tense and raised). Behaviour can vary from panicky to draw back” (Ista et al 
2009).  Anxiety as a symptom, can only be reported by the patient, so is redundant in the 
PICU population, where the majority of patients are pre-or non-verbal.  With agitation 
being the manifestation of anxiety, the presence of both terms in SOS presents the 
opportunity of scoring a single behaviour twice, which implies a flaw in content validity.  
The rationale for using facial expression as a measure of anxiety in infants is also not 
provided.   
Table 11.2 Definitions of irritability and related terms (bold terms show overlap with 
other terms 
Term Definition 
Irritability 
(medical) 
“the state of being abnormally responsive to slight stimuli, or unduly 
sensitive” (Miller-Keane Encyclopedia and Dictionary of Medicine, Allied 
Health and Nursing, 7th ed, 2003, Saunders.)   
Irritability 
(paediatrics) 
the “over response by an infant to harmless stimuli; fussiness, whining, 
fretfulness, despite attempts to comfort and console by the caregiver, 
but not necessarily crying. (Overlaps with inconsolable.)   
Irritability 
(colloquial) 
“the quality of a tendency to being easily annoyed.” 
Agitation 
(medical) 
“the excessive, purposeless cognitive and motor activity or restlessness, 
usually associated with a state of tension or anxiety; the manifestation 
of anxiety.  Also called psychomotor agitation.” (Dorlands Medical 
Dictionary, 2007 Saunders).  
Agitation 
(colloquial) 
“a state of anxiety or nervous excitement.”  
Anxiety A symptoms, which may be manifested as agitation. 
Anxiety 
(Colloquial)  
 
“ants in pants, fidgeting, pacing, pulling of clothes” (McGraw-Hill Concise 
Medical Dictionary, 2002). (Overlaps with uncoordinated /repetitive 
movements.)   
 
11.5.2 Nurse perspective 
Nurse definitions of ‘irritability’ sometimes included features of ‘insomnia’ or ‘motor 
disturbance.’ One nurse used the term ‘irritated’ when defining ‘irritability’ (N1).  Nurses 
found anything less than severe irritability hard to score, due to not knowing the child’s 
normal behaviour (N9) and differed in their opinion as to whether intensity (N10) or 
duration of irritability (N4, 11) or consolability (N5,6,7) should guide the score.  
Differentiating between irritability as a sign of withdrawal or induced by clinical 
interventions or care was highlighted by two nurses (N2,3).  One nurse admitted to 
always scoring patients ‘1’ (N12), whilst another felt limited by the choice of only two 
intensity options (N3).   
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11.5.3 Parent perspective (recognition of irritability and other similar signs) 
Eighteen of 20 parents who completed questionnaires identified irritability in their child, 
which they gave a median (IQR) rating of 8 (7-10) for distress.  When interviewed, all but 
one parent described irritability, which manifested as a range of idiosyncratic behaviours 
(Table 11.3). 
Table 11.3 Parent descriptions of irritability (bold terms show overlap with other terms) 
Parent Irritability Other related terms 
1 Yes Tantrums, screaming. 
2 Yes moving arms about, reaching out to grab things (hallucinations), 
scratching and itching, restlessness. 
Not keeping still, constantly itching, scratching and thrashing his 
arms around 
3 Yes Moving head side to side, rubbing face and nose, lip smacking 
4 Yes Very jittery, not settling 
5 Yes Agitated, didn’t want to be touched 
6 Yes Kicking round a lot, wriggling round a lot 
7 No No 
8 Yes His tongue was wild, constantly out of his mouth, lip smacking 
9 Yes Swimming movements with arms, throwing arms about 
(hallucinations) 
10 Yes Restless, flapping movements, arms flapping, trying to move 
himself 
11 Yes Agitation, thrashing round the bed,  
 
11.5.4 Signs documented in nursing clinical records 
Irritability was the only behaviour that prompted nurses to document additional 
information for every patient in the study. In ten of these patients, nurses described the 
behaviour as ‘agitated’ (Table 11.4). 
11.5.5 Summary  
This is a complicated term due to the range of idiosyncratic behaviours described within 
one SWS sign. The high prevalence of the behaviour in the SWS audit again suggests that  
this is a ubiquitous behaviour in critically ill children, rather than having diagnostic value 
in identifying withdrawal. This inference was reinforced by the challenges nurses 
described in differentiating irritability due to illness (such as the patient subsequently 
diagnosed with a large ASD), withdrawal or other co-morbidities (purposeless actions and 
inconsolability also being features of pediatric delirium (Creten et al 2011).  The challenge 
of interpreting behaviours is also revealed in the patient who was described as  “very 
nosey” (P3), but who may have been more accurately described as ‘abnormally 
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responsive to slight stimuli’.  Whether there is any clinically relevant difference between 
the terms agitation and irritability in terms of withdrawal behaviour, is debatable, but the 
extensive use of the former term by nurses suggests irritability alone is insufficient to 
describe the patient’s state.   
Table 11.4 Nurse documentation of behaviour related to irritability 
Patient Nurse documentation related to irritability 
Pt 1 Jittery, restless, agitated, very unsettled. 
Pt 2 agitated 
Pt 3 agitated, unsettled 
very nosey, reacting to all noises on the ward   
Pt 4 agitated, restless but not irritable. 
Pt 5 very agitated with cares, very unsettled, hard to console (abnormal eye 
movements) 
Pt 6 very unsettled, very agitated, doesn’t like to be handled (then diagnosed with 
large ASD) 
Pt 7 very agitated, does not like to be disturbed 
Pt 8 extremely agitated, unsettled, restless, grizzly 
Pt 9 Agitated, restless. 
Pt 10 Does not like to be disturbed. 
Pt 11 Very unsettled, very agitated. 
 
 
11.6 Sweating 
Sweating, as a sign of withdrawal, occurs as a result of autonomic dysfunction and is one 
of six signs that occur in all three withdrawal tools.  In SOS, sweating is scored “if not 
caused by room temperature, clothing, swaddling etc.” 
In WAT-1, any sweating during the two minutes of pre-stimulus observation is scored. 
11.6.1 Nurse perspective 
Two nurses documented additional information under this sign describing one patient as 
‘clammy’ (Pt 3) and another as ‘sweating profusely’ (Pt 5). 
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11.6.2 Parent perspective 
Sweating was recognised by 14/20 parents and scored a median (IQR) rating of 5(4-17) for 
distress.  When interviewed, 9/11 parents described sweating (Table 11.5) and also 
raising the issue about this sign being typical of patients with cardiac conditions.   
Table 11.5 Parent descriptions of sweating. 
Parent Description of sweating 
P3 Beaded sweat across hairline and forehead 
P4 His head and hair get soaked (but sweating is part of underlying condition) 
P6 The back of his head was wet, very clammy for 24-48h. 
P8 His back and the back of his head, little beads on his forehead, face was wet 
and clammy. 
P10 Dripping with sweat (and tachycardic) 
 
11.6.3 Summary 
This sign may indicate withdrawal if sweating is not typical to the child. 
 
11.7 Tremor 
Tremor occurs as an item in SWS, SOS and WAT-1.  Tremor was one of three signs that 
showed the greatest difference in prevalence between the withdrawing and not 
withdrawing groups in the OBWS and SBOWC studies described in Chapter 5. 
In SOS, as an indication of central nervous system (CNS) irritability, tremor is defined as 
“slight, involuntary rhythmic of hands and/or feet, either spontaneously, or in response to 
environmental stimuli”.  In WAT-1, moderate or severe tremor is scored, whereas mild or 
intermittent tremor is not scored.   
11.7.1 Parent perspective 
Tremor was recognised by 12/20 parents and scored a median (IQR) rating of 8 (7-8.5) for 
distress.  When interviewed, 5/11 parents described tremor; their varied descriptions 
pointing to a range of disordered movement other than tremor (Table 11.6). This suggests 
that parents construed ‘tremor’ in a similar way to ‘irritability’ as an umbrella term to 
describe a range of behaviours, the aetiology and meaning of which, in terms of 
withdrawal, may vary.  Movement and muscle tone are regulated by the extrapyramidal 
system (EPS), of which the basal ganglia are the main nuclei.  Damage to the EPS or basal 
ganglia results in disordered movement known as dyskinesias. Tremor is one example of 
dyskinesia.  It appears that withdrawal may temporarily disrupt the function of the EPS or 
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basal ganglia, which is manifested as abnormal movement and/or muscle tone. P11 infers 
an overlap in perception or interpretation of abnormal movement and convulsions; it is 
not clear which behaviour this represented. 
Table 11.6 Parent descriptions of tremor 
Parent Description of tremor 
P4 Constantly shaking, arms are never still, like a really bad twitch, his legs and 
arms are going. For a couple of days he’s never still. 
P6  Jittery hands 
P10 Tremor-like movements, a shiver and a bit of shaking. 
P11 Really big shakes, like seizures or rigors. 
 
11.7.2 Summary 
SOS and WAT-1 score different intensities of tremor and parents described a range of 
movement disorders under this term.  This sign may be open to interpretation by nurses 
but was not investigated in this study. A broader umbrella term such as movement 
disorder, may better or more accurately represent the range of dyskinesias expressed by 
withdrawing children. 
 
11.8 Sneezing and yawning 
Sneezing occurs in two of the three tools: SWS and WAT-1.   
In WAT-1, more than one yawn or sneeze during the 2 minutes of pre-stimulus 
observation is scored, whereas only one sneeze or yawn is not scored.   
Yawning is due to hyperstimulation of the parasympathetic system.  
11.8.1 Parent sign 
Sneezing was recognised by 9/20 parents and had the lowest ranked score median (IQR) 
of 0 (0-3) for distress. It was also recognised by 6/11 interviewed parents, one of whom 
expressed frustration that this was typical of her child, but was being interpreted by 
nurses as a sign of withdrawal: 
“every day he has some sort of sneezing fit and he yawns all the time. The 
nurses said it was signs of withdrawal, but that’s just how he is.  I really 
know it’s nothing to do with that.” P8 
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11.8.2 Summary 
This sign does not cause distress but may indicate withdrawal if it differs from the child’s 
typical or baseline behaviour: this depends on parent input during the assessment. 
 
11.9 Diarrhoea  
Diarrhoea, as a sign of withdrawal, occurs as a result of autonomic dysfunction and is one 
of six signs that occur in all three withdrawal tools. 
In SOS, under gastrointestinal dysfunction, diarrhoea is defined as watery stool, not 
related to feeding changes, or when the result of breastfeeding.  In WAT-1, diarrhoea is 
defined as any loose or watery stool in the previous 12h. 
The underlying aetiology of each sign is an important part of better understanding 
withdrawal; it is not clear whether this is gastrointestinal or autonomic.  
11.9.1 Parent signs 
Diarrhoea was recognised by 13/20 parents and was scored a median (IQR) 5 (4-6) for 
distress.  During interview, 6/11 parents reported this sign, one of whom explained that 
the diarrhoea had started before weaning was commenced, which limited the diagnostic 
potential of the sign; “She had diarrhoea for 4 weeks before she came in” (P9). Another 
parent explained that their child was usually loose and wasn’t worse during withdrawal; 
“He always had sloppy-ish bowel movements, so I’m not sure if there was additional” 
(P10). 
11.9.2 Summary 
This sign may indicate withdrawal if other causes for diarrhoea can be discounted: this 
includes typical behaviour, which also depends on parent input during the assessment.   
 
11.10 Vomiting  
Vomiting, as a sign of withdrawal, occurs as a result of autonomic dysfunction and is one 
of six signs that occur in all three withdrawal tools.  It was also one of three signs that 
showed the greatest difference in prevalence between the withdrawing and not 
withdrawing groups in the OBWS and SBOWC studies described in Study 2 (Chapter 5).  In 
SOS, under gastrointestinal dysfunction, vomiting is scored if occurring at least once in 
the previous 4 hours, if not related to feeding changes.  In WAT-1, any vomiting, 
spontaneous retching or gagging in the previous 12 hours, is scored.  These two criteria, 
whilst enabling an objective assessment of the behaviour, present operational differences 
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in terms of frequency and intensity. Consequently the scoring threshold for WAT-1 is one 
vomit in 12 hours compared with a threshold for SOS of two vomits in 4 hours.  
11.10.1 Parent perspective 
Vomiting was recalled by 9/20 parents and was scored a median (IQR) 5 (3-7) for distress.  
11.10.2 Nurse perspective 
Only one additional description was documented in nursing records, which recorded Pt6 
as “gagging on the (endotracheal) tube”.  Gagging on the tube is indicative of under 
sedation rather than a sign of withdrawal. 
11.10.3 Summary 
This evidence does not indicate a cohesive presentation or aetiology for vomiting as a sign 
of withdrawal. Other causes and gagging as a sign of under sedation in the ventilated 
child, may further confuse the meaning of this behaviour. 
 
11.11 Fever  
Fever, as a sign of withdrawal, is one of six signs that occur in all three withdrawal tools. 
The child’s temperature is not specified in SWS.  In SOS, fever is scored for any 
temperature >38.4C in the previous 4 hours.  In WAT-1, fever is scored if the most 
frequent temperature is >37.8C in the previous 12 hours. In the OBWS study, 
temperature >37.2C was scored, which was very common in both withdrawing (82%) and 
not-withdrawing (68%) patients respectively (Franck et al 2004). The rationale for the 
differences in scoring thresholds is not clear.  
The rationale for including fever as a sign of withdrawal is also not clear.  Temperature 
dysregulation is a feature of autonomic instability.  The autonomic component of 
thermoregulation mediates responses such as shivering, sweating and vasoconstriction to 
maintain body temperature.  Fever on the other hand, is an immune defence, mediated 
by endogenous pathogens which increase the usual target body temperature (Sessler et 
al 2008).  Autonomic instability may manifest as regulatory responses such as shivering or 
sweating being triggered at normal body temperature, or the absence of such responses 
when hypothermic or hyperthermic respectively. 
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11.11.1 Parent perspective 
Fever was recalled by 6/20 parents and was scored a median (IQR) 6.5 (3-8) for distress.   
 
11.11.2 Summary 
Fever lacks a cohesive operational definition and the aetiology as a sign of withdrawal is 
unclear.   
 
11.12 High pitch cry/distress 
All tools score crying or distress, each using slightly different terminology; high pitch cry 
(SWS), inconsolable crying (SOS), grimacing (SOS) and awake/distressed in WAT-1. 
In SWS, high pitch cry is a sign of neurological impairment, which is susceptible to 
subjective interpretation by the assessing nurse.  In SOS, under CNS irritability, 
inconsolable crying is scored if the child cannot be consoled by parents by offering 
distraction e.g. pacifier, food, or game playing with older children. Silent crying is scored 
in intubated children. Grimacing, also under CNS irritability, is scored separately and 
defined as eyebrows contracted and lowered, nasolabial fold visible. This is another SOS 
sign which is redundant in part of the PICU population, as this is describing an infant-only 
parameter.  In WAT-1, ‘state’ is scored if the child is awake/ distressed during the two 
minute pre-stimulus observation and additionally, if time taken to settle after stimulus is 
more than two minutes.  
Inconsolability is a feature of both PD tools. In CAPD (Traube et al 2014), it is considered 
to reflect the DSM delirium domains of cognition, psychomotor activity and 
affect/distress. In psCAM-ICU (Smith et al 2016) it reflects the feature “disorganised 
brain.” 
11.12.1 Parent perspective 
High pitch cry was recalled by 6/20 parents and was scored a median (IQR) 8 (6-9) for 
distress.  The parent descriptions add a novel perspective in terms of aetiology (Table 
11.7). Three parents described a cry that struck them as different from their usual cry, but 
they were not describing a high pitch cry.  Their description of a different cry is supported 
by research that suggests that neurological deficits alter the baby’s control of their vocal 
cords, which results in changes in the cry acoustics (Reggiannini et al 2013).   
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Table 11.7 Parent descriptions of high pitch cry 
Parent  Description of high pitch cry 
P1 Constant cry-ey, moany, making a lot of noise. 
P6 Not a cry I’ve heard before, constant, his eyes looked sad. 
P8 Bit more prolonged, slightly different, a different tone and stayed at that tone. 
It was a weird cry. 
P9 Noises I’d never heard before in terms of pitch. 
P11 He had that phase when he was crying a lot and really upset. 
 
11.12.2 Nurse perspective 
Nurses documented behaviours synonymous with distress on four occasions (Table 11.8) 
Table 11.8 Nurse documentation of distress behaviours 
Patient Additional comments in nursing records. 
Pt 1 Very distressed, upset. 
Pt 2 wimpering 
Pt 3 moany 
Pt 8 grumpy 
 
11.12.3 Summary 
It is not clear that high pitch cry, inconsolable crying, grimacing and distress are linked 
concepts in terms of withdrawal.  The aetiologies for these overlapping signs include 
neurological, extrapyramidal, pain and emotion, all of which limit its usefulness as an 
indication of withdrawal assessment. 
Parents may be able to recognise neurological dysfunction by subtle changes in their 
baby’s cry, which would not be perceptible to clinicians. This sign may indicate a number 
of differential diagnoses, including withdrawal and pediatric delirium.   
 
11.13 Respiratory distress 
Respiratory function occurs in two of the three tools: SWS and SOS. In SOS, under 
autonomic dysfunction, tachypnoea is defined as a breathing rate, which exceeds 
baseline value by ≥15%. A baseline is hard to define in this cohort, who are usually 
admitted to hospital with breathing difficulties and may be intubated and mechanically 
ventilated. 
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11.13.1 Parent perspective 
Respiratory distress was recalled by 10/20 parents and was scored a median (IQR) 9 (8-9) 
for distress, which was the highest score for a withdrawal sign, apart from convulsions. 
11.13.2 Nurse perspective 
Differentiating between respiratory distress as a sign of withdrawal or the patient’s 
underlying condition was highlighted as a challenge by four nurses (N5,6,7,8).   One nurse 
admitted to always scoring patients ‘1’ (N12), whilst another felt limited by the choice of 
only two intensity options, particularly when accounting for the patient’s baseline (N2,3). 
Others gave a rationale for their severity scoring based on effort and duration of 
respiratory distress (N4,9,10,11). 
There are many causes for respiratory distress in the critically ill child: their underlying 
condition, an artefact of mechanical ventilation, failure to tolerate reducing ventilatory 
support or clinical deterioration (Van der Zwaan, 2012). 
11.13.3 Summary 
Tachypnoea, as a sign of autonomic dysfunction, is a possible sign of withdrawal 
syndrome.  However, there is no evidence to link the broader construct of respiratory 
distress with withdrawal. This sign also lacks diagnostic value in this critically ill population 
for whom respiratory distress is widespread and, unlike a putative diagnosis of 
withdrawal, requires immediate intervention and treatment. 
   
11.14 Hypertonicity 
Hypertonicity, as a sign of withdrawal, is one of six signs that occur in all three withdrawal 
tools.  In SOS, under CNS irritability, increased muscle tension is defined as clenched fists 
or tense, clenched toes.  In WAT-1, muscle tone is scored if tone is increased during the 
one-minute stimulus observation. 
11.14.1 Nurse perspective 
Nurses did not feel confident about the scoring of this behaviour, either in terms of 
identification or severity. In relation to children with behavioural abnormalities, two 
nurses described seeking the parents’ opinion (N1,7). Two nurses were unfamiliar with 
the term (N9,12).  
11.14.2 Parent perspective 
The descriptions offered by parents again shed light on the meaning of behaviours (Table 
11.9).  Some of these descriptions appear to describe other concepts. Two parents (P4 
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and P8) may be describing behaviour synonymous with ‘negativism’ (apparently 
motiveless resistance), which is a sign of catatonia (Esseveld et al 2013).  It is concerning 
that nurses appeared dismissive of one parent’s concerns that her son was having a 
seizure.  
 
Table 11.9 Parent descriptions of hypertonicity 
Parent Description of hypertonicity 
P3 …clench fists, bring them up to his face, very stiff joints and limbs and if you 
tried to relax them, it would be very difficult. 
P4 Lock his arms or legs straight or both. There would be no shifting him, you 
wouldn’t be able to move him until he was ready to be moved. Lasting a minute 
or two a few times a day. 
P8 When I was picking him up, trying to comfort him, it was his whole body, as if to 
say “you’re not doing anything to me.” He was holding his body in a stiff way. 
P11 He would be lying comfortably then you would see him legs extended, arms 
extended, shaking like children have seizures, like when he’s had a seizure 
before, but they come up and say “No, it’s sedation-related.” (Copied to 
convulsions) 
 
11.14.3 Summary 
This signs demonstrates the diverse behavioural interpretations that can be made by 
parents and nurses.  A clear definition is required to describe this behavioural 
manifestation of withdrawal and minimise the blurring of different conditions with similar 
presentations. 
 
11.15 Convulsions, startle to touch and muscle twitching 
This sign only occurs in SWS, although SOS includes muscle twitching and WAT-1 includes 
‘startle to touch’.  Muscle twitching is included within the definition of motor disturbance, 
as an element of CNS irritability.  During the one-minute stimulus observation in WAT-1, 
moderate or severe ‘startle to touch’ scores, whereas mild ‘startle to touch’ does not 
score.  
11.15.1 Parent perspective 
Convulsion was the least commonly recalled sign by parents but scored a maximum 
distress score of 10 on both occasions. During interview, one other parent described 
similar behaviours (Table 11.10), which was discounted as a convulsion by the nurse. 
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Table 11.10 Parent descriptions of convulsions 
Parent Description of convulsions 
P4 Twitchy, seizures (eyes in the back of his head, shaking, going stiff, respiration 
rate and pulse up) lasting a few seconds. 
P10 Quite jumpy, quite a violent movement on the right side of his body. It lasted a 
minute or 2 and tied in with his colour started to change, his heart rate went up 
and he vomited. His right shoulder started twitching.  
P11 He would be lying comfortably then you would see him legs extended, arms 
extended, shaking like children have seizures, like when he’s had a seizure 
before, but they come up and say “No, it’s sedation-related.” 
 
11.15.2 Nurse perspective 
Nurses documented signs on four occasions (Table 11.11) 
Table 11.11 Nurse documentation of behaviours synonymous with convulsions/ 
twitching 
Patient Additional comments from nursing records 
Pt 1 Jittery, severe twitching. 
Pt 3 Flickering eyes, twitching hand (also referred to jerky hand under movement 
disorder and fidgety hand), 5 min episode eye tracking, lip smacking. Fidgety 
movements in hand when unsettled. Groaning on handling, becoming stiff, cries 
and grimaces, 
Pt 5 Abnormal eye movements. Eye rolling. 
Pt 10 Eyes rolling back. 
 
11.15.3 Summary 
This sign appeared to be open to misinterpretation and it is not clear which of the 
different operationalisations in the withdrawal assessment tools best reflects withdrawal 
behaviour. 
 
11.16 Movement disorder 
This occurs as motor disturbance in SOS and uncoordinated/repetitive movement in 
WAT-1.  It was also one of three signs that showed the greatest difference in prevalence 
between the withdrawing and not withdrawing groups in the OBWS and SBOWC studies 
described in Chapter 5.  In SOS, under CNS irritability, motor disturbance, occurring either 
spontaneously or in response to environmental stimulus, is defined as either slight muscle 
jerks (involuntary, of forearms/lower legs, muscle twitching) or uncontrolled, robust 
movements (choreoathetosis of arms, legs and/or head).  In WAT-1, moderate or severe 
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uncoordinated/ repetitive movements are scored if occurring during the 2 minute pre-
stimulus observation.   
11.16.1 Parent perspective 
Movement disorders were recalled by seven parents during interview (Table 11.12). 
Table 11.12 Parent description of behaviours synonymous with movement disorder 
Parent Description of movement disorder 
P2, P3, 
P4, P8 
Lip smacking is a tic (sign of disruption to extrapyramidal system control). 
P1, P9 Swimming movements: Floating hand, bringing her arm up like backstroke. 
Sort of treading water, as if she was swimming with her hands, as if she was 
batting things away. It looked like there was something there and she was 
batting it away with her hand, or it was distressing her in some way. 
P1 Head twitch, Shaky (like Parkinson’s disease), jumping (sounds like myoclonus 
from description). 
P2 Restlessness, he just couldn’t rest  
P3 Head movements from left to right [ (head shaking no-no)], rubbing his face, 
rubbing his nose, twitchy, lip smacking, licking his lips, rubs his eyes, rubs his 
hands and wrists together, jerked movements of hands and arms. 
P4 (describing tremor) Lip smacking and moving his tongue around. Constantly 
shaking, arms are never still, like a really bad twitch, his legs and arms are 
going. For a couple of days he’s never still. 
P8 His tongue was wild, like it had a mind of his own. His tongue was just 
constantly out of his mouth, he was moving it so much. He couldn’t keep his 
dummy in his mouth (usually has it 24/7). Neurological symptoms include 
lingual-oral dyskinesias e.g., protrusion of the tongue. 
P10 Restless, flapping movements, arms flapping, trying to move himself  
 
11.16.2 Nurse perspective 
Nurses documented behaviours synonymous with movement disorders in four patients 
(Table 11.13). 
Table 11.13 Nurse documentation of movement disorder 
Patient Additional comments from nursing records 
Pt 1 Jittery, constantly rolling in the bed, shaky, jerky movements, arching 
back, writhing round the bed. 
Pt 2 Lip smacking, flaying around. 
Pt 3 Lip smacking, jerky movements in hands. 
Pt 5 Cycling arms and legs 
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11.16 3 Summary 
A number of the movements described in this section are defined as automatisms, which 
are non-purposeful, stereotyped and repetitive movements, which occur in complex 
partial seizures (Alarcon 2012). Oral automatisms include lip smacking and chewing; 
motor automatisms include cycling movements, swimming movements, right-to-left head 
rolling, rubbing the nose with fingers and yawning.   Some of these automatisms are 
described as archaic, or ancestral, which were linked to survival reflexes, such as walking 
or swimming (Alarcon 2012).  It is thought that myoclonic jerking as one such reflex to 
stop us falling out of a tree, or nest at the onset of sleep. This group of behaviours and 
their range of possible causes highlight the wide ranging disruption to neurotransmission 
and state regulation of withdrawal syndrome. 
 
11.17 Communication disturbance 
None of the withdrawal assessment tools include this sign, but most parents (8 of 11) 
described this behaviour in their child, half of whom ranked it as the most distressing 
feature.  The absence of this sign from SWS, SOS and WAT-1 is worthy of further 
consideration. SOS is based on signs and symptoms from the literature, within which 
communication disorders were described (Hughes 1994, Sury et al 1989) but this did not 
feature in SBOWC (Ista et al 2008).  SWS was based on the Neonatal Abstinence Tool 
(NAS) (Finnegan et al 1975) and a newborn population, for whom these elements of 
communication are developmentally inappropriate.   
Communication disturbance is one of the diagnostic criteria for delirium (DSM-5 2013) 
and is a feature in both PD tools.  In the CAPD tool (Traube et al 2014), “Does the child 
make eye contact with the care giver?” reflects the DSM domain of consciousness (DSM 
2013).  In the psCAM-ICU (Smith et al 2016), “No eye contact” reflects the delirium 
feature of ‘inattention’ and “Unawareness of surroundings” reflects ‘disorganised brain.’  
If however, inattention is a fundamental sign of delirium (Smith et al 2016) it is difficult to 
determine whether the communication disorder described in the literature (Hughes 
1994) and by these parents is a sign of withdrawal, a sign of delirium, or both. It is not 
clear whether evidence exists in terms of onset, duration and treatment of 
communication disorders to support its place as a sign of withdrawal and/or delirium. 
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11.17.1 Parent perspective 
Seven parents recalled communication disturbances (Table 11.14) 
Table 11.14 Parent description of communication disturbances 
Parent Description of communication disturbance 
P1 Not recognising me/nothing there 
P2 Not engaging, not focussing on anything, looking vacant 
P3  No recognition, no communication 
P5 Had his eyes open but looking through you 
P6 Staring off past me, glazed look. 
P9 There was nothing coming back, she didn’t know who I was, she was a blank 
canvas. 
P11 Eyes pinned open constantly, but he wasn’t there, he didn’t respond when I was 
talking to him. 
 
11.17.2 Nurse perspective 
Only one nurse documented signs of communication disturbances, which related to P3 
who was noted as “not fixing or following.” This patient was subsequently diagnosed with 
neurological impairment. 
11.17 3 Summary 
There is insufficient evidence from the sign synthesis or the literature to determine 
whether communication disturbance is a feature of withdrawal and delirium, or just 
delirium. 
 
 
11.18 Hallucinations 
Hallucinations are perceptual disturbances (DSM-5 2013). This sign features in one 
withdrawal assessment tool (SOS) but is also one of the diagnostic criteria for delirium 
(DSM-5 2013). 
11.18.1 Parent perspective 
Four parents recalled behaviours that they interpreted as hallucinations (Table 11.16). 
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Table 11.16 Parent recall of hallucinations 
Parent Description of hallucination 
P1 Swimming with mermaids, dropped in the water with no arm bands. 
P2 Reaching out, like there was something there that he was trying to grab. 
P9 Sort of treading water, as if she was swimming with her hands, as if she was 
batting things away. It looked like there was something there and she was 
batting it away with her hand, or it was distressing her in some way. (copied 
to movement disorder too) 
P11 Sometimes he’d lie there and have a little giggle. I don’t know what it was. 
 
11.18.2 Summary 
Hallucination is another challenging item, because this item relies on patient report and 
most patients on PICU are non-verbal. Pt 1 was old enough to describe her hallucinations 
to her mother at a later stage in her recovery.  Relying on a behavioural interpretation 
may be inaccurate.  Perceptual disturbances are also a signs of Pediatric delirium (Traube 
et al 2014).  Patient reported symptoms should be avoided given the very young age of 
the patient population in PICU. 
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11.19 Summary synthesis  
Each of the four perspectives of withdrawal signs presented in this thesis; nurse objective, 
nurse subjective, parent objective and parent subjective, contributed a different view of 
these equivocal signs and added a layer of complexity that highlighted the challenge of 
interpreting these signs and behaviours.  In the absence of definitive signs of withdrawal, 
clinical utility of each sign depends on a shared recognition, understanding and meaning.  
The data from this synthesis have been drawn together to demonstrate to what extent 
there is agreement in operational definition between the withdrawal assessment tools 
and evidence of agreement in observer interpretation, from this synthesis (Table 11.18).   
Table 11.18 Agreement in definition and interpretation of signs identified by parents 
 Agreement in 
operational definition 
SWS/ WAT-1/ SOS 
Agreement in  
observer 
interpretation 
May indicate 
other differential 
diagnoses 
Insomnia    
Irritability 
Agitation 
Anxiety 
   
Sweating    (P) 
Tremor    
Sneezing and yawning    (P) 
Diarrhoea    
Vomiting    
Fever    
High pitch cry Distress    (P) 
Respiratory distress    
Hypertonicity    (P) 
Convulsion 
Startle, 
Twitching 
   (P) 
Movement disorder    
Communication 
disturbances 
   (P) 
Hallucinations    
Yes        No   (P) parent perspective may aid interpretation 
 
Signs which showed both a clear operational definition and agreement in observer 
interpretation were sweating, sneezing and yawning, diarrhoea and vomiting. Six signs 
also showed potential to be more easily interpreted by parents than nurses; these were 
sweating, sneezing and yawning, cry, hypertonicity, convulsion/twitch and 
communication disturbances.  A clearer definition may improve interpretation and  
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be more indicative of withdrawal in the cases of insomnia (complete absence of sleep 
rather than sleep disruption) and movement disorder (distinct behaviours).  
Signs such as irritability, agitation, fever and respiratory distress are highly prevalent in 
PICU patients. These signs do not differentiate withdrawal from other differential 
diagnoses and their presence may indicate deterioration and should prompt a medical 
review.  Two signs; irritability and communication disturbance, overlap with the 
diagnostic criteria of pediatric delirium (PD).  It is not clear whether this overlap is due to 
the co-existence of withdrawal and PD, or to inaccurate diagnoses of these conditions in 
the studies in this thesis and in the literature. The inclusion of signs in a withdrawal 
assessment, which are highly prevalent in PICU patients and/or indicative of deterioration 
and/or PD may bias decision-making, increasing the likelihood of cognitive error and a 
false positive diagnosis of withdrawal.  
11.19.1 The theoretical link between withdrawal syndrome and signs of 
withdrawal 
There are a wider range of signs of withdrawal than can be contained in one withdrawal 
assessment tool. This synthesis has shown that different interpretations of behaviours are 
possible; blurring of boundaries between some signs occurred with parent descriptions 
and formal definitions, similarly to the nurse interview findings in Study 3.  
The W-CAT focuses on the shared diagnostic features of withdrawal, rather than the 
heterogeneous presentation.  Whilst recognition of behavioural signs of withdrawal is a 
necessary component of a withdrawal assessment, the existing focus on identifying and 
summing behaviours may be less useful and more burdensome than a consideration of 
the impact of the behaviours on the child.  A focus on the impact of behaviours, rather on 
the inconsistent, unique and equivocal presentation of withdrawal, may provide a clearer 
indication of the clinical need to intervene with rescue medication or slowing the weaning 
rate. 
11.20 Conclusion 
Integration of the multiple sources of data presented in Studies 1 to 6 regarding the 
manifestation of withdrawal syndrome demonstrated differences in both the 
characterisation of withdrawal by the assessment tools and the potential for differences 
in interpretation of behaviours, which both limit clinical utility. 
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The sign synthesis did not identify a combination of signs that supports withdrawal 
assessment. Neither was a logically derived relationship between the concept of 
withdrawal and the signs of withdrawal identified.  No evidence was identified to support 
the specific combination of signs in any of the three existing withdrawal assessment tools; 
SWS (Cunliffe et al 2004), WAT-1 (Franck et al 2008) or SOS (Ista et al 2009). The lack of 
evidence underpinning the existing approach reinforces the consideration of a different 
approach.  The W-CAT, with a focus on shared features of withdrawal may offer an 
alternative approach, which also acknowledges the possibility of other causes for the 
behaviours. 
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Chapter 12: Conclusions, original contribution to knowledge 
and implications for practice and policy. 
 
12.1 Overview of conclusions 
The propositional model presented in Chapter 2 and expanded upon in response to the 
findings of Studies 1-6 of this thesis provided the framework for exploring the theoretical 
basis for withdrawal. The development of the model, in response to the literature review 
and findings from Studies 1-3 in Part 2 of the thesis, highlighted what is not known about 
withdrawal.  Withdrawal syndrome lacked a definitive name, a definition and diagnostic 
criteria; risk factors for withdrawal were confused with those for physical dependence, 
possibly because physical dependence and its variable onset in critically ill children are 
also poorly understood. Studies 1-3 also highlighted the contextual complexity within 
which withdrawal assessments are performed; children may be weaning from more than 
one sedative agent and other differential diagnoses are common and share similarities in 
their behavioural presentation with withdrawal.   
Study 4 in this thesis is the first study to consider the nurses’ perspective of withdrawal 
assessment, investigating how the decision-making stages of clinical reasoning aligned 
with different aspects of the withdrawal assessment. The findings illuminated the 
potential chances for cognitive error and also revealed the complexity of the context 
within which withdrawal occurs.  The existing approach to withdrawal assessment does 
not support decision-making, as the focus of cognitive effort is on the identification and 
interpretation of ambiguous behaviours rather than on the core features of withdrawal.  
Studies 5 and 6 in this thesis are the first studies to consider the parents’ perspective of 
withdrawal assessment.  The findings revealed that parents recalled a broader range of 
withdrawal signs than feature in the existing withdrawal assessment tools and that these 
signs were a cause of distress for parents. Parents’ preference for an active role in 
withdrawal assessment contrasted with their mostly passive role during their child’s 
critical illness.  The benefits of a reciprocal parent – nurse relationship for withdrawal 
assessment were proposed.  The nurse would benefit from parents’ perception of their 
child’s behaviour changes whilst parents benefit from active participation in care and 
being kept informed of their child’s condition. 
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The main contributions of the studies in this thesis arise from recognition of the 
complexity that surrounds the withdrawing child.  The context of the child includes the 
importance of knowing the child’s usual behaviour and the recent trend in behaviours to 
interpret the current behaviours.  The theoretical proposition is that withdrawing patients 
share diagnostic criteria, rather than a specific presentation in common. This proposition 
challenges the existing approach to withdrawal assessment, which relies on a 
homogeneous presentation. 
The synthesis chapters (Chapters 10 and 11) of the thesis sought to illuminate the 
theoretical relationship between physical dependence and withdrawal and between 
withdrawal and the signs of withdrawal; relationships which would underpin the 
construct validity of the existing withdrawal assessment tools; SWS (Cunliffe et al 2004), 
WAT-1 (Franck et al 2008) and SOS (Ista et al 2009).  Identifying these relational links 
provides a basis for improving assessment of withdrawal and delineating withdrawal from 
PD and other competing causes. 
The retrospective utility of the Withdrawal Causality Assessment Tool (W-CAT) was 
identified in Chapter 10. The emerging clinical utility of W-CAT is further strengthened by 
evidence of the operationalisation of the relational links presented in the propositional 
model to the diagnostic criteria of W-CAT (Table 12.1 and Figure 12.1).  The diagnostic 
criteria form the new defining criteria for paediatric withdrawal syndrome (PWS); a term 
which defines the unique features of physical dependence and withdrawal in this group of 
critically ill patients. 
Table 12.1 The Withdrawal-Causality Assessment Tool (W-CAT) 
Withdrawal 
likelihood 
Physical dependence 
possible 
Temporal relationship 
with change in dose 
Absence of 
differential diagnoses 
Probable Yes Yes Yes 
Possible Yes Yes No 
Unlikely No No No 
 
The sign synthesis in Chapter 11 did not identify a combination of signs that supports 
withdrawal assessment. Neither was a logically derived relationship between the concept 
of withdrawal and the signs of withdrawal identified.  Further research is needed to 
examine the overlap of behavioural signs of withdrawal and PD and to explore the nature 
of the relationship between these syndromes. Further research is also needed to identify 
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how clinical reasoning can be supported to distinguish the different co-existing causes of 
behavioural distress in critically ill children. 
The existing withdrawal assessment tools provide a structured assessment of withdrawal 
albeit in the absence of a theoretical basis to underpin the superiority of any one 
approach. Until such theoretical support is established, the propositional model supports 
the use of any of these tools, in partnership with the W-CAT criteria. 
 
 
Figure 12.1 Propositional model incorporating co-existence of Paediatric Withdrawal 
Syndrome (PWS) and other causes   
 
Paediatric withdrawal syndrome (PWS) has been introduced in this thesis as a term to 
describe withdrawal in critically ill children.  Diagnostic criteria for the likelihood of 
paediatric withdrawal syndrome are shown in Table 12.1.   
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Table 12.2 Diagnostic criteria of Paediatric Withdrawal Syndrome (PWS) 
Criterion A A change in behaviour causing distress or impacting on the child’s clinical 
condition which develop after stopping or reducing one or more sedative 
or analgesic infusions, or regular medications, which have been 
administered for at least four days. 
Criterion B Withdrawal signs develop within minutes to two days after Criterion A. 
Criterion C The behavioural signs are not due to the critical illness or deterioration and 
are not better explained by another medical condition or drug effect e.g 
pediatric delirium, adverse drug reactions. 
Criterion D Behaviours improve when the drug is restarted or increased to the 
previously tolerated dose, if clinically indicated. 
 
12.2 Summary of original contributions to knowledge 
 A conceptual framework demonstrating how the nurse and parent perspectives 
have contributed to a greater understanding of the challenges inherent in a 
withdrawal assessment in a child recovering from critical illness. 
 A propositional model that maps the links between sedation, physical dependence 
and withdrawal syndrome and provides an evaluative framework for withdrawal 
studies. 
 A formal definition and diagnostic criteria for paediatric withdrawal syndrome 
(PWS). 
 Diagnosis of withdrawal described in terms of probability (unlikely, possible, 
probable) to reflect the complexity of the context and the potential co-existence 
with other diagnoses, which may influence treatment decisions.  
 
12.3 Implications for practice and policy 
The propositional model identified the current knowledge gaps and provides a framework 
upon which future research on paediatric withdrawal syndrome can be based. 
Adoption of agreed diagnostic criteria for paediatric withdrawal syndrome will increase 
the generalisability of studies examining sedation weaning and withdrawal assessment. 
The W-CAT provides diagnostic criteria which, after formal evaluation, should be 
implemented into the clinical practice of sedation withdrawal assessment. 
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The relational link between physical dependence and withdrawal proposes that the 
incidence and severity of withdrawal may be moderated by considering ways to minimise 
the risk of physical dependence. 
 
12.4 Dissemination strategy 
The following dissemination strategies will be considered regarding the practical 
implications of the studies in this thesis.  
12.4.1 Publication plan 
One study (Study 4) has been published in the peer reviewed Journal of Advanced 
Nursing, which has an impact factor of 1.998.  A paper presenting the findings of Study 6 
will be submitted to the forthcoming special issue of Intensive and Critical Care Nursing 
on Family Centred Care in the ICU.  Further papers addressing the propositional model 
and the indistinct characterisation of withdrawal will be submitted to peer reviewed 
journals within six months of completing the PhD.   
12.4.2 Presentation strategy 
Implications of the clinical findings from the studies in this thesis will be presented firstly 
to the pain service (the clinical service that manages withdrawal assessment) at the 
hospital where this research took place.  The multidisciplinary team will debate potential 
changes to our existing approach to withdrawal assessment.  Guidelines will be written or 
adapted to reflect changes and will be highlighted to clinical teams with a presentation at 
the hospital’s “Grand Round.” 
Implications of the findings from Study 4 focus on clinical reasoning.  Improving 
awareness of System 1 intuitive thinking and System 2 deliberate thought will be 
implemented through the use of vignettes in in-house pain training for clinical staff.  
Discussion with clinical educators will take place to consider how clinical reasoning may 
be education programmes for nursing students. 
Presentation at an international level will be include submitting abstracts to the 7th 
Congress of the European Academy of Pediatric Societies (EAPS) meeting in October 
2018.   
 
 
 
 
 291 | P a g e  
 
12.5 Recommendations for future research 
Recommendations for future research include; 
I. Devising and prospectively evaluating the safety and efficacy of a paediatric 
withdrawal syndrome assessment based on W-CAT criteria, considering the clinical 
utility from the nurse perspective and the efficacy, acceptability and 
operationalisation of parent participation, from the nurse and parent 
perspectives.  
II. Investigating ways to reduce the incidence of withdrawal by examining the risk 
factors for physical dependence, including peak doses of sedative drugs and 
duration of treatment, and the impact of different approaches to weaning 
sedative drugs. 
III. Examining the experiences of withdrawal in critically ill children aged five years 
and older. 
IV. Exploring how nurses and parents differentiate between withdrawal and delirium 
in critically ill children. 
 
12.6 Conclusion 
The mixed methods studies in this thesis permitted the complexity of the child and 
context to be illuminated rather than concealed.  The level of complexity presents 
challenges for the existing approach.  The studies in this thesis present a new approach, 
which incorporates diagnostic criteria, the likelihood of withdrawal and justification for 
parents’ participation in withdrawal assessment. 
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Appendix 1: The Sedation Withdrawal Score (SWS) (Cunliffe et al 2004) 
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Appendix 2: The State Behavioural Scale (SBS) (Curley et al 
2006) 
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Appendix 3: Withdrawal Assessment Tool – 1 (Franck et al 
2008) 
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Appendix 4: The Sophia Observation Scale (SOS) (Ista et al 
2009)  
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